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Abstract
Monitoring clinical outcomes across healthcare providers is increasingly important in
the UK National Health Service. Neonatal care is no exception, but care is centralised,
so is delivered via co-ordinated networks of neonatal units (NNUs), with sicker infants
treated in larger centres. This results in frequent transfers, but it is unclear how to
attribute outcomes of transferred infants. Hierarchical regression is recommended for
assessing performance of healthcare providers, but existing studies have either excluded
transferred patients or assigned them to a single provider. In this thesis, hierarchical
Bayesian multiple membership (MM) models are used to evaluate NNU mortality of
very preterm infants, attributing outcomes to all NNUs providing care.
Data for all singleton infants born 2011-2013 below 32 weeks gestation and admitted
to neonatal care in England are obtained from the National Neonatal Research Database.
Using established methods, a series of Bayesian hierarchical models with two (infants
within NNUs) and three levels (infants within NNUs within networks) are developed for
non-transferred infants. This approach is extended to include transferred infants using
MM models. A variety of weightings, some speciﬁed using Beta distributions, are used
to allocate outcomes of transferred infants. In contrast to other applications of MM
models, results diﬀer across weightings due to transfer patterns. The recommendation
is that transferred patients are allocated equally to all providers, regardless of duration
or intensity of care, accompanied by sensitivity analyses using alternative weights.
Methodologically, this thesis demonstrates a statistically principled way of account-
ing for transfers when evaluating provider-speciﬁc outcomes, and presents a new appli-
cation of MM models with novel weightings. Clinically, the variation attributable to
providers is low, and for each NNU an estimate of risk-adjusted mortality compared
with similar NNUs is obtained. Practical implications extend beyond neonatal medicine
as centralisation and electronic patient data become integral to improving healthcare.
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Chapter 1
Introduction
Whilst most babies are born healthy, some are born too early or with a condition requir-
ing specialist medical attention in a neonatal unit (NNU1). In the UK, neonatal care
is centralised, so intensive care is not available at every site and infants are frequently
transferred. This poses challenges regarding assessment of clinical outcomes across in-
dividual NNUs as it is not clear to how to attribute outcomes of transferred infants.
Another aspect of centralised care is that neonatal units do not work independently of
each other, but rather in co-ordinated groups known as neonatal networks. Thus there
is a three level structure to the data: infants within NNUs within networks. Hierar-
chical models are a class of statistical model that is typically used for such structured
data, and also for evaluating outcomes across healthcare providers. The aim of this
thesis is to address the statistical issues posed by centralisation within the framework
of hierarchical models in the context of measuring mortality of preterm infants across
neonatal units in England, using data extracted from electronic patient records held in
the National Neonatal Research Database (NNRD).
In this chapter I present some context and motivation for the research questions of
this thesis. I give a background to preterm birth, describe the structure of neonatal
care in England and introduce key concepts in provider proﬁling, before describing the
research question in more detail and giving an outline for the rest of the thesis.
1The abbreviation used here is the convention in neonatal care
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1.1 Preterm birth
1.1.1 Deﬁnitions, incidence and trends
Preterm birth is deﬁned as birth at less than 37+0 weeks+days gestation, with full term
birth being 37+0 to 42+0 (40+0 weeks+days being the estimated due date). Preterm
infants are often categorised as extremely preterm (less than 28+0 weeks+days), very
preterm (28+0 to 31+6), moderately preterm (32+0 to 33+6) and late preterm (34+0 to
36+6)2(Blencowe et al., 2012). Preterm birth can occur spontaneously, or because risks
to the fetus and/or the mother prompt a clinical decision to deliver early (medically
indicated preterm birth).
International estimates of the preterm birth rate range from 5% to 18% of livebirths,
with higher rates in low-income countries (Blencowe et al., 2012). Within Europe, the
preterm birth rate varies from 5% to 10% of livebirths (Gissler and Mohangoo, 2010). In
England and Wales between 2007 and 2013, 7.2% of livebirths of known gestational age
were preterm (Oﬃce of National Statistics, 2014). Figure 1.1 shows the distribution of
births by gestational age based on Oﬃce of National Statistics (ONS) data on livebirths
in England and Wales. As the numbers born preterm are low, particularly less than 32
weeks gestation, I have shown the distribution over all births, all preterm births and all
very preterm birth separately.
Globally, there has been an increase in the preterm birth rate in recent decades
(Blencowe et al., 2012), though trends are not uniform (Zeitlin et al., 2013). In high-
income countries, increased use of fertility treatments and advanced maternal age have
led to higher multiple pregnancy rates, and multiple births are ﬁve to ten times more
likely to be delivered preterm compared with singletons (Blondel et al., 2002; Zeitlin
et al., 2013). This may be a key driver for the increasing preterm birth rate in some
areas: in half the countries in the Euro-Peristat project the preterm birth rate amongst
singletons remained stable or declined despite overall increases (Zeitlin et al., 2013).
Some of the increase in preterm birth may be driven by higher rates of medically indi-
cated late and moderate preterm birth, due to improved risk assessment and timely di-
agnosis of disorders in both mother and baby (Goldenberg et al., 2008; Shapiro-Mendoza
and Lackritz, 2012). In some countries there is evidence that the preterm birth rate is
slowing down and even declining, albeit slightly (for example the USA (Child Trends
Databank, 2015), Finland (Jakobsson et al., 2008) and the Netherlands (Schaaf et al.,
2011)). Nevertheless, increases in overall fertility mean that the absolute number of
preterm births continues to increase (Department of Health, 2009; Goldenberg et al.,
2008; Saigal and Doyle, 2008).
2Henceforth I will express the units as weeks only, with no superscript being shorthand for zero days
(so 31+6 weeks+days will be written as 31+6 weeks and 31+0 weeks+days will be written as 31 weeks)
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Figure 1.1: Percentage of all livebirths (blue), all preterm livebirths (orange) and all
very preterm livebirths (grey) born at each week of gestation, England and Wales 2007-
2013. Data from the Oﬃce for National Statistics licensed under the Open Government
Licence v.3.0.
1.1.2 Risk factors for preterm birth
The aetiology of spontaneous preterm birth is not fully understood, but it is thought
to be a syndrome induced by infection or inﬂammation, stress, and other immunologi-
cally mediated processes (Goldenberg et al., 2008). While there are known clinical risk
factors such as family history, maternal hypertension and short interpregnancy interval
(Blencowe et al., 2012; Goldenberg et al., 2008) the causal mechanisms linking these fac-
tors to preterm birth remain somewhat unclear, and it is therefore diﬃcult to attribute
preterm birth to the various potential causes. A number of sociodemographic factors
are associated with preterm birth such as stress, smoking, maternal age and ethnicity.
These are also linked to deprivation, leading to higher rates of preterm delivery in more
deprived areas (Gray and McCormick, 2009; Kramer et al., 2001).
Other risk factors include medical indications for early delivery such as pre-eclampsia
and HELLP syndrome (maternal conditions related to hypertension), growth restriction
in the fetus and placental problems. The deﬁnitions of “indicated” and “spontaneous”
are not consistently applied, nor are the medical indications for early delivery always
clear, rendering classiﬁcation diﬃcult (Goldenberg and Gravett, 2012).
As mentioned previously, multiple birth can lead to preterm delivery, both sponta-
neous and medically indicated. In England in 2013, 24% of infants born preterm were
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from a multiple pregnancy, in contrast with 1.5% of term births (Oﬃce of National
Statistics, 2014). There is some indication that singletons and multiples have a diﬀerent
distribution of gestational age, and possibly a diﬀerent “optimal” gestation at around
38 weeks (Buekens and Wilcox, 1993; Kiely, 1998; Minakami and Sato, 1996). Reasons
for indicated early delivery may diﬀer between multiples and singletons (Gardner et al.,
1995). Therefore the mechanisms resulting in early delivery of multiple births are not
the same as those for singletons.
1.1.3 Consequences of preterm birth
When infants are born too early their organs, in particular the brain and lungs, are
insuﬃciently developed and not ready for life outside the womb. This has a number of
short and long term health consequences.
Mortality
Globally, preterm birth is responsible for over a third of neonatal deaths (deﬁned as
death within 28 days of birth). The inﬂuence of preterm birth extends into childhood,
and it is the second most common cause of death amongst children under 5 (World
Health Organization, 2012). Infants born preterm have a much higher risk of mortality
than their term-born counterparts, and the causes of death are quite diﬀerent, with
respiratory problems and ventricular haemorrhage being the main factors in preterms
(Sidebotham et al., 2014). The mortality diﬀerence decreases with increasing gestational
age, though an additional risk persists even for late preterms. Figure 1.2 shows neonatal
deaths by gestational age based on ONS data for England and Wales 2007 to 2013, both
as numbers and as a percentage of all live births at that gestational age week. Although
ﬁgure 1.1 showed that birth at or below 32 weeks gestation is rare, hovering at just above
1% for the past few years in England and Wales, this gestational age group represent
the majority of neonatal deaths with a mortality rate of 12.1%.
Mortality of preterm infants varies widely globally: the risk of neonatal death is 12
times higher for an infant born preterm in Africa compared with Europe (World Health
Organization, 2012). Even within high income countries there is considerable variation.
MacDorman et al. (2014) compared data from the US and Europe using three sources
(US Vital Statistics, the Organisation for Economic Co-operation and Development
database and the European Perinatal Health Report) and found that infant mortality
(death within 1 year) varied for births between 24-27 weeks (16.5% in Sweden to 42.9%
in Poland) and 28-31 weeks (3.4% in Austria to 9.9% in Poland). However, variations in
stillbirth deﬁnition and resuscitation of infants at the limits of viability, amongst other
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Figure 1.2: Number (blue) and percentage (orange) of neonatal deaths by week of
gestation, for all livebirths in England and Wales 2007-2013. Adapted from data from
the Oﬃce for National Statistics licensed under the Open Government Licence v.3.0.
factors, limit the utility of such comparisons (Draper et al., 2009; Joseph et al., 2012).
In previous decades there have been a number of signiﬁcant medical advances leading
to substantial reductions in mortality of preterm infants. In 1975 half of all liveborn
preterm infants with a birth weight less than 1500g died, but by 1985 this had reduced to
a quarter, and to a sixth by 1995 (National Audit Oﬃce, 2007). Lung immaturity is one
of the most severe consequences of preterm birth and is a major contributing factor to
mortality of preterm infants. Surfactant is a substance which lines the alveoli (air sacs)
where oxygen is transferred into the blood and carbon dioxide is taken out. Without
it, there is too much surface tension, and with the pressure of exhalation the alveoli
collapse in on themselves, making inhalation diﬃcult. Surfactant occurs naturally in
the lungs, but the levels build up in the last trimester of pregnancy so infants born
preterm may not have suﬃcient quantities, resulting in respiratory distress syndrome.
Surfactant replacement, along with the provision of antenatal steroids to the mother to
accelerate fetal lung development, resulted in substantial reductions in mortality at the
end of the 20th century (Halliday, 2008).
More recent trends are not as dramatic as those seen in the 1980s and 1990s, but
there is evidence that mortality of preterm infants continues to decline in the UK, par-
ticularly for the earliest gestations. The EPICure studies, which examined short and
long term outcomes of extremely preterm infants in the UK, found a reduction in death
before discharge from 60% in 1995 to 47% in 2006 for infants born between 22+0 and
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25+6 weeks gestation (Costeloe et al., 2012). Improvements have also been observed
in population data from the US (Horbar et al., 2012; Patel et al., 2015), France (An-
cel et al., 2015) and Australia (Bolisetty et al., 2015). There have been a number of
strategies which may have contributed to further reductions in preterm mortality, in-
cluding centralisation of services (Costeloe et al., 2012). Centralisation involves shifting
services away from smaller providers to fewer, larger centres. The rationale for cen-
tralisation of neonatal care is that infants with the most complex needs have better
survival prospects at experienced, high-volume centres (Cifuentes et al., 2002; Lasswell
et al., 2010; Phibbs et al., 1996; Watson et al., 2014). It does not necessarily follow
that adopting a centralised service will result in improved outcomes for all, one reason
being that the increased burden on the larger centres may outweigh some of the ben-
eﬁt. Although there have been studies examining changes in survival before and after
centralisation (Binder et al., 2011; Neto, 2006) it is diﬃcult to attribute improvements
to centralisation policies as there are likely to have been other concurrent changes con-
tributing to the reductions (Gale et al., 2012b). The centralised structure of neonatal
services in the UK will be discussed further in section 1.2.
Other consequences
With survival of preterm infants improving, the sequelae for survivors are becoming
increasingly evident. Preterm birth can lead to neurodevelopmental impairment with
consequences for learning, behaviour and mental health in later life. Cerebral palsy is
often seen as a marker of intrapartum and neonatal care (Murphy et al., 1997; Saigal
and Doyle, 2008) and rates are higher in children born preterm; estimates from a meta-
analysis by Himpens et al. (2008) were 14.6% for extremely preterm and 6.2% for very
preterm, compared with 0.1% in term-born children. Cognitive and sensory impairments
are also higher following preterm birth (Saigal and Doyle, 2008).
While problems associated with lung maturation have been alleviated by steroids,
surfactant, and assisted ventilation, preterm infants remain susceptible to respiratory
problems. Bronchopulmonary dysplasia (BPD), which is associated with prolonged ven-
tilator use, aﬀects between 10% and 25% of very preterm infants and is often deﬁned
by the requirement for oxygen therapy, usually at 36 weeks postmenstrual age (Gortner
et al., 2011).
Necrotising enterocolitis (NEC) is a severe disease aﬀecting the gastrointestinal tract
which primarily aﬀects extremely preterm infants. In preliminary ﬁndings from the UK
Neonatal Collaborative NEC study, Battersby et al. (2014a) found 8% of infants born
23+0 to 25+6 weeks developed severe NEC requiring surgery, compared with 0.8% of
infants born 29+0 to 31+6 weeks with 40% of these infants dying before discharge from
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neonatal care. The rarity of the condition coupled with the lack of an agreed clinical
deﬁnition makes establishing preventative strategies through research diﬃcult.
As our understanding of the long-term consequences for preterm survivors has in-
creased, more attention has been paid to preventing preterm birth. The wide variety
of potential reasons for preterm birth combined with the lack of clinical understanding
of the causal mechanisms has made it a diﬃcult problem to tackle. While preventative
strategies are in use, such as tocolytic drugs to delay the onset of labour, these are
largely unsuccessful in improving clinical outcomes (Alﬁrevic, 2012; Zeitlin et al., 2013).
Until eﬀective interventions emerge, preterm birth is a public health issue which shows
no sign of abating.
1.2 Neonatal care
Neonatal care refers to specialist treatment in hospital that a newborn may require be-
yond routine postnatal care. Whilst most babies are born healthy, some are born too
early or with a condition requiring specialist medical attention in a neonatal unit. In
2014 there were over 86,000 admissions to neonatal specialist care in England represent-
ing 1 in 8 live births (Royal College of Paediatrics and Child Health, 2015). Preterm
birth and its associated sequelae account for around half of these admissions; other
reasons include low birth weight, congenital malformations and complications during
pregnancy and delivery. Neonatal medicine is a growing speciality. Increases in both
overall fertility and the rate of preterm birth have driven a rise in the number of babies
requiring admission to a neonatal unit (Department of Health, 2009; Goldenberg et al.,
2008; Saigal and Doyle, 2008). As discussed in section 1.1, improvements in medical
care have led to better chances of survival for babies born preterm. In particular the
proportion of infants born at the lower end of the gestational age range has increased
dramatically, along with their survival rates (Costeloe et al., 2012). This combination
of increased preterm admissions coupled with improved survival rates due to medical
and technological advances has led to escalating pressure on neonatal services (Depart-
ment of Health, 2009; Goldenberg et al., 2008; National Audit Oﬃce, 2007; Tucker and
McGuire, 2004).
One of the challenges of managing neonatal services is the heterogeneous needs of
the patient population. The type of care required can be grouped into three categories:
special care (SC), high dependency care (HDC) and intensive care (IC) using deﬁnitions
developed by British Association of Perinatal Medicine (BAPM)(2011)3. The category
of care (which is an integral part of determining resource use and funding for each NNU,
3A new version of these categories is to be published this year (2016) but is not yet in use, and will
not be retrospectively applied.
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see Department of Health (2009)) is determined daily by applying exact deﬁnitions based
on the procedures and treatments required each day. Below are the general principles
for the categories of care as given by the BAPM guidelines (2011, pp. 3-4):
Special Care Provided for babies who require additional care delivered by the
neonatal service but do not require either Intensive or High Dependency care.
Qualifying treatments/conditions include oxygen therapy via a nasal cannula, feeding
by nasogastric tube and phototherapy.
High Dependency Care Provided for babies who require highly skilled staﬀ but
where the ratio of nurse to patient is less than intensive care. Qualifying
treatments/conditions include non-invasive respiratory support, parenteral nutrition
and seizures.
Intensive Care Provided for babies who are the most unwell or unstable and have
the greatest needs in relation to staﬀ skills and staﬀ to patient ratios. Qualifying
treatments/conditions include mechanical ventilation, umbilical lines and any surgery.
In the event of death, the day of death is considered an intensive care day.
The staﬀ to patient ratios currently recommended by BAPM are 1:1 for intensive
care, 1:2 for high dependency care and 1:4 for special care (Department of Health, 2009).
While staﬃng shortages mean these are not always adhered to (Redshaw and Hamilton,
2005), each NNU should be working towards these standards as part of agreements with
service commissioners (Neonatal Critical Care Clinical Reference Group, 2015).
Neonatal intensive care is a particularly high-cost and low-volume speciality, so not
all types of care are available at every hospital with a maternity unit. Furthermore,
the need for neonatal specialist care is not always known prior to delivery, so postnatal
transfer is unavoidable in some cases. The category of care is dependent on treatment
received that day so a baby’s requirement can change over time, also leading to transfers.
I will examine types of transfer in more detail in section 1.2.2. Whatever the reason for
transfer, proper organisation of services is critical to ensure babies receive the care they
need close to home.
1.2.1 Restructuring of neonatal care into managed clinical networks
In response to the rise in both the size and complexity of care demands, the Department
of Health (DH) commissioned a review into the provision of neonatal specialist care in
2001. The working group published the resulting “National Strategy for Improvement”
in 2003 (Department of Health, 2003).
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The existing pattern of transfers was found to be unsatisfactory, with infants being
cared for far from home, so parents had to travel long distances or stay nearby. These
problems were exacerbated by limitations in capacity at the higher level NNUs. In
addition, there was an incoherence in the pattern of delivery of care, with a lack of
national standards to work to. DH recommended that care be provided within managed
clinical networks with the aim that transfers outside the network would be minimal,
and that communication and organisation within networks would improve, resulting in
improved transfer patterns. Their conclusions were in line with a number of studies
before and since, advocating centralisation of services by demonstrating that preterm or
low birth weight infants have better survival prospects at high volume NNUs (Cifuentes
et al., 2002; Lasswell et al., 2010; Phibbs et al., 1996; Watson et al., 2014). However
rather than simply closing smaller NNUs (as has been the case in some countries, see
Phibbs (2012)), DH proposed the networked model of care so as to maintain equity
of access and limit the burden of travelling for families of infants in neonatal care, as
transfers to more distant units would only be required for the sickest infants.
In 2007 the National Audit Oﬃce conducted a review of the reorganisation of neona-
tal services (National Audit Oﬃce, 2007). They examined how well the network struc-
ture had been established and whether it had resulted in improvements in how the
service functioned. They found varying degrees of success in establishing networks, but
reductions in long-distance transfers had been achieved. However there were still im-
provements to be made, including consistency in transfer arrangements across networks.
In response to this DH set up a Neonatal Taskforce, who issued the Neonatal Toolkit
(2009), which set forth eight principles to help guide commissioners and practitioners of
neonatal care, and provided further guidance on delivery of care under the networked
model.
To ensure that all services are available, the networks are comprised of diﬀerent types
of neonatal units providing diﬀerent types of care. These categories were redeﬁned in
the the Neonatal Toolkit as special care baby units 4, local neonatal units, and neonatal
intensive care units; however there is crossover between the types of units and the care
provided. The units are deﬁned as follows, taken from the Neonatal Toolkit (2009, p.
10):
Special care baby units (SCBUs) These provide special care for their own local
population. Depending on arrangements within their network, they may also provide
some high dependency services. In addition, SCBUs provide a stabilisation facility for
babies who need to be transferred to a NICU for intensive or high dependency care,
and they also receive transfers from other units in the network for continuing special
4The terminology has now changed to special care unit but the deﬁnitions for the duration of the
data used in this thesis are as given here.
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care.
Local neonatal units (LNUs) These provide neonatal care for their own catchment
population, except for the sickest babies. They provide all categories of neonatal care,
but they transfer babies who require complex or longer-term intensive care to a NICU,
as they are not staﬀed to provide longer-term intensive care. The majority of babies
over 27 weeks of gestation will usually receive their full care, including short periods of
intensive care, within their LNU. Some networks have agreed variations on this policy,
due to local requirements. Some LNUs provide high dependency care and short periods
of intensive care for their network population. LNUs may receive transfers from other
neonatal services in the network, if these fall within their agreed work pattern.
Neonatal intensive care units (NICUs) These provide the whole range of medical
neonatal care for their local population, along with additional care for babies and their
families referred from the network. Many NICUs in England are co-located with
neonatal surgery services and other specialised services.
In 2013 there were 179 NNUs in England and Wales across 24 networks (Royal
College of Paediatrics and Child Health, 2014). These networks have now been further
revised but in this thesis I will examine the managed clinical networks as this was the
main system in place for the duration of the data analysed (implications of the change
for future analysis will be discussion in chapter 9). The NNUs and networks are shown
in ﬁgure 1.3 and a list is given in appendix A. Note that the boundaries in ﬁgure 1.3
are approximated based on mother’s postcode as neonatal networks do not in general
have strict geographical boundaries.
1.2.2 Neonatal transfers
The change to a networked model of care has brought with it an increase in trans-
fers; indeed transfers and their organisation is seen as key aspect in how networks
operate (Redshaw and Hamilton, 2006). Comparison of transfer rates before and after
re-organisation, for infants born 27-28 weeks gestation, showed an increase from 25%
to 34% (Gale et al., 2012b), but changes have been inconsistent across regions (Cusack
et al., 2007; Kempley et al., 2006). National guidance from the NHS Neonatal Critical
Care Clinical Reference Group (2015) suggests that care should be provided by a NICU
when birth before 27 weeks gestation (28 for multiples) is anticipated, though there
may be local agreed variations. If preterm birth is medically indicated before labour
commences then delivery is arranged at a hospital with a NICU. Spontaneous deliveries
may involve a transfer if the mother presents at a SCBU or LNU, depending on the care
required. Transfer of infants requiring specialist care can either occur before birth (in-
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Figure 1.3: a) NNUs in England and Wales with red dots indicating NICUs, yellow for
LNUs and green for SCBUs. (Neonatal Data Analysis Unit, 2016), map data c© 2016
Google b) neonatal networks, with boundaries estimated based on area of residence of
the mother; data generating maps courtesy of the Neonatal Data Analysis Unit and the
North West London Collaboration for Leadership in Applied Health Research and Care
utero transfer) or after birth (postnatal transfer). In-utero transfer leads to improved
infant outcomes (Kolle´e et al., 1988; Lamont et al., 1983; Shlossman et al., 1997) but
is not feasible in all circumstances. If the need for specialist care is not known prior to
delivery then postnatal transfer is the only option. Even if the need is known at the
onset of labour (as is the case for extremely preterm infants), in-utero transfer may not
be possible due to the imminence of birth, the condition of the mother and baby, or lo-
gistical diﬃculties in ﬁnding a cot and arranging transport (Gale et al., 2012a; Kempley
et al., 2006).
Transfers can occur for several reasons. Although no oﬃcial classiﬁcation exists,Gill
et al. (2004, p. F221) summarise transfers as follows:
Acute Emergency transfer for more appropriate care
Specialist Non-emergency transfer for a specialist elective service such as surgery
Non-acute Transfer back to the local neonatal unit for step-down care
Capacity Transfer due to lack of space at current unit
The network system was set up to maximise the proportion of high-needs infants being
delivered at the appropriate location and to minimise inappropriate transfers (such as
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capacity and long-distance transfers) through improved co-ordination between NNUs.
There are conﬂicting reports as to whether these aims have been achieved. Gale et al.
(2012b) found that under networked care, 49% of infants born 27-28 weeks were delivered
at high-volume NNUs, in contrast to 18% beforehand. Kempley et al. (2006) found that
transfer times in the South-East of England had improved but this was in conjunction
with the introduction of a regional transfer service. It was accompanied by a decline in
in-utero transfers, echoed by Cusack et al. (2007), who in addition found that almost a
quarter of transfers were for inappropriate reasons. Neonatal networks are organised in
such a way that infants can, in general, receive all the care they require in one network.
This is not always the case (17% of all transfers are to a diﬀerent neonatal network, see
Royal College of Paediatrics and Child Health (2015)) but there are legitimate reasons
for this. The recommended transfer pathway may incorporate cross-network transfers
because the geographical distances are closer than those within the network, or due
to the patterns of clinical need in a region. If a mother delivers unexpectedly at a
location other than where she was booked to deliver (as is more likely to be the case
with spontaneous preterm births compared with term due to being unexpected), the
infant may be transferred across networks to receive care closer to home.
1.3 Provider proﬁling
Provider proﬁling refers to the estimation, assessment, and comparison of outcomes,
process measures and other performance indicators across multiple providers of public
services. Over the past few decades these types of analysis have proliferated both in the
UK and internationally (Bird et al., 2005; Burgess et al., 2000; Goldstein and Spiegel-
halter, 1996; Normand et al., 1997; Spiegelhalter et al., 2012). Increasing importance
is being placed on monitoring healthcare outcomes in the UK NHS, as evidenced by
the Department of Health (DH) White Paper (Department of Health, 2010). Neonatal
care is no exception: the Neonatal Toolkit (2009) recommended that measurement and
publication of clinical outcomes was a key element of providing high quality services.
Part of the surge in provider proﬁling, and particularly in placing results in the public
domain, is due to a the shift in the way public services operate, with an increased focus
on transparency, accountability and choice (Bird et al., 2005). For example, the NHS
Choices website allows members of the public to examine data on outcome measures such
as mortality, and process measures such as waiting times, for any NHS provider (NHS
Choices). Other purposes include examining the performance of individual providers,
comparing across diﬀerent providers, measuring overall variation, establishing suitable
performance targets, and identifying aberrant performance. Collecting and analysing
suitable data in a way which is appropriate for the purpose can be burdensome (Spiegel-
halter et al., 2012). Such analyses are often used by multiple stakeholders (patients
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and the general public, clincians, managers and policy-makers) and put to several of
the purposes previously described. However, as with any statistical analyses, provider
proﬁling studies are designed to estimate a speciﬁc quantity or test a speciﬁc hypothesis.
Thus a single analysis cannot usually serve multiple purposes adequately (Bird et al.,
2005), and the inferences we can draw depend on the assumptions and properties of
the methods used (Shahian and Normand, 2015; Shen and Louis, 1998). In chapter 4
I will consider what inferences are feasible within the conﬁnes of the data and analysis
methods used in this thesis.
1.3.1 Challenges in provider proﬁling
Provider proﬁling in healthcare is not a recent innovation. Florence Nightingale, while
better known by most for her nursing reforms, has been lauded by the statistical com-
munity for her meticulous data collection and novel graphical displays, illustrating vari-
ations across hospitals amongst other objectives (Kopf, 1916). As noted by Spiegelhalter
(1999), many of the challenges today were documented by Nightingale over 150 years
ago.
Case-mix diﬀerences
“. . . so many operations of such and such a nature, without reference to age,
sex or cause of the operation, followed by so many deaths, without reference
to age, sex or complications. Given these elements, divide the one by the
other, and you get the mortality. A statistical proceeding such as this can at
the best lead to very loose approximations.” Nightingale (1863, p. 171)
In order to make provider proﬁling analyses meaningful the signal (factors we are in-
terested in) needs to be identiﬁed separately from the noise (Lilford and Pronovost,
2010). Diﬀerences in case-mix (the age, sex and cause of the operation in Nightingale’s
case) represent a major source of noise. All else being equal, hospitals treating sicker
patients will have poorer outcomes. In order to draw fair comparisons across providers,
we need to control for patient characteristics Iezzoni (2003). We can never truly “level
the playing ﬁeld” as it is rarely possible to know about, let alone accurately measure and
control for, all case-mix variables. However we can minimise variation using statistical
techniques such as regression. Regression allows us to model a variable of interest (e.g.
the probability of death before discharge) as a function of diﬀerent variables (e.g. a
measure of illness severity at admission). This will be discussed further in chapter 3.
Misconception of “excess” deaths
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“It can convey but a very imperfect idea of the real state of the case. And
one thing is quite certain, it can lead to no practical result whatever, either
as regards the true causes of the mortality, or how these might be mitigated”
Nightingale (1863, p. 171)
If a provider has a higher mortality than is expected, these are often termed excess
deaths, and frequently interpreted as therefore being avoidable (Lilford and Pronovost,
2010). We can determine whether there are diﬀerences in mortality rates and we can
control for some case-mix diﬀerences. However we cannot understand (at least not from
routinely collected data) all the reasons why a death occurred or whether it could have
been prevented. Therefore if a provider has a high risk-adjusted mortality we cannot
conclude that this is because they are providing poor-quality care (Goldstein and Spiegel-
halter, 1996; Mohammed et al., 2009). This aspect is a source of notoriety of provider
proﬁling studies, with much debate surrounding the reliability of outlier detection, the
link between bad results and substandard care, and the utility of naming outliers as a
mechanism to drive improvement (Hofer et al., 1999; Lilford and Pronovost, 2010; Mar-
shall et al., 1998; Pitches et al., 2007). Large-scale epidemiological analysis should not
be seen as the ﬁnal word but rather a screening tool which prompts small-scale clinical
case review (Jones et al., 2008; Spiegelhalter, 1999), such as the conﬁdential enquiry
process in the UK (Manktelow et al., 2016). While potentially subjective, examination
of individual cases is generally required for a fuller understanding the circumstances
leading up to a death (Sidebotham et al., 2014).
Playing the system
“We have known incurable cases discharged from one hospital, to which the
deaths ought to have been accounted and received into another hospital, to
die there in a day or two after admission thereby lowering the mortality rate
of the ﬁrst at the expense of the second” Nightingale (1863, p. 171)
Though Nightingale’s example may seem extreme, similar actions have been observed
in more recent times. In a review of New York cardiac surgery proﬁling initiative,
Normand and Shahian (2007) documented ﬁndings from several studies where higher
risk patients (or those requiring higher-risk procedures) were referred elsewhere or even
refused treatment. More commonly, gaming occurs in the form of data entry, with
Green and Wintfeld (1995) ﬁnding that 41% of the apparent improvement in mortality
following coronary artery bypass graft could be explained by overstating risk factors and
the application of diﬀerent deﬁnitions. The choice of risk factors and data sources from
which they are obtained can have help reduce the risk of gaming; this will be discussed
in chapter 3.
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1.3.2 Hierarchical models for provider proﬁling
Regression models are often used as part of the risk-adjustment process (Iezzoni, 2003).
One of the assumptions behind regression is that all observations are independent, condi-
tional on model covariates. This is not the case for provider proﬁling as patients who are
treated by the same provider are likely to have similar outcomes; in fact the inﬂuence of
a provider on the outcome is the very thing we are interested in. Ignoring the structure
of the data by assuming independence leads to standard errors which are underestimated
for provider-level variables, and overestimated for patient-level variables (Rabe-Hesketh
and Skrondal, 2005). We could include a variable to estimate an independent eﬀect for
each provider (called a ﬁxed eﬀects model)but this is not feasible when there are many
providers, and may mean that small providers with only a few observations have to be
excluded. Hierarchical models speciﬁcally model the eﬀect of the cluster (in this case the
provider) on the outcome, but rather than have each provider eﬀect being independent
(equivalent to the ﬁxed eﬀects model) we assume that provider eﬀects are linked with a
common distribution. How we specify the structure of the model and what factors we
adjust for is driven by the purposes of the model, and hence the inferences we wish to
make about providers. I will describe hierarchical modelling in more detail in chapter 4
along with its advantages for the purposes of provider proﬁling.
1.4 Aims of the thesis
Measurement of clinical outcomes (provider proﬁling) after admission to neonatal care is
important for sharing best practice and identifying areas for improvement (Department
of Health, 2009). Determining outcomes such as mortality rates for individual neonatal
units (NNUs) in the UK is complicated by the structure of neonatal services. There are
three elements to this which I shall investigate in this thesis:
Transfers Not all services are provided at all NNUs so infants are often transferred
to receive the care they need, maybe multiple times. This raises questions for provider
proﬁling analyses as it is not obvious to which NNU the infant’s outcome should be
assigned. Infants requiring acute or specialist transfer are likely to be sicker than other-
wise similar infants who do not (Delaney-Black et al., 1989; Hohlagschwandtner et al.,
2001), so transfer could be considered as a risk factor to adjust for. Although rare, de-
liberate transfers of sick patients to avoid a death have been documented in other areas
(Normand and Shahian, 2007), so the potential for outcome monitoring in neonatal care
to inﬂuence transfer decisions should be considered.
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Type of neonatal unit Each neonatal unit is classed as a special care baby unit,
local neonatal unit or neonatal intensive care unit depending on the type of care it
provides. It may not be reasonable to compare NNUs across diﬀerent levels as they are
not designed to provide the same care. Infants are likely to be transferred across levels
as their clinical needs change, so analysis cannot be conducted separately within levels.
Neonatal networks Neonatal care is delivered via managed clinical networks with
each NNU being part of a network. Networks are not simply groups of NNUs, but
organisations with their own protocols, standards and care pathways as well as internal
procedures for training and clinical governance (Department of Health, 2003; National
Audit Oﬃce, 2007; Redshaw and Hamilton, 2006), so it seems plausible that we would
see correlated outcomes within networks in contrast to providers which do not coordinate
to provide care. Infants are already grouped within NNUs, so the organisation of NNUs
into networks creates a third level in the data (infants within NNUs within networks).
The dependencies between observations need to be correctly accounted for, but we are
also interested in measuring outcomes at the network level in addition to the NNU level.
Although networks are designed to provide comprehensive care, transfer to another
network can happen for a number of reasons. Cross-network transfers add another
complication as infants can be treated by multiple networks, not just multiple NNUs.
The aim of this thesis is to establish suitable statistical models to inform NNUs
how the expected mortality for infants in their care compares with that of similar in-
fants attending similar NNUs. In particular I investigate assignment of the outcomes
of transferred patients, modelling diﬀerences across NNU levels and handling of data
dependencies at the neonatal network level.
1.5 Structure of the thesis
In chapter 2 I introduce the data source for the thesis, select the cohort for analysis and
deﬁne the outcome. The data are described with respect to structural aspects of the
data that are key to the research questions, namely transfers, NNU levels and neona-
tal networks. Infant risk factors for mortality are explored in chapter 3, with selection
based on review of the literature and consideration of appropriate variables for provider
proﬁling. A risk adjustment model is developed and evaluated, and provider-level vari-
ables are considered. In chapter 4 I introduce hierarchical models, describe their use
in provider proﬁling studies and the extent to which standard methods can be applied
to the questions of the thesis. I review the literature for existing approaches to the
problems presented here, identify gaps in current practice, and introduce multiple mem-
bership models as a potential solution. Methods applied in the thesis are presented in
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chapter 5. I ﬁrst consider non-transferred infants only, presenting a series of hierarchi-
cal models incorporating NNU and network eﬀects in light of the descriptive analysis in
chapter 2 and including the risk-adjustment model developed in chapter 3. A simulation
study is described to explore the impact of diﬀerent multiple membership models in data
where the patterns of dependency are known. I then present multiple membership mod-
els which allow for transfers, building on the methods for the analysis of non-transferred
infants. Results are presented in chapters 6 (non-transferred infants) and 7 (multiple
membership models for simulated and neonatal data), and ﬁndings summarised in the
context of existing literature and the rest of the thesis. Chapter 8 illustrates results for
a single NNU as an example of how the ﬁndings from this thesis could be presented for
clinical purposes. Finally, in chapter 9 I give an overview of the whole thesis, including
limitations and further work.
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Chapter 2
Data
In section 2.1, I introduce the data source for the thesis, the National Neonatal Research
Database (NNRD), including its development, uses and content. Section 2.2 describes
the selection of the cohort of infants analysed in this thesis and deﬁnition of the outcome
of interest. Descriptive analysis of the cohort is provided in section 2.3. I present infant
characteristics (section 2.3.1), describe data by neonatal unit level (section 2.3.2), explore
transfers (section 2.3.3) and mortality (section 2.3.4). In section 2.4 I summarise and
discuss the ﬁndings of the chapter with relevance to other literature and implications
for the rest of the thesis. The purpose of this chapter is to explore data relating to the
structure of services and to provide background for the provider proﬁling analysis in
later chapters.
2.1 The National Neonatal Research Database
2.1.1 Development of the NNRD
As discussed in chapter 1, infants receiving neonatal specialist care frequently undergo
transfer as not all services are available at every hospital. Their medical records need
to be available at every hospital that cares for them. The Department of Health (DH)
review of neonatal services (2003) found that there was a lack of outcome data at a
national level and recommended that IT infrastructure be improved to facilitate data
collection. These requirements led to the recommendation that the clinical record for
infants in neonatal care be stored electronically, in order to be easily available should the
infant be transferred, and to facilitate outcome reporting. In 2004, a system to capture
data electronically at the point of care was launched in the South-East of England, and
has since extended to all NNUs in England, Wales and Scotland, replacing previous local
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data collections. The database operates on a web-based platform hosted and managed
by Clevermed Ltd. on NHS.net, allowing data to be shared across NNUs. Neonatal
units and networks can access data for the infants in their care, enabling local audit
and other regional initiatives. Collating the records on a national scale provides the
opportunity to use these data for purposes outside day-to-day clinical care, in particular
clinical research. In pursuit of this aim, the Neonatal Data Analysis Unit (NDAU) was
launched in 2007 with the purpose of supporting neonatal research and promoting data
quality. The NDAU is an academic unit which is part of Imperial College London and
based at the Chelsea and Westminster NHS Foundation Trust. Data from all NNUs
using the system are extracted quarterly by Clevermed and cleaned by NDAU to form
the NNRD.
The development of the NNRD from an electronic patient record to a national re-
source for clinical research was the primary aim of the Medicines for Neonates (MfN)
Research programme, funded by the National Institute of Health Resarch (Modi et al.,
2016). The programme, completed in March 2015, involved the expansion of the NNRD
to cover all NNUs in England, Wales and Scotland, the creation of the Neonatal Data Set
as a new NHS information standard (see section 2.1.2) and the assessment of the utility
of the NNRD for clinical research in a number of settings. The NNRD has approval as a
database from the National Research Ethics Service (10/80803/151). Each NHS Trust
contributing data has given Caldicott Guardian approval for data from their Trust to
be used for service evaluations by NDAU, including comparisons of mortality performed
by NDAU of which this PhD is an extension. The NNRD is used for a wide variety of
purposes including evaluation of the restructuring of neonatal care (Gale et al., 2012b)
and quality improvement initiatives (Battersby et al., 2014b), development of growth
charts for preterm infants (Cole et al., 2013), the National Neonatal Audit Program
(NNAP) (Royal College of Paediatrics and Child Health, 2015) and international col-
laborations (Shah et al., 2014), with integration into data collection for clinical trials
in the pipeline (Gale et al., 2016a). The NNRD is the only dataset of its kind in the
UK that provides national coverage of neonatal clinical data. Similar databases exist
in other countries such as Sweden (EXPRESS Group et al., 2009), the USA (Tyson
et al., 2008) and Japan (Kusuda et al., 2012) but these do not cover all admissions to
neonatal care nationwide. Furthermore, the NNRD is the only database to be derived
from electronic patient records rather than being a speciﬁc, separate collection (Modi
et al., 2016).
2.1.2 Contents of the NNRD
The data contained in the NNRD are a deﬁned set of items known as the Neonatal
Dataset (NDS), which is an approved NHS Information Standard (SCCI1595). This
40
means that any neonatal electronic patient record must collect these items as deﬁned,
ensuring consistency and future-prooﬁng against change in systems or suppliers. The
NDS incorporates core clinical data as it is an electronic patient record, as well as data
for commissioning purposes and to determine funding. Established neonatal collections
which have gone through considerable clinical review such as the NNAP dataset and
the Neonatal Critical Care Minimum Data Set are incorporated. Items in the NDS are
therefore generally well-deﬁned and clinically motivated.
While an infant is in neonatal care, data are collected on a static (once per baby),
episodic, daily or ad hoc basis. Note that an episode refers to a distinct admission to
an NNU; if an infant is transferred to another NNU this constitutes a second episode
and if the infant subsequently returns to the ﬁrst NNU this is a third episode. Ad
hoc data include occasional events such as screening for retinopathy of prematurity and
abdominal x-ray results. There is also a facility to record follow-up data when the infant
is two years of age. Variables recorded include infant characteristics (e.g. gestational
age and birth weight), parental characteristics (e.g. ethnicity and maternal age), care
given (e.g. surgical procedures and respiratory support) and clinical outcomes (e.g. blood
stream infections and necrotising enterocolitis). The NNRD currently contains data on
over 500,000 infants and 6 million days of care.
2.1.3 NNRD quality assurance
Data input is carried out by variety of NNU staﬀ, mostly nurses and trainee clinicians,
although some NNUs employ data clerks. Data are often checked internally by senior
clinical staﬀ, and some validation occurs on a wider scale which will be discussed in this
section. Utilising data for purposes outside day-to-day clinical care can help motivate
improvements data quality. For example activity data feeding into the daily level of care
an infant receives is used to determine funding from the NHS and for commissioning
services.
Regular data validation occurs through feedback to NNUs of data used in two annual
reports: the National Neonatal Audit Program (NNAP) (Royal College of Paediatrics
and Child Health, 2014) and the Neonatal Data Analysis Unit (NDAU) annual report
for neonatal network mortality (Neonatal Data Analysis Unit, 2015). The NNAP is a
national clinical audit established in 2006 to assess consistency of practice and adherence
to available guidelines concerning, for example, transfers out of network, screening for
retinopathy of prematurity and temperature on admission. For NNAP, quarterly reports
to NNUs indicate data completeness, and a ﬁnal summary is provided for each audit
question giving NNUs the opportunity to identify errors or missing data. A similar
exercise is conducted annually for the NDAU network mortality report, which includes
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data for individual infants, highlights potential errors and gives summary information
for each NNU (total number of distinct infants, total number of episodes, total number
of deaths occurring in the NNU). In both cases the NNU make corrections themselves on
the live data system so there is no direct feedback on the level of errors. The validation
process is not obligatory, so does not guarantee that errors are eliminated, and NNUs
may be under-resourced in terms of the staﬀ time required to perform the checks.
As part of the MfN programme (Modi et al., 2016) a one-oﬀ validation was con-
ducted to compare NNRD data with that recorded independently on the case report
form for the Probiotic in Preterm Infants (PiPs) randomised clinical trial. A variety of
outcomes, process measures, and infant and maternal characteristics were compared for
1,315 infants born less than 31 weeks gestation who were recruited to the trial between
July 2010 and July 2013. Rates of major discordancy were generally low, particularly
for data recorded once only at baseline, but there were some exceptions. Individual
variables will be discussed in chapter 3 with relevance to the risk factor data used in the
main analysis.
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2.2 Selection of data for the thesis
In chapter 1 I stated that this thesis will focus on mortality of infants born very preterm
(less than 32 weeks gestation). In this section I will further describe the selection of the
cohort and deﬁnition of the outcome.
2.2.1 Admissions to neonatal care in England
I am only including infants who are admitted to neonatal care. Infants born below 32
weeks gestation who survive birth are always admitted to neonatal care because of the
extent of prematurity. These neonatal admissions are a subset of all births below 32
weeks gestation, with the remainder being stillbirths and those who are born alive but
die on the labour ward before they can be admitted. Infants who are not admitted
to neonatal care are not part of the relevant population for the aims of the thesis.
Nevertheless it is important to point out that results cannot be directly compared with
estimates of preterm mortality for all births or all live births.
The NNRD in general only contains data on liveborn infants admitted to neonatal
units. There are a few exceptions to this as some NNUs contributing to the Vermont
Oxford Network Database (an international database of very low birth weight infants
born at contributing hospitals) also enter data for infants who died on the labour ward.
The scale of the problem is small: eight cases were identiﬁed through validation (see
2.1.3) and subsequently excluded. This is less likely to be an issue going forward as from
2014 a new ﬁeld indicating labour ward deaths was added to the data entry system, so
that any NNUs entering data for labour ward deaths could mark them as such, allowing
exclusion as necessary.
I will only examine data for infants admitted to English NNUs as data from Wales
and Scotland were not available before 2012. Data were contributed from 71% of neona-
tal units in England from the beginning of 2008, 80% in 2009, 86% in 2010, 97% in
2011, 99% in 2012 and 100% from 2013 onwards. To preserve completeness and restrict
analysis to before the further revision of neonatal networks (see chapter 1.2.1) I am only
including data for infants born 2011-2013.
2.2.2 Birth weight cohorts
Birth weight has traditionally been a widely used measure with which to identify vul-
nerable infants. While it is certainly an important predictor of mortality and morbidity
in infancy , childhood and later lifer (Barker, 1995; McCormick, 1985), other reasons for
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its frequent use may be its ready availability in most settings (including in routine and
freely available birth registry data) and the accuracy of measurement (Wilcox, 2001).
Standard categories for birth weight are extremely low birth weight (ELBW, less than
1000g), very low birth weight (VLBW, 1000 to 1500g), low birth weight (LBW, 1500
to 2500g), with infants born below 1500g a typical cohort for analysis. At the other
end of the scale, infants are considered macrosomic if they have a birth weight greater
than 4000 or 4500g, which can also bring risks to the mother and infant (Oral et al.,
2001). The remaining range (2500 to 4000 or 4500g) is considered normal range. Infants
delivered preterm will generally be smaller so selecting a cohort based on very low birth
weight is problematic because the cohort will be heterogeneous, including infants of low
gestation along with term infants who are growth-restricted (Arnold et al., 1991). I
have therefore deﬁned the cohort based on gestational age. For reference, from Oﬃce
of National Statistics (ONS) data on live births in below 32 weeks gestation in 2013,
36% were ELBW, 37% were VLBW, 24% LBW and the remainder above 2500g (Oﬃce
of National Statistics, 2014).
2.2.3 Gestational age criteria
In this thesis, I am focussing on infants born less than 32 weeks gestation for several
reasons. Any infant born at this gestation surviving beyond the labour ward would
be admitted to a neonatal unit and therefore included in the NNRD. Infants born at
later gestations might not be admitted, giving an incomplete denominator. The risk
factors for mortality in this population are more established, facilitating risk-adjustment.
Finally, mortality rates for this population are more suitable for comparison across
neonatal units and networks because amongst infants born at later gestations the rates
are so low that precision of the estimates would be very poor.
Hopsitals often have diﬀering policies regarding initiation of active treatment for
infants born at very early gestations, leading to variations in mortality (Rysavy et al.,
2015; Serenius et al., 2014). In the UK there is no oﬃcial limit of viability below which
resuscitation will not be attempted, but the Nuﬃeld Council for Bioethics (2006, pp.
154-157) proposed the following guidelines:
• before 22 weeks: resuscitation should only take place within a clinical research
study.
• 22+0 to 22+6 weeks: resuscitation should not be standard practice and should only
be done following request by the parents and in agreement with clinicians.
• 23+0 to 23+6: the decision to resuscitate/give intensive care should be directed by
the wishes of the parents, but clinicians should not be obliged to proceed should
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they believe the treatment to be futile.
• 24+0 to 24+6: standard practice should be full intensive care as required unless
the parents and clinicians agree otherwise.
• 25+0 and above: standard practice should be full intensive care as required unless
the infant is aﬀected by a severe abnormality incompatible with survival.
The British Association of Perinatal Medicine (BAPM) published a framework (Wilkin-
son et al., 2009) which echoed the Nuﬃeld report, with the additional advice that the
response of the heart rate should inform the clinical view.
In this thesis I will only include infants who are admitted to neonatal units, which
means that mortality rates could be aﬀected by the decision to resuscitate in the delivery
room. There is likely to be variation in resuscitation practices across NNUs due to both
clincial and parental views. The EPICure studies (Costeloe et al., 2000, 2012) which
examined short and long term outcomes for extremely preterm infants included babies
born 22 weeks gestation (i.e. 22+0 to 22+6). Some of these infants do survive and they
are of particular interest to the neonatal community. Based on this, and the above
guidelines, I will exclude infants born before 22+0 weeks gestation.
2.2.4 Congenital malformations
Congential malformations are conditions present at birth which are caused by abnormal
development of the fetus, and are the second most common cause of infant deaths in
England and Wales (Kurinczuk et al., 2010). Infants with congenital malformations are
often excluded from studies estimating or comparing neonatal mortality rates (Medlock
et al., 2011) either because death is certain, or because the risk of death is substantially
higher but the conditions are too rare in the cohort to model this additional risk ac-
curately. Yet there is no agreement in the clinical community about which conditions
should be considered lethal (Kurinczuk et al., 2010), and many malformations described
as lethal are not always so (Wilkinson et al., 2012). Congenital malformations can
be captured in the NNRD using International Classiﬁcation of Diseases (ICD) codes, a
widely-used system maintained by the World Health Organisation. For admitted infants
born below 32 weeks gestation in 2008-2014, only 0.1% had a recorded malformation
appearing on a list based on a review of the literature published by Wilkinson et al.
(2012). Congenital anomaly registers report a rate of around 3% (Kurinczuk et al.,
2010), indicating possible underestimation in the NNRD, but the denominator for this
ﬁgure is all livebirths and stillbirths, and therefore includes terminations and delivery
room deaths occurring as a result of the malformation. As the accuracy of the data on
45
malformations in the NNRD has not been veriﬁed I have not attempted to exclude any
infants with congenital malformations.
2.2.5 Multiple births
As discussed in section 1.1, multiple birth is one of the risk factors for preterm birth so
we would expect a higher frequency of multiple births in this cohort compared with the
general population. Of the infants in the NNRD born 2011-2013 below 32 weeks gesta-
tion, 73% were singletons, 24% were twins, 2.4% were triplets and 0.2% were quadruplets
or higher. Infants from the same pregnancy may have similar clinical outcomes due to
common factors such as genetic traits, lifestyle of the parents, and circumstances around
the pregnancy and birth (Ananth et al., 2005; Carlin et al., 2005; Yelland et al., 2015).
The consequences of correlated outcomes for statistical analysis in general was discussed
brieﬂy in chapter 1 and will be addressed further in chapter 4 in the context of provider
proﬁling. Examining the extent to which outcomes are correlated requires matching
infants from the same pregnancy (multiple birth sets). Multiple birth sets can be linked
in the NNRD using a maternal identiﬁcation number, which is usually an encrypted ver-
sion of the mother’s NHS number. Mother’s NHS number was missing for around 11%
of infants; in these cases a maternal ID was assigned during data processing conducted
by NDAU. Infants are assigned to the same maternal ID if the following variables are
identical: month and year of birth1, gestational week at birth, place of birth (in most
cases, hospital identiﬁer), maternal year of birth and area of residence (Statnikov and
Gray, 2015).
A substantial proportion of multiple birth sets are missing at least one sibling in
the NNRD: 26% of twin sets, 39% of triplet sets and 48% of quadruplet or higher sets
(for infants born 2011-2013 below 32 weeks gestation). As described in setion 2.2.1 very
preterm infants who survive beyond the labour ward are always admitted to neonatal
care. Siblings could be missing because they die (in-utero or postnatally) before they
can be admitted to a neonatal unit. The deﬁnition of multiple birth in the NNRD is
for the total number of fetuses delivered, whether live or stillborn. There is no speciﬁc
ﬁeld in the NNRD for recording the death of a sibling from the same pregnancy.
It is possible that the missing siblings are in the NNRD, but there is insuﬃcient
information to link them. This seems a likely contributing factor given that the pro-
portion of multiple births with missing siblings was 12% in those where mother’s NHS
number was available, compared with 43% in those where it was missing. The sibling
could have been admitted to neonatal care but the record is missing from the NNRD.
Infants in multiple birth sets are sometimes separated due to insuﬃcient cot capacity
1exact date is removed as part of pseudonymisation
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(Gale et al., 2012b). The infant with no record may have been transferred to another
neonatal unit not contributing to the NNRD, but postnatal transfers are usually still
recorded as a neonatal admission in the unit of birth. Furthermore at least 97% of
neonatal units were contributing data in 2010 onwards so the likelihood of admission
to a non-contributing unit is low. Another possibility is that the infant with a present
record was erroneously recorded as being from a multiple pregnancy, but this cannot be
determined using NNRD data alone.
To investigate whether mortality within multiple birth sets is correlated, I examined
outcomes for the 3625 twin pairs that could be matched (7250 infants in total). The
overall mortality rate was 8.8%, but if one sibling died, the mortality rate amongst the
second siblings was 38.5%. Some of this correlation will be accounted for by the fact
that the twins are of the same gestation, and other factors contributing to the similarity
could be included as risk factors (e.g. maternal smoking), but there is likely to be
considerable residual correlation from genetic eﬀects and other unmeasured similarities
(Carlin et al., 2005).
The aim of this thesis is to develop models to estimate NNU mortality rates account-
ing for the structural features of the data imposed by centralised care. Multiple births
impose a separate structure on the data, and are important given the high proportion of
multiple births in the population. However this is a separate issue to the one currently
being addressed, one which brings with it a separate set of problems, not least because
of the high proportion of missing siblings in the data set. I will therefore only consider
singleton infants for analysis in this thesis, including the descriptive analysis presented
later in this chapter (section 2.3). The limitations of this will be discussed in section 2.4
and I will consider the potential for extension to include multiple births in chapter 9.
2.2.6 Deﬁning mortality
Mortality was selected as the outcome because it is unambiguous, clearly deﬁned, well-
recorded, and of the utmost importance to clinicians and parents. Determining which
deaths to include can complicate comparative analyses of mortality of preterm infants.
For international comparisons that can be particularly diﬃcult because of variations in
stillbirth deﬁnition, registration of births, limits of viability and resuscitation policies
(Draper et al., 2009; Joseph et al., 2012). In this thesis I am only considering comparison
of mortality rates within England but there are still a number of issues which require
consideration.
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Timing of deaths
Neonatal mortality is usually deﬁned as death within 28 days, and sometimes subdivided
into early neonatal mortality (within 7 days) and late neonatal mortality (between 7 and
28 days). Globally, over a third of deaths in children under 5 occur within the ﬁrst 28
days of life (Lawn et al., 2005). These time points do achieve standardisation but
they are somewhat arbitrary. As neonatal care has progressed, an increased number
survive the neonatal period of 28 days but some of these infants die later during stay
(Sidebotham et al., 2014). Applying the 28 day deﬁnition means those infants would
be considered survivors. Furthermore, for the purposes of provider proﬁling all deaths
which occur in neonatal care are of interest. I will consider death before discharge from
neonatal care as the outcome in this thesis to ensure all deaths occurring on an NNU
are included, but death before 28 days will be included as part of the description of the
cohort in section 2.3.4 for comparison with other data sources.
Hospital mortality measures sometimes include deaths up to 30 days post-discharge
(e.g. the Summary Hospital Mortality Index produced for each English NHS Trust
(Health and Social Care Information Centre Clinical Indicators Team, 2016)), though
this is mainly relevant for mortality following elective procedures. While some work
has been done to link infants in the NNRD with death registry data (via the Oﬃce of
National Statistics and Hospital Episode Statistics linked mortality dataset) this was
only possible for a limited number of infants so was not considered further.
2.2.7 Missing mortality data
Mortality was determined by the discharge record for the last episode of care. If the
last discharge was a transfer for further neonatal care with no subsequent data avail-
able, death before discharge was considered missing; this occurred for 2% of infants
(341/16,710 based on singleton infants born 2011-2013 at or below 32 weeks gestation).
A similar level of missing outcomes persists even beyond 2013 when all NNUs con-
tributed data. Examination of infants with missing outcomes showed that most were
transferred to specialist surgical providers that are not standard neonatal units and do
not contribute data to the NNRD, such as Great Ormond Street Hospital. While these
centres are not NNUs, infants are transferred there and may be transferred back to an
NNU after the procedure, so the infants are still considered to be in neonatal care for
the duration. Infants not transferred back may be discharged home or to a paediatric
ward, or they may die at the specialist centre. Table 2.1 compares infant characteristics
for those with and without death data. Infants with missing death data tended to be
more vulnerable: of lower gestation, lower birth weight and more likely to be male (risk
factors for mortality will be described in more detail in chapter 3). They were also more
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likely to have missing data in other ﬁelds.
In order to assess what impact the missing data might have on the results we need
to consider why it is missing. Following Rubin (1976), missing data can be classiﬁed
in three ways: missing completely at random (MCAR), missing at random (MAR) or
missing not at random (MNAR). If data are MCAR, this means that the probability
of the data being missing is completely unrelated to the data itself, either observed or
unobserved (e.g. if some records are randomly deleted due to a computer error). In
such cases analysis of the complete case data only will give unbiased results, though
with larger standard errors than if the full dataset were available due to the sample
size reduction. The MAR criteria are less stringent than MCAR: here the probability
of missingness is conditionally independent of the unobserved data, given the observed
data. An example of this would be if men were less likely to fully complete a health
questionnaire than women, but this is unrelated to the answers beyond any gender
diﬀerences in the observed data. We can obtained unbiased inferences provided we ﬁll
in (impute) or re-weight the variables with missing data conditional on what we observe
(Little, 1987). If the missingness is dependent on the data which are missing (e.g. if
those with poor health are less likely to ﬁll out the questionnaire in full but we have
no data relating to health status) then the data are MNAR. Here we have to model the
probability of missingness as well as the analysis model of interest. As the missingness
mechanism is usually unknown, sensitivity analysis is crucial to check whether results
are robust to a variety of assumptions.
For infants with missing outcomes in the NNRD we can rule out MCAR because
most are transferred to particular providers for specialist treatment, and so diﬀer sys-
tematically from other infants. Missing at random is an untenable assumption as the
missingness is related to the outcome. Infants that die in the specialist centre will
certainly have a missing outcome in the NNRD, while those that survive may have a
missing outcome if they are discharged home or to a paediatric ward. We cannot impute
the missing outcomes based on the subpopulation of infants who were transferred for
specialist care for whom we do know the outcome as these infants are transferred back
to an NNU and therefore exclude deaths at the specialist centre. It therefore seems most
appopriate to treat the data as MNAR and further understanding of the missing death
data is required in order to construct sensible models for the missingness mechanism.
Given these complexities, for the purposes of exploring the main statistical issues at
hand I have limited the analysis in this thesis to complete outcome data, and acknowl-
edge that this may bias the results given the reasons for missingness and the diﬀerences
in characteristcs observed in table 2.1. Inclusion of infants with missing outcomes will
be discussed in chapter 9.
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Table 2.1: Comparison of infants with and without missing death data in the
NNRD, singleton infants born less than 32 weeks gestation 2011-2013
Non-missing Missing Total
n % n % n %
Gestational age 22+0 − 23+6 398 2.4 13 3.8 411 2.5
(weeks+days) 24+0 − 25+6 1873 11.4 76 22.3 1949 11.7
26+0 − 27+6 2896 17.7 82 24.0 2978 17.8
28+0 − 29+6 4443 27.1 90 26.4 4533 27.1
30+0 − 31+6 6759 41.3 80 23.5 6839 40.9
Birth weight < 500 131 0.8 9 2.6 140 0.8
(g) 500− 999 5378 32.9 182 53.4 5560 33.3
1000− 1499 6839 41.8 95 27.9 6934 41.5
1500− 1999 3725 22.8 50 14.7 3775 22.6
 2000 296 1.8 5 1.5 301 1.8
Sex Female 7342 44.9 135 39.6 7477 44.7
Male 9027 55.1 206 60.4 9233 55.3
Mode of delivery Vaginal delivery 6793 41.5 136 39.9 6929 41.5
Caesarean section 8377 51.2 152 44.6 8529 51.0
Missing 1199 7.3 53 15.5 1252 7.5
Maternal age <20 1327 8.1 29 8.5 1356 8.1
(years) 20 to 24 3166 19.3 71 20.8 3237 19.4
25 to 29 4292 26.2 84 24.6 4376 26.2
30 to 34 4336 26.5 92 27.0 4428 26.5
35 to 40 2451 15.0 49 14.4 2500 15.0
>40 726 4.4 9 2.6 735 4.4
Missing 71 0.4 7 2.1 78 0.5
Maternal White 10909 66.6 215 63.0 11124 66.6
Mixed 271 1.7 9 2.6 280 1.7
Asian 2119 12.9 35 10.3 2154 12.9
Black 1702 10.4 29 8.5 1731 10.4
Chinese 55 0.3 3 0.9 58 0.3
Other 248 1.5 5 1.5 253 1.5
Missing 1065 6.5 45 13.2 1110 6.6
Smoking∗ No 10605 64.8 199 58.4 10804 64.7
Yes 3145 19.2 64 18.8 3209 19.2
Missing 2619 16.0 78 22.9 2697 16.1
IMD† 1 (most deprived) 5543 33.9 115 33.7 5658 33.9
quintile 2 3695 22.6 79 23.2 3774 22.6
3 2740 16.7 54 15.8 2794 16.7
4 2081 12.7 39 11.4 2120 12.7
5 (least deprived) 1708 10.4 35 10.3 1743 10.4
Missing 602 3.7 19 5.6 621 3.7
* Any smoking in pregnancy
† Quintile of the ranked Index of Multiple Deprivation score for the mother’s
Lower Super Output Area
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2.3 Descriptive analysis
2.3.1 Infant characteristics
Table 2.2 shows the population characteristics for infants born 2011-2013 below 32 weeks
gestation and admitted to an NNU in England contributing to the NNRD. Infants with a
birth weight greater than 4 standard deviations from the gestation and sex speciﬁc mean
(based on UK-WHO preterm standards (Wright et al., 2010)) were excluded (n=23) as
gestation may have been incorrectly recorded. As discussed in section 2.2.7, those with
missing death data were excluded. All subsequent analyses in this chapter are based on
the cohort described in table 2.2.
The number of infants increases with gestational age, with 398 (2.4% of the cohort)
infants born at 22+0 to 23+6 weeksdays gestation over the three year period increasing
to 6759 (41.3%) at 30+0 to 31+6. A quarter of infants had a birth weight of over 1500g,
highlighting diﬀerences between gestational age and birth weight cohorts. There were
more males than females, slightly higher than for live births across all gestations (55.1%
vs 51.2% (Department of Health, 2014)). Half the infants were born by Caesarean
section compared with 13.2% of all deliveries. The proportion of infants born to white
mothers was lower than for live births overall (Oﬃce of National Statistics, 2015) (66.6%
vs 73.0%). The proportion of infants born to black mothers was higher (10.4% vs 4.5%),
as was the proportion born to Asian mothers, but to a lesser extent (12.9% vs 9.2%).
Nineteen percent of mothers were recorded as having smoked during pregnancy, which
is the same as the overall smoking prevalence amongst adults (Health and Social Care
Information Centre, 2016a), though almost as many were missing so this is likely to be
an underestimate. There is a disproportionate representation of deprived areas with a
third of infants coming from the ﬁfth most deprived areas2.
Table 2.2 also shows data by transfer status, and mortality data; these will be dis-
cussed in sections 2.3.3 and 2.3.4 respectively.
2Quintiles are determined by ranking Lower Super Output Areas (LSOAs) according to Index of
Multiple Deprivation 2010 (IMD) score. LSOAs are geographic areas approximately equal in population
size and are determined using mother’s postcode. The IMD is a composite score assessing deprivation
based on income, employment, health, education, housing, crime and living environment calculated by
the UK Department of Communities and Local Government (Department for Communities and Local
Government, 2011).
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Table 2.2: Description of cohort for the thesis (singleton infants born less than 32 weeks gestation
2011-2013, admitted to a NNU in England contributing to the NNRD, with known survival status
at discharge), by transfer status
Non-transferred Transferred Total
n % n % n %
Gestational age 22+0 − 23+6 223 2.2 175 2.9 398 2.4
(weeks+days) 24+0 − 25+6 701 6.8 1172 19.2 1873 11.4
26+0 − 27+6 1394 13.6 1502 24.6 2896 17.7
28+0 − 29+6 2813 27.4 1630 26.7 4443 27.1
30+0 − 31+6 5129 50.0 1630 26.7 6759 41.3
Birth weight < 500 68 0.7 63 1.0 131 0.8
(g) 500− 999 2464 24.0 2914 47.7 5378 32.9
1000− 1499 4626 45.1 2213 36.2 6839 41.8
1500− 1999 2879 28.1 846 13.8 3725 22.8
 2000 223 2.2 73 1.2 296 1.8
Sex Female 4691 45.7 2651 43.4 7342 44.9
Male 5569 54.3 3458 56.6 9027 55.1
Mode of delivery Vaginal delivery 4112 40.1 2681 43.9 6793 41.5
Caesarean section 5321 51.9 3056 50.0 8377 51.2
Missing 827 8.1 372 6.1 1199 7.3
Maternal age <20 851 8.3 476 7.8 1327 8.1
(years) 20 to 24 1967 19.2 1199 19.6 3166 19.3
25 to 29 2746 26.8 1546 25.3 4292 26.2
30 to 34 2731 26.6 1605 26.3 4336 26.5
35 to 40 1491 14.5 960 15.7 2451 15.0
>40 426 4.2 300 4.9 726 4.4
Missing 48 0.5 23 0.4 71 0.4
Maternal White 6801 66.3 4108 67.2 10909 66.6
ethnicity Mixed 168 1.6 103 1.7 271 1.7
Asian 1377 13.4 742 12.1 2119 12.9
Black 1025 10.0 677 11.1 1702 10.4
Chinese 32 0.3 23 0.4 55 0.3
Other 155 1.5 93 1.5 248 1.5
Missing 702 6.8 363 5.9 1065 6.5
Smoking∗ No 6438 62.7 4167 68.2 10605 64.8
Yes 2065 20.1 1080 17.7 3145 19.2
Missing 1757 17.1 862 14.1 2619 16.0
IMD† 1 (most deprived) 3677 35.8 1866 30.5 5543 33.9
quintile 2 2268 22.1 1427 23.4 3695 22.6
3 1622 15.8 1118 18.3 2740 16.7
4 1238 12.1 843 13.8 2081 12.7
5 1060 10.3 648 10.6 1708 10.4
Missing 395 3.8 207 3.4 602 3.7
Death before discharge Survived 9141 89.1 5584 91.4 14725 90.0
Died 1119 10.9 525 8.6 1644 10.0
Time of death Died within 24 hours 393 35.3 25 4.8 418 25.6
Died 1-7 days 300 27.0 123 23.6 423 25.9
Died 8 to 28 days 264 23.7 167 32.0 431 26.4
Died after 28 days 155 13.9 207 39.7 362 22.2
* Any smoking in pregnancy
† Quintile of the ranked Index of Multiple Deprivation score for the mother’s Lower Super
Output Area
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2.3.2 Structure of neonatal care
In section 1.2 I described the diﬀerent levels of neonatal unit (special care baby unit
(SCBU), local neonatal unit (LNU), and neonatal intensive care unit (NICU) in order
of increasing levels of care provided. This section describes the relative burden of care
for these NNUs in terms of patient volume and type of care.
For 2011-2013 there were data from 169 neonatal units (45 SCBUs, 78 LNUs and 46
NICUs) in 23 neonatal networks (see appendix A for a full list). Table 2.3 summarises
the number of admissions (episodes of care) and the number of distinct infants (i.e.
excluding multiple admissions of the same infant to the same NNU) by level of neonatal
unit for the cohort described in section 2.3.1. Figure 2.1 illustrates the distribution
of gestational age of admissions (not infants, so each admission counts and transferred
infants are therefore included multiple times). The higher the level of NNU, the more
infants are admitted and the lower gestational age. There is considerable variation in
care volumes even within NNU level.
SCBU LNU NICU
No. NNUs 45 78 46
No. admissions 61 ( 41, 83) 117 ( 86,149) 266 (226,325)
No. infants 47 ( 31, 62) 97 ( 74,134) 242 (206,290)
Length of stay (days) 14 (11,20) 30 (28,33) 34 (31,36)
Table 2.3: Summary of admissions by level of NNU for singleton infants born less than
32 weeks gestation 2011-2013; data shown as median (interquartile range) across NNUs
SCBU LNU NICU
Number of IC days 22 ( 13, 42) 402 ( 240, 645) 2558 (2016,3619)
Percentage of IC days 1.9 (1.3,3.1) 10.6 (8.2,15.1) 28.0 (25.2,32.7)
Number of HDC days 87 ( 29, 286) 892 ( 565,1285) 2896 (2310,3874)
Percentage of HDC days 7.1 (3.4,14.8) 24.1 (18.9,27.8) 30.6 (27.0,33.7)
Number of SC days 1152 ( 747,1506) 2364 (1838,3258) 3788 (2857,4968)
Percentage of SC days 91.2 (84.7,95.3) 64.6 (57.8,72.3) 40.8 (34.8,45.5)
Table 2.4: Summary of type of care by level of NNU for singleton infants born less than
32 weeks gestation 2011-2013; data shown as median (interquartile) across NNUs
In section 1.2 I described how each day that an infant is in neonatal care is classiﬁed
as special care (SC), high dependency care (HDC) and intensive care (IC) in order
of intensity. These categories form an integral part of how NNUs are funded so data
relating to the deﬁnitions are likely to be well-collected (Department of Health, 2009;
Gale et al., 2016b). Table 2.4 summarises the number and proportion of care days in
each category across NNUs, by level of NNU for the cohort described in section 2.3.1.
Higher level NNUs perform higher levels of care, and greater proportions of it with
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Figure 2.1: Distribution of gestational age at birth by NNU level of admission, singleton
infants born below 32 weeks gestation 2011-2013
some variation within NNU level. Although special care constitutes the majority of care
carried out at SCBUs (median 91% of care days), NICU conduct more special care in
terms of volume (median 3788 vs 1152 days). To give an indication of what category
of care happens when and where, ﬁgure 2.2 shows the number of care days by category
and postnatal age separately for each level of NNU. SCBUs have a peak in volume on
day one, on which over half the care days are intensive care, followed by a drop as
infants are transferred out to higher level NNUs. The volume of care then increases
again, and consists almost wholly of special care, as infants are transferred back to their
nearest NNU. In contrast, NICUs have a volume peak a few days after birth as infants
are transferred in and the majority of care for the ﬁrst ten days is intensive care. The
pattern for LNUs is in between that for SCBUs and NICUs, with a drop after day one
but a substantial amount of intensive care carried out in the ﬁrst few days. By day 28
nearly all intensive care is conducted in NICUs.
2.3.3 Transfers
Neonatal transfers were introduced in section 1.2.2 and reasons for transfer were de-
scribed. Transfers can occur either before or after birth, but whether in-utero transfer
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Figure 2.2: Number of care days at each category, by postnatal age and NNU level,
singleton infants born below 32 weeks gestation 2011-2013; scales are not comparable
to show patterns at SCBUs more clearly
is carried out or attempted is not recorded in the NNRD. In this thesis I am primarily
interested in transfers from the point of view of care provided by multiple NNUs, and
so only postnatal transfers are considered.
For each episode the reasons for admission and discharge are recorded. This infor-
mation could be used to classify transfers, though the admission and discharge ﬁelds do
not have the same categories (note they also do not correspond directly with the types
of transfer described in section 1.2.2). Table 2.5 compares the reason for admission for
transferred infants with the reason for discharge from the previous episode. If an infant
is transferred we would expect these reasons to correspond, but the extent to which this
occurred was limited. For example 60% of discharges for surgical reasons were recorded
as admissions for surgical reasons, and around 200 episodes were recorded as ending with
the infant being discharged home, even though a subsequent admission was recorded. I
therefore decided not to use these ﬁelds to classify transfers as they are unreliable, but
instead described transfers based on the levels of the discharging and admitting NNUs.
The timing of transfer and whether it is to a higher, lower or same level NNU can tell
us something about the type of transfer. For example early transfers to a higher level
NNU are likely to be acute transfers while later transfers to a lower level NNU are likely
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to be non-acute transfers.
It is diﬃcult to determine whether a transfer occurred for capacity reasons because
this depends not only on whether there is physical cot available but also on staﬃng,
both of which cannot be determined using the NNRD3.
Reason for previous discharge
Reason for admission Home/
foster care
Paediatric
ward
Continuing
care
Specialist
care
Surgical
care
Cardiac
care
Unknown/
Missing
IC 62 8 1933 1007 196 32 3
HDC 10 1 1236 62 30 2 1
SC 47 8 1712 49 18 2 0
Surgical care 46 0 65 134 515 2 2
Cardiac care 0 0 8 17 38 58 0
Specialist investigation 6 0 7 62 14 1 0
Back transfer for IC 0 1 323 5 7 11 1
Back transfer for HDC 3 1 529 5 3 0 0
Back transfer for SC 2 2 935 10 4 2 0
Social care 0 0 4 0 0 0 0
Transitional care 4 4 42 1 0 0 0
Other 16 0 8 20 13 1 0
Unknown/Missing 5 0 49 19 17 1 0
Table 2.5: Comparison of reasons for transfer with reason for admission for subsequent
episode, singleton infants born below 32 weeks gestation 2011-2013
Frequency Of the cohort described in section 2.3.1, 37% (6,109/16,369) were trans-
ferred at least once. Half of transferred infants (3,035/6,109) required only one transfer
and while the maximum number of transfers was 12, this was very unusual (around 1%
had 6 or more transfers).
Comparison of transferred and non-transferred infants Table 2.2 showed that
the gestational age and birth weight distributions diﬀered for transferred and non-
transferred infants, with the latter more likely to be of higher gestation and birth weight.
The proportion of transferred infants born at less than 28 weeks gestation was over
double that for non-transferred infants (46.7% vs 22.6%). Similarly, the proportion of
transferred infants born at less than 1000g was almost double that for non-transferred
infants (48.7% vs 24.7%). The proportion of boys was slightly higher for transferred in-
fants (56.6% compared with 54.3%). While transferred infants were less likely to come
from the most deprived quintile, this was not part of a trend reﬂected in the remaining
quintiles. Mortality diﬀerences between transferred and non-transferred infants will be
discussed in section 2.3.4
3Admission month and year are available in the NNRD but exact admission dates are not (all events
including admission times are recorded in minutes from birth). Therefore it is not possible to establish
the number and identity of the infants in an NNU at a particular time. Staﬃng data are not recorded.
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Gestational age The proportion of infants transferred is highest at the middle of
this gestational age range (ﬁgure 2.3). Infants born before the peak at 25 weeks are no
more likely to be born at hospital with a NICU (which remains at around 70% up to
27 weeks). Mortality rates are much higher below 25 weeks so it is possible that these
infants die before a transfer would have otherwise occurred. As gestational age increases
the transfer rate decreases, and infants are less likely to require multiple transfers also.
This is likely to be because of a reduced need for transfer as these infants will not
necessarily require care at a NICU (British Association of Perinatal Medicine, 2010).
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Figure 2.3: Percentage of infants transferred at each gestational age week, grouped by
the number of transfers, for singleton infants born below 32 weeks gestation 2011-2013
NNU level The median (interquartile range, IQR) across NNUs for the percentage
of infants transferred at least once was 79% (67,91) for SCBUs, 47% (39,54) for LNUs
and 53% (44,63) for NICUs. These percentages are based on unique infants admitted
to each NNU, so each transferred infant will contribute to every NNU he/she is treated
at, but repeat admissions to the same NNU are only counted once. Figure 2.4 shows
the level of the destination NNU by the level of the referral NNU. Note that while there
are fewer transfers from SCBUs, only 12% of episodes of care for this cohort occur at
SCBUs, 30% of which end in transfer.
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Figure 2.4: Direction of neonatal transfers by level of the referring NNU, singleton
infants born below 32 weeks gestation 2011-2013
Timing Figure 2.5 shows the timing of transfers, by whether they are to a lower, same
or higher level NNU. A large number of transfers occur within the ﬁrst 24 hours after
birth, with most of these being to a higher level NNU (ﬁgure 2.5). These are likely to
represent acute transfer of infants born at SCBUs or LNUs but who require specialist
treatment at a NICU; ﬁgure 2.4 shows that NICUs are the destination of most transfers
from SCBUs and LNUs. There are still some transfers to a higher level occurring even at
much later postnatal ages. Transfers to a lower level make up an increasing proportion of
the total transfers over time. These are likely to be non-acute transfers back to the NNU
closest to home, once the infant’s needs are less complex. However there are also a few
transfers to a lower level on day one. There are a non-negligible number of transfers to
another NNU of the same level, particularly after the ﬁrst week, most of which represent
NICU to NICU transfers (ﬁgure 2.4).
Cross-network transfers In the cohort 26% (2147/9542) of transfers were to neona-
tal unit in a diﬀerent network. The frequency of transfers within and between networks
is shown in ﬁgure 2.6. The diagonal points represent within-network transfers, with
some networks (e.g. London North East and Greater Manchester) transferring more
frequently. Networks are plotted in order of region and adjacent regions plotted to-
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Figure 2.5: Timing of neonatal transfers, grouped by direction of transfer for singleton
infants born below 32 weeks gestation 2011-2013
gether where possible. Most points are close to the diagonal line indicating that most
cross-network transfers are to a nearby network. Oﬀ-diagonal points are numerous but
generally quite small. This indicates that cross-network transfers are spread amongst
serveral diﬀerent networks with a few transfers each, rather than mostly to one other
network. There are some networks which tend to transfer more to each other, for ex-
ample London South East and Kent. The plot is fairly symmetrical, indicating that the
number of transfers between pairs of NNUs is similar in both directions (an example
exception to this that the Western network transfers more infants to Midlands South
West than it receives). Of the transfers to a diﬀerent network, 39% (946/2147) were to
another NNU of the same level (mostly NICU to NICU) in comparison with 19% of the
within-network transfers.
2.3.4 Mortality
The overall mortality rate was 10%, with around a quarter of deaths occurring within 24
hours of birth, another quarter by 7 days, another quarter by day 28 and another quarter
after 28 days (table 2.2). Associations between mortality and infant characteristics will
be discussed in chapter 3.
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Figure 2.6: Frequency of transfers between neonatal networks; area of the dot is pro-
portional to the number of transfers and networks ordered by region; singleton infants
born below 32 weeks gestation 2011-2013
Table 2.2 shows how mortality diﬀers by transfer status. Mortality was lower
amongst transferred infants compared with non-transferred infants (8.6% vs 10.9%)
and the timing of deaths was very diﬀerent for these groups. Few deaths occurred
within 24 hours of birth for the transferred infants because they have to survive long
enough to be transferred (4.8% vs 35.3% in non-transferred infants), and more occurred
after 28 days (39.7% vs 13.9%). Table 2.6 illustrates diﬀerences in mortality by transfer
status and NNU level. Mortality was calculated for each NNU as the mortality rate
amongst all infants who ever received care in the neonatal unit. Non-transferred infants
are therefore included for only one NNU, but transferred infants (who also appear in
the total) will be included at all NNUs caring for them, as indicated by the asterisks
in table 2.6. Higher level NNUs had higher crude mortality rates, with the biggest dif-
ferences amongst infants who were not transferred (median mortality at SCBUs 2.6%,
LNUs 5.2%, NICUs 15.1%). The aim of examining distribution of deaths was to illus-
trate where the deaths actually occur, so deaths of transferred infants were attributed
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to the ﬁnal NNU. The vast majority of deaths occur in NICUs, whether for transferred
(93.3%) or non-transferred infants (76.1%). In contrast, 39.3% of all infants who survive
are discharged from a NICU; this is lower (22.8%) for those who are transferred. These
results indicate how diﬀerent the care pathways are for infants who survive and those
that die. Mortality was also expressed overall by NNU level, again allocating infants to
the ﬁnal NNU. Mortality was lower for transferred infants than non-transferred infants
for SCBUs and LNUs, and higher for NICUs. This is opposite to diﬀerences in median
NNU mortality where infants are allocated to all NNUs.
Table 2.6: Mortality across levels of NNU, singleton infants born below 32 weeks gestation 2011-2013
SCBU LNU NICU
All infants
Mortality across NNUs %, median(IQR) 4.7 (3.2,6.8) 6.1 (4.4,8.1) 12.2 (9.3,15.5)
Distribution of deaths, n(%)† 33 (2.0) 269 (16.4) 1342 (81.6)
Distribution of survivals to discharge, n(%)† 2195 (14.9) 6738 (45.8) 5792 (39.3)
Overall mortality %† 1.5 3.8 18.8
Non-transferred infants
Mortality across NNUs %, median(IQR) 2.6 (0.0,11.2) 5.2 (2.8,7.7) 15.1 (10.9,21.1)
Distribution of deaths, n(%) 29 (2.6) 238 (21.3) 852 (76.1)
Distribution of survivals to discharge, n(%) 545 (6.0) 4075 (44.6) 4521 (49.5)
Overall mortality % 5.1 5.5 15.9
Transferred infants
Mortality across NNUs %, median(IQR) 4.7 (3.0,7.1) 8.3 (4.7,10.6) 9.8 (8.4,11.6)
Distribution of deaths, n(%)† 4 (0.8) 31 (5.9) 490 (93.3)
Distribution of survivals to discharge, n(%)† 1650 (29.5) 2663 (47.7) 1271 (22.8)
Overall mortality %† 0.2 1.2 27.8
 attributed to all NNUs caring for the infant
† Infants attributed to the ﬁnal NNU
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2.4 Discussion
2.4.1 Summary
In this chapter I described the data source for the thesis (the NNRD), the selection of
the cohort, and presented descriptive analysis of the data. The NNRD is constructed
from electronic clinical records for all admissions to neonatal care in England, Wales
and Scotland and contains a wide range of data relating to demographics, clinical obser-
vations, treatments and outcomes. I selected singleton infants born 2011-2013 between
22+0 to 31+6 weeks gestational age who were admitted to neonatal care in England.
The outcome was selected as death (from any cause) before discharge from neonatal
care, and any infants with missing death data were excluded. Description of infant
characteristics showed that the number of infants increased with gestational age. Males,
infants born to black mothers, and infants born to mothers from more deprived areas
were over-represented compared with national statistics for births across all gestations.
Higher level NNUs perform more days of care and at a higher category of care overall,
and on a per-NNU basis, but there was considerable variation within levels of NNU. The
intensity of care decreased with postnatal age. Over a third of infants were transferred
at some point during stay, many of which occurred during the ﬁrst 24 hours. Overall
higher intensity of care occurred earlier and was more likely to be carried out by higher
level NNUs. Infants were transferred in way that reﬂected this, but there are a non-
negligible number of infants and transfers which do not meet this pattern. A quarter of
transfers were to a diﬀerent neonatal network. Transferred infants were born at a lower
gestational age than non-transferred infants but mortality was lower with fewer deaths
within 24 hours and more after 28 days.
Mortality in the cohort was 10%, with around a quarter of deaths occurring within
24 hours of birth, another quarter by 7 days, another quarter by day 28 and another
quarter after 28 days. Deaths were more likely to occur in higher level NNUs and
surviving infants were more likely to be discharged from lower level NNUs. Thus there
are divergent care pathways based on sickness of the infant; these diﬀerences were larger
for transferred compared with non-transferred infants.
2.4.2 Data source
The NNRD is the only UK data source enabling national, risk-adjusted comparisons of
NNU mortality, thus there was no other single data source for the analysis. Perinatal
mortality data are speciﬁcally collected for MBRRACE-UK (Mothers and Babies: Re-
ducing Risk through Audits and Conﬁdential Enquiries(2016)) but these data only relate
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to deaths, with denominator data acquired separately from the ONS. The NNRD con-
tains data on all infants admitted to neonatal care, allowing all providers to be included,
and consists of detailed clinical data in contrast to administrative databases. Provider
proﬁling studies often use administrative databases which has attracted criticism for the
quality of data (Iezzoni, 2003; Krumholz et al., 2006). While similar concerns exist for
routine clinical data, the NNRD is comprised of data captured at the point-of-care, by
staﬀ with clinical knowledge rather than coded from medical notes, and some ﬁelds are
validated as described in section 2.1.3. Regular assessment of clinical outcomes is seen
as an essential aspect of quality improvement in health services, but the ﬁnancial and
labour costs of doing so can be prohibitive (Spiegelhalter et al., 2012). As it is derived
from electronic patient records, the NNRD has minimal additional costs and is an on-
going collection updated in a timely manner. While the aim of this thesis is primarily
to investigate methodology, the suitability of the NNRD for provider proﬁling purposes
is of note. A limitation of the NNRD is that outcomes for infants who are transferred
to specialist surgical centres which are not standard neonatal units are not included if
they do not return to neonatal care.
2.4.3 Selection of the cohort
The overall cohort consists of all singleton infants born 2011-2013 between 22+0 to 31+6
weeks gestational age and admitted to a neonatal unit in England, for whom survival
to discharge from neonatal care was known. All data analysed in the rest of this thesis
are subsets of this cohort. The rationale for these selections was given in section 2.2 but
the exclusion of infants with missing outcomes is a limitation of the thesis, potential
solutions to which will be discussed as part of further work in chapter 9.
I showed that multiple births are common amongst these infants, though sibling sets
cannot always be identiﬁed. For twins where matching is possible, their outcomes are
similar (i.e. the probability of survival is higher amongst infants whose twin survives).
As described in chapter 1 ignoring dependencies violates assumptions of statistical mod-
els. For the research questions addressed here there are further implications. Siblings
from the same pregnancy are usually treated at the same NNU. Unless correlations
within siblings are accounted for in the model, they will be incorrectly assumed to be
correlations within NNUs, thus overstating the variation between NNUs.
Correlation of outcomes has been acknowledged and utilised in twin studies for some
time (Carlin et al., 2005) yet this correlation is often ignored in studies in the general
preterm population (Ananth et al., 2005). In a systematic review of randomised clinical
trials in preterm infants, Yelland et al. (2015) found that less than a third accounted for
correlation within multiple birth sets in the primary outcome analysis. Investigating and
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accounting for correlations within siblings in the NNRD is hampered by the diﬃculty
of matching birth sets. Maternal and infant data which link infants is already used to
match siblings, but this is done on a deterministic basis, i.e. a deﬁnite match is required.
Probabilistic methods such as those used by Croft et al. (2002) might achieve more
matches. Even if multiple birth sets can all be identiﬁed, these dependencies present
particular challenges because the groups (multiple birth sets) are small and unlike twin
studies we are analysing all preterm infants (singletons and multiples) so some infants
are not part of a multiple birth set. These complexities will be discussed in chapter 9
where I consider possible approaches for extending the methods in this thesis to include
multiple births.
Singleton infants are a distinct and clinically relevant population in their own right,
but there are some limitations to making this restriction. Almost a quarter of infants
were excluded from the analysis because of multiple gestation, reducing power. This
could be mitigated by including one randomly selected infant from each pregnancy, but
the problems of matching birth sets remains an issue. Multiple births are diﬀerent from
singletons, so excluding these infants may produce diﬀerent results from an analysis
based on the whole cohort. Amongst all births, multiple birth is an established risk
factor for perinatal mortality with risks increasing with the number of foetuses (Blondel
et al., 2002). However this is not always the case amongst babies born preterm or
very low birth weight infants (Slattery and Morrison, 2002), with some studies ﬁnding
higher mortality for multiple births (Gardner et al., 1995; Tyson et al., 2008), some
lower (Doyle and Victorian Infant Collaborative Study Group, 2001; Kiely, 1998) and
others ﬁnding no diﬀerence (Mizrahi et al., 1999; Wolf et al., 1992). As discussed in
section 1.1, the mechanisms resulting in early delivery of multiple births are not the
same as those for singletons. Furthermore the consequences of preterm birth may also
diﬀer. The pattern of relative mortality risk across the gestational age and birth weight
range is diﬀerent for singletons and multiples (Buekens and Wilcox, 1993; Minakami
and Sato, 1996). Kiely (1998) showed that while singleton infants born at 36 weeks
gestation had a ﬁve-fold risk of perinatal death compared with the week corresponding
to the lowest mortality (40 weeks), for twins the same relative risk is not reached until
32 weeks (compared with the optimal gestation of 38 weeks). It is also thought that
the lungs mature faster in foetuses in a multiple pregnancy than in singletons (Leveno
et al., 1984; Ohel et al., 1987), though this has not demonstrably resulted in improved
outcomes (Friedman et al., 1997). Therefore inferences about provider eﬀects resulting
from analysis of singleton infants alone may not be generalisable to the whole cohort.
Furthermore, if we wish to include these infants changes may be required to the risk
adjustment, along with a statistical model that accounts for the dependencies in the
data.
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2.4.4 Infant characteristics
Distribution of infant characteristics in the cohort were compared with ONS data on all
live births to illustrate diﬀerences between the preterm and term populations. Infants in
the cohort were more likely to be male, born by Caesarean section, born to black mothers
and come from deprived areas. These ﬁndings are in line with risk factors for preterm
birth described in chapter 1. Data should be interpreted with caution because levels of
missing data were high for some variables (mode of delivery, smoking) and validation
against clinical trial data (see 2.1.3) showed that maternal ethnicity was unreliable with
10% of records discrepant. For area-level deprivation, the LSOA and therefore the
quintiles are approximately equal in population size so a random individual is equally
likely to come from any of the quintiles. However the same is not true of newborns as
fertility rates will vary by by LSOA. Nonetheless the distribution illustrates that the
burden of preterm birth is borne more heavily by deprived areas.
2.4.5 Structure of neonatal care and transfers
NICUs conduct the majority of care for the very preterm population analysed in this
thesis. However Gale et al. (2012b) showed that only 11 NICUs admit more than 100 very
low birth weight infants annually which is a recommended criterion for a “high-volume”
NNU under centralisation (Phibbs et al., 2007). Although special care constitutes almost
all of the care burden of SCBUs, NICUs conduct the majority of special care in terms
of volume for the cohort in this thesis. This highlights that infants are not always
transferred out to lower level NNUs once they no longer require intensive care. This
could be for a number of reasons: the NICU in question is their closest NNU, insuﬃcient
cot capacity or transfer facilities, or due to circumstances particular to the infant. Thus
neonatal services in the UK are not completely centralised: care is not as concentrated
in large NICUs, and NICUs also provide lower levels of care. It has been argued by
Phibbs (2012) that a stronger approach closing smaller NICUs would improve neonatal
outcomes, as has been seen in Portugal (Neto, 2006). I do not explore the extent of
centralisation further as this is not an aim of the thesis, but note that there remains
scope for further centralisation which could increase the relevance of this work.
The intentions of the network system and the types of transfer that are required (as
outlined in section 1.2.2) are, in general, borne out by the results of sections 2.3.2 and
2.3.3. The pattern of intensity of care with postnatal age, the level of NNU at which
care takes place, and the timing and direction of transfers all show a consistent picture.
In summary, infants who are not born at a hospital which can accommodate their care
needs are transferred, usually within 24 hours, to a higher level NNU for higher level
care. Most infants require only one or two transfers. Infants whose condition improves
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are transferred back and are discharged from the lower level NNU, while infants that
die tend to do so in NICUs. However there are exceptions to this: some intensive care
is provided at SCBUs up to day 14, not all transfers on day one are for a higher level of
care and there are a non-negligible number of transfers to NNUs of the same level.
Several other studies have examined neonatal transfer patterns. While not an aim
of this thesis, the ﬁndings from this chapter regarding transfer patterns add to existing
literature evaluating networks and transfers (Cusack et al., 2007; Gale et al., 2012b;
Redshaw and Hamilton, 2006). The transfer rate was higher than that documented in the
Trent region by (Cusack et al., 2007) but similar to the more recent NNRD data reported
by Gale et al. (2012b). The frequency of cross-network transfers is documented by the
National Neonatal Audit Programme. In 2014, 10% of all infants admitted to neonatal
care were transferred at least once, with 17% of transfers being to a diﬀerent network.
The ﬁgures reported in this chapter are much higher, reﬂecting the more complex needs
of very preterm infants. I showed that there are diﬀerences in the characteristics of
transferred and non-transferred infants, with the former constituting over a third of the
cohort, so excluding these infants is not desirable. The diﬀerence in where deaths and
discharges alive occur highlight that the condition of an infant will dictate their location
of care.
There is considerable variation in crude mortality but the number of infants at
individual NNUs is small. Diﬀerent patterns are observed when we consider overall
mortality by NNU level allocating infants to the ﬁnal NNU, and allocating infants to all
NNUs caring for the infant, but these are quite diﬀerent measures. Mortality in relation
to infant characteristics will be explored further in chapter 3.
The analysis in this chapter will help inform how the structural aspects of the data
(level of NNU and transfers) are handled in the provider proﬁling analysis in subsequent
chapters, and aid interpretation of the results. In the next chapter, mortality will
be considered in more detail and a risk-adjustment model developed; the inclusion of
transfer status and NNU level will also be considered with reference to the ﬁndings of
this chapter.
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Chapter 3
Risk factors for mortality of
preterm infants
In chapter 1, I discussed the use of regression analysis as a way of adjusting for risk
factors in provider proﬁling studies. The aim of this chapter is to decide which vari-
ables to adjust for and how to model their associations with mortality. These decisions
will inform the provider proﬁling analyses developed in the subsequent chapters. I ﬁrst
describe some considerations for selection of risk factors in provider proﬁling analyses
both in general (section 3.1) and for the thesis (section 3.2). I select infant risk factors
based on review of the literature (section 3.3). In section 3.4 the resulting infant factors
are examined in the National Neonatal Research Database (NNRD), and a risk adjust-
ment model for infant characteristics is developed and evaluated. Finally in section 3.5
I summarise the ﬁndings of the chapter and give the implications for the rest of the
thesis.
3.1 Background
In any observational study the association of interest may be exaggerated or attenuated
by a confounder which is associated with both the predictor and the outcome. For
example we may be interested whether birth order aﬀects the likelihood of the child
having Down’s syndrome. Some of the unadjusted association between birth order and
Down’s syndrome could be explained by maternal age, which increases with birth order
and is a known risk factor for Down’s syndrome (Rothman et al., 2008). Confounding
can occur in any non-randomised study because the distribution of confounders may not
be balanced.
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Patients are not randomised to healthcare providers, so we would not expect the dis-
tribution of relevant risk factors to be balanced. Some of the imbalance will be the result
of diﬀerences in the local population (e.g. race and ethnicity, individual and area-level
socioeconomic deprivation, employment, education) and other area-based factors (e.g.
pollution exposure, quality of other local health services). Commissioning decisions, in
particular centralisation, can also lead to diﬀerences in the patient population as some
hospitals may be limited in the range of services they oﬀer. Risk adjustment (also called
case-mix adjustment) is a broad topic and the subject of much research (Iezzoni (2003)
provides a summary and practical applications). Application of these methods to the
mortality of preterm infants is not the primary focus of this thesis, but identiﬁcation of
risk factors is a necessary step before addressing the main research questions.
3.1.1 Risk adjustment for provider proﬁling
In general we want to adjust for any patient factor which may inﬂuence the outcome and
is not under the control of the provider (Iezzoni, 1994). Adjusting for these variables
reduces any confounding which occurs because a provider has patients that are at higher
or lower risk than average through no action of their own. There are a number of
considerations to be made when selecting risk factors for adjustment which are particular
to provider proﬁling studies:
Inﬂuence of the provider The factors used for risk adjustment should not be those
which could be inﬂuenced by the provider. In particular, if a complication of care which
has a negative impact on the outcome is treated as a case-mix factor, the provider’s
performance will appear improved after risk adjustment, when in fact it should be
lowered (Normand and Shahian, 2007). Conversely if a clinical decision is made which
has, say, a positive eﬀect on the outcome via some indicator x, then adjusting for x
will not attribute the positive eﬀect to that provider. This is because we are adjusting
for something on the causal pathway between our factor of interest (being treated at a
particular provider) and the outcome. In a White Paper for the Centers for Medicare
and Medicaid Services, Ash et al. (2012) recommended, based on consensus from all
stakeholders involved, that only risk factors present at admission are considered to avoid
conﬂation with provider eﬀects.
Data quality and other systematic diﬀerences It has been shown that estimates
of risk-adjusted outcomes are sensitive to diﬀerences in coding (Bottle et al., 2011; Mo-
hammed et al., 2009). Similar biases will occur in any situation where the recorded value
for the same patient would diﬀer systematically by provider. Reasons for this include
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measurement diﬀerences in equipment or technique, or subjective measures which may
vary by assessor. Concerns over measurement diﬀerences can be minimised by select-
ing variables which are clearly deﬁned and accurately recorded (Normand and Shahian,
2007; Spiegelhalter et al., 2012). Data completeness is also important, because if miss-
ing outcomes diﬀer to those observed, results will be misleading, particularly if patterns
of missing data vary across providers (section 2.2.7 includes a discussion on types of
missing data).
Sociodemographic data Sociodemographic variables such as ethnicity and depriva-
tion, and variables related to health behaviour such as parental smoking and alcohol
consumption, are often considered as candidate risk factors in epidemiological studies
for a range of outcomes (Iezzoni, 2003). These variables usually have some spatial vari-
ability and may therefore confound the provider eﬀect on the outcome, as healthcare
providers predominantly serve the local community. As with clinical risk factors, this
can lead to some providers having better or worse outcomes due to the sociodemographic
proﬁle of the local population and could be considered as factors to adjust for. Several
authors have argued against adjusting for sociodemographic risk factors in provider pro-
ﬁling studies for a number of reasons. If sociodemographic variables are correlated with
the provider eﬀects themselves (e.g if true poor performers are located in more deprived
areas) then controlling for such variables may adjust for some of the factors we wish
to examine (Normand and Shahian, 2007). The correlation may not just be induced
by geography but could be intrinsically linked with provider performance. For exam-
ple Normand and Shahian (2007) argue that ethnicity and socioeconomic status should
not be included in risk-adjustment because they may be associated with system-level
factors (e.g. lack of translators or poor community outreach services). Thus adjust-
ing for sociodemographic factors mask situations where poor care is being provided to
disadvantaged patients, and could lead to providers believing that a lower standard of
care for these patients is acceptable (National Quality Forum, 2014). Sociodemographic
variables are likely to be of inconsistent magnitude across the country because they
are often proxies for underlying risk factors with direct physiological eﬀects (e.g. poor
diet, stress) (Nicholl, 2007). Applying a uniform risk adjustment across all providers
is therefore not reasonable, and while we can model varying eﬀects across providers
(see section 4.1) the inability to distinguish genuine variation in risk factor eﬀects from
provider-induced variation remains. Rather than include sociodemographic variables in
risk adjustment, it has previously been recommended that such data be used to give
context to any diﬀerences that emerge (Ash et al., 2012; Iezzoni, 2003; Krumholz et al.,
2006; Normand and Shahian, 2007).
The issue was subsequently re-examined by an expert panel convened by National
Quality Forum (NQF), a US organisation that promotes quality improvement in health-
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care (National Quality Forum, 2014). The driver for the re-examination was a concern
about the fairness in providers being held to account on the basis of outcomes which
were not adjusted for sociodemographic factors, particularly with regard to payment-by-
results and sanctions for poor performance. The NQF panel suggested that this could
also lead to further inequity in healthcare through a number of mechanisms. If providers
serving disadvantaged communities are ﬁnancially penalized for their results, subsequent
care may suﬀer. Funding will also be reduced for such providers if their results lead to
patients choosing to go elsewhere. Patients who are high-risk based on their sociode-
mographic proﬁle may have reduced access to care, as decisions on patient catchment
areas or expansion of facilities may be made to optimise reported outcomes and any
associated ﬁnancial reward. The conclusion of the NQF panel was that on balance these
concerns outweighed the existing arguments against adjusting for sociodemographic fac-
tors. They recommended that provided there was conceptual and empirical support for
the an association between a sociodemographic variable and the outcome, and the vari-
able met the same criteria applied to clinical risk factors, then it should be included in
the adjustment, but that the measure should be presented adjusted for clinical factors
only, stratiﬁed by the sociodemographic variable.
Provider level variables As with patient-level risk factors we do not want to adjust
for any provider-level variables which are caused by the provider, for example a quality
improvement programme initiated internally. Provider-level factors could be associated
with the outcome because they encapsulate unmeasured case-mix diﬀerences between
provider populations (urban or rural location), because they aﬀect the ability of the
provider (the number of beds available) or both (whether a hospital is public or private).
Provider-level summaries of individual-level characteristics can be included to yield more
nuanced inferences about individual-level eﬀects. For example, Aitkin and Longford
(1986), when investigating variation in examination results across schools, included an
IQ-type measure both at the pupil level and aggregated to school level to investigate
whether pupils do better when they are at school with either high or low scoring pupils.
Some provider-level factors might be considered noise if the aim of the analysis is to
distinguish variation which is not just associated with each provider, but beyond that
attributable to its characteristics. Austin et al. (2004) found that including hospital
peer group (an indicator grouping hospitals based on patient volume) accounted for
more between-hospital variation and resulted in fewer outlying hospitals than an analysis
using patient characteristics alone. It allowed estimation of performance relative to the
peer group average, but also of the average diﬀerences between peer groups. Therefore
including provider-level variables has another purpose in attributing variation between
providers to diﬀerent sources.
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The decision to adjust for a provider characteristic is not always clear, as there are
some which could be viewed as attributes which the provider should be credited for.
Ash et al. (2012) give the example that if a hospital has a special cardiac care unit, their
result should incorporate this beneﬁt rather than be conditional on it. If the presence
of such a unit is not included in the risk adjustment model the average eﬀects across all
providers is not estimated, but this may not be a suitable aim for some attributes.
It is often the whole proﬁle for a provider, combining diﬀerent interacting character-
istics, that inﬂuences the outcome in a complex manner rather than individual variables
acting independently, in which case separate examination of individual providers may be
more appropriate. In the review of NHS Trusts undertaken by Sir Bruce Keogh, the Med-
ical Director for NHS England (Keogh, 2013), fourteen trusts with unusual performance
were identiﬁed based on measures adjusted for patient risk factors only. A subsequent
detailed assessment of performance was made in the light of other provider-level data
such as staﬀ levels and sociodemographic data for the area. Similarly, the Summary
Hospital Mortality Indicators (SHMI) for English hospitals are published alongside a se-
ries of contextual indicators to help users interpret the results (Health and Social Care
Information Centre, 2016b). One such indicator is palliative care, which is not adjusted
for because of the variability in how data are recorded. Figure 3.1 shows an example
from the 2015 report (Health and Social Care Information Centre, 2016b) illustrating
where NHS Trusts who are repeat outliers for mortality lie regarding the level of pallia-
tive care coding. Of the ten trusts whose mortality was lower than expected, seven had
a higher than average proportion of deaths recorded as palliative care. If palliative care
had been adjusted for, the SHMI for these trust would have been even lower.
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Figure 3.1: Percentage of deaths with palliative care coding for all NHS Trusts and
those which are repeat outliers, January 2015-December 2015; c© 2015 Re-used with the
permission of the Health and Social Care Information Centre. All rights reserved.
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3.2 Risk adjustment for the thesis
Based on the above considerations, at the individual level I will only adjust for estab-
lished risk factors measured at or before birth which are not inﬂuenced by neonatal
care. I will consider several factors at the provider level, and again these should not
be inﬂuenced by the provider. For feasibility with regard to implementing the methods
developed in this thesis as part of routine reporting, all factors should be available in
the NNRD, clearly deﬁned and well recorded.
3.2.1 Clinical risk factors
Externally developed risk scores are often used for case-mix adjustment in provider
proﬁling studies (DeLong et al., 1997; Glance et al., 2003). They have the advantage
of being externally validated and reducing risk of subjectivity but may not capture
illness severity well for the cohort in question. Several risk scores have been developed
for the neonatal population such as CRIB (Clinical Risk Index for Babies) II (Parry
et al., 2003), SNAPPE (Score for Neonatal Acute Physiology Perinatal Extension) II
(Richardson et al., 2001) and PREM (Prematurity Risk Evaluation Measure) (Cole
et al., 2010). These scores have been developed to aid decision making for clinicians and
parents as well as for risk-adjustment. Some of these scores include variables which might
reﬂect care received. For example, CRIB II (Parry et al., 2003) includes temperature
at admission which is is a marker of the condition of the baby but can be inﬂuenced by
care (Guenther et al., 2015; Manktelow et al., 2010). Others include variables not well
recorded in the NNRD, such as base deﬁcit (a measure of the acid-base balance in the
blood) which is part of CRIB II and the PREM score (Cole et al., 2010). Some scores
are only suitable for a subset of the infants included in the cohort here. For example
the Neonatal Research Network of the National Institute of Child Health and Human
Development developed a prediction model for infants up born 22 to 25 weeks gestation
(Tyson et al., 2008). Given the multitude of models available and the inclusion of
unsuitable or unavailable variables in some models, I chose to develop an internal risk-
adjustment model, basing choice of risk factors on those used in existing models to
ensure only established predictors were included and to reduce subjectivity in variable
selection (Glance et al., 2006). This will be described in sections 3.3 and 3.4.
3.2.2 Sociodemographic factors
Some studies of variation perinatal mortality such as the reports produced by MBRRACE-
UK (Manktelow et al., 2016) have included socio-economic status (SES) as a risk factor.
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Associations between SES and both increased infant mortality and increased risk of
preterm delivery have been documented (Gray and McCormick, 2009; Kramer et al.,
2001) but the inﬂuence of SES on mortality in the preterm population is less well es-
tablished (Smith et al., 2009). The relationship is diﬃcult to assess partly because of
the number of contributing factors (for example income, education, employment, with
measures possibly considered at maternal, paternal and neighbourhood levels). Calling
et al. (2011) found substantial increases in infant mortality comparing low and high
income families in a study of nearly 50,000 preterm infants (< 37 weeks) in Sweden.
Smith et al. (2009) found no evidence of a link in the Trent region of the UK, though
the study was smaller, the population diﬀerent (< 32 week infants) and area-level rather
than individual measures of deprivation were used. A fundamental issue for assessing
the inﬂuence of SES on mortality for preterm infants is that the causal relationships
are complex: preterm birth is on the causal pathway between low SES and increased
mortality, so conditioning on gestation by only examining preterm infants may result
in biased inferences (Herna´n et al. (2002) illustrate this phenomenon in a perinatal
context). Neither Calling et al. (2011) nor Smith et al. (2009) raised the diﬃculty of
drawing causal inferences when conditioning on a mediating factor.
In the NNRD deprivation is only available at the area level rather so may not be
an accurate reﬂection of the circumstances at the individual level which is of interest
here. In particular for provider proﬁling, some areas may be more mixed than others
regarding deprivation, so the suitability of the area-level measure may be inconsistent
across providers. The only individual-level measure of SES in the NNRD is parental
occupation, but this is free text and is poorly completed. Ethnicity exhibits some of
the same risk-adjustment issues as SES: racial and ethnic groups have varying rates
preterm birth and infant mortality (Goldenberg et al., 2008; Manktelow et al., 2016),
and between-provider variation is likely to be due to diﬀerences in the local population.
Maternal ethnicity is over 90% complete but some categories are ambiguously deﬁned
(see table 2.2). Paternal ethnicity is only 70% complete and ethnicity of the infant is
not recorded in the NNRD.
In section 3.1 I discussed the advantages and disadvantages of adjusting for sociode-
mographic factors. Neonatal units (NNUs) are not rewarded or sanctioned on the basis
of their mortality rates, nor is this information currently publicly available, although
mortality data are published by neonatal network. Therefore some of the concerns that
lack of adjustment will drive inequality are not as applicable here. Given the quality of
SES and ethnicity data, and the conceptual diﬃculties of the associations with mortal-
ity, I have elected not to adjust for sociodemographic factors in this thesis. This has
implications for the interpretation and utility of the results which will be discussed in
section 3.5. Stratiﬁcation is not reasonable due to low number of infants at each NNU,
but area-level deprivation and maternal ethnicity are considered as contextual factors
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in the case study of chapter 8.
3.2.3 Adjusting for transfer status
In chapter 1 I described how transfers are an integral part of networked neonatal care
because not all services are provided at every NNU. Transfers in the NNRD were anal-
ysed in section 2.3.3, which showed diﬀerent patterns in infant characteristics, mortality,
timing of deaths and location of care. The need for transfer indicates that the infant
has complex needs, but conversely that they have survived long enough and are stable
enough to be transferred. This was demonstrated in chapter 2 as transferred infants had
lower gestational age and birth weight but there were fewer deaths within the ﬁrst 24
hours. In addition to the ﬁndings in the previous chapter, several studies have demon-
strated increased mortality or morbidity following transfers (Delaney-Black et al., 1989;
Hohlagschwandtner et al., 2001; Modanlou et al., 1979; Towers et al., 2000).
Therefore transfer is associated with the mortality, and as demonstrated in section
2.3.3 transfer rates vary across NNUs. This raises the question of whether we should
control for transfers in a provider proﬁling analysis. The need for transfer may tell us
further information about the condition of the infant which is not captured by the known
risk factors. However transfers are part of care provided by the NNU currently caring
for the baby as it is their responsibility to arrange the transfer, and so is on the causal
pathway between the provider’s actions and the outcome and should not be adjusted
for (section 3.1.1). Appropriate transfers are a sign of good care, but if the need for
transfer arose after birth it is possible that this need was a result of inadequate care.
The need for postnatal transfer could be a result of the failure to organise an in-utero
transfer (Gale et al., 2012a). Whether the transfer is part of care from the point of
view of the receiving NNU is less clear. While they have not yet cared for the infant,
they are involved in the arrangement of the transfer, and failed in-utero transfer may be
partly attributable to the receiving NNU (e.g. because of capacity management issues or
communication problems) (Gale et al., 2012a; Kempley et al., 2006). Network policies
and attributes are likely to have an impact on whether a transfer occurs, and when
it occurs. While there are national guidelines, networks have their own care pathways
contingent on the properties and locations of the NNUs in the network, and these specify
which infants should be transferred to a NICU. Initiatives such as a dedicated transfer
service to help organise in-utero transfers will aﬀect the likelihood and timing of transfer
(Kempley et al., 2006). Therefore from a network perspective transfers are under the
inﬂuence of care.
Within the data available in the NNRD, reasons for transfer do not meet the criteria
of being well-deﬁned clinical data (section 2.3.3). Whether an infant was transferred in-
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utero cannot be determined from the NNRD. We do know if a mother booked to deliver
at a diﬀerent location to the ﬁrst neonatal admission, but we do not know whether she
presented for delivery there and was subsequently transferred. The need for transfer is
merely a surrogate marker for underlying conditions, and the data we have only indicate
postnatal transfers which actually occurred. Diﬀerent types of transfer will indicate
diﬀerent illness severity but these types are not clearly deﬁned and are not estimable
from the data. We also do not know whether the need for transfer was present at birth.
This cannot be assumed even for very early transfers as even the ﬁrst minutes and hours
after birth are crucial (Empana et al., 2003; Fenton et al., 2004; Mohamed et al., 2010).
Another factor to consider in risk adjustment is whether the variable has a consistent
eﬀect across providers. Non-transferred infants include successful in-utero transfers as
well as those not needing transfer. If, on average, transferred infants have poorer out-
comes, then adjusting for transfer will penalise NNUs and networks who are better at
facilitating in-utero transfers as these infants will be assumed to have the risk level of a
non-transferred infant. As previously mentioned the need for transfer might be induced
by inadequate care; in such cases controlling for transfer will “adjust away” the very
eﬀect we are interested in.
Therefore I am not going to adjust for transfers as a risk factor in this thesis but
will consider results in light of transfer rates in chapter 7.
3.2.4 Provider-level variables
Neonatal units are designated at diﬀerent levels depending on the types of care they
provide (see section 1.2) so we would expect there to be variation in case-mix across
NNU levels, some of which is accounted for by known, measured risk factors. It may also
be that NNU level captures unmodelled variation in case-mix as additional (possibly
unmeasured) information about the sickness of the infant available before birth may
determine where they are cared for, either via planned place of delivery or in-utero
transfer. In section 2.3 I examined how the volume and intensity of care varies across
NNUs. Even within this cohort of very preterm infants SCBUs provided a lot less
intensive care, and a much lower volume of care. Deaths are more likely to occur
in higher level NNUs, and discharges home (or to a paediatric ward) are more likely to
occur from a lower level NNU. Therefore it may not be sensible to compare across NNUs
levels. NNU level is also a an objective, clearly deﬁned and pre-assigned measure. One
of the aims of case-mix adjustment is to compare like with like; including NNU level
in the model allows us to do this, and to estimate any diﬀerence between levels as was
discussed in section 3.1.1.
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Volume of care is another NNU characteristic which is sometimes adjusted for in
provider proﬁling studies, including in neonatal care (MacNab et al., 2005). It can
be speciﬁed in a number of diﬀerent ways, for example the number of very preterm
admissions, or the number of intensive care days. Adjustment for volume to reﬂect
peer group may not be necessary in the neonatal case as NNU level already serves
this purpose, however the analysis in section 2.3.2 shows there is considerable variation
in volumes within NNU level. The association between higher volumes and improved
outcomes forms the basis of the clinical arguments for centralisation (Cifuentes et al.,
2002; Phibbs et al., 1996). Watson et al. (2014), in an instrumental variable analysis
of NNRD data, showed a negative causal eﬀect of case volume on mortality. However,
this does not preclude a causal association in the opposite direction: well-performing
NNUs may through reputation attract higher volumes. In the UK, mothers can book to
deliver wherever they choose, though this requires a choice of hospitals oﬀering maternity
services within a reasonable distance. If this is the case, volume is on the causal pathway
between NNU performance and mortality, so I have chosen not to control for volume
in this thesis. In an approach similar to reports for the SHMI depicted in ﬁgure 3.1, I
will illustrate how descriptive data on NNU volume can contribute to a case study for
a single NNU in chapter 8.
The UK Neonatal Staﬃng study (2002) found that NICU mortality increased when
operating at either higher capacity or with higher infant-to-nurse ratios. Cot occupancy,
staﬃng levels and a perhaps summary measures of the characteristics of co-patients could
therefore be considered as risk factors. As discussed in section 2.3.3 it is not possible to
determine capacity or staﬃng levels from NNRD data. It is also arguable that capacity
should be considered part of the NNU eﬀects, and not a factor beyond provider control
which should be included in the adjustment. Therefore I do not consider capacity further
here. Other characteristics which are not attributes of the NNU but could be considered
as provider-level variables are economic indicators for the area, such as unemployment
rates. I am not considering adjusting for the reasons described in 3.1.1, but will include
area-level deprivation as a factor in the case study in chapter 8, along with maternal
age and ethnicity, to illustrate how such data can give context to mortality indicators.
The statistical methods for including provider-level variables will be reviewed in
chapter 4, and implementation set out in chapter 5. For the remainder of this chapter
I focus on developing a model for individual-level risk factors.
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3.3 Selection of infant risk factors
3.3.1 Literature review
Medlock et al. (2011) carried out a systematic review of prediction models for mortality
of preterm infants, one of the aims of which was to identify important predictor variables.
I selected infant risk factors based on the ﬁndings of this review. The authors searched
the MedLine database for studies which provided mortality predictions for infants born
before 32 weeks gestation and/or below 1500g birth weight, or subpopulations of this
group provided they did not have a speciﬁc disease or condition. Some assessment of
model performance had to be reported for the study to be included. Full methods for
the study and the resulting papers can be found in the published paper.
As there may have been further developments since publication of the study, I up-
dated the search using the same search strategy for papers published after May 2010
(the search date given by Medlock et al.). The search is up to date as of 11th April 2016.
This yielded 25 further relevant studies but this did not yield any further variables (see
appendix B for details). Two other reviews of predictive models were identiﬁed (Dor-
ling et al., 2005; Pollack et al., 2000), neither of which were systematic reviews. These
studies were identiﬁed by Medlock et al., and so did not yield any additional models.
There were 41 studies included and 11 variables which the authors deemed to be
frequent predictors: gestational age (included in 24 studies out of 28 which examined
the variable), birth weight(29/36), appropriate size for gestational age (AGA, deﬁned as
between the 10th and 90th percentiles of birth weight for gestation, 10/22 studies), sex
(18/30), ethnicity (9/20), antenatal steroids (11/20), Apgar score(18/26), temperature
on admission (5/12), measures of respiratory status (blood gas (11/16) and FiO2 (6/7)
and respiratory function (9/19)).
Of the variables listed above, ethnicity, Apgar score, admission temperature and the
three respiratory measures were not considered suitable risk factors for provider proﬁling
purposes. I have chosen not to adjust for ethnicity for reasons described in 3.2.2. The
Apgar score is a quick assessment of newborn health by carried out in the ﬁrst minutes
after birth, but is a subjective measure with high interobserver variability (O’Donnell
et al., 2006). It is therefore possible that Apgar scores could be inconsistent across NNUs
and adjustment could bias estimates of NNU mortality rates via mechanisms described
in 3.1.1. If staﬀ members at the same NNU are likely to give similar Apgar scores,
this bias could be even stronger. Temperature and respiratory measures on admission
were excluded on the basis that they can be aﬀected by neonatal care, particularly as
NNU staﬀ are often present at the delivery of very preterm infants (Guenther et al.,
2015; Manktelow et al., 2010). Steps can be taken in the delivery room to raise the
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temperature of an infant prior to admission (e.g.occlusive wraps and radiant warmers
(Royal College of Paediatrics and Child Health, 2015)), and decisions on respiratory
support are usually made in the delivery room (Guenther et al., 2015).
This left gestational, birth weight, size for gestation, sex and antenatal steroids as
risk factors for inclusion in the model. I shall describe these factors in general terms in
section 3.3.2 before descriptive analysis and modelling using NNRD data in section 3.4.
3.3.2 Description of risk factors and patterns of association
Gestational age Gestational age estimates can diﬀer depending on whether they are
determined from the date of last menstrual period (LMP), or by the ultrasound dating
scan oﬀered to all women at week 10-14 of pregnancy. The NNRD contains the best
obstetric estimate which is initially based on LMP and can be modiﬁed on the basis of
antenatal ultrasound. This estimate of gestational age is unaﬀected by the NNU since
both the LMP and scan estimates would have been derived during antenatal care. If
neither LMP nor scan data are available at delivery then the gestational age recorded
is based on a postnatal estimate of maturity by clinical staﬀ. There may be diﬀerences
in the postnatal estimates of maturity, but since some estimate of gestation should
always be made as part of routine antenatal care (National Institute for Health and
Care Excellence, 2008) it is unlikely that a postnatal estimate would be required.
The relationship between gestation and neonatal mortality (within 28 days) across
the gestational age range was illustrated in ﬁgure 1.2 using data from all livebirths in
England and Wales from the Oﬃce of National Statistics. This showed that the risk of
mortality is not uniform within the preterm population. Most of the variability occurs
in the gestational range below 32 weeks, which is the population for this thesis. Of the
livebirths in England and Wales from 2007 to 2013, 93% of those born at or before 22
weeks died within 28 days. Mortality decreases dramatically with each additional week
of gestation for these extremely preterm infants: 69% died after birth at 23 weeks, 38%
at 24 weeks, 23% at 25 weeks, 15% at 26 weeks and 10% at 27 weeks. After this the
reductions are less steep, with neonatal mortality of infants born at 31 weeks being 2.2%.
Thus the beneﬁt of an additional week in-utero is non-linear, decreasing as gestation
increases, though as previously described in section 1.1 a survival disadvantage remains
for those born even slightly before term.
Birth weight As discussed in section 2.2.2, birth weight is often used to classify
infants, with low birth weight indicating those at higher risk of mortality and morbidity,
even through to later life. I have chosen to use gestational age to deﬁne the population
analysed here, but within preterm infants birth weight is still an important predictor,
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as demonstrated by the frequency with which it appears in the prediction models for
survival of preterm infants described above.
Higher birth weight is not always better: when mortality across the birth weight
range for is examined for all newborns we see a reverse J-shaped pattern consistent
across populations (Basso and Wilcox, 2011; Wilcox, 2001). This shape is a steep decline
in mortality with birth weight for much of the range with the lowest rates lying between
one and two standard deviations above the mean, followed by an uptick for the highest
values. This pattern of adverse outcomes at the relatively higher birth weight values
is not so established for preterm infants, but has been demonstrated in some studies.
Da Fre` et al. (2015) found higher odds of mortality for those on or above the 90th
centile compared with those in the 75th to 89th centiles amongst infants born less than
32 weeks . In developing the PREM score for predicting survival for infants born less
than 32 weeks gestation, Cole et al. (2010) found a notable survival disadvantage in
infants with birth weight two standard deviations above the gestation-speciﬁc mean,
with the strength of the disadvantage increasing with gestation. Models were ﬁtted
in two separate datasets and the non-linearity was observed in both, reducing chances
of a spurious association. Cooke (2007) found that for infants born below 35 weeks
gestation, there was no diﬀerence in mortality for infants with a large birth weight for
gestation (greater than three standard deviations above the mean) compared with those
of average size, though the length of the study (25 years) could confound the associations
as both overall survival and composition of the population is likely to have changed in
the period.
Size for gestation As previously described birth weight can be expressed relative
to gestational age using z-scores (or equivalently percentiles) which indicate where the
infant’s birth weight lies on the gestation-speciﬁc distribution. The percentile of birth
weight for gestation is used to determine whether an infant is small (less than 10%),
appropriate (10 to 90%) or large (greater than 90%). It has been argued that these cut-
oﬀs are arbitrary as associations between fetal growth and subsequent health outcomes
are continuous (Oken et al., 2003; Wilcox, 2001).Such deﬁnitions may be useful for
identifying a cohort or for comparing rates of growth restriction in groups, but is an
unnecessary simpliﬁcation for modelling purposes where continuous data are available
as is the case here.
Sex Males are at higher risk of many adverse health outcomes throughout life, and the
perinatal period is no exception (Oﬃce of National Statistics, 2008; Peacock et al., 2012).
Preterm birth is more common in boys (Ingemarsson, 2003; Zeitlin, 2002); following
preterm birth boys are more likely to die in the neonatal period, due in part to lagging
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lung maturity (Costeloe et al., 2000; Peacock et al., 2012).
Antenatal steroids As discussed in section 1.1.3 routine administration of antenatal
steroids to women in preterm labour has played a part in the dramatic increase of survival
rates of preterm infants by improving lung function. The current guidelines from the
Royal College of Obstetricians and Gynaecologists (2010) state that the steroids are most
eﬀective when delivery occurs between 24 hours and 7 days after the second dose is given,
so preterm birth should ideally be anticipated at least 24 hours in advance of delivery.
In the NNRD, administration of antenatal steroids is recorded in two ﬁelds. One records
whether any dose of steroid was given at any point during pregnancy with the intention of
improving fetal lung maturation and the other records whether a complete or incomplete
course was given, though this does not include the timing and completeness was poor
for this ﬁeld.
3.4 Statistical modelling of infant risk factors
In this section I present NNRD data for the associations with mortality for each of
the risk factors selected in the previous section (gestational age, birth weight, average
size for gestation, sex and antenatal steroids). I then combine the risk factors in a
multivariable regression model and assess its predictive performance. Other methods
of standardisation exist which do not involve regression, but these are generally only
suitable for categorical risk factors (Aylin and Bottle, 2007). Note that the main methods
for the thesis will be presented in chapter 5; what follows here is a preliminary analysis
to establish the functional form of the continuous risk factors and assess the suitability of
the risk adjustment model prior to implementing hierarchical methods for the provider
proﬁling analysis. Hence I have not used hierarchical models here and the standard
errors for the covariates may be underestimated at this stage (see section 4.1 for further
discussion of this).
3.4.1 Methods
The data analysed in this section were as described in section 2.3. All statistical analysis
was carried out in Stata version 12 (StataCorp., 2011). Associations with mortality for
each risk factor were ﬁrst described using tables. Death before discharge was modelled
using logistic regression. All variables selected in section 3.3 were kept in the model;
the purpose of model selection here was to determine the shape of the associations with
continuous variables and how to model interactions. Let pi denote the probability that
infant i dies before discharge. To model the association between mortality and variables
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X1, ..., Xm which take values xi1, ..., xim for infant i then we have:
logit(pi) = log(
pi
1− pi ) = α+ β1xi1 + ...+ βmxim
Whether the mother received antenatal steroids was considered as a binary variable for
any dose, as data completeness was poor for whether a full course was given, and this
was how steroid use was generally treated in other prediction models in the review by
Medlock et al. (2011). For binary variables (sex of the infant and whether the mother
received antenatal steroids), exponentiating the β gives the estimated odds ratio (OR)
comparing one group the other. Continuous variables (gestational age and birth weight)
were mean-centred and standardised, so eβ gives the OR for a one standard deviation
increase in X, assuming a linear relationship between logit(p) and X.
Functional form for continuous variables
Linearity for continuous variables was checked by plotting the logit of observed mortality
rates against categories ofX. Non-linearity can be modelled using polynomials but these
can have undesirable properties (see section 3.5.3). Cubic plines are polynomials in X
joined at “knots” which allow the functional form to vary across the range of X. Forcing
the ﬁrst and second derivative of the functions either side of the knot to agree smooths
the spline at the knots. The tails (before the ﬁrst knot and after the last), are also
polynomials, but this can yield a poor ﬁt for extreme observations (Harrell, 2001). I
therefore used restricted cubic splines (RCS), also called natural splines, which are like
cubic splines but are ’restricted’ because they are constrained to be linear in the tails to
give improved ﬁt. From Harrell (2001), to model a variable X with a K-knot RCS, with
knots at values ki, i = 1, ...,K − 1 the terms X1, ..., XK to be included in the regression
model are given by:
X1 = X0
Xi+1 =
(X0 − ki)3+ − (kK − kK−1)−1{(X0 − kK−1)3+(kK − ki)− (X0 − kK)3+(kK−1 − ki)}
(kK − k1)2
i = 1, ...,K − 2 (3.1)
where
(a)+ = a a > 0
0 a  0
Models are in general sensitive to the number of knots but not to the location of the knots
(Durrleman and Simon, 1989; Harrell, 2001). I selected the number of knots from three,
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four or ﬁve based in minimising the Akaike Information Criterion (AIC) (Akaike, 1974)
and by inspecting plots of predicted values. The AIC is a measure of goodness-of-ﬁt,
penalised for the number of parameters so as to favour more parsimonious models and
avoid overﬁtting. The knots were at equally spaced percentiles of the variable, between
the 10th and 90th percentiles fo three knots and between the 5th and 95th percentiles
for four or ﬁve knots (Harrell, 2001).
Functional form for interactions
I followed recommendations of Harrell (2001) regarding model building with RCS. I
applied a Wald test to the joint null hypothesis that all the spline terms are equal to
zero, and if the null hypothesis was not rejected the variable was modelled as linear.
Then I plotted the spline function against the linear variable to check whether a the
spline could be replaced with a simpler function. If this appeared the case, I compared
the AIC of the spline model with that of the simpler function. If similar, I checked
whether there was evidence of non-linearity beyond the simpler function by creating a
5-knot spline of the simpler function and testing the joint hypothesis that all these terms
are zero. The aim of replacing the spline with a simpler function was to build a more
parsimonious model.
As described in section 3.3.2, gestational age and birth weight have interacting inﬂu-
ences which is one reason why z-scores are used. Reference populations used to calculate
z-scores diﬀer, although there is one standard in the UK endorsed by the Royal College
of Paediatrics and Child Health (Wright et al., 2010) which has been extended to include
infants born 23 weeks or later. I modelled birth weight in grammes rather than using
the standard z-score because it allows infants born at 22 weeks to be included.
I modelled the weight for gestation relationship using interaction terms in the re-
gression. This also avoids loss of information through categorisation of infants based on
size for gestational age as was discussed in 3.3.2. To determine any interactions involv-
ing spline terms, I began with the full model of all cross-products of the gestation and
birth weight terms. If the gestational age terms are denoted G1, ..., GS and the birth
weight terms are denoted B1, ..., BT then there are ST possible interactions given by
G1B1, ..., GSB1, G1B2, ..., GSB2, ..., G1BT , ..., GSBT . The strategy I took to reduce the
model was to apply Wald tests to check groups of interactions, testing the joint null
hypothesis that all terms are zero (Harrell, 2001):
• Full model vs. no interaction (test of ST terms)
• Full model vs linear x linear interaction G1B1 (test of ST − 1 terms)
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• Full model vs interactions involving linear birth weight terms G1B1, ..., GSB1 (test
of ST − S terms)
• Full model vs interactions involving linear gestation terms G1B1, ..., G1BT (test of
ST − T terms)
• Full model vs interactions involving linear terms G1B1, ..., G1BT , B1G2, ..., B1GS
(test of ST − S − T + 1 terms)
I reduced the model by removing the smallest set of term for which the null hypothesis
was rejected based on the tests above, using a p-value threshold of 0.05. I then repeated
the procedure to compare the resulting model with simpler models.
Plots of standardised Pearson residuals and Pregibon leverage were used to check
for poor ﬁt, departures from linearity and inﬂuential observations. The residual is
a measure of how much the observed value deviates from the predicted value (exact
deﬁnition can be found in Hosmer et al. (2013)). The leverage is a measure of how much
an observed covariate pattern deviates from average covariate patterns (see Pregibon
(1981) for deﬁnition).
Model performance and model comparison Discrimination (ability to diﬀeren-
tiate between infants that survived and those that died) was checked by calculating
the concordance-statistic, or c-statistic (Harrell et al., 1996). This is deﬁned as the
proportion of all possible pairs of individuals with discordant outcomes (where one has
the event and one does not) for which the model assigns the higher probability to the
correct individual. The c-statistic is equivalent to the area under the receiver operating
characteristic curve.
The Brier score was calculated as a measure of overall model ﬁt (Brier, 1950). The
Brier score is the mean squared error of the prediction. If infants i = 1, ..., N have
observed outcomes y1, ..., yN where 1 indicates death before discharge, the Brier score is
given by:
N∑
i=1
(yi − pˆi)2
Thus the Brier score takes values from 0 to 1 with smaller values indicating better ﬁt.
Calibration (comparability of actual and predicted survival) was checked using Cox’s
calibration (Cox, 1958; Miller et al., 1991). A logistic regression is constructed for the
outcome of interest against the linear prediction from the model that is being checked
(i.e. the logit of the predicted probabilities). If the model predicts perfectly the re-
gression intercept will equal 0 and the regression slope will equal 1. The intercept
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indicates if the overall predictions are too low or too high, with positive values indi-
cating under-prediction. The regression slope indicates if the predictions are under or
over-dispersed, with values over 1 indicating under-dispersion. By deﬁnition perfect cal-
ibration is achieved when the analysing the whole dataset used to build the model, so I
applied the calibration to gestational age subgroups (less than 28 weeks, and 28 weeks
or above).
Model performance may be over-estimated as the performance was assessed on the
same dataset used to build the model. Therefore the c-statistic, Brier score and Cox’s
calibration measures were corrected for optimism using bootstrapping (Harrell, 2001).
I took a bootstrap sample (a sample with replacement) of the dataset and estimated
the regression model on the sample with the same covariates but resulting in diﬀerent
parameter estimates, denoted modelboot. Each performance statistic for modelboot was
calculated on the bootstrap sample and the original data and optimismboot taken as
the absolute diﬀerence between these. This process was repeated 2000 times and an
estimate of the overall optimism was obtained as the average value of optimismboot.
The performance of the model was compared with three existing models to predict
death before discharge amongst preterm babies admitted to neonatal units:
1. CRIB II (Parry et al., 2003), a frequently used score based on data from infants
born in 1998-9 and admitted to a random sample of 35 UK NICUs;
2. a more recent UK model using data from The Neonatal Survey (TNS), an ongoing
data collection from NNUs in the East Midlands and Yorkshire region; (Manktelow
et al., 2013)
3. the National Institutes of Child Health and Development (NICHD) model (Tyson
et al., 2008) based on infants born 22+0-25+6 weeks gestation in 1998-2003 admit-
ted to 19 US hospitals.
While the NICHDmodel is based on older data from a diﬀerent country for a diﬀerent
gestational age range I have included it as a comparator because the accompanying web-
based prediction tool (National Institute for Child Health and Human Development)
means it is often used in clinical practice. Where the comparator model was restricted
to certain neonatal characteristics, the relevant subset of the NNRD cohort was used to
match the population. CRIB II required base deﬁcit data which was only available in
40% of observations and the TNS model is for white infants born at 23 weeks gestation
or over. The predicted survival rate, c-statistic, Brier score and the intercept and slope
from Cox’s calibration were compared between the NNRD and comparator models. For
Cox’s calibration the data were not split by gestational age as the data were already
subsetted according to the relevant population of each model.
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Non-linear terms and interactions mean the odds ratios for gestational age and birth
weight are not easily interpretable, therefore I constructed charts similar to those devel-
oped for the PREM score (Cole et al., 2010) to show associations in a more meaningful
manner. Contours indicating infants with the same survival probabilities are shown
across the gestational age and birth weight range. Birth weight relative to gestation is
shown by the birth weight centiles, calculated from the Royal College of Paediatrics and
Child Health (RCPCH) growth charts (Wright et al., 2010) which extend to preterm
infants. The probability of survival rather than death was shown as these charts were
intended for use in clinical practice.
3.4.2 Results
The overall distribution of all risk factors was shown in table 2.2. Associations with
mortality are shown in table 3.1. Mortality decreased with increasing gestational age.
It also decreased with increasing birth weight with a slight increase in mortality for the
highest birth weights, though the numbers were small. For gestational age and birth
weight the associations are both non-linear, as shown in ﬁgure 3.2 which plots logit(p)
for the observed probability of death in each category of gestation and birth weight in
table 3.1. Mortality was higher for males (10.9% vs 9% for females) and for those whose
mothers were not given steroids antenatally (18.8% vs 8.8%). The only risk factor with
any missing data was antenatal steroids, which was missing for 217 (1.3%) infants. The
mortality rate for those with missing data was 10%, identical to the cohort as a whole
(see table 2.2). These infants were excluded from subsequent analysis as numbers were
small. Note that the infants with missing birth weight z-score are those born at 22 weeks
gestation to whom the RCPCH reference does not apply.
Functional form for continuous variables
Table 3.2 shows the AIC for models for gestational age and birth weight using 3, 4 and
5 knots.
For gestational age the 3-knot model was selected for parsimony; ﬁgure 3.3(a) shows
that there is little diﬀerence in the predicted probabilities, though the 5-knot model
predicted slightly higher mortality for infants born at 22 weeks, of which there are few.
A 3-knot model has 2 terms, one of which is linear. The second term improved the ﬁt
of the model (χ2 = 19.7 on 1 degree of freedom (d.f.), p < 0.0001) supporting the spline
model over a linear model.
For birth weight the 5-knot model minimised the AIC but for gestational age there
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Table 3.1: Distribution of infant risk factors for death before discharge by
survival status
Survived to discharge Died Total
n % n % n
Gestational age 22 4 16.7 20 83.3 24
(weeks) 23 147 39.3 227 60.7 374
24 539 61.3 341 38.8 880
25 773 77.8 220 22.2 993
26 1108 83.8 214 16.2 1322
27 1377 87.5 197 12.5 1574
28 1932 92.4 158 7.6 2090
29 2254 95.8 99 4.2 2353
30 2837 97.2 81 2.8 2918
31 3754 97.7 87 2.3 3841
Birth weight < 500 52 39.7 79 60.3 131
(g) 500− 749 1395 67.7 665 32.3 2060
750− 999 2848 85.8 470 14.2 3318
1000− 1249 3277 94.1 205 5.9 3482
1250− 1499 3233 96.3 124 3.7 3357
1500− 1749 2579 97.8 57 2.2 2636
1750− 1999 1061 97.4 28 2.6 1089
2000− 2249 219 95.2 11 4.8 230
 2250 61 92.4 5 7.6 66
Birth weight < −2 667 82.3 143 17.7 810
z-score∗ -2 to -1 2390 88.8 300 11.2 2690
-1 to 0 5807 89.3 699 10.7 6506
0 to 1 4968 92.6 398 7.4 5366
1 to 2 786 93.0 59 7.0 845
> 2 103 80.5 25 19.5 128
Missing 4 16.7 20 83.3 24
SGA† No 12551 90.5 1315 9.5 13866
Yes 2170 87.5 309 12.5 2479
Missing 4 16.7 20 83.3 24
Sex Female 6681 91.0 661 9.0 7342
Male 8044 89.1 983 10.9 9027
Steroids‡ No 1585 81.2 366 18.8 1951
Yes 12945 91.2 1256 8.8 14201
Missing 195 89.9 22 10.1 217
* BWT z-score calculated using the RCPCH reference Wright et al. (2010);
note this does not extend to infants born below 23 weeks gestation so z-score
is missing for these infants
† SGA Small for gestational age
‡ Any dose of antenatal steroids given to the mother
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Figure 3.2: Non linearity of gestational age and birth weight with log odds of death
Akaike Information Criterion
Gestational age Birth weight
3 knots 8525.5 8819.2
4 knots 8525.1 8814.5
5 knots 8524.1 8805.2
Table 3.2: Akaike Information Criteria to compare number of knots
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was little diﬀerence. Plots of predicted probabilities suggested the 5-knot spline could
be replaced with a more parsimonious quadratic model (i.e. with linear and squared
birth weight). This gave a lower AIC of 8799.3, but plots of predicted probabilities
indicated that the quadratic term may force curvature in the extremes of the data, as
indicated in ﬁgure 3.3. Both the 5-knot spline and the quadratic model ﬁtted the data
better than a linear association alone (χ2 = 278 on 3 d.f., p < 0.0001; χ2 = 297 on 3 d.f.,
p < 0.0001 respectively). A spline ﬁtted to the quadratic term showed no improvement
in ﬁt, therefore there was no evidence of non-linearity beyond the quadratic model. I
therefore developed separate models specifying the association with birth weight both
ways with a view to comparing the ﬁnal models.
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Figure 3.3: Predicted probabilities from logistic regression models for (a) gestational
age and (b) birth weight, using 3, 4 and 5 knot splines
Functional form for interactions
First I considered the full model with a 3-knot spline for gestational age, a 5-knot
spline for birth weight, and with sex of the infant and whether the mother received
any antenatal steroids as binary variables. Interactions between all gestational age
and birth weight terms were included. This is the full interactions model in table
3.3. Evidence supporting the inclusion of interactions involving only non-linear terms
(G2B2, G2B3, G2B4) was weak (p = 0.073). These were removed to give the model with
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only linear×linear and linear×spline interactions (the linear interactions model in table
3.3). From this model, there was no evidence to support the inclusion on any interactions
involving non-linear terms (G1B2, G1B3, G1B4, G2B1) either considered together (p =
0.43) considering separately those non-linear in gestation (p = 0.34) and birth weight
(p = 0.31). This resulted in a model with only the linear×linear interaction, for which
there was strong evidence for inclusion (p < 0.001). The ﬁnal spline model is given by
model (3) in table 3.3.
A similar procedure was carried out modelling birth weight with linear and quadratic
terms; results from regression models are shown in table 3.4. Again there was little
evidence from the full model (table 3.4 full interactions model) to keep the interaction
with only non-linear terms (G2B
2, p = 0.11) resulting in the linear interactions model
in table 3.4 . Removal of further interactions did not improve the ﬁt of the model.
The AIC of the ﬁnal model with birth weight as a 5-knot spline was 8238 compared
with 8227 modelling birth weight as quadratic, with 9 covariates in each model. One
concern evident in ﬁgure 3.3 was that the quadratic shape was forcing the shape of the
model and potentially producing poor ﬁt for observations in the tails of the birth weight
distribution. I investigated this using residual and leverage plots. Plots of standardised
residuals against birth weight and predicted probabilities (ﬁgure 3.4) showed no evidence
of non-linearity as the smoothed values for the mean (given by locally weighted regres-
sion) gave a straight line along zero. Note that unlike linear regression we do not expect
a random scatter as all observed values are either zero or one. There was no evidence
of a diﬀerence between models for particular birth weight or probability ranges based
on patterns of residuals (ﬁgure 3.4). Some observations had disproportionate leverage
in the quadratic model (ﬁgure 3.5) compared with the spline model (ﬁgure 3.6). The
predicted probability of death was around 0.2 for these observations and they were for
infants of high birth weight and gestation approaching 32 weeks. The residuals were
small, indicating that they survived (as the observed outcome was close to the predicted
probability) and that the model ﬁts reasonably well for these observations. A sensitiv-
ity analysis was run excluding observations with leverage over 0.04, which gave almost
identical results to the model on the whole dataset. I therefore selected the quadratic
model as the ﬁnal model for the data as it gave the lowest AIC. The odds ratios for the
ﬁnal model and the sensitvity analysis are shown in table 3.5.
Figure 3.7 illustrates survival probabilities relative to gestational age and birth
weight. Probabilities depend on whether the infant is male or female and whether the
mother was given antenatal steroids, therefore the resulting charts will diﬀer. Figure
3.7 shows two charts: 3.7(a) for females whose mothers were given antenatal steroids
and 3.7(b) for males whose mothers were not given antenatal steroids, with the former
having better survival propsects as indicated by the odds ratios in table 3.5. Survival
89
Full Linear Simple
Male 0.35 0.34 0.34
(0.23,0.46) (0.22,0.46) (0.22,0.45)
Steroids -0.83 -0.83 -0.83
(-0.98,-0.68) (-0.98,-0.68) (-0.98,-0.68)
G1 -1.21 -1.69 -1.83
(-1.96,-0.46) (-2.21,-1.18) (-2.18,-1.49)
G2 -0.52 0.96 0.78
(-2.17,1.13) (0.45,1.48) (0.47,1.10)
B1 -1.87 -2.40 -2.44
(-2.71,-1.02) (-2.98,-1.83) (-2.83,-2.04)
B2 4.74 8.30 9.08
(-1.38,10.9) (4.75,11.8) (6.74,11.4)
B3 -10.9 -23.2 -24.5
(-33.5,11.8) (-35.7,-10.8) (-32.6,-16.4)
B4 10.1 29.3 26.7
(-24.7,44.9) (11.6,46.9) (15.5,37.9)
G1B1 -0.24 -0.58 -0.66
(-0.76,0.29) (-0.94,-0.22) (-0.86,-0.46)
G1B2 -4.04 -1.22
(-9.40,1.32) (-4.21,1.78)
G1B3 17.9 3.24
(-10.1,45.8) (-6.85,13.3)
G1B4 -49.4 -5.39
(-117.9,19.2) (-21.3,10.5)
G2B1 -0.91 0.24
(-2.18,0.35) (-0.25,0.73)
G2B2 7.15
(-0.95,15.3)
G2B3 -25.0
(-53.9,3.93)
G2B4 42.3
(-6.90,91.4)
Intercept -4.23 -4.95 -5.04
(-5.38,-3.09) (-5.72,-4.18) (-5.64,-4.43)
Table 3.3: Comparison of regression coeﬃcients (95% conﬁdence intervals) for models
with diﬀerent gestational age-birth weight interactions; birth weight modelled as a 5-
knot spline
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Full Linear
Male 0.34 0.34
(0.23,0.46) (0.23,0.46)
Steroids -0.83 -0.84
(-0.98,-0.68) (-0.99,-0.69)
G1 -2.26 -2.11
(-2.79,-1.74) (-2.60,-1.61)
G2 1.18 1.09
(0.73,1.63) (0.66,1.53)
B -0.36 -0.23
(-0.63,-0.080) (-0.45,-0.0038)
B2 0.57 0.67
(0.41,0.74) (0.55,0.78)
G1B -1.61 -1.26
(-2.27,-0.94) (-1.77,-0.75)
G1B
2 -0.43 -0.26
(-0.68,-0.19) (-0.38,-0.14)
G2B 0.57 0.35
(0.12,1.02) (0.015,0.69)
B2G2 0.14
(-0.031,0.31)
Intercept -3.26 -3.23
(-3.62,-2.90) (-3.59,-2.87)
Table 3.4: Comparison of regression coeﬃcients (95% conﬁdence intervals) for mod-
els with diﬀerent gestational age-birth weight interactions; birth weight modelled as
quadratic
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increases with gestation, with steeper absolute increases at earlier gestations indicated
by the closer contours. Survival in general increases with birth weight, though adverse
eﬀects of being very high birth weight for gestation can be seen at later gestational ages.
Final Sensitivity∗
Male 1.41 1.41
(1.25,1.59) (1.26,1.59)
Steroids 0.43 0.43
(0.37,0.50) (0.37,0.50)
G1 0.12 0.12
(0.074,0.20) (0.074,0.20)
G2 2.98 2.96
(1.93,4.61) (1.90,4.61)
B 0.80 0.80
(0.64,1.00) (0.64,1.00)
B2 1.95 1.95
(1.74,2.18) (1.74,2.18)
G1B 0.28 0.29
(0.17,0.47) (0.17,0.49)
G1B
2 0.77 0.77
(0.68,0.87) (0.68,0.88)
G2B 1.42 1.41
(0.99,2.04) (1.02,1.99)
* Excluding six points with high leverage (0.04)
Table 3.5: Comparison of odds ratios (95% conﬁdence intervals) for ﬁnal model and
sensitivity analysis excluding inﬂuential observations
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Figure 3.4: Standardised residuals against (a) birth weight and (b) predicted probabili-
ties comparing spline and quadratic models for birth weight
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Figure 3.5: Leverage from quadratic model against (a) predicted probabilities (b) stan-
dardised residuals (c) birth weight and (d) gestational age
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Figure 3.6: Leverage from spline model against (a) predicted probabilities (b) standard-
ised residuals (c) birth weight and (d) gestational age
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Model performance Table 3.6 shows the model performance statistics before and af-
ter correcting for optimism. The model showed good predictive performance (c-statistic
above 0.8, Brier scores and calibration intercepts close to zero and calibration slopes close
to one) with little diﬀerence between the apparent and optimism-corrected estimates.
Apparent Corrected
c-statistic 0.8214 0.8205
Brier score 0.0725 0.0727
Infants < 28+0 weeks gestation
Calibration slope 1.028 1.030
Calibration intercept 0.023 0.025
Infants  28+0 weeks gestation
Calibration slope 0.971 0.957
Calibration intercept -0.077 -0.117
Table 3.6: Comparison of apparent and optimism-corrected performance statistics
Model performance statistics compared with three other models are shown in table
3.7. For all models the predicted mortality for the NNRD model was closed to the
observed mortality than that predicted by the other models. Discrimination (indicated
by the c-statistics) and overall ﬁt (Brier score) were generally fairly similar comparing
the NNRD model with both he TNS and CRIB II models, with slightly better results
compared with the NICHD model. The NNRD was in general better calibrated than
the other models, though predictions for the NICHD model were under-dispersed. The
comparator models all gave predictions that were too high and over-dispersed.
Table 3.7: Comparison of NNRD model performance with: (i) the Trent Neonatal Survey model (TNS) (ii)
National Institutes of Child Health and Development model (NICHD) and (iii) the updated Clinical Risk
Index for Babies score (CRIB II)
TNS NICHD CRIB II
TNS NNRD NICHD NNRD CRIB II NNRD
N 10900 2252 6002
Obs. mortality n(%) 1055 (9.7) 799 (35.5) 529 (8.8)
Pred. mortality (%) 10.6 9.9 46.2 36.3 7.7 8.5
c-statistic 0.81 0.82 0.60 0.72 0.81 0.80
(0.80,0.83) (0.81,0.83) (0.58,0.63) (0.69,0.74) (0.80,0.83) (0.78,0.82)
Brier score 0.072 0.072 0.242 0.198 0.068 0.067
Calibration slope 0.88 1.00 0.48 1.24 0.76 1.00
(0.83,0.93) (0.95,1.04) (0.36,0.59) (1.09,1.39) (0.70,0.83) (0.92,1.08)
Calibration intercept -0.32 0.00 -0.54 0.09 -0.26 0.05
(-0.42,-0.22) (-0.10,0.09) (-0.62,-0.45) (-0.04,0.21) (-0.42,-0.09) (-0.13,0.23)
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3.5 Discussion
3.5.1 Summary
In this chapter I selected the covariates for risk adjustment. Transfers are a crucial
aspect of the thesis and known to be associated with mortality in a number of ways, so
were also considered as a risk factor but rejected as transfer management is an integral
part of care provided by both NNUs and networks. I considered level of NNU and volume
of care as possible provider-level characteristics. I selected only level of NNU as this is
an objective, pre-assigned measure whereas volume may be inﬂuenced by care through
increased referrals. Sociodemographic data such as ethnicity were not considered for
inclusion due to data quality, and because doing so can reduce the ability to draw desired
inferences about providers. Established clinical risk factors used in existing models
were gestational age, birth weight, average size for gestation, sex, ethnicity, antenatal
steroids, Apgar score, temperature on admission, measures of respiratory status. Of
these, Apgar score, temperature on admission, measures of respiratory status were not
selected because they may be inﬂuenced by initial neonatal care provided on the labour
ward, rendering these variables inappropriate for provider proﬁling purposes. Average
size for gestation is a reﬂection of birth weight for gestation, so I chose to model this
as an interaction so as not to lose information by categorisation. I then described
these variables in the NNRD data and their associations with mortality. I modelled the
interacting inﬂuences of gestational age and birth weight on mortality using restricted
cubic splines. The model showed good discrimination and calibration compared with
other existing prediction models.
3.5.2 Selection of risk factors
I chose to select variables based on the review by Medlock et al. (2011) rather than
conduct a repeat review of the literature. This study also formed the basis for risk
adjustment for other work produced by the Neonatal Data Analysis Unit (Modi et al.,
2016; Watson et al., 2014). The search strategy of Medlock et al. seemed adequate, the
review included all studies identiﬁed by other earlier (non-systematic) reviews, and no
further variables were found by updating the search. Therefore, while risk adjustment
models are never perfect it seems unlikely that any major clinical predictors have been
missed for the purposes of this thesis. Nonetheless there is the potential for inconsistency
in the variables selected. I only considered the variables deemed frequent predictors by
Medlock et al.. The authors did not give their exact criteria for this regarding inclusion
in ﬁnal prediction models, though they did state that those variables had to be tested
in at least ten studies. There were several other predictors which were examined in
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several studies but not classed as frequent predictors including maternal health risks
such as pregnancy-related hypertensive disorders. Application of diﬀerent criteria could
have resulted in diﬀerent variables being selected. Furthermore individual studies used
diﬀerent methods for variable selection, and smaller studies might not have suﬃcient
power to detect small eﬀects. An alternative and perhaps more comprehensive approach
might be to include all candidate variables in the risk adjustment model provided they
meet the criteria described in section 3.2
The factors we adjust for aﬀect the interpretation of the results and to what pur-
poses they can be used. The term “provider proﬁling” covers analyses with a wide range
of purposes, but broadly refers to the estimation, assessment or comparison of perfor-
mance indicators across multiple providers. In this thesis I am primarily concerned with
estimating risk-adjusted mortality rates for individual NNUs, rather than testing for
outliers or comparing NNUs with each other (the rationale for this approach is driven
by the data available and the methods used, and will be discussed in chapter 4). As
set out in the aims of the thesis (section 1.4) the purpose of estimating these rates is to
inform NNUs how the mortality for infants in their care compares with what we would
expect to see for similar infants attending similar NNUs. The choice of risk factors
governs the interpretation of “similar”. In this thesis I have adjusted for established
clinical risk factors but not sociodemographic variables for reasons discussed in sections
3.1 and 3.2, so the results are not adjusted for all the risk factors which are not under the
control of the provider. This means that if mortality at a particular NNU appears high
or low compared with what we expect, this is not necessarily caused by the provider as
we cannot rule out the inﬂuence of minor clinical risk factors or the sociodemographic
proﬁle of the patient population. The analysis is therefore useful as a starting point
for further investigation, rather than a conclusive estimate of performance. The current
situation is that NNUs have no provider-speciﬁc mortality data which includes trans-
ferred patients, so another use of the analysis is simply to provide information which
was not previously available. In chapter 8 I show how the results of the thesis could be
presented in a case study for a single NNU and describe how results could be used by
clinical and managerial staﬀ.
3.5.3 Statistical methods
There were 217 infants excluded because of missing data for antenatal steroids. As
discussed in section 2.2.7, 341 infants were already excluded because of missing outcome
data. The number of these infants is small and those with missing steroids data had a
mortality rate identical to the overall cohort so the impact of the missing data is likely
to be small. Techniques for handling missing data have been applied in some provider
proﬁling studies (Glance et al., 2009; Tekkis et al., 2003) and I will discuss how these
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can be incorporated into methods developed in this thesis in chapter 9.
I used restricted cubic splines to model the non-linear associations. Gestational
age can be considered as a categorical variable by week (or groups of weeks). While
this gives clear interpretation to the resulting parameters, given that a single week
can make such a big diﬀerence to mortality, rounding up or down by a few days is
non-negligible, and would be an unnecessary loss of information since the data are
available. Use of higher order polynomials (e.g. logit(pi) = α + β1xi + β2x
2
i ) is a
common option for non-linear associations and relatively easy to interpret (Cole et al.,
2010), with a more parsimonious if less interpretable variant in the form of fractional
polynomials (Manktelow et al., 2013; Royston and Sauerbrei, 2008) which allow non-
integer powers. These methods both have the disadvantage that the shape in some areas
(possibly only determined by a few data points) can force an incorrect relationship in
other areas of the distribution because the same functional form is assumed, as was
investigated here for the quadratic birth weight model. Another possible approach
generalised additive models, which describe complex relationships using sums of smooth
functions of the predictor of interest (Hastie and Tibshirani, 1986). The functions can be
non-parametric, so these models also oﬀer ﬂexibility without forcing the shape elsewhere.
Initial exploration using generalised additive models produced similar predictions but
a more thorough investigation is required to establish whether this method presents a
superior alternative.
3.5.4 NNRD data and associations with mortality
The validation exercise comparing NNRD data with that recorded independently for a
clinical trial (see section 2.1.3) found that data quality for the risk factors used here was
generally good with regard to diﬀerences that were classed as major discrepancies. The
proportion of infants with a major discrepancy recorded was 3% for gestational age (one
week or more), 0.9% for birth weight (100g or more), 0.2% for sex and 2.4% for antenatal
steroids. However 20.4% of infants had discrepancies of three to six days in their recorded
gestational age (up to two days was considered acceptable). In addition three of the
1258 infants had a diﬀerent survival outcome recorded. Errors can lead to biased results
in provider proﬁling studies if they are concentrated in particular providers. I have not
taken any further action in this thesis regarding checking for errors, but as described in
chapter 2, NNUs are given the opportunity to check and correct the data which feeds
into regular audit reports.
Gestation-speciﬁc mortality rates are very similar to those for neonatal mortality for
livebirths described in section 3.3.2. While this is not evidence of completeness of the
population, it is reassuring with regard to the potential for bias. Mortality was slightly
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lower at earliest gestations compared with Oﬃce of National Statistics data, possibly
because deaths soon after labour (prior to admission to neonatal care) are more likely
to occur at this age (see section 2.2.6). As described in section 1.1.3, mortality rates
for preterm infants, particularly those at the limits of viability, can vary across and
even within countries due to diﬀerences in resuscitation practices and other clinical
management decisions. The most similar cohort to that presented here come from the
EPICure 2 study (Costeloe et al., 2012) which found that of all infants born in England
in 2006 between 22+0 and 25+6 weeks gestation, 47% died before discharge. This ﬁgure is
considerably higher than the 36% found here, reﬂecting progress in survival of extremely
preterm infants over the past decade. Patterns of association between birth weight and
mortality are also similar to those described in the literature for all births. Mortality
decreased with birth weight, with the lowest mortality for infants with a z-score of
between 1 and 2, followed by an increase in mortality for those at the highest birth
weights.
3.5.5 Model performance and validation
There were minimal diﬀerences before and after optimism correction, possibly because
the sample size was large. Bootstrapping is advantageous over split-sample validation
because all the data can be used for developing the model. Although the overall sample
was large, there are few infants born at lower gestations and few deaths at the upper
gestations so using all available data was preferable. As stated in section 2.2.1 I did
not use data outside 2011-2013 because of incomplete population data prior to this
period and changes to the structure of neonatal services afterwards (these changes will
be discussed further in 9).
A strength of the analysis was that variable selection was based on evidence from the
literature rather than model-based selection, which can result in overﬁtting. Functional
form and interactions for gestational age and birth weight were determined as part of
the modelling process. This procedure could have been made more robust by applying
bootstrapping techniques to model selection as well as to correct for over-optimisim.
This is feasible for automated model selection procedures but more diﬃcult otherwise,
particularly if graphical assessment is used. As the NNRD is constructed from an
ongoing data collection a better way to validate all aspects of the model would check its
predictive properties on an independent dataset from a later time period.
The probabilities of death cover a wide range and gestational age is very discrimi-
natory, which means that the c-statistic will be high for any model incorporating ges-
tational age. This is supported by the c-statistic being lower for the models which use
smaller subgroups. The model performed well against comparator prediction models.
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The discriminatory power of existing models was good but calibration was poor and
the models in general over-predicted mortality. This could be because of population
diﬀerences but also because survival of preterm infants has improved since they were
developed. Comparator models also all gave over-dispersed values which is perhaps
more surprising as this result is usually an indication of over-ﬁtting (Steyerberg et al.,
2010), but these models were not ﬁtted to this dataset. A possible explanation for
this is that as the reductions in mortality seen over time have by and large been for
the lowest gestations (section 1.1.3), so the variability in predicted mortality will be
reduced, resulting in less dispersed predictions. The comparator models might have
performed better if re-calibrated to this population (Manktelow et al., 2010), presenting
an alternative approach to developing a model internally.
The results of this chapter provide the risk adjustment strategy to be adopted for
the rest of the thesis. In the next chapter I review methods for provider proﬁling; the
risk-adjustment developed here will be incorporated into the methods arising from this
review in chapter 5.
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Chapter 4
Review of hierarchical models
and provider proﬁling methods
The aim of this chapter is to summarise existing methods relevant to the research ques-
tions of this thesis. In chapter 1, I introduced provider proﬁling and brieﬂy described
how a class of statistical models known as hierarchical models are often used for such
studies. In section 4.1, I deﬁne hierarchical models and consider their use in provider
proﬁling studies generally and for this thesis. This is followed in section 4.2 by a system-
atic review of the literature to establish how patient transfers are handled in existing
provider proﬁling studies. I then introduce multiple membership models as a potential
method for allowing for transfers, and review their applications in the literature (section
4.3). Finally, in section 4.4 I will discuss alternative approaches and relate the ﬁndings
of the chapter to the aims of the thesis.
4.1 Hierarchical models
The aim of this section is to deﬁne a basic logistic hierarchical model and some of its
extensions, review the use of hierarchical models for provider proﬁling, and then discuss
the extent to which they can be used to answer the research questions of the thesis.
4.1.1 Deﬁnition
Observations often fall into groups, as seen in both in analysis of healthcare data (pa-
tients at the same GP surgery) and elsewhere (pupils in the same class, employees at
the same company, piglets in a litter). Observations in the same cluster are likely to
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a)
b)
individual (level 1)
group (level 2)
individual (level 1)
group (level 2)
group (level 3) 
Figure 4.1: Diagrams illustrating hierarchical data structures: (a) a two-level structure
of individuals within groups (b) As ﬁgure 4.1(a) but with the three levels, where each
group at level 2 is a member of a group at level 3
be correlated (e.g. due to peer group inﬂuence in a class), but standard statistical
models assume that all the observations are independent. Ignoring the structure of
the data by assuming independence leads to standard errors which are underestimated
for cluster-level variables and overestimated for individual-level variables (Rabe-Hesketh
and Skrondal, 2005). Hierarchical models (also called random eﬀects or multilevel mod-
els) provide a way of correctly accounting for dependencies in the data. It is said that the
observations are nested in clusters or levels. Figure 4.1(a) illustrates a basic two-level
structure. What follows is a brief introduction to hierarchical models; further details
can be found in standard texts such as Goldstein (2002); Rabe-Hesketh and Skrondal
(2005); Snijders and Bosker (1999).
Suppose we are interested in an outcome Y measured in N individuals and we wish
to adjust for some continuous covariate X. For consistency with the research question
for the thesis let Y be binary, and denote the probability of an individual i experiencing
the outcome as pi. As described when developing the risk adjustment model in section
3.4, we can model the probability as a function of the covariate using logistic regression:
logit(pi) = log(
pi
1− pi ) = α+ βxi (4.1)
In equation 4.1, α is the log odds of Y when X = 0 and β is the increase in the log
odds of Y corresponding to a one unit increase in X. We can obtain the odds ratio for
the eﬀect of X by exponentiating β. Suppose these N individuals are nested within J
clusters, for example patients treated at diﬀerent clinics. If we expect two patients in the
104
same clinic to have more similar values of Y than two patients in diﬀerent clinics, then
our observations are not independent. We can model the eﬀect of the cluster with an
additional term uj and the assumption that the uj arise from a common distribution,
for example Normal with mean 0 and variance σ2u. We also assume that the uj are
uncorrelated with covariates xij .
logit(pij) = α+ βxij + uj (4.2)
uj ∼ N(0, σ2u)
We use the subscript ij to denote individual i in cluster j. The uj is the increase in the
log odds of Y associated with cluster j. The uj can then be exponentiated to obtain an
odds ratio. This odds ratio is interpreted as the odds of Y for an individual in cluster j
compared with the odds of Y for an individual (with the same value of X) in an average
cluster. There is a slight change in the interpretation of the other parameters: α is
the log odds of Y when X = 0 and uj = 0, and β is the increase in the log odds of
Y corresponding to a one unit increase in X for individuals in the same cluster. The
cluster-speciﬁc interpretation of β in equation 4.2 is not the same as the covariate eﬀect
in the population as a whole (the interpretation in equation 4.1). This can be obtained
using a population-averaged (PA) model (also called a marginal model) (Szmaragd et al.,
2013). Population-averaged models present an alternative to hierarchical models for
analysing clustered data in some circumstances. In PA models the similarity between
individuals in the same cluster is not described using model parameters (the uj and σ
2
u
in equation 4.2), but is speciﬁed using a working correlation structure for the residuals
which describes the pattern of correlation with clusters. The correlation is considered a
nuisance parameter, rather than an aspect of the model that is of speciﬁc interest. The
between-cluster variance and cluster eﬀects cannot be estimated, so these models are
not suitable for the thesis and are not considered further here.
This model is often called a random intercept model as it is equivalent to allowing the
intercept term to vary randomly across clusters; in model 4.2 the intercept is decomposed
as a ﬁxed part α and a random part uj , with the uj called random eﬀects. Other
continuous or categorical covariates can be added to adjust for other factors either at
the individual level or the cluster level. The assumption of a common distribution
reﬂects the fact that the clusters are in some sense similar: if asked to guess the post-
operative morality rate for a surgeon, we might base the guess on the rates for other
surgeons, and perhaps close to other surgeons in the same hospital. It also means that
we only need to estimate one additional model parameter, σ2u, which tells us about
the amount of variation at cluster level. Without this assumption we would have to
estimate each uj independently, known as a ﬁxed eﬀects model. This may be infeasible
if there many clusters relative to the number of observations, and if some clusters are
small the estimates will be poor. In addition, ﬁxed eﬀects model cannot be used to
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model more than two levels of the hierarchy, accommodate cluster-level covariates, or
model variation in covariate eﬀects across clusters (see section 4.1.3 for how these can
be achieved using hierarchical models). However ﬁxed eﬀects models do not require the
assumption that the uj are uncorrelated with the other covariates.
In practice normal random eﬀects are the default option, though this is a reasonable
choice when the residual variation between clusters is the result of small variations, as the
sum of these will be approximately normal (Ohlssen et al., 2007b). The t distribution
is similar to a Normal but with heavier tails and can be used in place of a Normal
distribution in the presence of outliers. In addition to the mean and standard deviation,
the distribution is determined by an additional parameter (the degrees of freedom, here
denoted ν). As ν increases, the t distribution tends towards Normal. The t distribution
accommodates outliers when the distribution is symmetric, but there may be situations
where there are outliers on one side of the distribution, which could be modelled by a
skewed distribution (Lee and Thompson, 2008). Other less restrictive distributions are
also possible, such as mixtures of Normals (Austin, 2009) or ﬂexible distribution using
non-parametric techniques (Ohlssen et al., 2007a).
4.1.2 Model estimation
Hierarhical models can be estimated in a number of diﬀerent ways. Whether we wish to
use a frequentist or Bayesian approach is one consideration aﬀecting estimation method.
Frequentist (also called classical) methods are often used as a default as they provide
analytical solutions for most standard estimation problems which is not the case for
Bayesian methods. The logistic regression models in chapter 3 were estimated in this
way. More detail on Bayesian methods including basic theory will be provided in section
5.1, but the fundamental diﬀerence is how we view probability. The Bayesian view of
probability is a degree of certainty, so we can assign a probability distribution to anything
including quantities for which an unknown true value exists (e.g. mean birth weight in
a population). We can do so regardless of whether we have any data (e.g. a sample of
1000 birth weights). This is not the case under a frequentist view: the mean birth weight
is a ﬁxed value and any uncertainty we have is only expressed about the experimental
data we have (e.g. the probability that a particular range constructed from our sample
of 1000 birth weights contains the unknown true mean).
Taking a frequentist approach, we can ﬁt the model in a variety of ways (e.g. re-
stricted maximum likelihood and iterative generalised least squares). Likelihood meth-
ods for binary outcomes entail the use of approximations such as Gaussian quadrature
and Laplace approximations. The diﬀerent methods vary in eﬃciency, can produce
slightly diﬀerent results and enable diﬀerent hypothesis tests to be used; further detail
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can be found in Rabe-Hesketh and Skrondal (2005). A second stage of estimation is re-
quired to obtain the random eﬀects denoted by uj . The maximum likelihood estimates
are obtained by plugging in the estimated model parameters (taking them to be the
certain true values) then estimating the cluster eﬀects as unknowns (Rabe-Hesketh and
Skrondal, 2005). This is carried out separately for each cluster and therefore cannot
be estimated for clusters with no events or with only events (e.g. a hospital where no
patients die, or a hospital where all patients die). The alternative approach predicts
the cluster eﬀects based on the most likely values for the model parameters, including
those of the common distribution of cluster eﬀects. Known as empirical Bayes, this
method uses Bayesian principles in that the cluster eﬀects are assingned a probability
distribution. Unlike full Bayes we are using the data twice (once for the likelihood and
once to estimates the parameters of the random eﬀect distribution) though there are
ways to correct for this overconﬁdence (Carlin and Louis, 2008).
We can use full Bayesian methods to ﬁt the model and estimate the random the
random eﬀects in one step (Gelman et al., 2004). One diﬀerence between frequentist
and Bayesian methods which is of relevance here is that all estimated quantities are
considered random, unlike frequentist statistics where a distinction is drawn between
ﬁxed and random parameters in the model. Hierarchical models therefore ﬁt naturally
into a Bayesian framework: the random eﬀects distribution forms part of our prior in-
formation (our beliefs before seeing the data) and the posterior distribution (our beliefs
after seeing the data) for the random eﬀects are estimated in a similar manner to other
model parameters. Further explanation of prior and posterior belief, and the mechanics
of estimation, will be discussed in section 5.1. Whether empirical or full Bayes is used,
the resulting cluster eﬀects are shrunk towards the mean of their distribution (in this
case zero) in contrast to the maximum likelihood estimates. The extent of the shrinkage
depends on how much data we have relative to the prior, with smaller clusters experi-
encing more shrinkage. This is intuitive for some purposes: if estimating lung cancer
rates by area, in sparsely populated areas we might be more inclined to look to data
from neighbouring areas than in densely populated ones.
4.1.3 Extensions to the basic model
Individuals can be similar at more than one level (e.g. surgery patient i within surgeon
j within hospital k), with similarity now also occurring at the middle level(s) (e.g.
similarity of surgeons within the same hospital in the previous example). This structure,
illustrated in ﬁgure 4.1(b), can be modelled by adding another random eﬀect to the
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model speciﬁcation:
logit(pijk) = α+ βxijk + ujk + vk
ujk ∼ N(0, σ2u)
vk ∼ N(0, σ2v)
Note that we are now using the index ijk to accommodate the third level. As assumption
of independence from covariates xij now applies to both the ujk and the vk, and further
we assume that the ujk and the vk are uncorrelated. We can reparametrise the model
to consider each level separately:
logit(pijk) = βxijk + μjk (Level 1) (4.3)
μjk = νk + ujk (Level 2)
νk = α+ vk (Level 3)
ujk ∼ N(0, σ2u)
vk ∼ N(0, σ2v)
This parametrisation, known as hierarchical centring, emphasises the hierarchical struc-
ture of the data. There is a shift of focus, as rather than having one equation for the
individual we have a set of equations, one for each level of the hierarchy. This approach
is intuitive if we wish to add cluster-level variables into the model. If we have some
factor Z measured at level 2 of the hierarchy (say an area-level measure of air pollution
if examining lung cancer rates) then the estimated log odds of the outcome at hospital
j is given by μjk = νk + γzjk + ujk, i.e. it is a function of the cluster-level covariate.
In model 4.2 all cluster eﬀects arise from the same distribution with a single variance
parameter σ2u. It is possible to have diﬀerent variances (known as complex variation,
see Goldstein (2002)) if we expect the inﬂuence of the cluster on the outcome to be
heterogeneous. For example, in an educational context, small and large classes could be
assigned a diﬀerent variance. Another common extension is to allow covariate eﬀects (β
in equation 4.2) to vary with cluster as well (for example we might expect the eﬀects
of low income on lung cancer rates to vary by area). This is illustrated in equation 4.4
below.
logit(pij) = α+ βxij + u
(1)
j xij + u
(0)
j (4.4)
u =
(
u(0)
u(1)
)
∼ N(0,Ψ) Ψ =
(
σ2
u(0)
σu(0)u(1)
σu(1)u(0) σ
2
u(1)
)
Here, Ψ is the 2 x 2 variance covariance matrix for the random eﬀects. The diag-
onal terms of the matrix contain the variance of the random intercepts and coeﬃ-
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cient (σ2
u(0)
and σ2
u(1)
respectively), while the oﬀ-diagonal terms give the covariance
σu(0)u(1) = σu(1)u(0) which describes how the random terms are correlated. For example,
areas with higher than expected rates of lung cancer may also have stronger associations
between income and lung cancer, leading to a stronger correlation between intercept and
slope terms. These models are sometimes referred to as random coeﬃcient models.
4.1.4 Hierarchical models for provider proﬁling
The hierarchical models described in the previous section are widely used in public
health (Diez-Roux, 2000; Leyland and Goldstein, 2001) and have long been advocated
for provider proﬁling purposes (DeLong et al., 1997; Goldstein and Spiegelhalter, 1996;
Normand et al., 1997). In this context, the random eﬀects described above are called
provider eﬀects, terminology which I shall use in this thesis. These cannot necessarily
be interpreted as an eﬀect that is wholly caused by the provider (such that would be
obtained if patients were randomised to providers) because the interpretation depends
on the set of factors we have adjusted for. This set may not encompass all variables
beyond provider control, thus some of the between-provider variation may be due to
these unmodelled variables as discussed in section 3.5.2.
Early applications include Gatsonis et al. (1993, 1995) who described variation in
angiography rates across states, and Thomas et al. (1994) who estimated hospital-speciﬁc
log odds of mortality. Gatsonis et al. (1995) also allowed the provider eﬀects to vary with
patient characteristics using the random coeﬃcient formulation previously described.
These authors recommended the hierarchical analysis over the ﬁxed eﬀects approach
because it produces more reliable and precise provider-speciﬁc estimates (particularly
for smaller providers) through shrinkage, addresses problems of multiple comparisons,
accounts for uncertainty in a statistically principled way, and enables attribution of
variation to diﬀerent sources, including provider-level variables (DeLong et al., 1997;
Gatsonis et al., 1993, 1995; Goldstein and Spiegelhalter, 1996; Normand et al., 1997;
Thomas et al., 1994).
Normand et al. (1997) presented a framework for hierarchical methods for provider
proﬁling, incorporating complex variation to allow for diﬀerent hospital types to have
diﬀerent between-hospital variation. They used Bayesian methods to present provider
eﬀects as posterior tail probabilities of diﬀerent measures of poor performance, argu-
ing that these are a more interpretable quantity than the conﬁdence intervals obtained
using frequentist methods. Goldstein and Spiegelhalter (1996) also exploited the ﬂex-
ibility of Bayesian models to illuminate ﬂaws in simple league tables because of high
levels of uncertainty in the ranks. They highlighted that extension of their methods to
three-level models is straightforward, enabling proﬁling of providers within providers.
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Three-level models have been implemented in several studies, for example to examine
healthcare-associated infections in hospitals within regions in France (Chen et al., 2013),
and adherence to osteoporosis guidelines for physicians within clinics (Brookhart et al.,
2006).
In line with focus of public interest described in chapter 1, subsequent research is
concentrated in developing methods for detecting unusual performance using techniques
such as funnel plots (Jones et al., 2008; Spiegelhalter, 2005b). Similarly, the Stan-
dardised Mortality Ratio (SMR, which compares the observed deaths with the number
expected) is an intuitive, if much-criticised, measure of hospital performance (Lilford
and Pronovost, 2010), but it is less clear within the hierarchical framework how the nu-
merator and denominator should be calculated. Several diﬀerent deﬁnitions have been
proposed (Glance et al., 2003; Health and Social Care Information Centre Clinical In-
dicators Team, 2016; Shahian et al., 2005; Yang et al., 2013) but these do not always
yield consistent results (Mohammed et al., 2012). Whether we wish to quantify provider
eﬀects using odds ratios, SMRs, ranks or tail probabilities, in the context of hierarchical
models all of these approaches involve estimating the random eﬀects themselves in some
way. As previously described shrunken estimates of provider eﬀects can be calculated
using empirical or full Bayes. The former was used by Thomas et al. (1994) amongst
others (DeLong et al., 1997; Dimick et al., 2010) and is sometimes called a reliability
adjustment. Gatsonis et al. (1993) found both approaches gave similar results for their
purpose.
Provider proﬁling diﬀers from many standard applications of hierarchical models
(e.g. repeated measures, growth curves, cluster randomised trials) in that the random
eﬀects themselves are the focus of interest, not a nuisance source of variation to be
accounted for in order to correctly estimate other parameters (Ohlssen et al., 2007b).
Therefore the random eﬀects should be carefully speciﬁed with regard to the inferences
we wish to make, with sensitivity analysis to check for robustness to variation in the
assumptions. Several studies have explored using alternative distributions to Normal for
the random eﬀects. For provider proﬁling analyses a t distribution with low degrees of
freedom has been suggested (Normand et al., 1997; Ohlssen et al., 2007b) but there are no
speciﬁc recommendations about exact values for ν. Values of ν = 1 or 2 have an inﬁnite
variance so are not appropriate choices. Within a Bayesian framework we can attempt
to estimate ν from the data (setting a suitable prior) but unless the data (or prior)
are very informative this does not yield a useful posterior and is similar to specifying
a Normal distribution (Daniels and Gatsonis, 1999). Austin (2005) demonstrated using
simulation that assuming a normal model to estimate provider eﬀects arising from a t
distribution with ν = 3 and ν = 5 resulted in over-shrinkage but there was no basis
for choosing ν. In some situations a skewed distribution may be suitable, for example
if there are a few providers who are particularly high performing. Lee and Thompson
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(2008) present an example concerning a clinical trial comparing teleconsultations with
standard appointments, where treatment eﬀects were expected to diﬀer by consultant.
They used ﬂexible Normal and t distributions for the random eﬀects with parameters,
estimating both ν and a skewness parameter from the data, though in this case there
was little diﬀerence in model ﬁt compared with symmetry.
There are some limitations to using hierarchical models for provider proﬁling. While
shrinkage of providers is desired for some purposes it can lead to a false sense of com-
placency for smaller providers (Walker et al., 2013). In such cases the tail probabilities
advocated by Normand et al. (1997) may be useful to indicate the extent to which un-
usual performance can be ruled out. Another consequence of shrinkage is that smaller
providers will be shrunk more towards the mean than larger providers. Direct compari-
son of posterior means between providers may therefore yield incorrect inferences (Shen
and Louis, 1998). Aylin et al. (2003) argue that if an aim of the analysis is to detect
outliers then it may be preferable to minimise the risk of type II error (not detecting a
genuine outlier) in comparison with the type I error (erroneously identifying a provider
as an outlier); in such cases a ﬁxed eﬀects model may be preferable to a hierarchical
model. A similar argument was made by Austin et al. (2003) who demonstrated that hi-
erarchical models in general had greater speciﬁcity for correctly identifying outliers while
ﬁxed eﬀects models had greater sensitivity, even when all providers were high-volume
centres. Notably, the authors found that ﬁxed eﬀects models outperformed hierarchical
models if the underlying distribution of provider eﬀects was trimodal, but a unimodal
random eﬀects distribution was assumed. The requirement to assume a distribution for
the random eﬀects can therefore be a limitation, one which is not present for ﬁxed eﬀects
models.
Hierarchical models also require the assumption that the provider eﬀects are uncor-
related with covariates. This can be violated if there are unmeasured confounders (i.e.
variables which are associated with both the provider and the outcome that are not
in the model) that are also associated with included covariates, because the eﬀects of
the omitted variables are absorbed into the provider eﬀects. Sociodemographic variables
such as ethnicity and economic deprivation can be confounders because they have spatial
variability and have eﬀects on health outcomes, but provider proﬁling analyses are often
not adjusted for them to avoid masking the eﬀects of interest. This was discussed in
chapter 3, along with the eﬀect on the interpretation that some of the between-provider
variation could be due to unmeasured confounding. A further eﬀect of adopting this
approach occurs if the unmeasured sociodemographic variables, and hence the provider
eﬀects, are correlated with any of the clinical risk-adjustment factors. Then the assump-
tion of independence of provider eﬀects and covariates is violated, resulting in biased
estimates of the covariate eﬀect (Rabe-Hesketh and Skrondal, 2005). An advantage of
ﬁxed eﬀects models is that they do not require that provider eﬀects be independent from
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covariate eﬀects.
The concept of hierarchical modelling (and caveats associated with the results) can
be diﬃcult to explain to a non-statistical audience. Sometimes these diﬃculties relate
to aspects which are otherwise considered advantageous. The Centers for Medicare and
Medicaid Services (CMS) in the US received several criticisms from consumers regarding
the use of hierarchical models (Ash et al., 2012): the methods did not show any variation
because of shrinkage and were therefore not useful; the performance of small hospitals is
masked; concepts surrounding hierarchical models are diﬃcult to convey. Nevertheless
hierarchical models have now gone ﬁrmly beyond the statistical literature and have been
put into practice by the CMS (Shahian et al., 2005) and many others such as the UK
Healthcare Comission (Spiegelhalter, 2005a) (now the Care Quality Commission) and
the UK Health and Social Care Information Centre (Health and Social Care Information
Centre Clinical Indicators Team, 2016).
In summary, hierarchical models are an established approach for provider proﬁling,
and this thesis builds on these existing approaches. Some aspects of the structure of the
neonatal data can be modelled using techniques described thus far. As with all regression
models, continuous and categorical patient risk factors can be adjusted for. Hierarchical
models allow for variation at both the NNU and network level to be estimated using a
three-level model. Level of NNU can be incorporated into the model as a provider-level
covariate, and heteroscedasticity by level of NNU investigated by including separate
variance terms. These methods will be described in detail in section 5.2. A limitation
of these established methods is that they only allow for attribution to a single provider.
The problems posed by transfers for provider proﬁling analyses (see chapter 1) and
analysis of transfer patterns (chapter 2) indicated that attribution to a single provider
is not a reasonable approach for these data, nor is excluding transfers altogether. In the
next section I will review the literature for how transfers have been handled in existing
provider proﬁling studies.
4.2 Literature review of transfers
The objective of this literature review is to ﬁnd out whether there are any existing studies
which either accounted for transfer of patients in hierarchical provider proﬁling analyses,
or considered the theoretical aspects of doing so. Included studies are those which
attempted to assign patients to all providers involved in care, but I am also interested
in the relative frequency of such studies, compared with those excluding transfers, and
those assigning to a single provider.
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4.2.1 Search strategy
The search strategy was designed to return papers containing terms relating to hierar-
chical modelling, provider proﬁling and transfer. For provider proﬁling there are few
standard phrases which are used consistently across the literature so a variety of search
terms were chosen based on re-occurring terminology which featured in initial reading.
The exact search terms are shown in table 4.1, with the asterisk indicating a wildcard
to allow diﬀerent forms of the term of interest:
Table 4.1: Results from systematic review
Hierarchical terms multilevel OR hierarchical OR mixed model OR random eﬀects
Proﬁling terms hospital comparison OR institutional comparison
OR
(rank* OR proﬁling OR benchmark*)
AND
(institut* OR hospital OR provider)
OR
(measur* OR compar* OR monitor*)
AND
(performance OR quality)
AND
(institut* OR hospital OR provider)
Transfer terms transfer* OR transport* or discharg*
All terms with multiple words were searched as a single phrase
I have included both the speciﬁc phrases for hosptial/institutional comparison and
the individual words along with performance/quality. The rationale is that the phrases
alone may not capture relevant results, but including the individual words without per-
formance/quality yields many irrelevant results as what is being measured or compared
does not relate to providers. Therefore speciﬁc phrases are included, along with the
individual words with the requirement that performance/quality be present as well.
I searched the PubMed database, using Medical Subject Headings (MeSH terms)
where available, searching all ﬁelds. Titles and abstracts of the resulting papers were
reviewed with papers selected for full-text review provided they appeared to concern
provider proﬁling, with the possibility of using hierarchical models as this was not always
mentioned in the abstract. On full text review, studies were considered relevant if the
treatment of transferred patients in the analysis was mentioned, where a transferred
patient was any patient treated at more than one provider included in the analysis.
Studies which either excluded transfers or assigned to a single provider were noted, and
studies assigning to multiple providers were reviewed more fully. The selection was
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Multilevel terms
84,581
Profiling terms
531,855
Transfer terms
1,071,420AND AND
Search result
438
Full text review
69
369 not relevant based on 
title/abstract
Mentioned transfers
35+10=45
34 not relevant based on 
full text
Hand-searching
10
Excluded transfers
15
Included transfers
26
Review papers
4
Assigned to one 
provider
15
Assigned to all 
providers
6
Assignment unclear
5
Figure 4.2: Flowchart illustrating the literature review
limited to papers published in English where the full text of the paper was available.
Reference lists and forward citations of the relevant texts were hand-searched. Review
papers were included where relevant.
4.2.2 Results
The PubMed search yielded 438 results, of which 35 were relevant and a further 10
articles were found from hand-searching reference lists or forward citations of relevant
texts, yielding a total of 45 papers which mentioned transfers. Figure 4.2 is a ﬂowchart
illustrating the literature review. The search is up to date as of 11th April 2016.
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These 45 papers were applications or review articles concerning provider proﬁling
using hierarchical models which mentioned the treatment of transferred patients (see
appendix C for the full list of studies). Four of these (Bruckel et al., 2016; Jollis and
Romano, 1998; Krumholz et al., 2007, 2006) were review papers which discussed transfers
but none provided suggestions for allocation to multiple providers.
Of the 15 studies which excluded transfers, only four of those (Aelvoet et al., 2016;
Reeves et al., 2010; Reistetter et al., 2015; Sethi et al., 2007) mentioned the number of
patients that this applied to, with proportions ranging from 2% to 37%. Another 15
studies assigned transfers to a single provider, of which eight studies (Ben-Josef et al.,
2014; Bratzler et al., 2011; Kim et al., 2015; Marcin and Romano, 2004; Reineck et al.,
2014; Rumsfeld et al., 2006; Seghieri et al., 2012; Suter et al., 2014), allocated patients to
the ﬁrst provider, in line with recommendations from three of the review papers (Jollis
and Romano, 1998; Krumholz et al., 2007, 2006). The rationale generally presented
was that the ﬁrst provider is responsible for the decision to transfer, and allocation
to the receiving provider inappropriately penalizes those receiving more complex cases
(assuming this is not captured by risk-adjustment), as well as potentially encouraging
premature transfer to avoid attribution of a negative outcome. Five studies (De´gano
et al., 2015; Gomez et al., 2015; Jan et al., 2013; White et al., 2013; Xu et al., 2015)
mentioned that transfers were included but did not state how they were assigned.
Therefore of a total of 41 studies (excluding review papers) of hierarchical provider
proﬁling analyses which mention transferred patients, only six (Bottle et al., 2013; Camp-
bell et al., 2012; Hassani et al., 2015; Kosseim et al., 2006; Rasmussen and Abildstrom,
2008; Samadashvili et al., 2015) attempted to assign patients to multiple providers.
Study summaries of these six papers are shown in tables 4.2 and 4.3. Three studies
Bottle et al. (2013); Kosseim et al. (2006); Samadashvili et al. (2015) speciﬁcally set
out to investigate the impact of transferred patients on variations in mortality across
providers. Bottle et al. (2013) were concerned with the impact of excluding transferred
patients, while Kosseim et al. (2006) and Samadashvili et al. (2015) sought to compare
allocation to the transferring and receiving hospital. Campbell et al. (2012) and Hassani
et al. (2015) documented methods used for national comparisons for hospital mortality
in England and Norway respectively, while Rasmussen and Abildstrom (2008) conducted
a research study examining trends in medicine use.
Setting and outcomes All but one study concerned mortality in adults following
hospital admission for acute coronary syndrome (ACS) or acute myocardial infarction
(AMI). The proportion of ACS/AMI patients undergoing transfer ranged from 1% to
over 50%; transfer rates were much lower in the remaining populations. Only one study
(Bottle et al., 2013) mentioned the number of admissions per patient (at most ten) but
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in two studies it was implied by the ability to assign patients to either the transferring
or receiving hospital that patients were only transferred once (Kosseim et al., 2006;
Samadashvili et al., 2015). All studies used administrative databases rather than medical
records as the data source for analysis. As Bottle et al. (2013) remark, administrative
databases are often used for provider proﬁling analyses, and they often contain limited
information which may make it diﬃcult to link episodes of transferred patients. Three
studies (Hassani et al., 2015; Kosseim et al., 2006; Samadashvili et al., 2015) calculated
a risk-standardised mortality rate, though all were calculated in diﬀerent ways. Two
studies (Bottle et al., 2013; Campbell et al., 2012) calculated standardised mortality
ratios (again using slightly diﬀerent methods) and the remaining study (Rasmussen and
Abildstrom, 2008) considered variation in the odds of death using odds ratios. Most of
the studies were interested in best and worst performers, outliers and overall variation
measured by ranges, with no studies examining changes in provider eﬀects for individual
hospitals.
Methods Four studies (Bottle et al., 2013; Kosseim et al., 2006; Rasmussen and Abild-
strom, 2008; Samadashvili et al., 2015) conducted multiple separate analyses, each of
which assigned the patient to a single provider. Two of these (Bottle et al., 2013; Kosseim
et al., 2006) in addition compared results with the frequently used strategy of excluding
transferred patients. Bottle et al. (2013) also conducted an analysis treating admissions
as the unit of analysis; a similar strategy was taken by Campbell et al. (2012). In these
analyses, if the patient was admitted to several hospitals and then died, the death was
attributed to the last hospital and the preceding admission(s) treated as survivals. This
counts transferred patients multiple times, but without accounting for the dependence
between these outcomes (as patients can only die once). However in Campbell et al.
(2012) less than 1% of patients were transferred and in Bottle et al. (2013) this was
only one of four analyses and was designed to illustrate the eﬀect of ignoring all transfer
information.
Hassani et al. (2015) was the only study which attempted to allocate patients to all
providers without considering each admission separately. In this study, a ﬁxed eﬀects
analysis was used including a parameter for each hospital treating the patient, weighted
according to the proportion of their total stay which took place in the hospital in ques-
tion. The study determined outliers using these ﬁxed eﬀects regression coeﬃcients, but
then applied a Bayesian hierarchical model to shrink the coeﬃcients assuming they fol-
low a t distribution with 5 degrees of freedom, applying these shrunken coeﬃcients when
calculating a risk adjusted mortality rate. The two-stage nature of this analysis means
that any uncertainty from the ﬁrst stage is not carried through. Hassani et al. (2015)
did not discuss transfers or their approach to accommodating them in detail, but they
cite another study (Kristoﬀersen et al., 2012) from the same group for their method.
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Kristoﬀersen et al. (2012) also used weighted ﬁxed eﬀects, but did not use hierarchi-
cal modelling and so did not meet the search criteria for the review. They compared
weighting according to length of stay with excluding transfers and treating each admis-
sion separately. They applied weights proportional to length of stay arguing that this
method has simplicity and transparency in its favour, but suggested weighting critical
care more heavily if such information is available. The authors of the study were not
aware of any previous study attempt to assign transferred patients to multiple hospitals.
Results Several authors found that results were sensitive to how patients were allo-
cated, with no clear preferred way of attributing transferred patients (Kosseim et al.,
2006; Kristoﬀersen et al., 2012; Samadashvili et al., 2015). Of the three studies which
sought to compare results from diﬀerent ways of allocating transfers, two found diﬀer-
ences in which hospitals were the top and bottom performing providers (Kristoﬀersen
et al., 2012; Samadashvili et al., 2015), though neither study shows whether these dif-
ferences are notable compared with random variation. Kristoﬀersen et al. (2012) also
found substantial diﬀerences in ranks and outlier status. However no adjustment was
made for multiple testing, no measures of uncertainty around the ranks were calculated
and outliers were determined simply by the extremes of the hospital eﬀects, which will
exist even if all hospitals are performing equally well.
Kosseim et al. (2006) suggest that if results for a hospital improve when patients are
assigned to the referring hospital it suggests that the hospital is doing well at stabilising
them prior to transfer. However it could instead be a reﬂection of the good perfor-
mance at the receiving hospital being erroneously attributed. Kosseim et al. (2006) and
Samadashvili et al. (2015) both found that patients who were transferred were generally
less sick (lower mortality, younger and with fewer co-morbidities). Samadashvili et al.
(2015) was the only study to look at transfers by hospital type, ﬁnding diﬀerences in
rates of transfer, and a mortality diﬀerence in transferred and non-transferred patients.
Bottle et al. (2013) also investigated how methods for handling transfers inﬂuenced
results, and found minimal diﬀerences in the SMR between the models including trans-
fers, but notable diﬀerences if all transfers were excluded. Kosseim et al. (2006) found
the variation in risk adjusted rates was similar whichever method was used to allocate
transfers. Rasmussen and Abildstrom (2008) stated that their ﬁndings (one of which was
between hospital variation) were robust to allocating transfers to the discharge hospital
rather than ﬁrst admission, but no further details are provided.
The exact methods, particularly regarding the speciﬁcation and estimation of hier-
archical models were unclear in several of the studies (Bottle et al., 2013; Rasmussen
and Abildstrom, 2008; Samadashvili et al., 2015) and data dependencies were ignored in
other ways (multiple episodes from the same patient in Bottle et al. (2013) and Camp-
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bell et al. (2012), and higher levels of hierarchy in Hassani et al. (2015)). Several studies
did not fully incorporate uncertainty into ﬁndings, looking at measures such as ranks
and tertiles without a measure of uncertainty (Kosseim et al., 2006; Samadashvili et al.,
2015) or using ﬁxed eﬀects analysis without adjusting for multiple testing (Bottle et al.,
2013).
Discussion of transfers Some authors cited centralisation (only some hospitals per-
forming more specialised procedures) as a reason for transfers becoming more common
(Kosseim et al., 2006; Kristoﬀersen et al., 2012; Samadashvili et al., 2015). Kristoﬀersen
et al. (2012) also noted the increase in transfers due to centralisation, but found fre-
quent transfers from larger to smaller hospitals for patients admitted for stroke and hip
fracture, representing rehabilitatory care.
Several studies commented on the diﬃculties that transfers pose. Two studies
(Campbell et al., 2012; Kosseim et al., 2006) highlighted that patient transfers can
be a product of clinical care (if the care provided aﬀects the condition of a patient, de-
termining clinical need for transfer) and management (the decision-making and logistics
behind the transfer itself), with delayed transfer and transfer of unstable patients both
leading to poorer outcomes. Bottle et al. (2013) and Rasmussen and Abildstrom (2008)
both adjusted for transfer status (the former in some of the comparative analyses) but
neither of these studies considered that transfers could be a reﬂection of care provided.
Though this issue was not speciﬁcally addressed by the study, Campbell et al. (2012)
highlighted that all providers treating a patient can inﬂuence the outcome so it is not
strictly fair to assign their outcome to one provider alone. They applied the advice from
the UK Department of Health (who commissioned and funded the study) in allocating
deaths to the ﬁnal provider but pointed out (as did Bottle et al. (2013) and Samadashvili
et al. (2015)) that allocation to the receiving hospital could lead to premature, inap-
propriate or unnecessary transfers in order to “game” the system, resulting in biased
hospital eﬀects and, more seriously, adverse consequences for patients. This is the reason
that it is usually recommended to assign transfers to the referring hospital (Jollis and
Romano, 1998; Krumholz et al., 2007, 2006; Samadashvili et al., 2015). However it is
done, allocation to a single provider means that we are attributing the performance of
one provider to another. Campbell et al. (2012) (citing methodology used by Dr Foster
(Aylin et al., 2010), who provide independent assessments of NHS hospitals) suggest
that allocating outcomes to all providers is possible in some situations if outcomes are
calculated separately for each hospital rather than using a hierarchical model.
The rationale for assigning patients to multiple providers was generally practical,
concerning sensitivity of results and fairness in allocation rather than use of statistically
appropriate methodology. None of the studies mentioned that by assigning individuals
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to a single provider, data dependencies are not correctly accounted and the estimates of
between-hospital variation may be incorrect .
In this review several studies have considered the problem of transfers. The studies
indicated scope for diﬀerent methods outside the hierarchical modelling context using
ﬁxed eﬀects (Hassani et al., 2015; Kristoﬀersen et al., 2012), allocating to all hospitals
involved by estimating hospital eﬀects outside the model (Aylin et al., 2010; Camp-
bell et al., 2012) or by treating each episode separately (Bottle et al., 2013; Campbell
et al., 2012). However there were no satisfactory solutions using hierarchical models.
In the next section I propose using multiple membership models as a way of including
transferred patients in hierarchical models.
4.3 Multiple membership models
The hierarchical models introduced in section 4.1 can be extended to allow individuals
to belong to more than one cluster, e.g. for patients treated at more than one provider.
These models are known as multiple membership (MM) models (Browne et al., 2001;
Fielding and Goldstein, 2006; Goldstein, 2002). The MM structure for data with two
levels is illustrated in ﬁgure 4.3(a) in contrast to the single membership structure in
4.1(a). The aim of this section is to introduce multiple membership models and describe
some of the existing literature.
4.3.1 Deﬁnition
In the basic hierarchical model described in equation 4.2 for an individual i in a single
cluster j, we had one random eﬀect uj representing the eﬀect of cluster j on the log odds
of the outcome Y . The multiple membership is modelled by replacing this single eﬀect
with a weighted sum of random eﬀects, one for each cluster of which the individual is a
member, with the weights constrained to sum to one for each individual. This is similar
to the method implemented by Hassani et al. (2015) in a ﬁxed eﬀects context. A change
in notation is required because of the multiple membership: we drop the j subscript for
the individual as they are no longer a member of a single cluster j and let U(i) denote
the set of clusters to which individual i belongs (sometimes referred to as classiﬁcation
notation (Goldstein, 2002)). Extending the two-level random eﬀects model in equation
4.2 we have:
logit(pi) = α+ βxi +
∑
j∈U(i)wijuj (4.5)
uj ∼ N(0, σ2u)
∑
j∈U(i)wij = 1
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a)
b)
individual (level 1)
group (level 2)
individual (level 1)
group (level 2)
group (level 3) 
Figure 4.3: Diagrams illustrating multiple membership (MM) data structures: (a) as
ﬁgure 4.1(b) but with one individual being a member of two groups; MM indicated by
dashed lines) (b) as ﬁgure 4.3(b) but with two individuals with MM, indicated by dashed
lines)
The choice of weights will be discussed in section 4.3.2. As with other hierarchical mod-
els, the random eﬀects uj are often assumed to have a Normal distribution, but the same
considerations discussed in section 4.1 apply. Likelihood-based methods for standard hi-
erarchical models exploit the nested structure of the data which is not present for MM
models (Goldstein et al., 2007). MM models are more straightforward to estimate using
Bayesian Markov Chain Monte Carlo (MCMC) estimation because of the ﬂexibility of
the iterative approach (Browne et al., 2001); these methods will be discussed in section
5.1.
Any cluster-level variables need to be weighted in the same way as the random
eﬀects (Fielding and Yang, 2005; Goldstein et al., 2007). For this reason the hierarchical
centring parametrisation is advantageous as we avoid specifying multiple terms for each
cluster at the individual level. We can also have MM occurring in three-level models.
Figure 4.3(b) shows MM only at the individual level, but it is also possible for level 2
clusters to belong to more than one level 3 cluster. Let V (j) denote the set of level 3
clusters to which level 2 cluster j belongs. We can then extend the three-level model
described in 4.3 to incorporate multiple membership, and also add a continuous covariate
122
Z at level 2:
logit(pi) = βxi +
∑
j∈U(i)wijμj Level 1 (4.6)
μj = γzj +
∑
k∈V(j)wjkνk + uj Level 2
νk = α+ vk Level 3
uj ∼ N(0, σ2u)
vk ∼ N(0, σ2v)
4.3.2 Existing literature on multiple membership models
Multiple membership models were ﬁrst introduced by Hill and Goldstein (1998) as a
way of modelling uncertainty about which higher level unit an individual belongs to. In
their example, the weight wij represented the probability that a pupil i attended school
j, where the probabilities could be informed by data on location of school, and previous
or subsequent schooling of the pupil. Several studies (Cafri et al., 2015; Goldstein et al.,
2007; Leckie, 2009) have used MM models to examine pupil mobility, ﬁnding notable
diﬀerences compared with single membership models (those allocating pupils to only one
of the schools attended). Leckie (2009) noted that, in contrast to the hospital transfers
studies described in section 4.2, educational studies tended to assign pupils to the ﬁnal
school attended. In the medical literature, Roberts and Walwyn (2012) used MMmodels
to allow for therapist eﬀects in psychotherapy trials where patients are treated by more
than one therapist. Life course epidemiology studies have used MM models as a way of
modelling spatially and temporally correlated health eﬀects (Ali et al., 2007; Chandola
et al., 2005; Leyland and Næss, 2009). Leyland and Næss (2009) modelled the eﬀect of
area of residence at three diﬀerent census points on subsequent mortality, allowing for
complex variation by time point to reﬂect the varying strength of inﬂuence over time.
Silcocks and Kendrick (2010) also applied MM models to spatial eﬀects in the context of
overlapping populations in cluster randomised trials. Where data are longitudinal with
repeated measurements, and cluster membership available at a series of time points,
MM models can be used to estimate carryover eﬀects (e.g. a primary school’s inﬂuence
on a pupil’s test result in the ﬁrst year of secondary school) (Cafri et al., 2015).
Comparison with single membership models It has been shown that ignoring
MM structures can lead to biased estimates of both ﬁxed and random parameters
(Browne et al., 2001; Chung and Beretvas, 2012). Ignoring the MM structure and
simply assigning individuals to one cluster has been shown to result in underestimation
of the cluster-level variance (Chung and Beretvas, 2012; Fielding and Goldstein, 2006;
Goldstein et al., 2007; Leckie, 2009). Chung and Beretvas (2012), when examining the
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impact of ignoring MM structure using simulated data, found an average 16% downward
bias in the between-cluster variance, with the level of bias dependent on the proportion
of individuals with multiple membership. The contribution of the clusters to the total
variation is, for an individual i :
var(
∑
j∈unit(i)wijuj) = σ
2
u
∑
j∈unit(i)w
2
ij (4.7)
Under single membership this is simply σ2u, but for an individual that is a member of
more than one cluster, the sum of wij is always less than 1, so the variance contribution
is less than σ2u. Using the example of pupil mobility and educational outcomes described
by Goldstein (2002) and Leckie (2009), suppose a pupil attends two schools for an equal
period of time. For this pupil, the contribution of schools to the total variance is
0.52σ2u + 0.5
2σ2u = 0.5σ
2
u, so the observed variance for this individual is only half the
true school-level variance. Ignoring the MM structure implicitly assumes the school-
level variance contribution is the same for all individuals, regardless of pupil mobility,
thereby underestimating the between-school variance and producing estimated school
eﬀects uˆj which biased towards zero. The relative importance of schools in the overall
variation in educational outcome (as measured by the intraclass correlation coeﬃcient
or variance partitioning coeﬃcient, which will be described in section 5.2.6) will also be
reduced. As demonstrated by Chung and Beretvas (2012), as more pupils move schools,
the variance underestimation increases. For a pupil attending four schools, the variance
attributable to schools is 4 × (0.252σ2u) = 0.25σ2u. This has an intuitive interpretation
in that the more schools a pupil attends, the more “average” their experience is. If a
single membership model is assumed, the variance underestimation will more marked in
situations where pupils are highly mobile.
Choice of weights For membership deﬁned by time (e.g. how many years a pupil at-
tends a school) weights could be deﬁned as the proportion of time spent in each cluster;
this is a standard choice (Browne et al., 2001; Fielding and Goldstein, 2006; Goldstein
et al., 2007; Leckie, 2009). For membership deﬁned by space (e.g. the neighbourhood
eﬀects modelled by Silcocks and Kendrick (2010)) weights could be deﬁned by the rela-
tive distance from the individual. For MM models involving discrete time periods, it is
possible to use ﬁxed weights. For example, secondary education from 11 to 16 years of
age, if the last two years representing GCSE examinations were considered most impor-
tant, weights could be set to assign 10% each to the ﬁrst three years and 35% each to
the ﬁnal two years. An alternative parametric approach was suggested by Leyland and
Næss (2009) where the weights are proportional to the square root of the between-cluster
variance at that time point. However this is only possible when each cluster membership
is deﬁned for ﬁxed time points (in that study, area of residence for three diﬀerent census
years) so that a separate variance can be estimated for each cluster eﬀects at the same
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time point.
The analyst has to make a choice regarding the weighting scheme to be used. In
equation 4.7, we see that individuals with diﬀerent MM patterns will have diﬀerent
amounts of their variance that is attributable to clustering. Similarly to the bias when
estimating σ2u and uj that occurs if the single membership is assumed, we might expect
biased results if we apply a MM weighting scheme that does not reﬂect the data. In
practice, studies using MM models to evaluate eﬀects of pupil mobility found that results
were robust to alternative weightings (Goldstein et al., 2006; Leckie, 2009), as did a study
of teachers in multiple teaching groups (Fielding and Yang, 2005). Goldstein et al. (2006)
applied a variety of weightings placing diﬀerent relative importance on diﬀerent years
of schooling as a sensitivity analysis, but found little diﬀerence and selected the ﬁnal
model based on Deviance Information Criterion, a Bayesian measure of model ﬁt which
will be deﬁned in section 5.1. A similar approach of comparing several weights was
taken by (Silcocks and Kendrick, 2010) using Akaike Information Criterion (see 3.4.1
for deﬁnition). Wolﬀ-Smith and Beretvas (2014) investigated the eﬀects of misspecifying
weights using simulation. The authors generated data where the eﬀect of school attended
had an equal inﬂuence on the outcome in some datasets and unequal in others. They then
analysed the data under the true model and a variety of assumed models. They found
that cluster variance was underestimated when unequal weights were used to analyse the
equal weight data. Returning to the simple example in the previous section, suppose we
analyse the pupil mobility data with a MM model that places 90% of the weight on the
ﬁrst school. The pupil who attends two schools for an equal period of time will now be
assumed to have a school-level variance contribution of 0.92σ2u+0.1
2σ2u = 0.82σ
2
u. If the
observed variance for the pupil is 0.5σ2u as before, then this leads to an underestimation
of the school-level variance. We might expect the converse (overestimation of the σ2u
when using equal weights to analyse unequal data) as the variances for individuals
will be assumed to be smaller fraction of σ2u than they really are. Wolﬀ-Smith and
Beretvas (2014) found this to be the case only in two scenarios, in which applying
the true weighting also overestimated the variance, so this may be an artefact of the
data generation process. In this study, as with the others mentioned here, estimation
of cluster-speciﬁc results as not the primary aim with analysis limited to comparing
cluster-level variance and the correlating the ranks of cluster eﬀects.
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4.4 Discussion
4.4.1 Summary
In this chapter I reviewed existing statistical methods relevant to the research ques-
tions of the thesis. I introduced hierarchical models and described their applicability to
provider proﬁling studies in general and for this thesis. I conducted a systematic review
of the literature to ascertain existing strategies for accommodating transferred patients
using hierarchical models. Almost all studies including transferred patients allocated
them to a single provider, or conducted separate analyses comparing diﬀerent single
allocations. Only one study attempted to allocate patients to all providers but this was
done using a ﬁxed eﬀects model, with a hierarchical analysis applied afterwards to shrink
the provider eﬀects. There were four review papers discussing the problem of transferred
patients but none presented a suitable solution. The results of the systematic review
highlighted a gap in knowledge. I then introduced multiple membership models which
weight the random eﬀects as a possible solution to the problem of transfers. Multiple
membership models were developed in education primarily to model pupil mobility. I
described some of the applications and in the literature, and some of the theoretical
ﬁndings. In this thesis I am particularly interested estimation of the provider eﬀects
themselves, but there has been limited attention in the literature as to how these are
aﬀected by diﬀerent weighting choices.
4.4.2 Hierachical models
Hierarchical models are an established and recommended method for provider proﬁling
studies, and are particularly applicable for the research questions of this thesis. Elements
of the structure of neonatal services can be reﬂected in the structure of the hierarchical
model. The ability to model clustering at more than two levels is essential because NNUs
are nested within neonatal network; ssee Chen et al. (2013) and Brookhart et al. (2006)
for implementation of these methods in a provider proﬁling context. This precludes the
use of other methods to handle clustered data such as generalised estimating equations
(a method for estimating population-averaged models) as these only accommodate clus-
tering at one level. Allowing the mean and variance of provider eﬀects to be speciﬁc
to type of NNU follows from the large diﬀerences in patterns of care documented in
chapter 2, and may be a way of adjusting for diﬀerences in case-mix not captured by the
risk factors (see chapter 3). This can be incorporated into hierarchical models as set out
Normand et al. (1997). The aim of including these aspects in the model is to produce
NNU eﬀects which correspond to the inferences we wish to draw as well as to account
for clustering in a statistically principled manner. For example including clustering at
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the neonatal network level will mean that network eﬀects can be estimated, NNU eﬀects
are adjusted for any variation attributable to the network level, and more information is
borrowed from other NNUs within the network. In chapter 5 I will propose a selection
of models to reﬂect the diﬀerent inferences we might wish to make.
Birth before 32 weeks gestation is relatively rare and subsequent mortality rarer still,
with a wide range in the volume of care provided at NNUs (see section 2.3.2). There are
some NNUs with very small numbers, in particular special care baby units (SCBUs)1
perform very little care for infants at or below 32 weeks gestation, with a median of 47
infants admitted across SCBUs over the three year period. Therefore shrunken estimates
of NNU eﬀects as obtained by emprical Bayes or full Bayesian methods are desirable as
they will be more reliable for smaller providers. The variation in volume means that
we are likely to have diﬀerent amounts of shrinkage (Rabe-Hesketh and Skrondal, 2005)
(with results for smaller NNUs being shrunk closer to the mean). Using NNU eﬀects
from hierarchical models to detect outliers or directly compare individual NNUs (e.g.
using ranks) is therefore inadvisable, but they are useful from the perspective of an
individual NNU. The NNU eﬀects tell us how the expected mortality for infants in their
care compares with that of similar infants attending similar NNUs (with the extent of
the similarities depending on the model). This is the clinical purpose of the provider
proﬁling methods developed in this thesis. To this end, in chapter 8 I present a case
study for a single NNU as an example of how the ﬁndings from this thesis could be
presented for clinical purposes.
Alternatives to the hierarchical approach would be to estimate NNU eﬀects inde-
pendently using a ﬁxed eﬀects model, or to calculate Standardised Mortality Ratios
(SMRs). While there are potential solutions to the problem of transferred patients us-
ing ﬁxed eﬀects models (Hassani et al., 2015) and SMRs (Aylin et al., 2010). I will not
apply them here. The large number of NNUs renders the ﬁxed eﬀects approach infea-
sible, as well as leading to eﬀects being poorly estimated due to low volumes. Fixed
eﬀects models cannot model variation by NNU level, or clustering by neonatal network,
both of which are central to the investigations of this thesis. Similar problems occur
for the standard deﬁnition of the SMR using a ﬁxed eﬀect approach. Deﬁnitions using
hierarchical models have been proposed, but they give inconsistent results (Mohammed
et al., 2012). Therefore to avoid ambiguity in interpretation I will express NNU eﬀects
as adjusted odds ratios obtained from exponentiating the random eﬀects.
A limitation to using hierarchical models is that they require that the random eﬀects
to be uncorrelated with covariates. For the analysis in this thesis, this would occur
if NNU eﬀects are correlated with the following clinical risk factors included in the
1one of the three categories of neonatal unit as described in section 1.2.1, the others being local
neonatal unit (LNU) and neonatal intensive care unit (NICU)
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model: gestational age, birth weight, infant sex and whether or not the mother received
antenatal steroids. I have chosen not to adjust for any sociodemographic variables based
on evidence for association, data quality and resulting interpretation of provider eﬀects
(see sections 3.1.1 and 3.2). Any residual confounding eﬀects of these variables will be
absorbed into the NNU eﬀects, so a correlation can be induced if there is an association
between the sociodemographic variables and clinical risk factors and the former vary
by NNU. Gestational age at birth exhibits variation by ethnicity; for example, black
mothers are likely to deliver earlier (Goldenberg et al., 2008). As Kramer et al. (2001)
report, while socioeconomic status is unlikely to have a direct eﬀect, it is associated
with stress and health behaviours that can lead to prematurity and lower birth weight.
Both ethnicity and socioeconomic deprivation vary by NNU, and ethnicity was found
to be a frequent independent predictor of mortality in preterm infants (Medlock et al.,
2011) though the evidence for the eﬀects of SES on mortality beyond that mediated by
gestation are unclear (see section 3.2.2). Therefore a limitation of this thesis is that this
assumption may be violated, which would lead to biased estimates of the covariate eﬀect
(Rabe-Hesketh and Skrondal, 2005), as well as higher between-NNU variance from the
inclusion of unmeasured confounders that was acknowledged in chapter 3. This could be
avoided by using a ﬁxed eﬀect or population-averaged models, but discussed earlier in
this section they are unsuitable for the purposes of this thesis. Stratiﬁcation by ethnicity
and SES would reduce the eﬀects of unmeasured confounding but is problematic because
of data quality and the number of infants at each NNU. Another possible solution to
address the bias in the covariate eﬀects for gestation and birth weight is to include
calculate the mean covariate value at each NNU and include this in the regression
model (Bafumi and Gelman, 2006; Mundlak, 1978; Rabe-Hesketh and Skrondal, 2005).
However the NNU eﬀect would then be interpreted as comparing mortality with what
would be expected for an NNU with the same mean gestational age and birth weight, as
well as NNU level, neonatal network and infant-level clinical characteristics. Exploration
of this issue, including the impact on results and possible solutions, remains as further
work beyond this thesis.
Mortality of preterm infants has been analysed using the NNRD by neonatal network
as part of annual reports by the Neonatal Data Analysis Unit (2015). The same infant
risk factors discussed in chapter 3 were adjusted for, but in other respects the strategy
adopted in that analysis diﬀers to the approach taken in this thesis. Infants were assigned
to the neonatal network where mothers booked to deliver so the eﬀect of transfers was
not considered. Hierarchical models were not used as there were only 23 networks with a
reasonable number of infants in each network; instead SMRs were calculated separately
for each neonatal network and illustrated using funnel plots as one aim of the analysis
was to detect outliers.
Also using the NNRD, the National Neonatal Audit Programme (NNAP) (Royal
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College of Paediatrics and Child Health, 2015) assesses adherence to standards for pro-
cesses and outcomes (which do not currently include mortality) for NNUs across England
and Wales. For some audit questions funnel plots were used to identify outliers, with
the limits determined from hierarchical models to allow for underlying variation be-
tween NNUs. Smaller NNUs (those with fewer than ten eligible infants) were excluded
from NNAP outlier analyses; in addition lack of power was less of a problem as the audit
questions concerned continuous or more frequent outcomes. For all questions transferred
infants were excluded from the analysis, network-level variation was not modelled and
types of NNU were not diﬀerentiated. In this thesis I am not looking at outlier detection
because of insuﬃcient power and variability across NNUs in the level of shrinkage.
There have been several studies in a neonatal care setting which applied hierarchical
models to examine variations in clinical outcomes (Bonet et al., 2011; Lee et al., 2013;
MacNab et al., 2005). Bonet et al. (2011) examined variation in breastfeeding rates
amongst very preterm infants in diﬀerent European regions and infants were assigned
to the NNU where they spent the ﬁrst 48 hours. Lee et al. (2013) modelled length of
stay in Californian NICUs, excluding infants who were transferred out but investigating
whether this was related to length of stay. Most similar to this thesis, MacNab et al.
(2005) used a hierarchical Bayesian to estimate NNU-speciﬁc mortality rates in Canadian
NICUs. The study only considered NICUs and adjusted for whether the infant was born
in the same hospital but transfers were not mentioned. Therefore the main questions
of this thesis regarding networked care were not addressed in this study. Using random
coeﬃcient models they examined whether the eﬀects of patients covariates diﬀered across
NICUs, ﬁnding variation in the eﬀects of being small for gestational age and having a
congenital anomaly. In this thesis I am focussing on how to incorporate the structure of
neonatal services into a provider proﬁling analysis so further exploration of risk factor
eﬀects are not of immediate concern. However random coeﬃcient models could be a
useful extension to identify if a provider has aberrant outcomes for particular patient
groups.
4.4.3 Transfers
The problems posed by accounting for transferred patients in provider proﬁling studies
has been raised in the literature, as shown by the review in section 4.2, with several
studies recommending allocation to the referring provider (Jollis and Romano, 1998;
Krumholz et al., 2007, 2006). This is not possible in neonatal care as infants may have
multiple transfers, in which case an NNU can both receive and refer the same infant.
This could be interpreted as allocation to the ﬁrst NNU caring for the infant, but as
shown in chapter 2 many infants are transferred within 24 hours of birth. Most surviving
infants will remain in neonatal care until they reach term equivalent age (eight weeks for
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an infant born at 32 weeks gestation). While initial care is important, it does not seem
reasonable to assign their outcome to an NNU caring for them for such a small fraction
of total stay, nor does it result in desirable inferences if we are interested in more than
initial care. Many studies excluded transfers but as 37% of the cohort were transferred
at least once and transferred infants cannot be considered representative of the whole
cohort (section 2.3.3), doing so would introduce bias. Furthermore, as discussed in
section 3.2.3, several studies mentioned that transfers are an important part of the
care provided so patients undergoing transfer should be included. For neonatal care,
whether an infant is transferred is not always determinable at birth, and can be aﬀected
by events that occur while on the neonatal unit, so excluding this group would mean
excluding based on care provided. Several studies attributed increases in transfers to
centralisation, demonstrating that the questions surrounding structure of services which
this thesis attempts to address are not unique to neonatal care. Samadashvili et al.
(2015) examined how results changed for diﬀerent types of hospital depending on how
transfers were allocated; I will take a similar approach for types of NNU.
For reasons outlined earlier in this discussion, hierarchical models are more appro-
priate for the neonatal data than assuming independence of provider eﬀects. Therefore
ways of handling transfers which were revealed in the review (the weighted ﬁxed eﬀects
approach of Hassani et al. (2015) and Kristoﬀersen et al. (2012), and allocation to all
provider as done by Aylin et al. (2010)) are not suitable for the neonatal data. While the
studies considering admissions as the lowest level of analysis did not properly account
for the dependency between episodes from the same patients, there are methods that
can do so. Discrete time logistic regression is used to model the conditional probability
of an event occurring in a time period given that it has not already occurred. These
models would also allow risk factors to vary over the course of postnatal age. This could
help more accurately describe the condition of an infant that is transferred in. However,
when reviewing risk factors for preterm mortality Medlock et al. (2011) found that the
addition of later data did not provide improved prediction over models limited to data
available at birth. A hierarchical discrete time logistic model was used by Diya et al.
(2010) to examine associations between nurse staﬃng factors and mortality for elective
cardiac surgery patients in Belgium. In this study there were only 4 time periods which
all surviving patients progress through. This is not the case for preterm infants: the
number of episodes ranges from one to twelve, with varying admission and discharge
times and no routine progression, so I have not considered this method further here.
A limitation of the review is that the search strategy may not have captured all
relevant studies. The neonatal length of stay study by Lee et al. (2013) is one example
as, unlike the other neonatal applications of hierarchical models mentioned previously,
transfers were speciﬁcally mentioned. This is likely to be because there are many dif-
ferent phrases associated with provider proﬁling studies (Lee et al. (2013) discussed
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variation across NICUs). I did consider expanding the search but many of the terms are
very general and would retrieve a large number of results. I mitigated the limitations of
the search this by also searching reference lists and forward citations for relevant papers
which yielded eleven studies of interest (the ten in ﬁgure 4.2 plus Kristoﬀersen et al.
(2012)).
4.4.4 Multiple membership models
Multiple membership (MM) models present an attractive potential solution to accom-
modating neonatal transfers within the hierarchical framework. For the purposes of
this thesis we only consider MM at the individual level (and not a level two group
being a member of more than one level three group) because NNUs are only in one net-
work. However, even in this case it is still possible for an individual to be a member of
more than one level three group (as illustrated in ﬁgure 4.3(b)) describing cross-network
transfers. Assigning weights to all clusters an individual belongs to is similar to the
approach of Hassani et al. (2015) and Kristoﬀersen et al. (2012) but within a single
hierarchical model. Hassani et al. (2015) conducted a two stage analysis to shrink the
provider eﬀects, but this is more cumbersome and does not properly carry through the
uncertainty from the ﬁrst stage into the ﬁnal model. Multiple membership has been
used to model pupil mobility (Goldstein et al., 2007; Leckie, 2009) which is similar in
nature to neonatal transfers. The school eﬀects were themselves of interest just as NNU
eﬀects are here, mobility was linked to education attainment as transfers are linked to
mortality, and membership is deﬁned by time, with diﬀerent patterns for each individ-
ual. There are also diﬀerences between the two. Transfers are to some extent dictated
by the NNUs and networks, which is not the case for pupil mobility (with the rare ex-
ception of expulsions). Infants are transferred for more or less intense care at diﬀerent
times dependent on need, so the patient ﬂows for an NNU will be linked to the type of
care it oﬀers as described in chapter 2. No such patterns have been described for the
pupil mobility data: while we might expect pupils to move schools more at particular
times (e.g. after major examination years) we might not expect these patterns to diﬀer
strongly by school in the way that transfer patterns diﬀer by NNU. Transfer patterns
are also related to the outcome of the infants as demonstrated in chapter 3. A similar
relationship was modelled in detail for pupil mobility data by Leckie (2009) who looked
at associations between moves at diﬀerent time points and educational attainment. I
have elected not to adjust for transfers as they are part of care provided. The methods of
Leckie (2009) could prove useful if looking at associations between transfer and clinical
outcome, although in the educational case moves can only occur at a few time points
based on the school year whereas neonatal transfers can occur at any time.
In a provider proﬁling setting we may only be interested in initial care, in which case
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allocation to the ﬁrst provider may be reasonable, but the MM literature indicates that
it is not appropriate if we want to evaluate provider performance regardless of when
care occurs. This limitation was not mentioned in any of the studies in the review in
section 4.2. Transfers are common for preterm infants, with many infants having mul-
tiple transfers so the underestimation of cluster variance when using single membership
models may be notable. I will describe methods to investigate this in chapter 5, and
to compare the random eﬀects estimated by single and multiple membership models, as
existing studies have not done so beyond correlating the ranks.
In section 4.1.4, I discussed how there are particular modelling concerns when using
hierarchical models for provider proﬁling because it is the random eﬀects themselves
that drive our inferences about speciﬁc providers. Similar concerns exist when choosing
the weighting as this may inﬂuence the random eﬀects. We may wish all providers to
have equal accountability for the patient, or for those providing more care to have a
greater share, as is reﬂected by the standard MM weights which would assign patients
to providers based on length of stay. Alternatively, we may want provider eﬀects to
reﬂect the patients under their care at the most crucial points in stay. The suggestion
to weight critical times more heavily was made in the context of AMI, stroke and hip
fracture patients by Kristoﬀersen et al. (2012). Other options of ﬁxed-value or variance-
based weights described in existing studies cannot be applied to the neonatal data as the
timing of hospital episodes is variable: one infant’s ﬁrst admission might be for one day,
another’s for one week. Whilst several studies found conclusions to be robust to diﬀerent
weights, this may not be the case for the neonatal data because of the nature of transfer
patterns, how they vary across NNUs, and their dependence on the health of the infants.
When examining sensitivity of cluster eﬀects to diﬀerent weights, all studies (including
the simulation study by Wolﬀ-Smith and Beretvas (2014)) were limited to looking at
cluster variance and correlation of the ranks, rather than the eﬀects themselves which is
more of interest in this thesis. Therefore in this thesis I aim to implement MM models
with a range of weights suitable for neonatal transfers with a focus on estimating NNU
eﬀects.
In the next chapter I will describe the methods for the thesis, building on the review
of existing methods in this chapter. I will use Bayesian methods in this thesis as, in
addition to the advantages for estimating hierarchical models and resulting provider
eﬀects described in 4.1, they accommodate the non-nested structure of MM models.
A brief background to Bayesian methods will be given in section 5.1. In section 5.2 I
will develop a hierarchical model to estimate NNU eﬀects on mortality of the subset of
preterm infants who were not transferred, adjusting for the risk factors determined in
chapter 3. Based on the ﬁndings of this chapter I will explore two and three level models
to incorporate variation at the NNU and network level respectively, allowing the mean
and variance of NNU eﬀects to vary by NNU level, and using diﬀerent assumptions for
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the random eﬀects distribution. Next I will use MM models to allow the inclusion of
transferred infants. This chapter indicated that choice of weights may be important but
that the true weight is unknown. In section 5.3 I will describe a simulation study to
investigate how diﬀerent weights suitable for modelling neonatal transfers might aﬀect
individual provider eﬀects, in contrast to existing studies. I will then apply MM models
to the neonatal data, incorporating data on the intensity of care as suggested by the
ﬁndings of this chapter.
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Chapter 5
Methods for the thesis
In this chapter I describe the analysis methods used in this thesis, building on the
methods reviewed in the previous chapter and incorporating the risk factors selected
in chapter 3. This chapter begins with a preliminary introduction to the Bayesian
techniques (section 5.1) before moving to the main methods for the thesis. Section
5.2 describes the hierarchical models incorporating neonatal unit (NNU) and network
eﬀects but only for non-transferred infants so infants can be assigned to a single NNU.
I then set out the methods for the multiple membership models, ﬁrst applied to explore
sensitivity to diﬀerent weights using simulated data in section 5.3 and then to neonatal
data (including transferred infants) in section 5.4.
5.1 Bayesian hierarchical models
In this section I give a brief introduction to the Bayesian view of probability and model
estimation, to give both a theoretical and practical basis for the methods used in this
thesis. More detail about the standard techniques discussed here can be found in Gelman
et al. (2004). Bayesian methods provide a diﬀerent framework for statistical inference
from the framework provided by frequentist methods. In a frequentist setting we assume
the parameter θ we are trying to estimate using observed data y takes an unknown true
value. This is ﬁxed so we cannot make probability statements about it such as “there
is a 95% probability that θ is greater than 0”; it either is or it is not. The probability
statements we can make under the frequentist paradigm refer to the experiment we are
conducting to estimate the value, not value itself. For example we can calculate the
p-value as probability of observing data y (or something more extreme) under some
assumed null hypothesis for θ. Correspondingly, we can construct a conﬁdence interval
for θ using the data y such that the probability that the interval contains θ is over a
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certain percentage. As these are probabilities about what we observe, we can think of
them as long-run frequencies were we to repeat our experiment many times.
In a Bayesian setting our uncertainty can be expressed directly as a probability in
terms of θ, so we are allowed to make statements such as “there is 95% probability
that θ is greater than 0”. Our uncertainty about the parameters after the experiment
is quantiﬁed by the posterior distribution (the probability of the parameter θ given the
data y), which is calculated using Bayes’ theorem (Bayes and Price, 1763):
p(θ|y) = p(y|θ)p(θ)/p(y) ∝ p(y|θ)p(θ) (5.1)
The likelihood, p(y|θ), is the same as that required by likelihood-based frequentist
methods, but additionally we now require a prior, p(θ). The prior quantiﬁes our beliefs
about the distribution of θ prior to seeing the data y. The posterior distribution is
what we use to draw inferences. The extent to which the prior inﬂuences the posterior
depends on the how much information is the prior contributes relative to the data. This
makes sense if we consider the probability distributions of the parameters of interest in
terms of our belief: if we have some idea about the parameters prior to seeing the data,
but the data do not tell us much about the parameters, then the posterior distribution
will be similar to the prior. Similarly if we have no idea about the values the parameters
might take and we have a reasonable amount of data from our experiment, the posterior
will mainly be informed by the data (and as the sample size tends to inﬁnity we arrive
at the same numerical estimates as those obtained by maximum likelihood, though the
interpretation is diﬀerent).
The prior distributions are included in the speciﬁcation of the model. For example
in model 4.1 we might assign the priors
α ∼ N(0, 100000)
β ∼ N(0, 100000)
For model 4.2 we might assign
α ∼ N(0, 100000)
β ∼ N(0, 100000)
uj ∼ N(0, σ2u)
σu ∼ U(0, 100)
This demonstrates the continuity between single level and hierarchical models in a
Bayesian framework which arises because there are no ﬁxed parameters: all parameters
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are considered random since they are assigned a distribution. The only diﬀerence in the
speciﬁcation is that in the hierarchical model, the distribution of the uj is governed by
a higher level parameter σu, known as a hyperparameter, which is also assigned a prior
distribution (a hyperprior).
As mentioned previously, it is reasonable to assume that the provider eﬀects are not
identical, nor independent, but similar. This notion is formalised in Bayesian statistics
as exchangeability. A set of parameters θ1, ..., θn are deﬁned as ﬁnitely exchangeable if
the joint distribution p(θ1, ..., θn) remains unchanged for any permutation of the labels
1, ..., n. That is, if I know the set of providers 1, ..., n, knowing which provider is number
1, which is number 2 and so forth, does not change my beliefs about θ1, ..., θn. We do not
require independence, so knowledge of some of the parameters can give us information
about the others. It is this borrowing of information that results the provider eﬀects
being shrunk towards the mean, with more shrinkage where there is less information.
Exchangeability is also a crucial part of Bayesian estimation itself as it allows the joint
prior for all parameters to be decomposed into a product of conditional distributions,
further details can be found in Gelman et al. (2004).
5.1.1 Choice of priors
It is recommended to check the sensitivity to the choice of prior by implementing a
community of priors (Spiegelhalter et al., 1994) which reﬂect diﬀerent positions of belief
about the parameters. In practice we do not always have much information on which
to base the priors, so they can be set to convey minimal information (e.g. a ﬂat distri-
bution over all possible values). These are usually called vague or reference priors. For
some parameters we may be interested in a transformation, in which case to be truly
non-informative a prior has to be so under transformation. Priors can also be weakly
informative, a term applied to those which are restricted to plausible values but do not
express any particular prior belief (Gelman, 2006).
For location parameters such as regression coeﬃcients, a Normal distribution with
zero mean and a very large variance is a standard option (Lunn et al., 2012). Such
parameters are usually insensitive to choice of vague prior when there is a reasonable
amount of data available (Gelman, 2006; Lambert et al., 2005). Scale parameters can
be more sensitive, in particular the variance parameters in hierarchical models. Gelman
(2006) recommends a uniform prior on the standard deviation with a suitably large
upper limit if a proper prior is required (as is the case for the OpenBUGS software used
here), provided the number of groups not less than ﬁve.
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5.1.2 Estimation of Bayesian models
A closed-form of the posterior distribution is only available in a limited number of
cases. Beyond this, there are various ways of evaluating the required integrals but the
most widely used is Markov Chain Monte Carlo (MCMC). Monte Carlo integration
is used to approximate any summary of a probability distribution by calculating that
summary across repeated independent draws from the distribution. The accuracy of
the approximation increases as the number of samples increases. A Markov Chain is
a sequence of random variables such that given the present, the future is independent
of the past, so all information about the history of the process is contained within the
present state. The key property of interest to Bayesian inference is that Markov chains
with particular properties converge to a stationary distribution (Gilks et al., 1996). Say
we have our parameter vector of interest θ and a set of initial values θ(0). If we can
construct a transition distribution (the set of probabilities governing movement from
one set of samples to the next) for which gives the distribution of θ(t+1) given θ(t)
such that the resulting Markov chain converges on the posterior distribution p(θ|y),
we will obtain a series of samples from a distribution suﬃciently close to the target
posterior distribution which are independent of the starting values. The starting values
can be chosen using the data (as they are not part of our prior belief) but should
be suitably diﬀerent for each Markov chain to allow convergence to be checked (Lunn
et al., 2012). This brings us to the required samples we need to carry out Monte
Carlo integration as previously described. Gibbs sampling is one way of proceeding
from one set of samples to the next using conditional distributions (Gelfand and Smith,
1990; Geman and Geman, 1984) and is the method implemented in the OpenBUGS
software (OpenBUGS Project Management Group, 2014) used in this thesis. Practically
speaking, if we have a set of parameters it means we sample the next value for one of
these parameters (or a subset of several) at a time conditional on the current value of all
the other parameters. This approach can be applied to transformations of parameters,
allowing us to obtain measures of uncertainty for quantities whose distribution cannot
be described parametrically.
5.1.3 Model convergence and estimation of the joint posterior distri-
bution
We take successive samples until we believe that the Markov chain has converged to
a stationary distribution. There are no tests which prove convergence but there are a
number of statistics to help assess the likelihood of convergence. It is recommended
to use multiple ways of assessing convergence as diﬀerent methods (Lunn et al., 2012);
I will describe a number of methods here. Multiple chains can be run from diﬀerent
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starting points and the sampled values plotted for each parameter over time (trace
plots). If the paths of the chains are indiscernible from one another and look like a
random trace then this is consistent with convergence. The Brooks Gelman Rubin
(BGR) statistic compares the posterior variability pooling samples from both chains
with the average of the posterior variability measured in each chain separately; this
ratio should tend to 1 as convergence is reached (Brooks and Gelman, 1998; Gelman
and Rubin, 1992). The Geweke statistic (Geweke, 1991) assumes that the chain has
converged by the half way point, and compares the last 50% of the chain with the ﬁrst
10% (these are typical values used). If these sections of the chain are diﬀerent then this
is taken as evidence that the chain has not converged by 10% of the way through. The
Heidelberger-Welch stationarity diagnostic (Heidelberger and Welch, 1983) tests a null
hypothesis of convergence, ﬁrst using the whole chain, then discarding an increasing
percentage of the initial part of the chain up to 50%.
Once we believe convergence has been reached we can then discard the MCMC
samples up to this point (called burn in) and run the MCMC until we have enough
samples with which to summarise the posterior distribution with suﬃcient precision.
Even once the MCMC simulation has run long enough to reach stationarity, we will still
have correlation from one iteration to the next because of the nature of Markov Chains.
Independence is not an assumption of Monte Carlo integration, so our inferences are still
valid, but they are less eﬃcient (Gilks et al., 1996). If there is a high level of correlation
from one sample to the next, it is more diﬃcult for the sampler to explore the parameter
space. Autcorrelation can be reduced by only keeping some of the samples (known as
thinning), though using the whole chain results in more accurate posterior inferences
(Lunn et al., 2012).
5.1.4 Model checking and model comparison
Posterior predictive checks are a way of checking whether predictions produced by the
model (using the parameters estimated by the posterior distribution) give results that
are similar to the original data (Gelman et al., 1996). If the model is correct we would
expect that the observed data would be likely to occur under the posterior distribution.
Note that, as with most checks of model ﬁt, the converse does not hold, so the lack of
apparent problems does not mean that the model is true. Rather, posterior predictive
checks are used to investigate ways in which the model might be deﬁcient. We can
make predictions for the same individuals and new clusters, or for new individuals and
clusters (or combinations thereof) depending on what we are interested in. To conduct
posterior predictive checks we simulate data based on sets of parameters sampled from
the joint posterior distribution (which is straightforward when we already have such
samples from MCMC). We then choose test statistics with which to compare the real
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and replicated data. A range of test statics should be chosen to reﬂect the various ways
in which the model may be inadequate, with a focus on the inferences we are interested
in (Gelman et al., 2000).
Quantile-quantile (Q-Q) plots can be used to check the assumed distribution of the
random eﬀects.These plot the sample (posterior means of the random eﬀects) against
the theoretical quantiles of the desired distribution. Even if the model is true and the
underlying provider eﬀects follow the speciﬁed distribution, the distribution of posterior
means will be underdispersed relative to the estimated random eﬀects variance, as the
estimates are shrunk towards the overall mean. It is for this reason that the posterior
means themselves do not provide a good estimate of the overall variability (Shen and
Louis, 1998).
There are a number of statistics which describe how well the model ﬁts the data.
The deviance, D(θ) is a measure of how likely the data are under the parameters θ and
is given by:
D(θ) = −2 log p(y|θ)
The better the ﬁt of the model, the lower the deviance. This measure does not take
into account the complexity of the models; usually we want to quantify the trade-oﬀ
between improvement in ﬁt and added complexity from extra parameters. The Akaike
Information Criterion (AIC) which was used in section 3.4.1 does this by adding twice
the number of parameters to the estimated deviance. For Bayesian models the number
of model parameters is not clear because the parameters are constrained by the priors
(Lunn et al., 2012). We consider instead the eﬀective number of parameters, pD which
has a number of alternative deﬁnitions (Gelman et al., 2004) but I will use that proposed
by Speigelhalter (Spiegelhalter et al., 2002):
pD = D¯ −D(θ¯)
where D¯ is the mean of the posterior distribution of the deviance andD(θ¯) is the deviance
of the posterior means of the parameters θ. The Deviance Information Criterion (DIC)
is an analagous to the AIC and is deﬁned as:
DIC = D¯ + pD = D(θ¯) + 2pD
I presented DIC, D¯ and pD for all models.
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5.2 Hierarchical analysis of non-transferred infants
5.2.1 Aim
In chapter 4 I described how Bayesian hierarchical models can be used to estimate
provider eﬀects where individuals attend a single provider. The aim of this section is
to describe the application of these models to estimate NNU eﬀects1 for mortality of
the subset of preterm infants who were not transferred. The purpose of the analysis
is to investigate some of the other modelling issues raised by the research question
before adding the complexity of transfers. In particular I sought to compare diﬀerences
between modelling clustering by NNU only, and by NNU and neonatal network and
ways of modelling diﬀerences across NNU levels. I also aimed to assess sensitivity to
choice of prior distributions.
5.2.2 Data
The data used in this chapter are a subset of those described in 2.3.1 restricted to single-
ton infants who were not transferred postnatally i.e. they were treated in a single NNU.
As discussed in chapter 2, all infants with missing data were excluded (the limitations
of this will be discussed in chapter 9).
5.2.3 Statistical models
In chapter 3 I selected the infant risk factors for inclusion in the model as gestational
age at birth, birth weight, sex, and whether the mother received antenatal steroids.
Gestational age and birth weight have interacting, non-linear eﬀects. This was modelled
with a 3 knot spline for gestation and a quadratic term for birth weight. Interactions
between linear gestation with all birth weight terms, and linear birth weight with all
gestation terms were included. The same infant risk factors and functional form were
applied in all the models described here.
Level of neonatal unit (special care baby unit (SCBU), local neonatal unit (LNU)
and neonatal intensive care unit (NICU) in order of increasing level of care provided, see
section 1.2 for deﬁnitions) is the only provider-level variable I included. The rationale
for this was discussed in chapter 3. As the categorisation of NNU into levels is a key part
of the structure of neonatal services and therefore of the research question, I compared
1As mentioned in section 4.1.4, the word “eﬀect” is from the random eﬀects terminology. NNU eﬀects
are not wholly caused by the NNU, as they may be attributable to unmodelled factors which are not
under the control of the NNU.
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models with and without NNU level as a covariate, and with and without complex
variation by NNU level. In chapter 4 I described how hierarchical models can be used to
describe clustering at more than two levels. I therefore compared models with both two
levels (infants within NNUs) and three levels (infants within NNUs within networks).
Similarly to the notation for the risk model in section 3.4 and the hierarchical models
introduced in section 4.1, let pij denote the probability that infant i in NNU j dies before
discharge, with i = 1, ..., N . Let the gestational age spline terms for infant i be denoted
by g
(1)
ij and g
(2)
ij , birth weight by bij , with the variables mean centred and standardised
as before. Binary indicators for male sex and whether the mother received any antenatal
steroids are given by mij and sij respectively. As before the NNU eﬀects are given by uj
and the between-NNU variance by σ2u. To incorporate the level of NNU into the model
speciﬁcation we use the notation level(j) to mean the level of NNU j.
The two-level models are described as follows.
Model 1 A two-level model (infants within NNUs), adjusted for infant risk factors
only:
logit(pij) = β1g
(1)
ij + β2g
(2)
ij + β3bij + β4b
2
ij
+ β5g
(1)
ij bij + β6g
(1)
ij b
2
ij + β7bijg
(2)
ij
+ β8mij + β9sij + μj i = 1, ..., N
μj = α+ uj j = 1, ..., J (5.2)
Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
uj ∼ N(0, σ2u)
Hyperprior
σu ∼ U(0, 5)
Model 2 A two-level model (infants within NNUs), adjusted for infant risk factors
and NNU level, taking LNU as the baseline category:
logit(pij) = β1g
(1)
ij + β2g
(2)
ij + β3bij + β4b
2
ij
+ β5g
(1)
ij bij + β6g
(1)
ij b
2
ij + β7bijg
(2)
ij
+ β8mij + β9sij + μj i = 1, ..., N
μj = α+ γ11SCBU(j) + γ21NICU(j) + uj j = 1, ..., J
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Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
γt ∼ N(0, 100000) t = 1, 2
uj ∼ N(0, σ2u)
Hyperpriors
σu ∼ U(0, 5)
where:
1type(j) =
{
1 if level(j) = type
0 if level(j) = type type ∈ {SCBU, NICU}
Model 3 A two-level model (infants within NNUs), adjusted for infant risk factors
and NNU level, with level-speciﬁc variance for the NNU eﬀects:
logit(pij) = β1g
(1)
ij + β2g
(2)
ij + β3bij + β4b
2
ij
+ β5g
(1)
ij bij + β6g
(1)
ij b
2
ij + β7bijg
(2)
ij
+ β8mij + β9sij + μj i = 1, ..., N
μj = α+ γ11SCBU(j) + γ21NICU(j) + uj j = 1, ..., J
Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
γt ∼ N(0, 100000) t = 1, 2
uj ∼ N(0, σ2u(level(j)))
Hyperprior
σu(level(j)) ∼ U(0, 5) level(j) ∈ {SCBU, LNU, NICU}
Similarly to equation 4.3, for the three level model we use the ijk subscript to denote
infant i in NNU j in network k, where k = 1, ...,K.
Model 4 A three-level model (infants within NNUs within networks), adjusted for
infant risk factors only:
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logit(pijk) = β1g
(1)
ijk + β2g
(2)
ijk + β3bijk + β4b
2
ijk
+ β5g
(1)
ijkbijk + β6g
(1)
ijkb
2
ijk + β7bijkg
(2)
ijk
+ β8mijk + β9sij + μj i = 1, ..., N
μjk = νk + ujk j = 1, ..., J
νk = α+ vk k = 1, ...,K
Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
ujk ∼ N(0, σ2u)
vk ∼ N(0, σ2v)
Hyperpriors
σu ∼ U(0, 5)
σv ∼ U(0, 5)
Model 5 A three-level model (infants within NNUs within networks), adjusted for
infant risk factors and NNU level:
logit(pijk) = β1g
(1)
ijk + β2g
(2)
ijk + β3bijk + β4b
2
ijk
+ β5g
(1)
ijkbijk + β6g
(1)
ijkb
2
ijk + β7bijkg
(2)
ijk
+ β8mijk + β9sij + μj i = 1, ..., N
μjk = νk + γ11SCBU(j) + γ21NICU(j) + ujk j = 1, ..., J
νk = α+ vk k = 1, ...,K
Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
γt ∼ N(0, 100000) t = 1, 2
ujk ∼ N(0, σ2u)
vk ∼ N(0, σ2v)
Hyperpriors
σu ∼ U(0, 5)
σv ∼ U(0, 5)
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Model 6 A three-level model (infants within NNUs within networks), adjusted for
infant risk factors and NNU level, with level-speciﬁc variance for the NNU eﬀects:
logit(pijk) = β1g
(1)
ijk + β2g
(2)
ijk + β3bijk + β4b
2
ijk
+ β5g
(1)
ijkbijk + β6g
(1)
ijkb
2
ijk + β7bijkg
(2)
ijk
+ β8mijk + β9sij + μj i = 1, ..., N
μjk = νk + γ11SCBU(j) + γ21NICU(j) + ujk j = 1, ..., J
νk = α+ vk k = 1, ...,K
Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
γt ∼ N(0, 100000) t = 1, 2
ujk ∼ N(0, σ2u(level(j)))
vk ∼ N(0, σ2v)
Hyperpriors
σu(level(j)) ∼ U(0, 5) level(j) ∈ {SCBU, LNU, NICU}
σv ∼ U(0, 5)
OpenBUGS code for these models is provided in appendix D.
5.2.4 Prior distributions
In the models above I have speciﬁed a Normal distribution for the NNU and network
eﬀects and a Uniform (0,5) prior for standard deviation of the random eﬀect distribu-
tions. The upper limit for the Uniform distribution is equivalent to an upper limit of
25 for the variance of the log odds ratios. This corresponds to a 95% range of 0.007 to
148 on the odds ratio scale, so still much wider than we would expect and so should be
suﬃciently far from the tails of the posterior distribution. As provider eﬀects can be
sensitive to the choice of priors and hyperpriors I conducted several sensitivity analyses
based on the ﬁndings of chapter 4. I speciﬁed a t distribution with 4 degrees of freedom
for the NNU eﬀects (in place of the Normal distribution speciﬁed above). I did not
use an alternative distribution for the network eﬀects as there are too few networks to
compare ﬁt. Regarding hyperpriors for the standard deviation of NNU and network
eﬀects, I replaced the U(0, 5) in the main analysis with a Uniform on a wider range of
U(0, 5). For the ﬁxed parameters (intercept and regression coeﬃcients) I have used a
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vague Normal prior with a large variance.
5.2.5 Model estimation and checking
All analyses were run in R version 3.2.3 (R Core Team, 2015) OpenBUGS version 3.2.3
(OpenBUGS Project Management Group, 2014). I ran two MCMC chains with dispersed
initial values and used trace plots and the BGR statistic (Brooks and Gelman, 1998;
Gelman and Rubin, 1992) to determine the initial burn-in period. I ran the MCMC
chains until the upper limit of the conﬁdence interval for the BGR was less than 1.1
for all regression coeﬃcients, random eﬀect variances and a selection of NNU eﬀects.
I then doubled the number of iterations and used the Geweke (Geweke, 1991) and
Heidelberger-Welch (Heidelberger and Welch, 1983) tests to assess whether any more
initial iterations should be discarded as burn in. I conducted both tests on both MCMC
chains and discarded further iterations if there was evidence of non-convergence for
any single parameter from more than one source. The rationale for this approach was
that these procedures both involve hypothesis tests on multiple parameters so, at a
signiﬁcance level of 0.05, we would expect one in 20 tests to be statistically signiﬁcant
under convergence. I then continued running the MCMC iterations until the Monte
Carlo standard error (a measure of the accuracy with which the samples estimate the
posterior) had been reduced to 5% of the posterior standard deviation (SD) for all
parameters. This is equivalent to having 400 independent samples (called the eﬀective
sample size (ESS)) which is satisfactory for most purposes (Lunn et al., 2012). For this
thesis I am not reliant on tail probabilities, for which a much larger ESS is required for
the necessary precision, so the standard approach is adequate. All model checks were
done using the CODA package for R (Plummer et al., 2006).
To conduct posterior predictive checks I drew 1000 replications of the data, predicting
for the same infants within the same NNUs (i.e. simulating Y newijk = Bernoulli(pijk) for
each infant i in NNU j in network k in the dataset, with pij as deﬁned for each model 1 to
6). I compared the mortality rates at NNUs, neonatal networks and by NNU level for the
observed and replicated data as these quantities relate to how the structure of neonatal
services is incorporated in the model. I used graphical checks to detect discrepancies,
plotting histograms of the predicted mortality rate across simulated datasets along with
the observed rate as a vertical line.
Quantile-quantile (Q-Q) plots were used to check the assumed distribution of the
NNU eﬀects and the deviance, eﬀective parameters and DIC compared across models.
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5.2.6 Presenting results
Infant and provider characteristics were presented as mean posterior odds ratios and
95% credible intervals (the 2.5th to 97.5th percentiles of the posterior distribution).
Density plots were used to illustrate the posterior distribution for the variance param-
eters. The mean of the standard deviations of the posterior distributions of individual
NNU eﬀects (averaged across NNUs) was presented to give an estimate of the uncer-
tainty in estimating provider eﬀects. The variance partitioning coeﬃcient (VPC) was
used to estimate the proportion of total variation attributable to diﬀerences between
providers. For continous variables partitioning the variance is straightforward, but for
binary variables the link function (in this case the logit) means amount of variation
is expressed on diﬀerent scales at diﬀerent levels of the model (as a probability at the
individual level and continuously at the cluster level). Here I used the latent variable
approach (also called the linear threshold method) to calculate the VPC (Goldstein
et al., 2002; Snijders and Bosker, 1999). We consider the observed binary outcome as
resulting from a latent continuous variable such that the observed value is 0 if the latent
variable is below a threshold, and 1 if it is above the threshold. The latent variable
(under the logistic model used here) follows a logistic distribution with variance π2/3,
which we then take to be the individual-level variance on the continuous scale of the
latent variable. For the two-level models, the VPC for the between NNU variance σ2u is
therefore calculated as
V PCu =
σ2u
σ2u +
π2
3
For the three-level models the VPC for the between network variation takes a similar
form to the above but with the variation at three levels in the denominator:
V PCv =
σ2v
σ2u + σ
2
v +
π2
3
In the three level model we can also consider the VPC for NNUs and networks combined:
V PCudiff =
σ2u + σ
2
v
σ2u + σ
2
v +
π2
3
The posterior mean NNU eﬀects were compared using pair-wise scatter plots and
correlations. Density plots of the posterior means by level were presented for each model.
Finally plots of the smallest and largest estimates of uj across models for each NNU
were plotted, with 95% credible intervals, by NNU level to illustrate how results for
individual NNUs vary across models. Neonatal units and networks are not named as
this was an exploratory analysis to investigate methodology.
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5.3 Multiple membership analysis using simulated data
5.3.1 Aim
In chapter 4, I reviewed how transferred patients have been handled using hierarchical
models in the provider proﬁling literature, and introduced multiple membership (MM)
models as a possible alternative. MM models require the speciﬁcation of weights to
describe how individuals are assigned to each cluster. As described in section 4.3.2, the
weighting scheme used to analyse the data aﬀects the estimates of σ2u, uj and the VPC
because the assumed cluster-level variance contribution for an individual will vary by
scheme. For provider proﬁling purposes the weights chosen should reﬂect the inferences
we want to make about the provider eﬀects. However we need to acknowledge that
these weights may attribute variation in a diﬀerent way to the underlying processes that
gives rise to the observed data. The aim of this section is to use simulated data to
investigate the diﬀerences in variance parameters and provider eﬀects under a variety of
data scenarios and analysis models.
5.3.2 Weighting schemes
A standard option for the weights is the proportion to time spent in each cluster (length
of stay for hospital patients), as described in section 4.3. I discussed there that, for
provider proﬁling, we may also want to consider weights that reﬂect the intensity of
care, which could vary throughout the patient journey. Although infants may not be in
the ﬁrst neonatal unit for long, initial care prior to transfer is considered crucial. Indeed
the term golden hour has been borrowed from adult emergency medicine to refer to
the ﬁrst postnatal hour (Annibale and Bissinger, 2010). While, as with adult trauma,
the evidence to support the importance of this exact hour is limited, several studies
suggests that diﬀerences in initial care lead to variations in mortality (Empana et al.,
2003; Marlow et al., 2014; Watson et al., 2014). Infants have to be resuscitated and
stabilised appropriately and a transfer organised(Fenton et al., 2004). More intensive
care is performed earlier during stay (section 2.3.2),and the risk of mortality is higher
(section 2.3.4). Therefore there is a clinical argument for placing greater weight on
the earlier part of stay in the neonatal setting so this led the weighting choice for the
simulation study.
Since the sum of the weights over the whole stay is one, and since the total length
of stay varies, I speciﬁed the weight as the area under the Beta probability density
function (pdf) as a function of the proportion of total stay. The Beta distribution has
two parameters which describe the shape, here denoted by a and b. For an episode with
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Figure 5.1: Multiple membership weights described by Beta distributions. The weights
are given by the area under the line for that part of stay. For example, for the ﬁrst episode
ending at time d1(shaded area), the Beta(1,3) weighting gives the greatest weight to the
hospital and the Beta(1,1) weighting the smallest weight.
admission time t1 and discharge time t2 (with these times expressed as a proportion of
total stay) where fB(t; a, b) and fB(t; a, b) denote the pdf and cumulative distribution
function (cdf) of the Beta distribution with parameters a and b, then the weight w for
this episode is
w =
∫ t2
t1
fB(t; a, b) dt = FB(t2; a, b)− FB(t1; a, b) (5.3)
Figure 5.1 shows the pdf for Beta(1,1), Beta(1,2) and Beta(1,3) distributions. The
Beta(1,1) is ﬂat, so the weighting formula above is equivalent to the standard option
of apportioning weight according to length of stay. A Beta(1,2) distribution gives more
weight to the earlier part of stay, equivalent to half the weight allocated to the ﬁrst 30%
of stay. As the second Beta parameter increases, the weight becomes more unevenly
distributed, with the extreme scenario being all weight allocated to the ﬁrst provider. A
Beta(1,3) distribution is equivalent to half the weight allocated to the ﬁrst 20% of stay.
To show the diﬀerence in cluster-level variance contribution across weighting schemes,
suppose we have an individual who spends an equal amount of time in two clusters. Un-
der the Beta(1,1) weight their variance contribution will be 0.52σ2u + 0.5
2σ2u = 0.5σ
2
u,
under Beta(1,2) 0.752σ2u+0.25
2σ2u = 0.625σ
2
u and under Beta(1,3) 0.875
2σ2u+0.125
2σ2u =
0.781σ2u.
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5.3.3 Data
A simple model was followed with only two levels (individuals within provider) and no
individual-level or provider-level covariates. I simulated data from 15,000 infants across
100 providers.
All infants were randomly assigned to a ﬁrst provider from the 100 providers with
equal probability. 25% of the infants were randomly selected to be transferred once. The
second provider was randomly selected from all providers other than the ﬁrst. Transfer
times as a proportion of total stay were selected using a Uniform (0,1) distribution. This
is a simpler transfer than that observed in the neonatal data as described in chapter 2;
limitations of this will be discussed in section 7.5.
The log odds of mortality for providers were drawn from a Normal distribution
with a mean of -2.2 and standard deviation 0.4, corresponding to 95% of underlying
provider-speciﬁc mortality rates lying between 5% and 20%. Therefore the log odds
ratios representing provider eﬀects, denoted uj were drawn from a Normal distribution
with mean 0 and standard deviation 0.4. The outcome for infant i was generated as a
Bernoulli random variable with probability pi given by
logit(pi) = −2.2 + uj for individual i treated in a single provider j
logit(pi) = −2.2 + wi1uj1 + wi2uj2 for individual i treated in two providers j1 and j2
The weights wi1 and wi2 were determined by a Beta(a, b) distribution as described in
equation 5.3. For wi1, t1 = 0 and t2 is the time of transfer for individual i. For wi2, t1
is the time of transfer for individual i and t2 = 1.
For simulating the data we assumed three scenarios: weight proportional to length
of stay (LOS) which is equivalent to Beta(1,1); moderate emphasis on the early part of
stay calculated with a Beta(1,2) distribution; and a strong emphasis on the early part
of stay using a Beta(1,3) distribution. For convenience I will label these LOS, Beta2
and Beta3 respectively. These three options were chosen because they seemed the most
plausible for the neonatal data compared with alternatives allocating greater weight to
the middle or later parts of stay. Two “early” options were chosen rather than one
because it allows us to see if results are sensitive to lesser misspeciﬁcation. For each of
the three scenarios I simulated 200 datasets (600 datasets in total). The datasets were
identical across the four analysis models, but vary across the three weighting scenarios as
well as within scenarios. The stochastic elements were the Bernoulli survival indicator,
the transfer times and the allocation of individuals to providers. Provider eﬀects were
generated once only as these were examined across models and scenarios.
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5.3.4 Statistical models and estimation
For analysing the data, in addition to the three weighting schemes used to generate
the data, an additional analysis attributing each individual to the ﬁrst provider only
was carried out to investigate the impact of ignoring the multiple membership. This
weighting is labelled First for convenience. This gave twelve sets of results in total:
three scenarios (LOS, Beta2, Beta3 ) each analysed with four diﬀerent weightings (LOS,
Beta2, Beta3,First). Adopting the more general notation for the weights that was used
in 4.3 and hierarchical centring for consistency with analysis models in section 5.4, we
let U(i) denote the set of providers treating individual i. As in section 5.2, Bayesian
methods were used to estimate the models, with the same vague priors applied for the
intercept and random eﬀect variance. Vague priors were used to mimic the lack of
knowledge about provider eﬀects for real data analysis. The analysis models are given
by:
logit(pi) =
∑
j∈U(i)wijμj i = 1, ..., N
μj = α+ uj j = 1, ..., J
Prior
α ∼ N(0, 100000)
uj ∼ N(0, σ2u)
Hyperprior
σu ∼ U(0, 5)
with weights as described in equation 5.3, setting t1 as 0 and t2 as the time of transfer
for individual i. For the First analysis, all weight is assigned to the ﬁrst provider. Model
estimation was as described in section 5.2.5.
5.3.5 Presenting results
The posterior mean averaged over the M simulated datasets was presented for α and
σu for each of the 12 analysis-scenario combinations. A variety of measures were used
to describe the diﬀerences between the estimates produced by the analysis models and
the parameters which generated the data. Percentage bias, empirical standard errors
(SE), mean square error (MSE) and coverage for α and σu are presented, with these
measures deﬁned as follows (Burton et al., 2006). If β is the parameter of interest, βˆm
is the posterior mean of β from simulated dataset m,m = 1, ...,M and
¯ˆ
β is the mean of
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βˆ over the M simulations then he percentage bias is given by
¯ˆ
β − β
β
× 100% (5.4)
the empirical SE is given by √√√√ 1
M − 1
M∑
m=1
(βˆm − ¯ˆβ)2 (5.5)
and the mean square error is given by
(
¯ˆ
β − β)2 + SE(βˆ)2 (5.6)
The coverage is percentage of the M datasets where the 95% credible interval includes
the known true parameter.
To examine the impact on provider eﬀects we present the bias, MSE and coverage
averaged over all 100 providers. The average posterior SD over all providers is presented
as a measure of the uncertainty around provider eﬀects. To investigate whether the
Deviance Information Criterion (DIC) (Spiegelhalter et al., 2002) discriminates between
the diﬀerent models, I present the mean DIC and the proportion of datasets where the
correct analysis model is chosen based on DIC (applying a minimum diﬀerence of 5
(Spiegelhalter et al., 2003)).
5.4 Multiple membership analysis using neonatal data
5.4.1 Aim
The aim of this section is to describe methods to estimate NNU eﬀects on mortality for
singleton preterm infants, including those who were transferred. I applied MM models
described in section 4.3, building on the methods for the hierarchical analysis of non-
transferred infants described in section 5.2. I explored sensitivity to diﬀerent weights,
as was done with simulated data in section 5.3.
5.4.2 Weighting schemes
In addition to the four analysis weightings used in the simulation study (LOS, Beta2,
Beta3,First) I applied two other weightings which are relevant for provider proﬁling
purposes. As explained in chapter 1, for each day an infant is in the neonatal unit their
care is classiﬁed as intensive care (IC), high dependency care (HDC) or special care
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(SC) in decreasing order of intensity. Therefore we can augment the LOS weighting
described in section 5.3 by assigning weight according to the intensity of care received
each day. This weighted length of stay approach is labelled WLOS for convenience. For
each infant, each day in neonatal care (across all NNUs providing care) was assigned a
weight of 1 for IC, 0.5 for HDC and 0.25 for SC. These ratios are the nurse staﬃng ratios
recommended by the British Association of Perinatal Medicine (1:1 nurse to infant ratio
for IC, 1:2 for HDC and 1:4 for SC, see section 1.2). Letting dICij denote the number of
IC days infant i has in NNU j, and dICij the total number of IC days for infant i (with
similar deﬁnitions for HDC and SC) then the weights are then given by:
wij =
dICij + 0.5d
HDC
ij + 0.25d
SC
ij
dICi + 0.5d
HDC
i + 0.25d
SC
i
As discussed in chapter 4, in some provider proﬁling analyses which did not use
hierarchical models, individuals were assigned to all providers that treated them. A
similar approach for multiple membership models is to assign individuals to all providers
equally regardless of length of stay, i.e.
wij = 1/Ni ∀j ∈ U(i)
where U(i) denotes the set of Ni providers treating individual i. This weighting is given
the label Equal. A summary of all six weights is shown in table 5.1.
Table 5.1: Weightings for multiple membership models for simulated and neonatal data
Label Description
LOS The outcome is attributed in proportion to the length of
stay
Beta2 The outcome is attributed using the Beta(1,2) weight
Beta3 The outcome is attributed using the Beta(1,3) weight
First The outcome is attributed to the ﬁrst provider only
WLOS
(neonatal data only)
The outcome is attributed according to length of stay
weighted by the type of care received, using recommended
nurse staﬃng ratios
Equal
(neonatal data only)
The outcome is attributed equally to all NNUs caring for
the infant, regardless of length of stay or intensity of care
5.4.3 Data
The data used in this chapter are a subset of those described in 2.3.1 restricted to
singleton infants with no missing data, as for the analysis of non-transferred infants
described in 5.2. I also excluded any infants without a complete episodic record with all
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care in English NNUs. Episodic records were determined as incomplete if there was a
missing episode of care based on the episode number, or by discrepant details (more than
24 hours between discharge from one NNU and admission to another, or if the discharge
destination NNU was diﬀerent to the NNU of the next episodic record). Infants who had
an episode where the episode number, admission or discharge times, the NNU providing
care or daily care level data were missing were also excluded. A brief description of this
cohort is provided in chapter 7. I summarised the distribution of the total weight for all
infants across NNU levels and episodes of care to illustrate how the weighting schemes
diﬀer in practice.
5.4.4 Statistical models and estimation
As for the analysis of non-transferred infants, risk factors included in the model were
those determined in chapter 3: gestational age at birth, birth weight, sex, and whether
the mother received antenatal steroids, with spline terms and interactions as described
in 5.2. Modelling strategies for neonatal network eﬀects, variation by level of NNU, and
prior distributions for the random eﬀects were guided by the ﬁndings of the analysis
described in 5.2. Using Model 1 (equation 5.2) as an example we have:
logit(pi) = β1g
(1)
i + β2g
(2)
i + β3bi + β4b
2
i
+ β5g
(1)
i bi + β6g
(1)
i b
2
i + β7big
(2)
i
+ β8mi + β9si +
∑
j∈U(i)wijμj i = 1, ..., N
μj = α+ uj j = 1, ..., J
Priors
α ∼ N(0, 100000)
βs ∼ N(0, 100000) s = 1, ..., 9
uj ∼ N(0, σ2u)
Hyperprior
σu ∼ U(0, 5)
Note that, as described when these models were introduced in 4.3, we subscript any
quantities at the infant level with i rather than ij as the infant is no longer nested in a
single NNU. Multiple membership for the other models follows in the same way (the μj
is replaced by
∑
j∈U(i)wijμj).
Six diﬀerent models were run, one for each of the weighting schemes described in
table 5.1. Model estimation and convergence were as described in section 5.2.5. The
three-level models allow for the cross-network transfers described in chapter 2 as the
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network eﬀects are speciﬁed in the μj and weighted accordingly (see equation 4.6)
5.4.5 Presenting results
In addition to the results and model ﬁt statistics presented in 5.2.6, I investigated
patterns by transfer rate, considering proportion transferred, transfers in and out, and
transfers within 24 hours. The rationale for this is that any sensitivity to diﬀerent
weights is most likely to be seen in NNUs with the highest transfer activity, and analysis
in chapter 2 showed diﬀerences between early and late transfers, with early transfers
generally being for a higher level of care.
5.5 Summary
In this chapter I described the statistical methods for the main analyses of the thesis.
First I set out a series of models to investigate some of the statistical issues raised by
the research question before considering transfers. In particular I sought to compare
diﬀerences between modelling clustering by NNU only, by NNU and neonatal network,
and ways of modelling diﬀerences across NNU levels. I also aimed to assess sensitivity to
choice of prior distributions. Then I described a simulation study to assess how sensitive
parameters of interest are under a variety of data scenarios and analysis models. I
compared the usual weight applied in MM models (proportional with time spent in each
cluster i.e. length of stay) with weighting more heavily on the earlier part of stay in line
with the ﬁndings of chapter 2, and with allocation to ﬁrst provider to reﬂect standard
practice in the proﬁling literature. Finally I described the application of MM models
with a series of diﬀerent weights to the neonatal data, building on the models developed
in the non-transferred infants. In addition to the weights applied in the simulation study,
I weighted the length of stay at each NNU according to the category of care provided,
and a simple measure assigning infants to each NNU equally. The results of applying
the methods of this chapter are presented for the whole population in chapters 6 and
7. A case study for a single NNU is presented in chapter 8 and any methods pertaining
solely to that chapter are described there.
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Chapter 6
Results I: Non-transferred infants
In this chapter I present the results of applying the methods described in section 5.2. I
compare the six Bayesian hierarchical models to estimate neonatal unit (NNU) eﬀects
on mortality of non-transferred infants. The purpose of this chapter is to explore how
the diﬀerent ways of modelling the data structure aﬀect the results before including
transferred infants in chapter 7. I ﬁrst recap the methods for the chapter (section 6.1),
describe the data (section 6.2) and the results of model checking procedures (section 6.3).
Associations between the infant and provider characteristics are presented in section 6.4.
The key ﬁndings concern the NNU and network eﬀects; these are presented in section
6.5. The overall distribution and standard deviation estimates are compared across
models, along with individual NNU and network eﬀects. The interpretation of the
results, including implications for the transfers analysis is presented in section 6.6.
6.1 Methods recap
This section is a brief summary of the methods underlying the results for this chapter;
full details were given in chapter 5. Six Bayesian hierarchical models were estimated
using Markov Chain Monte Carlo methods. The response variable was death before
discharge from neonatal care. The population was all singleton infants born below 32
weeks gestation between 2011 and 2013 and admitted to an NNU in England contributing
data to the National Neonatal Research Database (NNRD) who were not transferred
during the course of neonatal care.
Model 1 A two-level model (infants within NNUs), adjusted for infant risk factors
based on the ﬁndings of chapter 3 (gestational age (as a restricted cubic spline
with 3 knots), birth weight (as linear and quadratic), all interactions between
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gestation and birth weight involving linear terms, sex and whether the mother
received antenatal steroids)
Model 2 As Model 1, but including level of NNU (special care baby unit (SCBU), local
neonatal unit (LNU) or neonatal intensive care unit (NICU), in increasing order
of level of care oﬀered) as an NNU-level variable in the model
Model 3 As Model 2, but allowing the between-NNU variance to diﬀer by level of NNU
(complex variation)
Model 4 As Model 1 but with a third level of the data hierarchy corresponding to
neonatal networks
Model 5 As Model 2 but with a third level of the data hierarchy corresponding to
neonatal networks
Model 6 As Model 3 but with a third level of the data hierarchy corresponding to
neonatal networks
I considered both a Normal distribution and a t distribution with four degrees of
freedom for the NNU eﬀects, and a Normal distribution was assumed for the network
eﬀects. Vague priors were used for all parameters. As results can be sensitive to choice
of prior for the random eﬀects variance, and a U(0,100) prior for the between-NNU
standard deviation was used a sensitivity analysis to the main U(0,5) analysis. The
focus of interest is comparing results across models is to see whether inferences regarding
NNU and network eﬀects change, and to inform modelling choices for chapter 7.
6.2 Data
Table 6.1 shows the infant characteristics of the cohort analysed in this chapter. This
cohort is a subset of the cohort described in section 2.3.1 restricted to non-transferred
infants only and excluding the 147 non-transferred infants for whom data on antenatal
steroids was missing. As these infants were only treated in one NNU, data are presented
by the level of NNU to illustrate diﬀerences in the population. Higher level NNUs have a
higher proportion of lower gestation and lower birth weight infants and higher mortality
rates, in line with the description in chapter 1 and the analysis of all infants in chapter
2.
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Table 6.1: Description of cohort for analysis of non-transferred infants by NNU level, all
data shown as n(%)
SCBU LNU NICU Total
Gestational age 22+0 − 23+6 5(0.9) 20(0.5) 192(3.6) 217(2.1)
(weeks+days) 24+0 − 25+6 5(0.9) 71(1.7) 622(11.7) 698(6.9)
26+0 − 27+6 9(1.6) 436(10.3) 930(17.5) 1375(13.6)
28+0 − 29+6 94(16.6) 1312(30.9) 1362(25.7) 2768(27.4)
30+0 − 31+6 454(80.1) 2407(56.7) 2194(41.4) 5055(50.0)
Birth weight < 500 0(0.0) 7(0.2) 61(1.2) 68(0.7)
(g) 500− 999 25(4.4) 619(14.6) 1789(33.8) 2433(24.1)
1000− 1499 235(41.4) 2177(51.3) 2142(40.4) 4554(45.0)
1500− 1999 282(49.7) 1333(31.4) 1224(23.1) 2839(28.1)
 2000 25(4.4) 110(2.6) 84(1.6) 219(2.2)
Sex Female 253(44.6) 1940(45.7) 2426(45.8) 4619(45.7)
Male 314(55.4) 2306(54.3) 2874(54.2) 5494(54.3)
Steroids∗ No 71(12.5) 530(12.5) 655(12.4) 1256(12.4)
Yes 496(87.5) 3716(87.5) 4645(87.6) 8857(87.6)
Death before discharge Survived 539(95.1) 4015(94.6) 4456(84.1) 9010(89.1)
Died 28(4.9) 231(5.4) 844(15.9) 1103(10.9)
* Any dose of antenatal steroids given to the mother
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6.3 Model checking
6.3.1 Convergence
All models were run with a burn-in of 20,000 iterations and a subsequent posterior
sample of 150,000 iterations for models 1,2 and 3 and 200,000 iterations for models 4,5
and 6. All models appeared to converge though mixing was poor for some parameters,
hence a large number of posterior samples were required to achieve the minimum eﬀective
sample size. Model details and convergence assessment were as described in section 5.2;
the Monte Carlo standard error and eﬀective sample size are provided in appendix E.
6.3.2 Choice of random eﬀect distribution and priors
Modelling the NNU eﬀects with a t distribution with 4 degrees of freedom gave a better
ﬁt than the Normal distribution (see section 6.5), therefore results from the t-4 models
are presented as the main results. An alternative prior of U(0,100) on the NNU standard
deviation terms produced very similar results, see appendix E.
6.3.3 Posterior predictive checks
Posterior predictive checks were carried out to check whether the models could have
produced the observed data (methods described in section 5.2.5). Overall there was
no indication from any of the posterior predictive checks of an inconsistency between
predicted and replicated data.
Figure 6.1 shows the distribution of mortality rates across 1000 replicated datasets
for each of the 23 neonatal networks, with data replicated according the joint posterior
parameter distribution from model 1 (the basic two level model) with t-4 NNU eﬀects.
The vertical lines show the actual mortality rates observed in the data. There are no
networks for which the observed data are inconsistent with the replicated data, so it is
reasonable that the posterior parameter distribution could have generated the observed
data. We might expect that allowance for network variation would produce replicates
that were more consistent with the observed data, but this was not noticeably the case
(model 4, ﬁgure 6.2. Similar plots were generated for each of the 6 models for both t-4
and Normal distributions and results were very similar across all models.
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Figure 6.1: Posterior predictions from model 1 for crude mortality by neonatal network;
values from data shown as vertical lines, t-4 distribution for NNU eﬀects
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Figure 6.2: Posterior predictions from model 4 for crude mortality by neonatal network;
values from data shown as vertical lines, t-4 distribution for NNU eﬀects
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As there are many NNUs, similar plots for number of deaths were generated for a
random sample of 24 NNUs, and again no evidence of a disparity between the observed
data and replications from the posterior distribution was found. Figure 6.3 shows this
plot for model 1. There was some indication in models 1 and 4 that NNU level speciﬁc
mortality was inconsistent (though not completely incompatible) between observed and
replicated data; this improved after adding NNU level to the model (models 2 and 5
respectively). Figures 6.4 compares observed and replicated data across NNU levels for
models 4 (without NNU level) and 5 (with NNU level).
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6.3.4 Model ﬁt
Table 6.2 shows the Deviance Information Criterion (DIC), the deviance and the eﬀective
number of parameters for models 1 to 6 assuming a t-4 distribution for the NNU eﬀects.
There was very little diﬀerence between models; diﬀerences of less than 5 may not
be indicative of model superiority (Spiegelhalter et al., 2003). Model choice will be
considered in section 6.6.
DIC Deviance Eﬀective parameters
Model 1 4728 4676 52.32
Model 2 4727 4675 52.14
Model 3 4728 4676 52.00
Model 4 4728 4677 50.91
Model 5 4725 4677 48.59
Model 6 4726 4675 51.67
Table 6.2: Model performance, t-4 NNU eﬀects U(0,5) prior
6.4 Infant and provider characteristics
Table 6.3 shows the posterior mean odds ratios (OR) and 95% credible interval (95%
CrI) for the infant risk factors across all 6 models, assuming a and t distribution for
the random eﬀects respectively. These factors and their functional form were selected in
chapter 3. Results were similar across all six models and between Normal at t models;
results for the Normal NNU eﬀects model are given in appendix E. Unlike the OR
for covariate eﬀects in single level models which describe the eﬀects across the whole
population, these OR have a cluster-speciﬁc interpretation; that is, they are the OR
for infants in the same neonatal unit and network (see section 4.1.1). Additionally, the
population is diﬀerent here as only non-transferred infants are included. Nevertheless,
results were fairly similar to those from the single level model developed in chapter 3,
with the most notable diﬀerence being a higher OR for males (1.6 in Model 1 compared
with 1.41 in table 3.5). The similarity of the results of the hierarchical and single level
models is because of the low level of between-NNU and between-network variation (see
section 6.5.2).
Diﬀerences in mortality across NNU level are also shown in table 6.3 for the four
models which adjusted for them. Mortality is highest at SCBUs though the 95% CrI were
wide and include zero (OR 95% CrI comparing with LNUs ranging from 1.44 (0.80,2.46)
in model 6 to 1.53 (0.92,2.48) in model 2). Mortality was also higher for infants treated
at NICUs (OR 95% CrI comparing with LNUs ranging from 1.27 (1.01,1.59) in model
3 to 1.33 (1.07,1.65) in model 5). Assuming a Normal distribution for the NNU eﬀects
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produced very similar results.
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6.5 NNU and network eﬀects
6.5.1 Distribution of NNU eﬀects
The quantile-quantile plots against a Normal distribution for the NNU eﬀects (the log
odds ratios denoted by uj) showed indication of heavy tails, even for the most complex
model, model 6 (ﬁgure 6.5)(a). A slightly better ﬁt was produced by the t distribution
with 4 degrees of freedom (ﬁgure 6.5)(b), hence the t-4 models are presented as the main
results.
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Figure 6.5: Quantile-quantile plots for posterior means from model 6, all NNUs, (a)
Normal distribution and (b) t distribution with 4 degrees of freedom
166
6.5.2 Standard deviation of NNU and network eﬀects
Figure 6.6 shows the posterior distribution of the between-NNU and between-network
standard deviations (SD) for each of the six models, assuming the NNU eﬀects follow
a t distribution with 4 degrees of freedom. Model 1, the basic model with NNU eﬀects
but no network eﬀects and no adjustment for NNU level , gives a between-NNU SD
of 0.37 (95% CrI 0.23,0.53), corresponding to a variance partitioning coeﬃcient (VPC)
of 4% . Little of this variability was explained by the level of NNU (as σu for model
2 is very similar (0.36 (0.22,0.52)) but some is explained by clustering at the network
level as σu in model 4 is 0.31 (0.13, 0.49), with a between-network SD of 0.18 (0.02,
0.,37). The VPC for NNU and network level combined in model 4 is similar at 3.8%.
Once network variation is included in the model, the addition of NNU level (model 5)
changes standard deviation estimates slightly with σu reducing to 0.27(0.07,0.46) and
σv increasing to 0.22 (0.03,0.4); this diﬀerence is visible comparing ﬁgures 6.6 (d) and
(e).
Allowing for the between-NNU SD to vary by NNU level shows a diﬀerent pattern
across the three levels (ﬁgure 6.6 (c) and (f)). For model 3 (the two level model without
network variation) there is evidence of variation across NICUs (σNICUu 0.41 (0.24,0.47).
For SCBUs and LNUs the credible intervals are very wide, with posterior means higher
for SCBUs (σSCBUu 0.51 (0.02,1.45)) and lower for LNU (σ
LNU
u 0.26 (0.03,0.57). Once
network variation is added, between-NICU variation is lower and more uncertain (σNICUu
0.29 (0.07,0.48)) as some of the similarities within NICUs are explained by similarities
within network. The between network variation is almost identical regardless of whether
NNU variation is modelled with a single term or by NNU level.
Patterns of variation were similar for the Normal model, but the standard deviation
was lower and more precise across all models, for example 0.35 (0.23,0.39) for model 1,
see appendix E for corresponding plot.
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Figure 6.6: Posterior distribution provider SD terms, t-4 NNU eﬀects. Models 1-6 shown
in ﬁgures (a) to (f)
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6.5.3 Comparison of NNU eﬀects across models
Figure 6.7 shows the correlations of individual NNU eﬀects for each pair of models, and
distribution of posterior means of NNU eﬀects by NNU level. The lowest correlation was
between results for models 1 and 6 (0.78) and the highest between models 1 and 4 (0.99).
Correlations within NNU level were very high (over 95% for all). The distributions of
the posterior means showed markedly diﬀerent patterns for all models, suggesting that
whilst they may be closely correlated the values themselves might be quite diﬀerent.
Overall posterior means are more dispersed for models 1 to 3 which do not account for
clustering at the network level, which is consistent with the higher σu seen in ﬁgure 6.6
(a) and (b) compared with (d) and (e). The higher the between-NNU variance, the less
similar NNUs are to each other and the less we borrow information, so the shrinkage
eﬀect is smaller. This can also be seen in the scatter plots as the range is wider models
1 to 3.
As SCBUs are smaller (table 6.1), their eﬀects are shrunk more towards zero when
they are assumed to be similar to all other NNUs. When SCBUs are modelled to have
their own independent variance (models 3 and 6), they are more dispersed (corresponding
to the higher between-SCBU SD described earlier) and also more uncertain. Each NNU
eﬀect has an associated SD describing its uncertainty. The average SD across SCBUs
was 0.35 and 0.28 in models 2 and 5, increasing to 0.55 and 0.61 in models 3 and 6 (table
6.4). In contrast, for LNUs the eﬀects are shrunk more when LNUs have an independent
variance (models 3 and 6), so they are more similar to each other than NNUs are to each
other in general, under the common variance model. The shrinkage eﬀect for LNUs is
larger when network variation is also included in the model. Including network eﬀects
also results in more precise estimation of eﬀects (table 6.4). NICUs, being the type of
NNU with the highest volumes, experience the least shrinkage, particularly in models
1-3 where variance at the network level is not modelled.
Table 6.4: Posterior mean standard devia-
tion for NNU eﬀects, averaged over NNU,
t-4 distribution for NNU eﬀects, U(0,5)
prior
All SCBU LNU NICU
Model 1 0.31 0.36 0.32 0.24
Model 2 0.30 0.35 0.31 0.24
Model 3 0.33 0.55 0.26 0.25
Model 4 0.28 0.31 0.28 0.23
Model 5 0.25 0.28 0.25 0.22
Model 6 0.31 0.61 0.20 0.24
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Figure 6.7: Correlation of NNU eﬀects across models, t-4 distribution for NNU eﬀects
170
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
●●
●●
●●
●●
●●
●●
●●
●●
●●
●
●
●
●
●●
●●
●●
●●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
32
19
1
64
45
141
159
125
17
135
106
40
18
87
117
128
22
95
77
129
93
33
2
65
153
47
134
96
100
42
23
119
142
50
154
110
62
152
4
−2 −1 0 1 2
Log OR
N
N
U
●
●
●
●
●
●
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Figure 6.8: Caterpillar plot for SCBUs, showing smallest and largest eﬀects across models, t-4
NNU eﬀects
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Figure 6.9: Caterpillar plot for LNUs, showing smallest and largest eﬀects across models, t-4
NNU eﬀects
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Figure 6.10: Caterpillar plot for NICUs, showing smallest and largest eﬀects across models, t-4
NNU eﬀects
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Figure 6.11: Caterpillar plot for networks, showing smallest and largest eﬀects across models,
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Figures 6.8 to 6.11 show plots comparing SCBUs, LNUs, NICUs and neonatal net-
works respectively. They show the smallest and largest posterior mean log OR produced
by the models with 95% CrI. The NNU eﬀects are ranked to better illustrate patterns,
though as discussed in chapter 4 no inferences can be drawn regarding whether one
NNU is better or worse than another based on the rank order. These plots are some-
times called caterpillar plots. The reduced shrinkage of SCBU eﬀects produced by model
6 is evident in ﬁgure 6.8 as model 6 produces the highest estimates for SCBUs with high
log OR, and lowest estimates for SCBUs with the lowest log OR, thus the overall distri-
bution of posterior means is more dispersed. Model 6 also produces much wider credible
intervals for SCBU eﬀects which contain the credible interval of the least extreme result.
This increased uncertainty is in line with the higher average SD seen in table 6.4. The
smallest absolute eﬀects (where they are noticeably diﬀerent from the largest absolute
eﬀects) were from models 4 and 5, which from ﬁgure 6.7 produced the least dispersed
posterior means.
For the majority of LNUs there was little diﬀerence in the smallest and largest
eﬀects in the context of the uncertainty of the estimates (ﬁgure 6.9). Where there
were diﬀerences, the highest log ORs were generally produced by model 2 and the
lowest by model 6, which is consistent with the patterns seen in ﬁgure 6.7. Despite the
uncertainty, diﬀerences may be meaningful when we consider the diﬀerences in terms
of the probability of exceeding a certain threshold. For example for NNU 73, model 2
estimates the posterior probability that the OR exceeds 1.2 (equating to a log OR of
0.18) as 65%, while model 6 gives an estimate of 31%.
Posterior means of NICU eﬀects are not shrunk as much as smaller NNUs , so in
ﬁgure 6.10 there are fewer NNU eﬀects close to the zero line. Whereas for SCBUs and
LNUs the smallest and largest eﬀects was negligible for NNUs in the middle (those with
eﬀects near zero) this was not the case for NICUs. For example, the probability of the
OR for NNU 73 exceeding 1.2 was 28% in model 1 but 12% in model 5. Models 4 and
5 produced estimates closest to zero. Model 1 tended to produce the highest estimates
and model 3 the lowest. Model 1 is not adjusted for NNU level, therefore the increased
mortality seen in NICUs overall as shown by the ORs in 6.4 is included in the individual
NNU eﬀects. Credible intervals for NICU eﬀects are much narrower than for SCBU and
LNU eﬀects, consistent with the lower average SD seen in table 6.4.
Figure 6.11 shows that there is little variation in network eﬀects across models given
the overall uncertainty. Estimates from model 4 (which does not include NNU level) pro-
duced NNU eﬀects with slightly smaller magnitude (consistent with the lower estimate
of between network variation seen in ﬁgure 6.6 (d)), but diﬀerences were small.
Corresponding plots for Normal NNU eﬀects showed a similar pattern and are pro-
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vided in appendix E.
6.6 Discussion
6.6.1 Summary
In this chapter I presented results from the analysis of non-transferred infants, applying
the methods described in section 5.2. There were diﬀerences in mortality between NNU
levels beyond that attributable to the included risk factors, with both SCBUs and NICUs
having higher mortality rates than LNU. Infants treated at the same NNU and the
same network had similar outcomes, though this accounted for only 4% of the overall
variance as estimated by the VPC. It is possible that variation is higher for SCBUs
and NICUs compared with LNU, though the evidence for this was weak as standard
deviation estimates were very uncertain. Estimates of individual NNU eﬀects were also
subject to a lot of uncertainty, but diﬀerences in results across models were meaningful
for some NNUs. Assuming a t distribution with 4 degrees of freedom appeared to ﬁt
the data better than the standard approach of Normal random eﬀects. There was no
indication of a discrepancy between the model and the data for any of the models based
on posterior predictive checks and there was very little diﬀerence in DIC. However there
were some diﬀerences regarding variation across NNU, both with overall measures and
for individual NNU results that may aﬀect model choice, which I shall discuss further
in this section.
6.6.2 Model checking
I used a variety of convergence checks, which was important as I found that the ini-
tial assessment from trace plots and the Brooks Gelman Rubin statistic often indicated
convergence when the other tests did not. There was poor mixing for some parameters
despite taking steps to prevent this by centring and standardising covariates, and spec-
ifying the model using hierarchical centring parametrisation (see section 5.1). I used
the default samplers chosen by OpenBUGS (diﬀerent samplers are chosen automatically
for diﬀerent parameters) so it is possible that mixing could be improved and adequate
eﬀective sample size achieved more quickly by altering the sampler speciﬁcation. For
consistency with this chapter I continue to use the default samplers in chapter 7 but
would consider alternatives in any future analysis.
Mixing was particularly poor for the intercept term where multiple variance param-
eters were being estimated in models 3 to 6. Figure 6.6 shows that with the exception
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of models 1 and 2, some of the posterior mass for the standard deviation terms is very
close to zero. Were the random eﬀects simply nuisance parameters, as is often the case
in hierarchical models, this might support their omission. Similarly there was little evi-
dence of model superiority from the DIC, supporting selection of the simplest model if
the random eﬀects were nuisance parameters. Here it is the random eﬀects themselves
that are of interest so model choice should be driven by the inferences we can draw from
these parameters. However the lack of diﬀerence in DIC does tell us that the diﬀerences
between networks and NNU levels are not substantial enough to improve the ﬁt of the
model. This could be a useful when considering the potential impact of clustering in
other studies of preterm mortality.
I found that a t-4 distribution for the NNU eﬀects gave a better ﬁt than the Nor-
mal distribution. The latter is often used as the default speciﬁcation for random eﬀects.
There was no further indication of poor ﬁt or asymmetry so I did not consider more ﬂex-
ible alternatives or skewed distributions mentioned in section 4.1. However, sensitivity
to the degrees of freedom of the t distribution was not investigated. The t distribution
provides a better ﬁt as it accommodates NNUs with extreme results as observed in ﬁg-
ure 6.5. While the NNUs which appear outliers may indeed be so, and this warrants
further investigation, this is not an aim of this thesis. As described in section 4.4, for
many NNUs there is limited power to conﬁdently determine outlier status, thus a fair
assessment cannot be made.
Results were robust to whether the priors for the NNU and network standard devi-
ations were set as U(0,5) or U(0,100). Both are vague priors; for further discussion on
the choice of prior see section 5.2. A limitation of the analysis is that I did not consider
any informative priors. There was a lot of uncertainty around the NNU eﬀects and it is
possible that this could be improved by using a more informative prior for the between-
NNU standard deviation. If NNU eﬀects were to be regularly assessed as part of routine
monitoring, understanding of variations in mortality across NNUs would develop. This
could enable a selection of informative priors to be speciﬁed based on previous patterns.
6.6.3 Infant and provider characteristics
There was some indication that mortality was highest in SCBUs. The diﬀerence had
a wide credible interval but the direction of the association is consistent with several
studies advocating centralisation of neonatal care due to poorer outcomes at less expe-
rienced NNUs (Binder et al., 2011; Neto, 2006; Phibbs et al., 2007). However mortality
was also higher at NICUs than at LNUs in this study. As described in chapter 1 one
of the aims of neonatal networks is that where possible infants requiring the highest
levels of care should be treated at NICUs. Therefore in general we would expect infants
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treated at NICUs to be sicker than those treated at LNUs, resulting in increased ICU
mortality. Indeed, Watson et al. (2014) found the beneﬁts of tertiary care on mortality
were underestimated in a standard regression analysis compared with an instrumental
variable analysis which attempts to estimate causal eﬀects as if infants were randomised
to NNU level. It should be noted that while the direction of eﬀect in the standard re-
gression analysis still showed lower mortality in NICUs in contrast to the ﬁndings here,
the population was slightly diﬀerent as transferred infants were included and assigned
to the NNU of birth. This resulted in a very diﬀerent patient proﬁle, with 6% mor-
tality at NICUs compared with the 16% seen here. Based on the ﬁndings of Watson
et al. (2014) which used the same data source, it seems unlikely that the diﬀerence in
mortality between LNUs and NICUs represents a diﬀerence in quality of care.
There are two factors contributing to this diﬀerence. Firstly, infants at NICUs are
more sick to begin with. This is plausible as, unlike LNUs, the NICU population includes
sicker infants who had a planned delivery or in-utero transfer there. Secondly, as care
progresses infants who do not require transfer are likely to be sicker ones at NICUs
and less sick ones at LNUs. For LNUs non-transferred infants are those that did not
require NICU care (though they also include those who died so soon after birth that they
could not be transferred). While SBCU do not in general provide intensive care (which
many infants born at less than 32 weeks will need), LNU often do, with considerable
variation in the volume provided across LNU as described in chapter 2. For NICUs,
non-transferred infants include the local population for whom the NICU is the nearest
NNU, but also those that did not recover to have a subsequent step-down transfer to
their nearest NNU.
Some diﬀerences in population across NNU levels would be captured by the risk
adjustment model as the distribution of risk factors diﬀered across levels of NNU (table
6.1). There may be other infant characteristics which determine the place of delivery
(and are therefore known at birth) which would improve the risk adjustment model
but these were not revealed by the risk factor selection process described in chapter 3.
While such factors may not be such strong predictors of mortality, they could be strong
confounders if they dictate where an infant is cared for. Further work is required to
examine the reasons determining NICU delivery and establish whether such information
can be included in the risk adjustment model.
In this thesis the primary purpose of including NNU level is not to estimate a causal
eﬀect of NNU level. The purpose of including NNU level in the model is to indicate
whether mortality at a particular NNU is higher or lower than would be expected for
infants of the same clinical characteristics treated at NNUs of the same level. Given the
diﬀerences in the care provided at each NNU level described in chapters 1 and 2, and
the diﬀerences in mortality described here, this seems a sensible approach.
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6.6.4 NNU and network eﬀects
Variation in mortality across NNUs accounted for 4% of the total variation as estimated
by the VPC for model 1. Using this method of calculation of the VPC we consider
the binary variable as a manifestation of an underlying continuous variable (see section
5.2.6), which gives the individual-level variance on the continuous scale. Other methods
exist which produce VPC estimates based on the probability of the response, and are
dependent on the individual-level covariates (see Goldstein et al. (2002) for further
details). It is reasonable to infer that diﬀerences between NNUs are not responsible for
large variations in mortality, though our inferences are on the continuous scale of the
latent variable (the propensity to die) rather than on the probability scale. Some of this
variation was attributable to neonatal networks; this was more apparent after adjusting
for NNU level. Networks consist of a combination of levels of NNU, therefore σv which
measures the extent to which NNUs in the same network are similar, will be dampened
by the the diﬀerences between NNU levels until this is adjusted for. Network variation
is of interest in itself as many commissioning, operational and policy decisions are made
at the network level. Although NNUs and networks combined did not account for any
more variation than NNUs alone, it is important to adjust for network variation when
estimating NNU eﬀects to avoid mistakenly attributing variation at the wrong level. In
addition, accounting for clustering by network gives slightly higher precision in the NNU
eﬀects (table 6.4).
There was little evidence that between-NNU variation diﬀered by type of NNU:
while posterior means diﬀered, ﬁgure 6.6 shows that eﬀects are very uncertain and did
not improve the ﬁt of the model.An argument for using hierarchical models in provider
proﬁling is to enable the borrowing of information for smaller providers. We cannot
do this if we allow the between-NNU variance to diﬀer across NNU levels because all
SCBUs have few admissions in this gestational age group. If SCBUs can only borrow
information from each other, the resulting estimates are extremely uncertain, as shown
in ﬁgure 6.8 and table 6.4. Therefore I will not allow for level-speciﬁc variance in chapter
7. However it is interesting to note the possibility of higher variation between SCBUs.
This could be an artefact of small sample sizes, but could also represent the varying
success with which infants are stabilised and transferred out for further care at lower
level NNUs (Marlow et al., 2014). A larger sample size would be required to investigate
this further.
Provider proﬁling analyses comparing diﬀerent methods (for example those described
in section 4.2) often focus on changes in rank, particularly for the providers at the top
and bottom. As discussed in section 4.4.2, the number of infants at each NNU is
variable and overall fairly small. This results in variability in shrinkage with smaller
NNUs being shrunk closer to the mean, and low power to detect outliers in general,
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so in this thesis I have focussed on estimation of individual NNU eﬀects rather than
comparison among them or assessment of outliers. NNU eﬀects from all models were
closely correlated within NNU level but not overall, suggesting that ranking results
(though not a focus of this thesis) would give similar results regardless of the model
used provided this was done separately for NNU levels. However the distributions of
posterior means were quite diﬀerent across models, so there are diﬀerences in the actual
estimates, which are of interest here. The caterpillar plots showed that the models
producing the highest and lowest eﬀects diﬀer by NNU level, therefore the choice of
model will impact some NNUs diﬀerently from others. For many NNUs, particularly the
smaller ones, the diﬀerences between models are not notable in the context of uncertainty
of the estimates. However this is not always the case, particularly when we consider
NNU eﬀects in terms of probability of exceeding a threshold, a measure which is often
considered more interpretable than a conﬁdence interval or credible interval (Normand
et al., 1997). There were diﬀerent amounts of shrinkage for diﬀerent NNU levels even
when the same variance was assumed across levels. This is to be expected as patient
volume diﬀers by NNU level, re-iterating the diﬃculty of directly comparing results for
NNUs at diﬀerent levels. It also means that we cannot draw the same conclusions about
a SCBU with an average result as we can for a NICU: for example from model 6, SCBU
65 and NICU 145 both have OR very close to 1 (0.99 and 1.01 respectively) but their
credible intervals support very diﬀerent ranges (SCBU 65 (0.23,4.08) and NICU 145
(0.60,1.68)).
The approach taken here is based on existing Bayesian hierarchical methods for
provider proﬁling. As described in chapter 4, these models have been applied in neonatal
care but I am not aware of any other studies speciﬁcally examining NNU and network
eﬀects in England or another setting with a similar structure. Therefore I am unable to
draw comparisons with other studies regarding these eﬀects, particularly with regard to
how they are aﬀected by modelling strategies as was the main focus of the investigation
here. MacNab et al. (2005) investigated variation in NICU mortality in Canada; while
this was not in a networked setting they did assess both Normal and t-distributions
(with 2 to 5 degrees of freedom) for the random eﬀects. Near identical parameter
estimates were obtained with no indications of poor ﬁt though there were only 17 NNUs,
so departures from distributional assumptions may not have been clear. They found
conclusions to be robust to a variety of hyperpriors for the standard deviations, applying
a wider selection than the Uniform priors applied here. Further sensitivity analysis would
help make the conclusions drawn in this thesis more robust.
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6.6.5 Clinical summary
From a clinical perspective, there does appear to be variation in mortality between
NNUs and networks but it is low, and accounts for a small proportion of the overall
variation. For each NNU we obtain an ORs comparing the mortality at that NNU to
that for similar infants (based on gestational age, birth weight, sex and antenatal steroid
administration) in similar NNUs (based on neonatal network and NNU level, depending
on the model). However, these are subject to high levels of uncertainty so it is diﬃcult
to say conclusively whether the outcomes are better or worse than expected. While
the lack of variation is reassuring for those managing services, is also means that the
results do not provide strong evidence of which NNUs may require additional attention
or resources. Tail probabilities for the OR (as given here as examples) may be a useful
measure in practice but suitable thresholds for the OR must be chosen.
There are diﬀerences between NNU levels in the non-transferred populations that
go beyond that described by the main clinical risk factors. Some of the diﬀerence may
be due to factors known at birth determining place of delivery, while some is due to
selection bias by examining only non-transferred infants. While bias from selecting only
non-transferred infants for a research cohort is well-understood, this indicates that the
selection eﬀects diﬀer across NNU levels.
6.6.6 Implications for the thesis
One of the aims of this chapter was to develop a suitable model on which to base the
multiple membership analysis which follows in chapter 7. From the ﬁndings of this
chapter I will include networks as a third level of variation in the model and allow
the mean of NNU eﬀects to be speciﬁc to NNU level, but with a common variance
(model 5). While networks do not account for any more variation than NNU alone, the
network eﬀects are themselves of interest. Furthermore, it means the variance will be
correctly attributed between NNUs and networks, and gives a slight increase in precision
of NNU eﬀects. Adjusting for NNU level ensures that NNUs are compared with the
relevant average. This is particularly important given the substantial diﬀerences in
infants treated at diﬀerent NNU levels which goes beyond the infant characteristics
controlled for. In addition the mixture of NNU levels within each network appears to
dampen the between-network variation, though the eﬀect on individual network results
was negligible. There was little evidence for allowing diﬀerent variance between NNU
levels. Doing so limits the extent to which we can borrow strength to estimate eﬀects at
smaller providers and may result in poor estimates if the variances are unstable. Model
5 also produces the least extreme results for many SCBUs and NICUs (ﬁgures 6.8 to
6.10), lowest uncertainty in NNU eﬀects and the least variation in uncertainty across
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NNU levels (6.4).
In chapter 7 I build on model 5 to include transferred infants by applying multiple
membership models as described in section 5.4. Results from model 5 in this chapter
are presented for a single NNU as part of a case study in chapter 8.
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Chapter 7
Results II: Including transferred
infants
In this chapter I present the results of applying the methods described in sections 5.3
and 5.4.
Multiple membership (MM) models have been proposed as way to handle postnatal
transfers in neonatal provider proﬁling analyses. An infant’s care is not attributed to
a single neonatal unit (NNU). Instead it is shared between all NNUs treating the in-
fant using weights. In section 7.2 I present a simulation study to investigate the eﬀect
of diﬀerent MM weightings on the between-provider standard deviation and individual
provider eﬀects under diﬀerent data scenarios. Section 7.4 builds on the results of chap-
ter 6, including transferred infants in the analysis by weighting the NNU eﬀects using
multiple membership models. Infant and provider characteristics (section 7.4.4), and
provider eﬀects (section 7.4.5) are compared across six diﬀerent multiple membership
weighting schemes. In section 7.5 I summarise the ﬁndings from the chapter and con-
sider the practicalities of applying these methods both within neonatal care and more
widely.
7.1 Methods recap for simulation study
This section is a brief summary of the methods underlying the results for this section; full
details were given in chapter 5.3. The aim of the simulation study was to investigate the
diﬀerences in variance parameters and provider eﬀects under a variety of data scenarios
and analysis models for multiple membership, with a view to informing the analysis of the
neonatal data where the parameters generating the data are unknown. The simulation
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was done prior to the analysis presented in 6 and so does not reﬂect some of the insights
from that chapter, such as modelling the provider eﬀects with a t-distribution rather
than Normal, and some of the parameters do not equate with what was observed in the
data.
A two-level structure was considered (individuals within providers). Data were sim-
ulated for 15,000 individuals across 100 providers, with 25% of individuals transferred
once. Provider-speciﬁc log odds of mortality were drawn from a Normal distribution with
a mean of -2.2 and standard deviation 0.4, corresponding to 95% of provider mortality
rates lying between 5% to 20%. No infant or provider characteristics were included.
Data were generated using three scenarios with diﬀerent MM weightings: proportional
to length of stay (denoted LOS ), moderate emphasis on the early part of stay (Beta2 ),
and a strong emphasis on the early part of stay (Beta3 ). For each of the three scenarios
I simulated 200 datasets (600 datasets in total).These weightings, along with allocation
to the initial provider only (denoted First) were used to analyse the data, resulting in 12
sets of results in total. For reference, weightings are summarised in table 7.1, which also
describes two weights only used in the analysis of neonatal data in section 7.4. Bayesian
Markov Chain Monte Carlo (MCMC) methods were used to estimate the models. Aver-
age posterior means, empirical standard errors (SE), percentage bias, mean square error
(MSE) and coverage for the standard deviation and intercept were calculated and the
average bias, MSE and coverage for the provider eﬀects (see section 5.3.5 for deﬁnitions
of these quantities). The Deviance Information Criterion (DIC) was calculated and used
to compare models.
Table 7.1: Weightings for multiple membership models for simulated and neonatal data
Label Description
LOS The outcome is attributed in proportion to the length of
stay
Beta2 The outcome is attributed using the Beta(1,2) weight
Beta3 The outcome is attributed using the Beta(1,3) weight
First The outcome is attributed to the ﬁrst provider only
WLOS
(neonatal data only)
The outcome is attributed according to length of stay
weighted by the type of care received, using recommended
nurse staﬃng ratios
Equal
(neonatal data only)
The outcome is attributed equally to all NNUs caring for
the infant, regardless of length of stay or intensity of care
184
7.2 Results from simulation study
Results from analysing simulated data are shown in table 7.2. The mean intercept
(the average log odds of death) was correctly estimated as -2.2 for all scenarios and all
analysis models, with low bias (<1% for all cases).
Between provider variation The posterior mean between-provider standard de-
viation (σu) was underestimated using the First analysis weighting, with the largest
downward bias of 36% for the LOS scenario, reducing to 15% for the Beta3 scenario.
The First analysis yielded poor coverage for the σu (as to be expected when bias is
high), with the 95% credible interval (95% CrI) including the true value in only 3% of
iterations for LOS scenario increasing to 73% of iterations for the Beta3 scenario. The
average σu was similar for models which do not ignore the MM structure, with estimates
ranging from 0.36 to 0.42, compared with the true value of 0.4. The average σu was
always lower when the analysis weighting was more “uneven” than the scenario weight-
ing but diﬀerences between MM models were small. A more even analysis weighting
than the scenario weighting did not consistently result in a higher σu. Using the same
weighting to generate and analyse the data did not consistently minimise the bias or
MSE for σu.
Provider eﬀects There was a large downward bias in the estimation of the posterior
mean provider eﬀects (around 50% for matching scenario and analysis weightings) due
to shrinking of the estimates towards the mean of the random eﬀects distribution. In all
scenarios, matching scenario and analysis weightings gave the smallest average bias and
MSE for the provider eﬀects, but again the diﬀerences between MM models were very
small. The First analysis gave the most biased but most precise estimates (as measured
by the average posterior SD of provider eﬀects), resulting in poorer coverage than the
MM models.
DIC Matching scenario and analysis weightings produced the lowest average Deviance
Information Criterion (DIC). However the proportion of iterations where the diﬀerence
in DIC between the scenario and analysis weightings was at least ﬁve was variable (79%
for LOS, 19% for Beta2 and 40% for Beta3 ), with the variation in percentages reﬂecting
the similarity of alternative models.
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Analysis weighting
Scenario weighting Parameter LOS Beta2 Beta3 First
LOS
σu
Mean 0.415 0.389 0.364 0.257
SE 0.038 0.037 0.037 0.040
% Bias 3.9 -2.8 -9.1 -35.8
MSE 0.002 0.002 0.003 0.022
% Coverage 99.0 96.5 88.5 3.0
α0
Mean -2.216 -2.213 -2.209 -2.193
SE 0.029 0.029 0.029 0.029
% Bias 0.7 0.6 0.4 -0.3
MSE 0.001 0.001 0.001 0.001
% Coverage 100.0 100.0 100.0 98.5
uj
Ave % Bias -42.8 -46.3 -51.5 -72.1
Ave MSE 0.060 0.063 0.066 0.094
Ave Coverage 95.5 93.8 92.2 76.9
Ave SD 0.255 0.243 0.233 0.187
DIC
Mean 9828 9838 9849 9897
% correctly identiﬁed 78.5 – – –
Beta2
σu
Mean 0.414 0.414 0.402 0.314
SE 0.035 0.033 0.032 0.032
% Bias 3.4 3.5 0.4 -21.6
MSE 0.001 0.001 0.001 0.008
% Coverage 99.0 99.5 99.0 42.0
α0
Mean -2.212 -2.215 -2.215 -2.201
SE 0.028 0.028 0.028 0.027
% Bias 0.6 0.7 0.7 0.1
MSE 0.001 0.001 0.001 0.001
% Coverage 100.0 100.0 100.0 100.0
uj
Ave % Bias -58.2 -55.2 -56.0 -65.2
Ave MSE 0.059 0.057 0.057 0.073
Ave Coverage 95.6 95.7 95.1 86.9
Ave SD 0.254 0.249 0.243 0.207
DIC
Mean 9851 9841 9843 9886
% correctly identiﬁed – 18.5 – –
Beta3
σu
Mean 0.407 0.420 0.414 0.338
SE 0.036 0.034 0.034 0.032
% Bias 1.7 5.1 3.5 -15.4
MSE 0.001 0.002 0.001 0.005
% Coverage 99.0 99.0 99.0 72.5
α0
Mean -2.205 -2.212 -2.213 -2.202
SE 0.026 0.026 0.026 0.026
% Bias 0.2 0.5 0.6 0.1
MSE 0.001 0.001 0.001 0.001
% Coverage 100.0 100.0 100.0 100.0
uj
Ave % Bias -55.2 -48.7 -48.7 -61.4
Ave MSE 0.061 0.057 0.056 0.066
Ave Coverage 95.5 96.0 95.6 89.4
Ave SD 0.252 0.251 0.246 0.214
DIC
Mean 9888 9867 9864 9899
% correctly identiﬁed – – 40.0 –
Table 7.2: Results from simulation study comparing four analysis models of three dif-
ferent multiple membership scenarios 186
In summary the simulation study which showed that ignoring multiple membership
structure and assigning individuals to a single provider resulted in underestimating
the provider variance and poorer coverage of the variance and provider eﬀects. Biases
were larger when the weights generating the data were more evenly distributed than
those used to analyse the data. In comparison, biases from assuming an incorrect MM
weight were minimal. There was some indication of variance underestimation when
a more uneven attribution was assumed but not the converse. Estimates of provider
eﬀects themselves were less strongly aﬀected than the provider variance, with any biases
overshadowed by shrinkage eﬀects. While the average DIC was lowest for correct analysis
models, the DIC had limited utility for model selection. These results will be discussed
in section 7.5.
7.3 Methods recap for analysis of neonatal data
This section is a brief summary of the methods underlying the results for this section;
full details were given in chapter 5.4. Following from the results of chapter 6, three-level
Bayesian hierarchical logistic regression models (infants within NNUs within networks)
were used to analyse the data, estimated using MCMC. The response variable was death
before discharge from neonatal care. The following infant risk factors were adjusted for:
gestational age (as a restricted cubic spline with 3 knots), birth weight (as linear and
quadratic), all interactions between gestation and birth weight involving linear terms,
sex and whether the mother received antenatal steroids. The level of NNU was included
as a provider-level characteristic. The population was all singleton infants born below 32
weeks gestation between 2011 and 2013 and admitted to an NNU contributing data to
the National Neonatal Research Database (NNRD) including those transferred during
the course of neonatal care. A t distribution with four degrees of freedom was assumed
for the NNU eﬀects, with a common variance across NNU levels. This corresponds to
model 5 in section 6.1.
Transferred infants were included by applying MM models. The weightings applied
were the four described for the simulation study (LOS, Beta2, Beta3 and First) together
with weighting the length of stay according to the intensity of care received each day
(WLOS ) and assigning to each NNU equally regardless of of the length or intensity
of care Equal. The weightings are summarised for reference in table 7.1. Details for
calculating the weights were provided in sections 5.3.2 and 5.4.2. Results are compared
across weightings to check the sensitivity of inferences regarding NNU and network
eﬀects.
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7.4 Results for analysis of neonatal data
7.4.1 Data
Table 7.3 shows the infants characteristics of the cohort analysed in this chapter. The
data used in this chapter are a subset of the infants described in section 2.3.1. Consistent
with the analysis of non-transferred infants presented in chapter 6 I excluded infants with
missing risk adjustment data (n=217, see section 3.5 for a discussion of these exclusions).
I also excluded 614 infants without a complete episodic record. This left a total of 15,538
infants in the analysis, 95% of the original cohort of 16,369. Altogether these infants
had a total of 24980 records. Table 7.3 presents data separately for transferred and non-
transferred infants as does the corresponding table prior to exclusion presented in table
2.2; results were similar before and after exclusions. Descriptive data were not presented
by NNU level as the non-transferred cohort described in table 6.1 was because infants
attend multiple NNUs across levels.
Table 7.3: Description of cohort for analysis of transferred infants by transfer status
Non-transferred Transferred Total
Gestational age 22+0 − 23+6 217(2.1) 144(2.7) 361(2.3)
(weeks+days) 24+0 − 25+6 697(6.9) 1006(18.5) 1703(11.0)
26+0 − 27+6 1375(13.6) 1330(24.5) 2705(17.4)
28+0 − 29+6 2767(27.4) 1458(26.9) 4225(27.2)
30+0 − 31+6 5054(50.0) 1490(27.5) 6544(42.1)
Birth weight < 500 68(0.7) 54(1.0) 122(0.8)
(g) 500− 999 2432(24.1) 2526(46.5) 4958(31.9)
1000− 1499 4554(45.0) 2015(37.1) 6569(42.3)
1500− 1999 2837(28.1) 763(14.1) 3600(23.2)
 2000 219(2.2) 70(1.3) 289(1.9)
Sex Female 4618(45.7) 2384(43.9) 7002(45.1)
Male 5492(54.3) 3044(56.1) 8536(54.9)
Steroids∗ No 1256(12.4) 619(11.4) 1875(12.1)
Yes 8854(87.6) 4809(88.6) 13663(87.9)
Death before discharge Survived 9009(89.1) 4963(91.4) 13972(89.9)
Died 1101(10.9) 465(8.6) 1566(10.1)
* Any dose of antenatal steroids given to the mother
7.4.2 Weight distribution
Table 7.4 compares how the total weight across all infants is allocated to the diﬀerent
NNU levels, shown for the whole cohort and by survival status. More care was attributed
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to higher level NNU, similarly to the analysis in section 2.3.2. In particular, infants that
died were mostly allocated to neonatal intensive care units (NICUs) (consistent with
section 2.3.4) but the diﬀerences were less strong for the First weighting. Otherwise,
deaths were distributed fairly similarly across NNU levels for weightings, though there
was slightly less care allocated to NICUs under Equal weighting. The WLOS weighting
allocated the lowest proportion of survivors to NICUs compared with other weights
and, correspondingly, the highest proportion for special care baby units (SCBUs) and
local neonatal units (LNUs). The Beta3 weighting allocated the highest proportion of
survivors to NICUs compared with other weights. There was no consistent pattern to
the weights as more weight was placed at the beginning of stay (comparing Beta2, Beta3
and First).
To show how the weight was distributed over the course of stay, table 7.5 compares
how the total weight across all transferred infants is allocated to the ﬁrst NNU, interim
NNU(s) and last NNU they are treated in (infants only transferred once they will only
have a ﬁrst and last NNU). The LOS weighting places the most weight with the ﬁnal
NNU treating the infant. After the First weighting, the Beta3 and Beta2 weightings
place the most weight on the ﬁrst NNU, but the diﬀerences compared with the other
weights are not large. Comparison of the LOS and WLOS weightings shows a diﬀerence
for survivors, with the end of stay downweighted for the latter.
7.4.3 Model checking
Convergence Model details were described in section 5.4. All models were run with
a burn-in of 20,000 iterations and a subsequent posterior sample of 200,000 iterations.
Similar to the analysis presented in chapter 6, autocorrelation was high for some pa-
rameters so a large number of posterior samples were required to obtain the required
eﬀective sample size. Convergence assessment was described in section 5.4; the Monte
Carlo standard error and eﬀective sample size are provided in appendix F.
Model ﬁt Table 7.6 shows the DIC, deviance and eﬀective number of parameters for
the diﬀerence MM models. There were substantial diﬀerences in DIC across models
(minimum diﬀerence of 20), with the LOS weighting giving the lowest DIC and the
First weighting the highest DIC. Here the models diﬀer only in the NNU eﬀects, so
a higher eﬀective number of parameters indicates larger diﬀerence between the NNU
eﬀects (i.e. a higher between-NNU variance, as will be discussed in section 7.4.5).
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SCBU LNU NICU
All infants
Equal 9.4 40.0 50.7
LOS 9.4 40.2 50.4
Beta2 7.5 38.8 53.7
Beta3 6.5 38.1 55.4
WLOS 7.9 38.8 53.3
First 8.1 40.1 51.8
Survivors
Equal 9.9 41.8 48.3
LOS 10.1 42.4 47.5
Beta2 8.0 40.9 51.0
Beta3 6.9 40.0 53.1
WLOS 8.5 40.9 50.6
First 8.2 41.0 50.8
Deaths
Equal 4.5 23.8 71.6
LOS 3.0 20.4 76.6
Beta2 2.8 20.3 76.9
Beta3 3.0 20.8 76.2
WLOS 3.0 20.2 76.9
First 7.1 31.5 61.4
Table 7.4: Distribution of multiple membership weight across NNU levels
7.4.4 Infant and provider characteristics
Table 7.7 shows the posterior mean odds ratios (OR) and 95% credible intervals (95%
CrI) for the infant characteristics. Results were fairly similar across all six weights,
though diﬀerent to those estimated for inborn infants alone in table 6.3. The odds
ratios for male sex and antenatal steroids were both lower than that for non-transferred
infants, but more similar to those in the single level model developed in chapter 3 (see
table 3.5).
The ORs comparing mortality in SCBUs and NICUs with LNUs varied considerably
across the six weights, with all results diﬀerent from those for non-transferred infants,
where both SCBUs and NICUs had higher mortality than LNUs. The LOS weighting
gave the largest diﬀerences with the odds of mortality in SCBUs being half those in
LNUs (OR 0.46 95% CI (0.28,0.75)), while the OR for NICUs was 2.68 (2.18,3.30). The
Equal and WLOS weightings produced similar but less extreme results: Equal SCBU
OR 0.62 (0.40,0.93) NICU 2.22 (1.82,2.73); WLOS SCBU 0.64 (0.38,1.04) NICU 2.01
(1.62,2.47). There was a pattern of decreasing mortality in NICUs as more weight was
assigned to the early part of stay: Beta2 1.79 (1.48,2.18); Beta3 : 1.33 (1.10,1.60); First :
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First Interim Last
All transferred infants
Equal 40.3 19.4 40.3
LOS 26.6 18.7 54.6
Beta2 37.7 23.4 38.9
Beta3 45.1 25.3 29.6
WLOS 35.2 22.4 42.4
First 100.0 0.0 0.0
Survivors
Equal 39.8 20.5 39.7
LOS 26.5 19.7 53.8
Beta2 38.2 24.7 37.1
Beta3 45.7 26.8 27.5
WLOS 35.8 23.7 40.4
First 100.0 0.0 0.0
Deaths
Equal 45.9 8.0 46.1
LOS 28.6 8.1 63.3
Beta2 32.6 9.0 58.4
Beta3 38.2 9.1 52.7
WLOS 28.7 7.9 63.3
First 100.0 0.0 0.0
Table 7.5: Distribution of multiple membership weight across episodes, transferred in-
fants only
DIC Deviance Eﬀective parameters
Equal 7644.00 7589.00 55.08
LOS 7572.00 7513.00 59.21
Beta2 7712.00 7663.00 48.72
Beta3 7758.00 7713.00 44.94
WLOS 7686.00 7633.00 53.06
First 7778.00 7736.00 42.23
Table 7.6: Model performance
0.93 (0.80,1.08).
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7.4.5 NNU and network eﬀects
Standard deviation of NNU and network eﬀects
Figures 7.1 compares the between-NNU and between-network standard deviation (σu
and σv) for each of the six weights. Figure 7.2 compares σu across all six weights
and ﬁgure 7.3 does the same for σv. The posterior mean of σu was highest for the LOS
weighting (0.31) and lowest for the First weighting (0.14). For comparison, the between-
NNU standard deviation was 0.27(0.07,0.46) for the same model for non-transferred
infants (without the MM, model 5 in chapter 6). For weights Beta3 and First, which
attribute the most weight to initial part of stay, σu was more uncertain with posterior
mass near zero, see ﬁgures 7.1 (d) and (f).
The σv was fairly similar across models (posterior mean of around 0.23) but slightly
less for the First weighting (0.20). This is similar to the result of σv 0.22 (0.03,0.4)
in non-transferred infants. In contrast to non-transferred infants only (ﬁgure 6.6 (e))
σu was more uncertain than σv, and of lower magnitude for three weighting schemes
(Beta2, Beta3 and First), see ﬁgures 7.1 (c),(d) and (f).
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Figure 7.1: Posterior distribution for σu and σv for each MM weighting: (a) Equal, (b)
LOS, (c) Beta2, (d) Beta3, (e) WLOS and (f) First
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Figure 7.2: Posterior distribution comparing σu (between-NNU SD) across all multiple mem-
bership weights
0
2
4
6
0.0 0.2 0.4 0.6
value
de
ns
ity
MM weighting
Equal
LOS
Beta2
Beta3
WLOS
First
Figure 7.3: Posterior distribution comparing σv (between-network SD) across all multiple mem-
bership weights
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Comparison of NNU eﬀects across models
Figure 7.4 shows the correlation of individual NNU eﬀects for each pair of weights, and
the distribution of posterior means of NNU eﬀects by NNU level. The lowest correlation
(0.64) was between the LOS and First weightings and the highest correlation (0.98)
was between the LOS and WLOS weightings. Overall the First weighting was not well
correlated with the other weights (0.64-0.83) while the WLOS weighting correlated well
with all weights (0.9 or greater) except First. Within NNU level, correlation between
weighting schemes was generally lowest for SCBUs and highest for NICUs. Similarly to
the analysis of non-transferred infants shown in ﬁgure 6.7, the lower level NNUs were
more shrunk towards the mean. Shrinkage was most apparent in the Beta2, Beta3 and
First weightings, corresponding to the lower σu seen in these models. There were a
few outlying NNUs which were particularly apparent for the Equal, LOS and WLOS
weightings.
Table 7.8 shows the precision of the NNU eﬀects, as measured by the average SD.
The lower the σu (ﬁgure 7.2), the more information is borrowed and the greater the
precision. NNU eﬀects had the most uncertainty for SCBUs and the least for NICUs,
consistent with diﬀerences in size.
Figures 7.5 to 7.8 show caterpillar plots for SCBUs, LNUs, NICUs and networks.
Across all levels of NNU, the largest log OR were generally produced by the LOS weight-
ing and the smallest by First and Beta3, consistent with the between-NNU SD (ﬁgure
7.2) and shrinkage of posterior means (ﬁgure 7.4). There was considerable overlap in the
credible intervals, even for NICUs, with wider intervals for the larger eﬀects produced
by the LOS weight, consistent with the precision in table 7.8.
For most SBCUs there was little diﬀerence between the smallest and largest OR
compared with the uncertainty. SCBU 36 had a substantial diﬀerence between the
smallest and largest NNU eﬀect, which can also be seen in ﬁgure 7.4. This NNU had
178 admissions, all of which were transfers in and all survived to discharge. Therefore
the Equal and LOS weightings do not reﬂect the lower intensity of care, resulting in a
very low (though uncertain) log OR for this NNU.
For LNUs the diﬀerences across models were slightly bigger than for SCBUs, but
generally small relative to uncertainty. For NICUs there were more diﬀerences observed
across the range with less of a consistent pattern. Credible intervals were a little smaller
for NICUs, though still much larger than the diﬀerences across weights. There were a
few LNUs and NICUs where both the largest and smallest estimates of the OR were on
the same side of zero, but the credible intervals always included zero. As with the results
in chapter 6, diﬀerences between weightings may be meaningful when expressed as the
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probability of exceeding a certain threshold. For example for SCBU 104, the probability
of the OR exceeding 1.2 (equating to a log OR of 0.18) is 31% for the LOS weighting
but only 6% for the First weighting. Diﬀerences can also occur for NICU where the
credible intervals are narrower; for example, for NICU 162 the probability of the OR
exceeding 1.2 is 28% under the Equal weighting and 8% under the Beta3 weighting.
For LNUs and NICUs it was not always the case that NNUs with more extreme
results had the bigger diﬀerences across weightings (as was observed when comapring
models using caterpillar plots in chapter 6). This suggests that for a particular NNU,
diﬀerences in the log OR across weightings are not solely driven by the overall between-
NNU variance and amount of shrinkage, but also by how the weightings allocate care of
infants treated in that NNU. This is consistent with the low correlation across weight-
ings seen in ﬁgure 7.4 and suggests that choice of weightings will aﬀect some NNUs
diﬀerently to others. To investigate this I reordered the caterpillar plots by the propor-
tion transferred, considering transfers in and out, and transfers within 24 hours. None
of these plots showed any particular patterns. Figure 7.9 shows LNU eﬀects ordered by
the proportion of infants transferred out within 24 hours as an example, the remaining
plots are provided in appendix F.
There were little diﬀerences between results for neonatal networks given the overall
uncertainty, though the WLOS weight tended to produce eﬀects closest to the null.
All SCBU LNU NICU
Equal 0.25 0.31 0.25 0.21
LOS 0.28 0.33 0.28 0.22
Beta2 0.22 0.25 0.22 0.18
Beta3 0.18 0.20 0.19 0.16
WLOS 0.25 0.30 0.25 0.20
First 0.14 0.15 0.14 0.13
Table 7.8: Posterior mean standard deviation for NNU eﬀects, averaged over NNU, MM
models
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Figure 7.4: Correlation of NNU eﬀects across multiple membership weights
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Figure 7.5: Caterpillar plot for SCBU eﬀects showing smallest and largest eﬀects across
multiple membership weights
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Figure 7.6: Caterpillar plot for LNU eﬀects showing smallest and largest eﬀects across
multiple membership weights
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Figure 7.7: Caterpillar plot for NICU eﬀects showing smallest and largest eﬀects across
multiple membership weights
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Figure 7.8: Caterpillar plot for networks eﬀects showing smallest and largest eﬀects
across multiple membership weights
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Figure 7.9: Caterpillar plot for LNU eﬀects, ordered by the proportion of infants trans-
ferred out within 24 hours
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7.5 Discussion
7.5.1 Summary
In this chapter I presented the results from the multiple membership analyses. First I
presented the simulation study which showed that ignoring multiple membership struc-
ture and assigning individuals to a single provider resulted in underestimating the
provider variance and poorer coverage of the variance and provider eﬀects. Biases were
larger when the weights generating the data were more evenly distributed than those
used to analyse the data. In comparison, biases from assuming an incorrect MM weight
were minimal. There was some indication of variance underestimation when a more
uneven attribution was assumed but not the converse. Estimates of provider eﬀects
themselves were less strongly aﬀected than the provider variance, with any biases over-
shadowed by shrinkage eﬀects. While the average DIC was lowest for correct analysis
models, the DIC had limited utility for model selection. In summary, multiple mem-
bership models were superior to allocation to a single provider, even when the analysis
weighting diﬀered to the scenario weighting, and individual provider results were not
strongly aﬀected by diﬀerent weights.
I then applied multiple membership models to the neonatal data, extending the
analysis presented in chapter 6. Associations with infant characteristics were slightly
diﬀerent from those found for the analysis of transferred infants only, though the risk
proﬁle and crude mortality was also diﬀerent. In contrast with the analysis of non-
transferred infants, mortality was in general highest for NICUs and lowest for SCBUs.
This was consistent with the descriptive analysis showing that deaths tended to occur in
NICUs and discharges home tended to occur from SCBUs after convalescent care. The
ORs for NNU level were sensitive to the MM weights with the largest diﬀerences for the
weight proportional to LOS.
As was seen in the simulation study, allocating infants to the ﬁrst NNU only resulted
in the lowest estimate of the between-NNU SD (σu). The standard approach of assigning
infants proportional to length of stay in the NNU yielded the highest estimate of σu, and
similar values were obtained using weighted LOS and equal allocation. The between-
network variation was fairly similar across MM weights. The DIC was lowest for the
weight proportional to LOS with substantial diﬀerences between models, much greater
than those seen in the simulated data.
The NNU eﬀects arising from allocation to the ﬁrst provider did not correlate well
with those from other MM weights and were shrunk more heavily towards the mean
(as were those from the other weights placing more emphasis at the start of stay). The
increase shrinkage meant that more information is borrowed and the uncertainty around
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the NNU eﬀects is lower. Hence the NNU eﬀects from the ﬁrst only weight produced
posterior mean NNU eﬀects which were smallest in magnitude, while the largest were
generally produced by the LOS weight. Diﬀerences across weights were small for the
most part and were overshadowed by the uncertainty. There were no clear patterns
when examining the NNU eﬀects by the level of transfers.
In summary the diﬀerent aspects of the analysis produced a consistent pattern across
the weighting schemes. The standard MM weighting of allocating in proportion to LOS
produced the largest diﬀerences between NNU levels and the largest NNU eﬀects. From
a modelling perspective, this weighting also gave the lowest DIC and the largest between-
NNU variance, and placed the most weight on the discharging NNU. In contrast, the
standard provider proﬁling approach of allocating all infants to the ﬁrst NNU produced
opposite eﬀects: the smallest diﬀerences between NNU levels and NNU eﬀects, the
largest DIC and the smallest between-NNU variance.
7.5.2 Simulation study
In line with previous MM studies (Chung and Beretvas, 2012; Leckie, 2009), the between-
cluster variance was underestimated when a conventional hierarchical model was applied,
assigning individuals to the ﬁrst provider and thereby ignoring the MM structure of the
data. The bias was much smaller when MM models were used, but notably the between-
cluster variance was underestimated when the allocation of weight was more uneven than
was implied by the model used to generate the data. The converse was not the case (use
of a more uneven weight did not result in overestimating the variance). These results
are drawn into question because using analysing the data using the MM weights that
generated the data did not consistently minimise the bias or MSE for σu, which we
would expect. The bias was calculated by comparing σˆu with the value of 0.4 used to
generate the data, but random variation when sampling the hospital eﬀects may mean
that ¯ˆσu is higher than 0.4, particularly as only 200 datasets were used. In this case any
MM weighting which underestimates the between-cluster standard deviation will result
in a lower bias. This could be further investigated using a higher number of simulations,
which would reduce sampling variation and bring ¯ˆσu closer to 0.4. In support of the
ﬁndings, Wolﬀ-Smith and Beretvas (2014) also found that a more uneven weight did
not result in overestimating the between-cluster variance (see section 4.3.2), though the
authors did not comment on why these results might occur.
Allocation to a single provider could be seen as an extreme case of uneven weighting.
Returning to equation 4.7, the variance contribution under MM is scaled by the sum of
the squared weights which is minimised when the weights are equal. This also implies
that misspeciﬁcation of the weight would lead to overestimation of the variance if the
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applied MM weight is more even than than the underlying process generating the data.
This was not seen in the simulation study here, and while some overestimation was
observed in the study of Wolﬀ-Smith and Beretvas (2014), in those scenarios application
of the “correct” weight also yielded too high a variance.
Estimation of the provider eﬀects themselves were slightly less biased with smaller
mean square error when the correct analysis model is chosen, but diﬀerences are small
and coverage across all MM models was good. Biases were larger and coverage was
poorer in the simulated data when the MM structure was ignored. This has not been
demonstrated in previous studies of MM models, but is important for provider proﬁling.
Goldstein et al. (2006) used the DIC to select the weighting scheme, though I found
that comparing DIC did not reliably distinguish the weight used to generate the data.
For provider proﬁling purposes we are not always interested in estimating the exact
process generating the data. For example we may want all providers to be equally
accountable, even though this may not reﬂect the inﬂuence each provider has on the
outcome. This seems a reasonable strategy to take, as results from the simulation study
showed that provided MM models were used, the diﬀerences between them were minimal
regardless of the true process. The results also suggest that allocating the weight equally
amongst providers is the least likely to results in biased variance estimates so is a suitable
default choice in the absence of a a priori weight distribution.
The conclusions drawn above may not be generalisable outside of the simulation
study. The study was limited as I only applied a narrow range of assumed true weights
and analysis models, and did not vary other simulation parameters. In particular the
inﬂuence of the size of the dataset (number of individuals and number of providers),
the proportion transferred, the number of times individuals were transferred and the
between hospital variance were kept constant, and patient volume was equal across
hospitals. This has the advantage of being easier to interpret, but limits the utility of
the conclusions which can be drawn. To extend the simulation I would consider using
the real neonatal data but simulating the NNU eﬀects to more accurately reﬂect transfer
patterns.
7.5.3 Analysis of neonatal data
For the neonatal data there were notable diﬀerences in the variance estimates and DIC
across the diﬀerent MM weightings, as well as diﬀerences in direction of NNU level
eﬀects. This is in part due to diﬀerences in transfer patterns across infants. Whether an
infant is transferred, when transfer occurs and where the infant is transferred to are all
inﬂuenced by health status before birth, at birth and beyond. Transfer patterns were
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apparent from ﬁndings earlier in the thesis: in chapter 2 I demonstrated that infants
who require a higher level of neonatal care than is available at their hospital of birth
are transferred early, usually within 24 hours of birth. Infants whose condition improves
are transferred later on for step-down care and are discharged from lower level NNUs,
while infants that die tend to do so in NICUs. The aim of estimating NNU eﬀects is
to compare mortality at an NNU with what would be expected for similar infants at
similar NNUs, but we cannot infer that any variation is caused by the NNU itself as
there may be unmodelled confounders contributing to the NNU eﬀects. The transfer
patterns contribute additional between-NNU variation which is not caused by the NNU,
but occurs in the opposite direction; that is the infant’s condition inﬂuences which NNU
they are treated in rather than care provided by the NNU aﬀecting the infant’s condition.
The standard MM weighting of allocating in proportion to LOS (here denoted
LOS )showed the largest variation between NNUs and the largest diﬀerences between
NNU levels. This weighting places the greatest weight on the discharging NNU (table
7.5) and thus leads to greater separation as to which NNUs survivors and deaths are
allocated to. Table 7.5 showed the WLOS weighting mitigates this by downweighting
the lower-level convalescent care for survivors. As infants that die are unlikely to have
many days that are not intensive care, the diﬀerence in the LOS and WLOS weightings
are negligible for them. The Beta2, Beta3 and First weightings place much less weight
on the discharging NNU, and as a result show the least variation between NNUs and the
smallest diﬀerences between NNU levels. The Equal weighting to some extent avoids
this problem: if an infant is born at SCBU A and transferred to NICU B for intensive
care, then the equal weight assignment is identical whether or not the infant survives
to return to SCBU A for convalescent care. Other selection eﬀects remain: if the infant
had not survived long enough to be transferred then all the weight would be allocated
to SCBU A, but in such cases all weights would be the same as the infant is only treated
in one NNU.
Some of the ﬁndings warrant further investigation. NNU eﬀects for SCBU are more
susceptible to diﬀerences in weighting (as shown by the lower correlation in ﬁgure 7.4).
As shown in chapter 2 a higher proportion of SCBU admissions are transferred, but
diﬀerences would be stronger if there is variation in the success of stabilising infants,
as suggested by the higher (but very uncertain) between-SCBU variation discussed in
6.6. Despite allocation of weight for transferred patients being the only diﬀerence across
models in this chapter, comparison of results for individual NNU by level of transfer
using a variety of measures did not show any patterns. These are blunt summaries
of complex patient pathways; a more detailed analysis, perhaps for the NNUs in one
network, might help elucidate the reasons for diﬀerence in results across MM weights.
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Comparison with previous ﬁndings
In comparison with the results for the same model for non-transferred infants (model
5 in chapter 6), the ORs for the infant characteristics were fairly similar, but the ORs
for NNU level were very diﬀerent. The between-NNU variation was slightly lower here
for most models. There are a number of possible for this: diﬀerences between the MM
weightings used to analyse the data and the underlying patterns of variation in the data
(as discussed in section 4.3.2); diﬀerences in the population; or genuine diﬀerence in
eﬀect for transferred and non-transferred infants. Analysis of transferred infants only
may help in understanding this, but this might not be feasible as the sample size would
be reduced to a third.
In the simulation study diﬀerences between MM weightings were minimal regardless
of the underlying process, but this was not the case for the neonatal data. There
are a number of diﬀerences between the simulated and neonatal data: the variation
attributable to the reverse causal eﬀect may be large in comparison with NNU eﬀect on
mortality; the patterns generating the data are heterogenous across infants; and those
patterns are very diﬀerent to the analysis weights used. Diﬀerences in the eﬀects of NNU
level were seen between MM models but comparisons with simulated data could not be
made as there were no provider-level variables in the simulation study. A more elaborate
simulation study using the NNRD data including transfer patterns but controlling the
NNU eﬀects could be used to investigate this, as was discussed in 7.5.2.
Substantial diﬀerences across weighting schemes were not seen in most MM studies
looking at pupil mobility (Fielding and Yang, 2005; Goldstein et al., 2007; Leckie, 2009).
The destination school of a transferring pupil is perhaps more likely to be due to external
reasons (e.g. moving house) than educational attainment. In contrast, Wolﬀ-Smith and
Beretvas (2014) ﬁnd diﬀerences in the between-school variance when diﬀerent weights are
applied and suggest the possibility that pupil mobility could be aﬀected by educational
attainment, though the mechanisms for this are not discussed.
7.5.4 Conclusion
Hierarchical models can be put to diﬀerent purposes. In many cases, including some of
the existing MM studies previously described, we want the random eﬀects to capture the
variation in the data and choose models that appear to ﬁt the data best. For provider
proﬁling purposes we want the random eﬀects to reﬂect the inferences we want to make
about the provider eﬀects, as was discussed in chapter 4. This is quite a diﬀerent aim,
and, as shown in this chapter, may not correspond to the models selected based on
measures of ﬁt such as the DIC. Models which capture the most variation may not
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exclusively model the source of variation that we are interested in, and therefore could
yield misleading conclusions.
The eventual purpose of these results is to inform NNUs how the expected mortality
for infants in their care compares with that of similar infants attending similar NNUs. As
with all provider proﬁling studies, any diﬀerences could be due to performance but they
be also be due to unmodelled factors, in this case transfers. For transferred infants, we
cannot consider the infants at diﬀerent NNUs to be similar because the location of care
is determined partly by their condition in a way that was not known at birth. This issue
is characteristic of any networked system of care, as the transferred patients at larger
centres will primarily be the sickest patients from outside the locality, and therefore will
either die at the larger centre or survive to be transferred back when their condition
improves. Given the importance of monitoring clinical outcomes and the increasing use
of centralisation it is necessary to clarify what these methods can achieve and what the
caveats are. Alternative methodological approaches will be brieﬂy considered in 9.4.3.
Equally attributing the weight across all NNUs caring for an infant regardless of
length of stay, timing of stay or intensity of care gives an intuitive interpretation of
assigning equal accountability while reducing the extent to which the reversal causal
association is captured. For neonatal care, the weighted LOS approach combining care
level data and recommended staﬃng ratios provides one suitable comparison as the re-
sulting NNU eﬀects will be more inﬂuenced by infants to whom more care was provided.
Results should be considered alongside those for non-transferred infants only as these
provide NNU eﬀects which are not aﬀected by postnatal transfer patterns. Other data
on case-mix and volume of care may also help interpret results. An example of how
these results might be presented graphically for a single unit is given in chapter 8.
More generally, equal weighting is a reasonable default choice given the ﬁndings of the
simulation study. Equal weighting is simple to implement and explain to non-statistical
users and do not require any arbitrary numerical choices or thresholds. Sensitivity
analysis using a range of weights to reﬂect both desirable interpretations of provider
eﬀects and plausible clustering patterns in the data is recommended. This is particularly
important where the transfer pattern may be related to the provider eﬀects themselves,
the outcome, or both, as is the case here. Understanding the drivers for the transfer
patterns is crucial to interpreting any diﬀerences between weights which may arise.
In this chapter I presented results from multiple membership models using a variety
of weights applied to simulated and neonatal data, and discussed how these could be
implemented in practice for provider proﬁling. Results from the equal and weighted
LOS models in this chapter are presented for a single NNU as part of a case study in
chapter 8 alongside results for non-transferred infants and other descriptive analysis.
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The ﬁndings from this chapter will be discussed in the context of the whole thesis in
chapter 9.
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Chapter 8
Case study
8.1 Aim
This chapter is a case study to show how the results arising from chapters 6 and 7 might
be presented graphically alongside other descriptive data from chapter 2 for a single
neonatal unit (NNU) in a comparable way.
8.2 Methods
The overall cohort for this chapter was the same as that described in chapter 2: infants
born 2011-2013 at or below 31+6 weeks gestation and admitted to an NNU in England
contributing to the National Neonatal Research Database (NNRD). As for previous
analyses, infants with a birth weight greater than 4 standard deviations from the gesta-
tion and sex speciﬁc mean (based on the Royal College of Paediatrics and Child Health
preterm standards (Wright et al., 2010) were excluded as were those with missing death
data. For descriptive analyses every unique admission was counted, i.e. transferred in-
fants were assigned to all NNUs caring for them, but readmissions of the same infant to
the same NNUs were not counted twice unless otherwise stated. Non-transferred infants
were assigned to the sole NNU providing care. For each analysis, infants with missing
data for the variable in questions were excluded. The results for the NNU of interest
(NNU X in neonatal network Y) are shown in the context of all other NNUs, NNUs
at the same level (in this case Neonatal Intensive Care Unit (NICU), the highest level,
see 1.2 for deﬁnitions) and, for volume data, NNUs in the same network. The NNU of
interest is highlighted in blue and all others are shown in grey.
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8.2.1 Volume
Volume of care was calculated in three ways: the number of infants in the cohort who
were admitted to each NNU over the three-year period; the number of care days of any
type provided by each NNU (where a care day is one day of care provided to one infant);
and the number of intensive care days provided (the highest level of care, see 1.2 for
deﬁnitions). For these plots the NNUs are displayed on order of the measure of volume,
with NNU X highlighted. For each admission to NNU X (including readmissions of the
same infant) I described the source of the admission: whether the infant was inborn
(the admission to NNU X was the ﬁrst admission to neonatal care), transferred from
one of the six other NNUs in the same neonatal network (two special care baby units
(SCBUs), three local neonatal units (LNUs) and one NICU), or transferred from an
NNU in a diﬀerent network.
8.2.2 Population
A selection of population attributes were compared between NNU X and the overall
patient population, ﬁrstly for all NNUs and for NICUs only. Six factors were described:
gestational age, birth weight, estimated risk of death, the level of socioeconomic depri-
vation in the maternal area of residence, maternal ethnicity and maternal age. Of these,
the last three were not adjusted for in the mortality analysis described in section 8.2.3.
Estimated risk of death was calculated using the logistic regression model described in
chapter 3. For socioeconomic deprivation, the Index of Multiple Deprivation (IMD) of
the Lower Super Output Area (LSOA) is used, which is an area-level composite mea-
sure, see section 2.3.1 for more details. The LSOA is determined from postcode of the
infant’s mother, and all LSOAs in England are ranked according to the IMD score. The
decile of the rank is the measure used in the analysis. Gestational age, socioeconomic
deprivation and maternal ethnicity were described using histograms and birth weight,
risk of death and maternal age using density plots.
8.2.3 Mortality
Mortality data was shown separately for non-transferred infants, and for all infants
together reﬂecting the separate analyses of chapters 6 and 7. The unadjusted mortality
across all NNUs for non-transferred infants (i.e. those whose sole admission was to
NNU X), was calculated as the number that died over the total. For all infants, this is
calculated including deaths in the numerator for all NNUs treating the infant, not just
the NNU in which the death occurred.
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A risk-adjusted measure of mortality for non-transferred infants in each NNU is
given by the odds ratio (OR) calculated using model 5 in chapter 6, full details of
which can be found therein and statistical methods in section 5.2. The model used is a
three-level hierarchical Bayesian logistic regression model (infants within NNUs within
networks), adjusted for gestational age, birth weight, sex, whether the mother was given
any antenatal steroids and level of NNU. The adjusted OR for NNU X can be interpreted
as how the expected odds mortality for infants in their care compares with that of similar
infants attending similar NNUs, with values above 1 indicating higher mortality than
expected. The estimate we obtain is the mean of the posterior distribution, which
describes the probability distribution for the OR. The 95% credible interval describes
the 2.5% to 97.5% range of the distribution; this is provided for NNU X as an error bar
to give a measure of uncertainty. Using a hierarchical model means that the ORs are
more reliably and precisely estimated as they are shrunk towards the expected value for
that provider. It also means clustering in the data is properly accounted for. All infants
are non-transferred so they can be assigned to one NNU.
A risk-adjusted measure of mortality for all infants in each NNU, including those
who are transferred, is given by the OR calculated using the multiple membership (MM)
models in chapter 7. Like the model used to determine the OR for non-transferred in-
fants, these are three-level models adjusted for the same infant and provider character-
istics. In contrast, rather than just being assigned to one NNU infants are assigned to
all NNUs that treat them using weights. Two models are presented here corresponding
to diﬀerent MM weights and hence diﬀerent interpretations. The ﬁrst weighting is equal
across all NNUs providing care, regardless of what type of care was provided and for
how long. This approach for assigning is similar to that for unadjusted mortality. For
the second weighting infants are assigned relative to the duration and intensity of care
at each NNU so the resulting OR gives more responsibility to NNUs providing a greater
share of care. These weightings are denoted Equal and WLOS respectively as was de-
scribed in chapter 7; more details on the MM models and calculation of the weights can
be found in section 5.4.
I have brieﬂy summarised the results presented in the graphs but clinical inferences
for the NNU are minimal as the case study is primarily for illustrative purposes.
8.3 Results
The results are shown in ﬁgures 8.1 to 8.33.
NNU X is one of the larger NNUs in terms of volume, particularly with regard to the
amount of intensive care conducted. NNU X is also one of the larger NICUs in relation
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to intensive care volume and conducts much more intensive care than all the other NNUs
in network Y (ﬁgures 8.1 to 8.9). More infants are transferred in to NNU X than are
inborn, and more infants are transferred out for further care than are discharged home
(ﬁgures 8.10 and 8.11). The gestational age distribution for NNU X is quite diﬀerent to
that both overall and for other NICUs (ﬁgures 8.12 and 8.13). The distribution appears
bimodal, with a peak at 26 weeks gestation and another at 30 weeks gestation. Infants
admitted to NNU X have lower birth weight than NNUs overall but a similar distribution
to the NICU population (ﬁgures 8.14 and 8.15). In contrast infants in NNU X are more
vulnerable based on estimated risk of death when compared with other NICUs, as well
as other NNUs in general (ﬁgures 8.16 and 8.17). Compared with other NNUs and
NICUs, the mothers of infants treated at NNU X are less likely to come from the most
or least deprived areas , less likely to be of white ethnicity, and are slightly older.
Mortality for NNU X is high compared with all NNUs but less so for NICUs (22%
for non-transferred infants and 13% for all infants) before using regression models to
adjust for risk factors and shrink the NNU eﬀects. This changes after adjustment, with
all mean posterior odds ratios for NNU X being less than one. While there are some
diﬀerences in the adjusted ORs for NNU X between the three adjusted models (for non-
transferred infants, for all infants using the Equal MM model and for all infants using
the WLOS MM model), the estimates are all very uncertain and span much of the range
of NNU eﬀects. The upper limit of the credible interval is lower for for both MM models
compared with the model for non-transferred infants, particularly for the WLOS model.
This means that probability of NNU X having a high odds ratio (greater than 1.2, say)
is lower when all infants are included, particularly when we consider the amount and
level of care provided.
8.4 Discussion
In this chapter I combined results from the thesis for a single NNU to give an example
of how they might be presented graphically for provider proﬁling purposes. Clinicians
could use this information locally to understand whether the NNU mortality rate is
higher or lower than expected, the strength of the evidence behind this and how this is
relates to information about the NNU, such as deprivation and volume. A commissioner
might look at these results to see if diﬀerences in clinical need and outcomes across the
NNUs under his or her remit matches funding and resource use. These results are not
be suitable for the purposes of patient choice as, for reasons described in 4.4.2, they
should not be used for direct comparison of individual providers.
The manner of presentation is similar to that used by the Health and Social Care
Information Centre illustrated in ﬁgure 3.1. I have only presented the ﬁgures here, but
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these would need to be combined with a summary of the data, methods, and advice on
interpretation (including caveats) to form a coherent report. The nature of this and the
level of detail would depend on the audience. The data presented could be extended
(other clinical data for medical staﬀ, other transfers data for managers), as could the
weights used in the MM models. For example if staﬀ at a SCBU are interested in
outcomes for infants they stabilise, all the weight (or an increased proportion) could be
placed on the ﬁrst day. Similar reports could be constructed for a network, both for
NNU eﬀects with all NNUs in the network highlighted, and for network eﬀects.
In all cases the adjusted ORs are the exponentiated NNU eﬀects, which compare
the NNU with an average NNU, adjusting for infant and provider characteristics. This
may not be the desired comparison - for example we may have reason to compare across
all NNUs regardless of level, and so do not want to adjust for this. To do this we can
exponentiate the sum of the NNU eﬀect and relevant NNU level regression coeﬃcient
arising from the hierarchical model to obtain the relevant OR. While this has not been
implemented here, it shows the ﬂexibility of the modelling approach to make diﬀerent
comparisons across providers.
There are drawbacks to presenting the ORs for mortality in this way. These plots
rank the data, and estimated ranks are known to be unstable. Furthermore, ranking
encourages direct comparison between NNUs which is not a reasonable inference for
the methods used here (see 4.4.2). For these reasons I did not name the other NNUs,
give explicit ranks, or present mortality data for the NNUs in the same network only
(as there are only seven). I added the 95% credible interval for the OR to show the
high levels of uncertainty. If results are produced separately and conﬁdentially for each
NNU and not in a single report, then the focus is on comparing a set of data for one
NNU rather than one outcome across many NNUs, and conducting direct comparison
would be diﬃcult. Alternatively, the Bayesian methods applied in this thesis allow
presentation of probabilities of interest directly, along with the associated uncertainty,
which can be easier to interpret by users than frequentist measures (Normand et al.,
1997). For example we could present the posterior probability of being in the top
quantile of providers, the posterior probability of having an OR (exponentiated NNU
eﬀect) greater or less than a threshold, with input from clinical and managerial staﬀ
on the appropriate quantile/threshold to apply. If ranks were of interest these could be
provided with credible intervals to show the uncertainty (Goldstein and Spiegelhalter,
1996). Despite the limitations and the relative complexity of the underlying models,
the case study provides a clear picture of where an NNU sits in terms of its workload,
population and mortality data, with a common method of presentation allowing these
aspects to be assessed simultaneously.
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Fig. 8.3 Number of IC days for NNU X (blue) and other NNUs (grey)
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Fig. 8.12 Gestational age distribution
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Fig. 8.13 Gestational age distribution
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Fig. 8.16 Distribution of predicted risk of death
for NNU X (blue) and all NNUs (grey)
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Fig. 8.17 Distribution of predicted risk of death
for NNU X (blue) and all NICUs (grey)
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Fig. 8.18 IMD distribution
for NNU X (blue) and all NNUs (grey)
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Fig. 8.19 IMD distribution
for NNU X (blue) and all NICUs (grey)
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Fig. 8.20 Maternal ethnicity distribution
for NNU X (blue) and all NNUs (grey)
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Fig. 8.21 Maternal ethnicity distribution
for NNU X (blue) and all NICUs (grey)
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Fig. 8.22 Maternal age distribution
for NNU X (blue) and all NNUs (grey)
10 20 30 40 50
Maternal age (years)
Fig. 8.23 Maternal age distribution
for NNU X (blue) and all NICUs (grey)
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Fig. 8.24 Crude mortality for non−transferred infants at NNU X (blue) and other NNUs (grey)
0.0
0.1
0.2
0.3
0.4
P
ro
po
rti
on
 o
f i
nf
an
ts
 th
at
 d
ie
d
Fig. 8.25 Crude mortality for all infants at NNU X (blue) and other NNUs (grey)
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Fig. 8.26 Crude mortality for non−transferred infants
at NNU X (blue) and other NICUs (grey)
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Fig. 8.27 Crude mortality for all infants
at NNU X (blue) and other NICUs (grey)
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Fig. 8.28 Adjusted OR for non−transferred
infants, NNU X (blue) and other NNUs (grey)
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Fig. 8.29 Adjusted OR for non−transferred
infants, NNU X (blue) and other NICUs (grey)
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Fig. 8.30 Adjusted OR from equal weight 
 MM model, NNU X (blue) and other NNUs (grey)
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Fig. 8.31 Adjusted OR from equal weight 
 MM model, NNU X (blue) and other NICUs (grey)
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Fig. 8.32 Adjusted OR from weighted LOS 
 MM model, NNU X (blue) and other NNUs (grey)
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Fig. 8.33 Adjusted OR from weighted LOS 
 MM model, NNU X (blue) and other NICUs (grey)
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Chapter 9
Conclusion
In the ﬁnal chapter of the thesis I begin by revisiting the research question (section 9.1)
and reviewing the chapters (section 9.2). In section 9.3 I summarise the contributions
of the thesis to the relevant research areas. These are discussed in more detail in section
9.4 including the limitations and relation to existing literature. Further work following
from the thesis is discussed in section 9.5 before concluding in section 9.6.
9.1 Research question
Hierarchical models are often used to conduct comparisons of clinical outcomes across
healthcare providers (provider proﬁling). Such models acknowledge the dependencies in
the data while explicitly modelling the variation that occurs at provider level. In the UK,
neonatal care is one speciality where the structure of services is particularly complex.
Neonatal units (NNUs) are categorised based on the type of care they oﬀer. In order
to provide comprehensive care, the service is delivered via managed clinical networks,
with infants transferred between NNUs as required. All NNUs caring for an infant need
access to his or her medical records, so for several years clinical data has been captured
on a web-based database. This is collated and cleaned to form the National Neonatal
Research Database (NNRD), but its use for monitoring mortality rates for individual
NNUs has been limited by the complex structure of the data. The aim of this thesis was
to establish suitable statistical models to inform NNUs how the expected mortality for
infants in their care compares with that of similar infants attending similar NNUs. In
particular I investigated assignment of the outcomes of transferred patients, modelling
diﬀerences across NNU levels, and handling of data dependencies at the neonatal network
level.
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9.2 Thesis summary
In chapter 1 I described preterm birth, its risk factors and its consequences, demonstrat-
ing the increasing importance of this vulnerable population. I motivated the research
questions of the thesis by describing the structure of neonatal services in the UK, the
factors underlying the development of the network structure, and the nature of post-
natal transfers. I gave a background to provider proﬁling studies, including some of
the challenges, before describing the research question and setting out the plan for the
thesis.
Chapter 2 described the data source for the thesis (the NNRD), justiﬁed the selec-
tion of the cohort and presented descriptive analysis of the data. I focussed the research
question by deﬁning the cohort and the outcome for analysis. I chose to analyse death
before discharge for singleton infants born 2011-2013 between 22+0 to 31+6 weeks ges-
tational age who were admitted to neonatal care in England. Decisions were based on
obtaining a complete and well-deﬁned population for whom a suitable risk-adjustment
model for a clinically relevant outcome could be developed. Descriptive analysis showed
that the infant characteristics and transfer patterns are broadly consistent with the
existing knowledge about preterm birth and neonatal care described in chapter 1.
In chapter 3 I developed a risk adjustment model including gestational age, birth
weight, sex and antenatal steroids as factors. Variable selection was based on a review of
the literature but restricted to those suitable for provider proﬁling purposes. The model
showed good predictive performance in comparison with existing models. I discussed
adjusting for provider-level variables and for postnatal transfer, selecting only NNU level
as a factor for inclusion in subsequent analysis.
Existing statistical methods were reviewed in chapter 4. I described the suitability
of hierarchical models, in particular Bayesian techniques, for provider proﬁling generally
and for the thesis. These methods were shown to be suitable for modelling variation at
the neonatal network level and diﬀerences in levels of NNU, but not neonatal transfers.
A systematic review of the literature for approaches to handling transferred patients
showed that all studies either excluded transfers, allocated to a single provider or did
not use hierarchical models. I then proposed multiple membership (MM) models as a
potential solution and described some existing applications and methodological ﬁndings
relevant to the thesis. In particular I described considerations with regard to choosing
MM weights and found that little attention has been paid to estimating the random
eﬀects themselves, which is the focus of this thesis.
Chapter 5 sets out the methods for the thesis. As a preliminary I gave an overview
of the Bayesian techniques that would be employed in the chapter. I then described a
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series of models to investigate modelling variation by NNU level and neonatal network,
applied to non-transferred infants only. This was followed by a simulation study to
assess how sensitive parameters of interest were to a variety of MM data scenarios and
analysis models, proposing some alternatives to the standard weight which might be
more suitable for neonatal data. Finally I described the application of MM models with
a series of diﬀerent weights to the neonatal data, building on the models developed for
the non-transferred infants.
Results for non-transferred infants were presented in chapter 6. There were diﬀer-
ences in mortality between NNU levels with both special care baby units (SCBUs) and
neonatal intensive care units (NICUs) having higher adjusted odds of mortality than
local neonatal units (LNUs). There was some indication of higher variation for SCBUs
and NICUs compared with LNUs, but variance estimates were uncertain. As this led to
less borrowing of information for smaller providers and greater uncertainty in the result-
ing estimates, a common between-NNU variance was modelled instead. There was little
evidence of variation between neonatal networks but modelling this allows us to obtain
estimates of network eﬀects, which is important given that they are also providers.
In chapter 7 I presented results from the MM analyses. The simulation demon-
strated that assigning weight too unequally across providers (with assignment to a single
provider being the most extreme case) underestimated the between-provider variance.
Assignment to a single provider produced provider eﬀects which had lower uncertainty
but poorer coverage, with less diﬀerence seen across the MM models. These results
were echoed in the analysis of neonatal data, but diﬀerences were larger. The diﬀerent
aspects of the analysis produced a consistent pattern across the weighting schemes, with
the standard MM weighting of allocating in proportion to length of stay (LOS) produc-
ing the largest diﬀerences between NNU levels and the largest NNU eﬀects. When and
where an infant is transferred is dependent on his or her health status. MM weights
that place greater emphasis later during stay, when there is greater separation in the
location of care for infants that survive to discharge and infants that die, produce larger
diﬀerences. These diﬀerences persist after adjustment for NNU level, suggesting there
are diﬀerences in care pathways which are not completely characterised by NNU level.
Chapter 8 showed how the results arising from chapters 6 and 7 might be presented
graphically alongside other descriptive data from chapter 2 in a comparable way as a
case study for a single NNU.
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9.3 Contributions of the thesis
In this section I brieﬂy summarise the novel ﬁndings from the thesis which will be
discussed further in section 9.4.
Neonatal care In this thesis I have developed methods to evaluate mortality of
preterm infants at individual NNUs across England, which has not been done before
at a national level. I have showed that there is a low level of residual variation in mor-
tality across NNUs and networks after controlling for key infant characteristics and level
of NNU. The risk adjustment model developed as part of this process showed improved
model performance compared with three existing models currently in use. Descriptive
analysis of transfer patterns and diﬀerences in care provided across levels of NNU pro-
vides insight into the functioning of the network system, and its impact on the burden
of care across levels of NNU. A case study for a single NNU showed how the descriptive
data could be presented alongside the mortality analysis to aid interpretation.
Provider proﬁling I have demonstrated a statistically principled way of accounting
for transfer between hospitals in provider proﬁling studies which has not been done
before either in neonatal care or in other specialities. Hierarchical Bayesian approaches
are an established method for provider proﬁling; this thesis adds to this body of work
as a practical application of evaluating providers at two levels (NNUs and networks),
with providers of diﬀerent types (levels of NNU) in the context of centralised care. It
also shows the utility of using electronic patient records for provider proﬁling purposes.
Methodology This thesis represents a new application of MM models for modelling
patient transfers, including transfers to a diﬀerent network. I used Beta distributions
with diﬀerent parameters as a family of weights for MM models, which to my knowledge
has not been done before. The simulation study demonstrated that the bias and coverage
for the random eﬀects was poorer when the MM structure was ignored. Results suggested
a pattern regarding the underestimation of the cluster variance and the MM weights
used, providing support to the use of equal weights. Application of MM models to the
neonatal data revealed that results are more sensitive to choice of MM weights when
the pattern of membership is associated with the outcome.
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9.4 Discussion
9.4.1 Neonatal care
NNU eﬀects
Mortality of preterm infants at individual NNUs in England has not been evaluated at
a national level before. In this thesis I demonstrated that hierarchical multiple member-
ship models yield NNU-speciﬁc estimates of risk-adjusted mortality in the form of odds
ratios, allocating infants to all NNUs which have cared for the infant, and incorporating
neonatal network eﬀects and diﬀerences across types of NNU. Mortality at the neonatal
network level has been evaluated using Standardised Mortality Ratios (Neonatal Data
Analysis Unit, 2015), and other outcomes at the NNU level for the National Neonatal
Audit Programme (Royal College of Paediatrics and Child Health, 2015), where trans-
fers were either excluded or assigned to one NNU. Hierarchical models have been used to
proﬁle neonatal providers elsewhere (Bonet et al., 2011; Lee et al., 2013; MacNab et al.,
2005), though again transfers were assigned to a single provider. The diﬀerences in
approach between those studies and this thesis were described in more detail in section
4.4.2. While this thesis has established the means for calculating and reporting mortal-
ity data for NNUs, all admissions should be included before it can be implemented. In
particular, the methods shown here should be extended to include infants with missing
data and those from a multiple pregnancy. This will be discussed as part of further work
in section 9.5.
The inferences drawn about the NNU eﬀects depend on the MM weightings used
(see section 9.4.3). That said, NNU eﬀects themselves are fairly robust to diﬀerent
speciﬁcations for MM weights, given the overall uncertainty. NNU eﬀects should also be
interpreted in light of other data about the NNU which, for reasons discussed in section
3.2, were not included as risk adjustment variables. To illustrate this, in chapter 8 I
showed how the results could be presented in the context of descriptive data in a case
study for a single NNU.
Risk adjustment
While the risk adjustment model developed here did not use any novel methodology,
there were no other models in the review by Medlock et al. (2011) (the basis for variable
selection in chapter 3) which used restricted cubic splines to model the eﬀect of gesta-
tional age. While discrimination was similar, the model for this thesis gave improved
prediction over three existing models ((Manktelow et al., 2013; Parry et al., 2003; Tyson
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et al., 2008)), all of which over-predicted mortality. This highlights the importance of
re-calibrating models using recent data to keep current with improvements in neonatal
survival. This is made feasible by using the NNRD, as it is an ongoing and regularly
updated data source. Estimates of gestation-speciﬁc mortality showed an improvement
from 2006 estimates reported by the EPICure 2 study (Costeloe et al., 2012) for neona-
tal admissions born 22+0 and 25+6 weeks gestation. Data were consistent with recent
estimates for livebirths from the UK Oﬃce of National Statistics, supporting the validity
of the ﬁndings.
Transfer patterns
Although not a primary aim of the thesis, the descriptive analyses of patterns of care
and transfer described in chapter 2 are interesting ﬁndings which build on other national
(Gale et al., 2012b; Redshaw and Hamilton, 2006) and regional (Cusack et al., 2007)
studies, while the detail regarding type and timing of transfer has not been reported at
a national level before. A limitation of the analysis is that causal inferences cannot be
drawn from the diﬀerences between levels of NNU described in chapters 6 and 7. There
are several studies (Binder et al., 2011; Marlow et al., 2014; Neto, 2006; Phibbs et al.,
2007; Watson et al., 2014) providing evidence of better clinical outcomes for preterm
infants born at hospitals with neonatal intensive care facilities. The associations found
here suggest higher mortality at NICUs compared with LNUs even after risk-adjustment.
In sections 6.6 and 7.5 I argued that this is likely to be due to a selection eﬀect as they
treat higher risk infants and conduct more intensive care. The selection eﬀects are
ampliﬁed for transferred infants because the condition of an infant determines where
they are transferred to (this is also observed within level of NNU, as will be discussed in
9.4.3). These diﬀerences in case-mix were not captured by the risk adjustment. For non-
transferred infants, exploration of factors known before birth which determine whether
an infant requires planned delivery at (or in-utero transfer to) a NICU could yield other
variables to improve risk adjustment. For transferred infants, a diﬀerent method which
can model risk factors that change over time is required; possibilities for this will be
discussed in section 9.4.3.
9.4.2 Provider proﬁling
This thesis showed that provider proﬁling analyses can accommodate patient transfers in
a hierarchical modelling framework without assigning to a single provider or undertaking
multiple analyses to compare assignment to diﬀerent providers. The approach taken
to accommodate transfers is similar to that of Hassani et al. (2015) and Kristoﬀersen
et al. (2012) in that outcomes for transferred patients are shared across all providers.
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Those studies used ﬁxed eﬀects regression, with Hassani et al. (2015) shrinking the
provider eﬀects in a second stage. Using MM models means the provider eﬀects can
be estimated in a single analysis. Several studies in the systematic review (section 4.2)
advocated allocation to the referring provider. This thesis showed that following this
recommendation is not suitable if we want the provider eﬀects to reﬂect the whole of
stay as it underestimates the between-provider variance and results in provider eﬀects
which are over-shrunk, with credible intervals that have poor coverage of the true eﬀects.
In addition, this recommendation as a general rule is unsuitable for neonatal care (and
possibly for other networked specialities), as there are multiple referring providers for
infants transferred more than once. If taken to mean the ﬁrst provider, it would result
in many transferred infants assigned to an NNU providing less than 24 hours of care.
The hierarchical Bayesian models applied here are an established method for provider
proﬁling which is suitable for settings with many small providers (DeLong et al., 1997;
Goldstein and Spiegelhalter, 1996; Normand et al., 1997). Some analyses have adjusted
for type or provider in some way to enable peer group comparison (Austin et al., 2004;
MacNab et al., 2005), with others allowing for complex variation by type of provider
(Goldstein, 2002). Extensions of basic models have been implemented to accommodate
a third level of dependence (Brookhart et al., 2006; Chen et al., 2013) but not to my
knowledge in the context of networked care, where the third level presents a co-ordinated
group of providers at the lower level. The thesis also serves as an example of using
electronic patient records for provider proﬁling, which is advantageous as it minimises
additional costs, including staﬀ time for data entry. Some practical aspects of using
routine data require further attention: though some validation processes are in place
(section 2.1.3) no further validation was conducted speciﬁcally for the thesis, nor was the
potential eﬀect of data errors on the results investigated. Infants with missing outcome
or covariate data were excluded; further work on handling missing data is described in
section 9.5.
Provider proﬁling studies are often focussed on detecting unusual performance and
comparing providers (Goldstein and Spiegelhalter, 1996; Ohlssen et al., 2007b). Shrunken
provider eﬀects arising from hierarchical models are often used for these purposes, though
the limitations regarding power and inconsistent shrinkage are known (Aylin et al., 2003;
Shen and Louis, 1998). As discussed in section 4.4, the results of this thesis are not suit-
able for these purposes. Birth below 32 weeks gestation is rare, and subsequent mortality
more so, therefore power to detect unusual performance is limited, even at the larger
NNUs. There was considerable variation in the size of NNU (both in general and in
terms of the number of high risk infants), so the level of shrinkage varied across NNUs,
limiting the utility and fairness of comparison and outlier detection. I have instead fo-
cussed on estimation of NNU-speciﬁc mortality. However, as seen in the caterpillar plots
in sections 6.5 and 7.4.5, uncertainty around the provider-speciﬁc estimates is high, par-
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ticularly for smaller NNUs. This is an unavoidable limitation given the numbers involved
for this particular population and outcome. This could be mitigated by examining data
over a longer period of time (perhaps on a rolling basis to enable regular assessment to
be conducted) but a drawback is the loss of currency. Models and weights where more
information was borrowed across NNUs yielded more precise results. This could be in-
creased by including more provider-level variables (e.g. co-location of surgical facilities,
availability of a specialist transfer service), as this reduces the residual between-NNU
variability by reﬁning the peer group to which NNUs are compared.
9.4.3 Methodological
This thesis presents a new application of MMmodels, motivated by their use in modelling
pupil mobility in education (Goldstein et al., 2007; Leckie, 2009), which is a similar
problem. Neonatal transfers are an interesting application for multiple membership
models with features that may be useful to others applying MM models.
Firstly, data on the intensity of care are available to inform weights, allowing for
weights to vary by individual. Secondly, episodes of neonatal care are not of discrete
duration and total length of stay varies considerably across infants (as is likely to be
the case for patient transfers in general). This led to the use of the Beta distribution
to specify MM weightings. While this was not ﬁnally selected as the most appropriate
method for this application, it may prove useful in other applications of MM models.
It allows the analyst to describe a family of weights with diﬀerent shapes, so could be
used to check sensitivity to assumptions.
Finally, in neonatal care the location of care at a point in time is indicative of the
infant’s outcome, so there is the potential for a stronger relationship between weighting
patterns and clustering eﬀects which was made evident in chapter 7. This has implica-
tions for the choice of MM weight, unlike many of the existing MM studies which found
results were robust to choice of weight (Fielding and Yang, 2005; Goldstein et al., 2006;
Leckie, 2009). I argued in sections 7.5.3 and 7.5.4 that for provider proﬁling purposes
the choice of weighting should be driven by the inferences we wish to make, so equal
weight is a reasonable choice as it has an intuitive interpretation of equal accountability.
For neonatal care, and other settings exhibiting similar patterns, equal weight is appeal-
ing for its neutrality and simplicity, but sensitivity analysis using diﬀerent weightings
is important, giving us a range of results with diﬀerent inferences. In neonatal care,
the weighted LOS is a useful comparison as it mitigates some of the problems of the
standard LOS weighting (see section 7.5.3).
Logistic regression treats death as a single binary outcome, and therefore we only
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have a single set of risk factors measured at birth. In section 4.4 I considered discrete
time logistic regression models as a possible alternative which models the outcome at
the end of each episode as a set of sequential, dependent outcomes. These would allow
the condition of the baby at the start of each episode to be considered separately (if
a suitable set of risk factors can be found) which, in light of the ﬁndings from chapter
7, might help resolve the issue of divergent pathways for sicker patients. However I
am unaware of any hierarchical implementation of these models where individuals have
diﬀerent numbers of episodes of varying lengths, as is the case here. Another possible
alternative is to treat the outcome as a survival time. While this is not a standard
approach for perinatal mortality given the short timescale, it would allow the risk of
dying to change over time. Random eﬀects models for survival data are known as
frailty models. Transferred infants whose cluster membership changes could possibly be
modelled by a time-dependent frailty term, though these are primarily used for recurrent
events (Manda and Meyer, 2005; Yau and McGilchrist, 1998). I have not explored these
methods further as part of the thesis, but their complexity in contrast to MM models
may limit their utility in routine reporting of clinical outcomes.
It is already known that cluster variance is underestimated when the MM structure
is ignored (Chung and Beretvas, 2012; Fielding and Goldstein, 2006; Goldstein et al.,
2007; Leckie, 2009). The simulation study here indicated that the underestimation is also
present when the weights applied in the MM analysis are more unequal than the process
generating the data. This is in line with ﬁndings from Wolﬀ-Smith and Beretvas (2014)
but results here also suggest greater underestimation for more unequal weights. I also
showed that the random eﬀects were more biased towards the null, and uncertainty was
underestimated resulting in poorer coverage. Previous studies comparing MM weights
and single membership models have not examined these issues. The simulation study
here was limited and further exploration with a wider range of parameters and more
complex data is required to solidify these ﬁndings. In particular, further support for the
proposition that assuming equal MM weight results in minimal bias would strengthen
the case for using equal weights.
9.5 Further work
9.5.1 Missing data
Infants were excluded if they had missing covariate or outcome data. Having developed
methods suitable for complete case data I consider how these could be extended to
include missing outcome data. The Bayesian Markov Chain Monte Carlo (MCMC)
methods applied here are well suited to missing data problems because our uncertainty
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about the missing data is no diﬀerent to the uncertainty about any other parameter,
and possible values for the data are imputed with each MCMC iteration (Gelman et al.,
2004). Were the infants with missing outcomes no diﬀerent to those with complete
data, the logistic regression model would already capture all our knowledge about the
outcome. We can use this same model to impute a posterior distribution for the missing
outcomes (following the addition of a suitable prior for the missing data to the model
formulation).
In section 2.2.7 I discussed the reasons for missing outcomes and the resulting sta-
tistical implications. Brieﬂy, the most plausible reason for missing outcomes is that
infants have been transferred to specialist surgical providers. The fact that the outcome
is missing is likely to be associated with the outcome itself: the need for surgery is an
indication of illness severity, and the surgery itself will aﬀect the outcome. Therefore a
model for the missingness mechanism is required. Similarly to constructing the hierar-
chical models by considering each level separately (infants, NNUs, networks), so we can
have a separate “submodel” for the missingness mechanism, with all parameters esti-
mated simultaneously (Mason et al., 2010). We model the probability of missingess as
a function of the outcome and any other information we wish to include, though careful
thought is required as to how this could feed back into the provider eﬀects. Such models
usually require informative priors for parameters of the missingness model, with a range
of priors applied to reﬂect diﬀerent assumptions regarding the missingness mechanism.
Even if we can model the data and missingness in suitable ways, a further question
is how the outcome for these infants should be attributed to the NNUs caring for the
infant. Outcomes for these infants could be attributed as if the (imputed) death or
discharge home occurred from the ﬁnal NNU. This ignores the role the specialist unit
plays in the survival of the infant, which is possibly a crucial one. Specialist units are not
amongst the providers being proﬁled as they are not neonatal units. There is currently
too little data to include them in any modelling, though a possible future development
is that surgical providers will input data into the electronic data capture system.
9.5.2 Multiple births
The cohort for the thesis consisted of singleton infants only who, while a distinct and
clinically relevant population in their own right, comprise only part of the admissions to
neonatal care (73% of infants in the NNRD born 2011-2013 below 32 weeks gestation).
Including multiple births poses two areas of diﬃculty. Firstly, infants from multiple
pregnancies are diﬀerent from their singleton counterparts and therefore may require a
diﬀerent risk adjustment model (see section 2.4 for further discussion). Secondly, they
result in additional correlations in the data because infants in the same multiple birth
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set are likely to have similar outcomes beyond the similarity in measured risk factors
such as gestational age. The extent of these correlations requires investigation, but as
described in 2.2.5 multiple birth sets could not be adequately matched in the NNRD
data. The structure of multiple birth data is problematic because the clusters (multiple
birth sets) are small, which can lead to estimation problems, and because not all the
data are clustered because singleton infants are not part of a set. Generalised estimat-
ing equations are often used in the twin literature but they cannot be combined with
hierarchical models (Carlin et al., 2005; Marston et al., 2009). While ignoring partial
clustering in the term population when the proportion of multiple births is low may
be reasonable (Marston et al., 2009) this is not the case for preterm infants. Further-
more, as it is the clustering at NNU level which is of interest and multiple births are
usually treated in the same NNU (Gale et al., 2012b), any unexplained variance from
multiple birth sets will be attributed to NNU level, resulting in over-estimation of the
between-NNU variance.
Partially clustered data are frequently seen in psychotherapy trials (Baldwin et al.,
2011). Patients receiving treatment from a psychotherapist are clustered within thera-
pists, (as we would expect there to be some correlation due to the subjective nature of
the treatment) while those in a control group or receiving self-administered treatment
would not be clustered. One approach is to model an interaction between the cluster-
ing variable (therapist treatment arm or, in our case, multiple birth indicator) and the
random eﬀect, so that the clustering eﬀects are only modelled for the clustered data.
For psychotherapy trials this is intuitive as only those receiving therapy have a variance
contribution from the therapist eﬀect. This is not the case when considering infants
and multiple births. The similarity between twins will be due to the characteristics of
the parents, the pregnancy and the birth. Singletons will also be subject to these inﬂu-
ences so it may be more sensible to model them as a cluster of size one. Sauzet et al.
(2013), motivated by the high proportion of multiple births in the preterm population,
showed that hierarchical models produced unstable parameter estimates for continuous
outcomes. Additionally they found that the random eﬀects variance was underestimated
when the number of clusters was small, when there were many predictors or where there
was less heterogeneity between clusters. The models developed in this thesis can in the-
ory be extended to accommodate multiple births using partial clustering at the infant
level, but a simulation approach in the manner of Sauzet et al. (2013) is advisable to
check sensitivity.
The proportion of preterm infants from a multiple pregnancy is substantial and
possibly growing, as the rise multiple birth rates is thought to be a key drivers of
increases in preterm birth. The reasons for early delivery are not the same as those for
singletons and their clinical needs may also diﬀer. Including multiple births is therefore
a priority for development of this work.
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9.5.3 Other applications
Death before discharge was chosen as the outcome of interest for this thesis as it is
clearly deﬁned, well-recorded and of the utmost clinical importance. Very preterm birth
and subsequent mortality is, fortunately, relatively rare in the UK, meaning that there
is little power to determine with certainty whether the mortality at an individual NNU
is particularly high or low. In section 1.1 I mentioned other adverse consequences of
preterm birth. Of these bronchopulmonary dysplasia (BPD) is well-deﬁned and recorded
in the NNRD, occurs with higher frequency, and aﬀects infants born at later gestations
(32 to 37 weeks) who form the majority of the preterm population. Daily data on
the type of respiratory support received by each infant is well-recorded in the NNRD,
so could be used to inform the MM weights. A UK-wide survey regarding neonatal
resuscitation practices by Mann et al. (2012) revealed variations in clinical management,
particularly by NNU level. If there are speciﬁc policies which are of interest, these could
be considered for inclusion as provider-level variables. Examination of BPD using the
methods developed in this thesis may help determine if such variations have clinical
consequences.
The NNRD is being employed more extensively beyond service evaluations, audits
and commissioned studies. Of particular note is ongoing research into using the NNRD
for clinical trials (Gale et al., 2016a). While the focus is not on estimating random
eﬀects as in this thesis, appropriate handling of dependence is required for unbiased
and accurate estimation of treatment eﬀects. The methods used in this thesis may have
applications in the analysis of multi-centre trials using the NNRD. Utilising routinely
collected health data for pragmatic trials is growing in popularity due to the gains in
eﬃciency it can bring to the extent that trials which would otherwise be too costly and
too much of a burden to run become feasible. These types of data are often collected in
settings with complex patient pathways (e.g. GP referrals, multiple hospital episodes)
so there could be uses outside neonatal medicine as well.
There is growing evidence of the beneﬁts of focussing resources at a few key specialist
centres rather than attempting to oﬀer all services at all providers (centralisation).
Coupled with increasing costs and higher technology of medical care and eﬃciency drives
putting pressure on public services, it is not surprising that networked models with
diﬀerent categories of provider are being advocated as the solution. In April 2013, the
UK Department of Health launched a new system of networks across variety of clinical
areas, neonatal care being one. Known as Operational Delivery Networks (ODNs), these
15 geographically deﬁned networks were applied to existing networked specialisms with
the potential for extension to other areas (NHS Commissioning Board, 2012). I chose to
consider only the managed clinical network system because most of the data analysed
were prior to the introduction of ODNs in April 2013, and even though they technically
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came into being on this date, new systems take some time to embed. Despite managed
clinical networks now being obsolete, the methods in this thesis will be applicable to
the new ODNs for neonatal care and transferable to other clinical areas. Currently
adult critical care, burns and major trauma are already delivered via networks in the
UK NHS, and similar models are being considered for adult congenital heart disease,
paediatric congenital cardiac surgery and paediatric neuroscience (NHS Commissioning
Board, 2012).
9.6 Conclusion
This thesis has achieved the aim of developing methods to evaluate risk-adjusted mor-
tality of preterm infants across networked NNUs in England using electronic patient
records. In doing so, methodological contributions have been made regarding a novel
way of specifying MM weightings, and new ﬁndings relating to the impact of misspeci-
ﬁed weights on random eﬀects. The thesis lays the foundations for future development
to enable application of the methods to multiple births and for investigating challenges
regarding the causal determinants of location of care. Practical implications could ex-
tend beyond neonatal medicine as centralisation, monitoring of clinical outcomes and
electronic patient data become more integral to improving healthcare.
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Appendix A
List of neonatal units included in
the thesis
The table below lists all the neonatal units (NNUs) in England with at least one ad-
mission of an infant born below 32 weeks gestation between 2011 and 2013 included in
the National Neonatal Research Database (NNRD) and therefore included in this thesis.
Note that some NNUs did not contribute data for the whole period due to closures and
mergers. NNUs are grouped by neonatal network, and the level of NNU (special care
baby unit (SCBU), local neonatal unit (LNU) and neonatal intensive care unit (NICU),
see section 1.2 for a description of these classiﬁcations).
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Table A.1: Neonatal units contributing data to the National Neonatal Research Database
and included in the thesis (continues to table A.2)
Neonatal network Neonatal Unit Level
Bedfordshire and Hertfordshire Bedford Hospital SCBU
Queen Elizabeth II Hospital SCBU
Watford General Hospital LNU
Lister Hospital LNU
Luton & Dunstable Hospital NICU
Cheshire and Merseyside Whiston Hospital LNU
Leighton Hospital LNU
Macclesﬁeld District General Hospital LNU
Countess Of Chester Hospital LNU
Ormskirk District General Hospital LNU
Warrington Hospital LNU
Arrowe Park Hospital NICU
Liverpool Women’s Hospital NICU
Eastern James Paget Hospital SCBU
West Suﬀolk Hospital SCBU
Hinchingbrooke Hospital SCBU
Queen Elizabeth Hospital, King’s Lynn LNU
Colchester General Hospital LNU
Peterborough City Hospital LNU
Ipswich Hospital LNU
Princess Alexandra Hospital LNU
Broomﬁeld Hospital LNU
Rosie Maternity Hospital, Addenbrookes NICU
Norfolk & Norwich University Hospital NICU
Greater Manchester University Hospital Of South Manchester LNU
Tameside General Hospital LNU
Royal Albert Edward Inﬁrmary LNU
Fairﬁeld General Hospital LNU
Rochdale Inﬁrmary LNU
North Manchester General Hospital LNU
Stepping Hill Hospital LNU
Salford Royal Hospital NICU
Royal Bolton Hospital NICU
Royal Oldham Hospital NICU
St Mary’s Hospital, Manchester NICU
Kent Darent Valley Hospital SCBU
Maidstone General Hospital SCBU
Queen Elizabeth The Queen Mother Hospital SCBU
Tunbridge Wells Hospital LNU
Medway Maritime Hospital NICU
William Harvey Hospital NICU
Lancashire and South Cumbria Furness General Hospital SCBU
Royal Lancaster Inﬁrmary LNU
Victoria Hospital, Blackpool LNU
Royal Preston Hospital NICU
Lancashire Women & Newborn Centre NICU
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Table A.2: Neonatal units contributing data to the National Neonatal Research
Database and included in the thesis (continued from table A.1)
Neonatal network Neonatal Unit Level
London - North Central The Royal Free Hospital SCBU
Chase Farm Hospital SCBU
Barnet Hospital LNU
Whittington Hospital LNU
University College Hospital NICU
London - North East King George Hospital SCBU
Southend Hospital LNU
Basildon Hospital LNU
North Middlesex University Hospital LNU
Queen’s Hospital, Romford LNU
Whipps Cross University Hospital LNU
Newham General Hospital LNU
The Royal London Hospital - Constance Green NICU
The Royal London Hospital NICU
Homerton Hospital NICU
London - North West Ealing Hospital SCBU
West Middlesex University Hospital SCBU
Hillingdon Hospital LNU
Northwick Park Hospital LNU
St Mary’s Hospital, London LNU
Chelsea & Westminster Hospital NICU
Queen Charlotte’s Hospital NICU
London - South East Princess Royal University Hospital SCBU
Queen Elizabeth Hospital, Woolwich LNU
University Hospital Lewisham LNU
Guy’s & St Thomas’ Hospital NICU
King’s College Hospital NICU
London - South West Epsom General Hospital SCBU
Croydon University Hospital LNU
Kingston Hospital LNU
St Helier Hospital LNU
St George’s Hospital NICU
Midlands - Central Warwick Hospital SCBU
Queen’s Hospital, Burton On Trent SCBU
George Eliot Hospital SCBU
Kettering General Hospital LNU
Northampton General Hospital LNU
University Hospital Coventry NICU
Leicester Neonatal Service NICU
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Table A.3: Neonatal units contributing data to the National Neonatal Research
Database and included in the thesis (continued from table A.2)
Neonatal network Neonatal Unit Level
Midlands - South West Good Hope Hospital SCBU
Alexandra Hospital SCBU
Hereford County Hospital SCBU
Worcestershire Royal Hospital LNU
City Hospital, Birmingham LNU
Birmingham Women’s Hospital NICU
Birmingham Heartlands Hospital NICU
Midlands North SSBC County Hospital, Staﬀordshire SCBU
Manor Hospital LNU
Russells Hall Hospital LNU
Royal Shrewsbury Hospital LNU
University Hospital Of North Staﬀordshire NICU
New Cross Hospital NICU
North Trent Bassetlaw District General Hospital SCBU
Barnsley District General Hospital LNU
Rotherham District General Hospital LNU
Chesterﬁeld & North Derbyshire Royal Hospital LNU
Doncaster Royal Inﬁrmary LNU
Diana Princess Of Wales Hospital LNU
Scunthorpe General Hospital LNU
The Jessop Wing, Sheﬃeld NICU
Northern South Tyneside District Hospital SCBU
Queen Elizabeth Hospital, Gateshead SCBU
Wansbeck General Hospital SCBU
Darlington Memorial Hospital SCBU
Cumberland Inﬁrmary SCBU
West Cumberland Hospital SCBU
University Hospital Of North Durham SCBU
Sunderland Royal Hospital NICU
Royal Victoria Inﬁrmary NICU
James Cook University Hospital NICU
University Hospital Of North Tees NICU
Peninsula - South West Torbay Hospital SCBU
North Devon District Hospital SCBU
Royal Devon & Exeter Hospital LNU
Royal Cornwall Hospital LNU
Derriford Hospital NICU
* Midlands North, Staﬀordshire, Shropshire and Black Country
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Table A.4: Neonatal units contributing data to the National Neonatal Research
Database and included in the thesis (continued from table A.3)
Neonatal network Neonatal Unit Level
South Central (North) Horton Hospital SCBU
Wexham Park Hospital LNU
Milton Keynes Hospital LNU
Royal Berkshire Hospital LNU
Stoke Mandeville Hospital LNU
John Radcliﬀe Hospital NICU
South Central (South) Dorset County Hospital LNU
Poole Hospital LNU
Royal Hampshire County Hospital LNU
Basingstoke & North Hampshire Hospital LNU
Salisbury District Hospital LNU
St Richard’s Hospital LNU
St Mary’s Hospital, Isle of Wight LNU
Princess Anne Hospital NICU
Queen Alexandra Hospital NICU
Surrey and Sussex Royal Surrey County Hospital SCBU
Frimley Park Hospital SCBU
Worthing Hospital SCBU
Princess Royal Hospital SCBU
Conquest Hospital SCBU
Eastbourne District General Hospital SCBU
East Surrey Hospital LNU
St Peter’s Hospital NICU
Royal Sussex County Hospital NICU
Trent Pilgrim Hospital SCBU
Lincoln County Hospital LNU
King’s Mill Hospital LNU
Royal Derby Hospital LNU
Nottingham City Hospital NICU
Nottingham University Hospital NICU
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Table A.5: Neonatal units contributing data to the National
Neonatal Research Database and included in the thesis (con-
tinued from table A.4)
Neonatal network Neonatal Unit Level
Western Yeovil District Hospital SCBU
Taunton & Somerset Hospital LNU
Royal United Hospital LNU
Great Western Hospital LNU
Gloucestershire Royal Hospital LNU
St Michael’s Hospital NICU
Southmead Hospital NICU
Yorkshire Scarborough General Hospital SCBU
Harrogate District Hospital SCBU
Dewsbury & District Hospital SCBU
York District Hospital LNU
Airedale General Hospital LNU
Pinderﬁelds General Hospital LNU
Calderdale Royal Hospital LNU
Bradford Royal Inﬁrmary NICU
Leeds Neonatal Service NICU
Hull Royal Inﬁrmary NICU
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Appendix B
Updating the search to identify
risk factors for mortality of
preterm infants
Medlock et al. (2011) carried out a systematic review of prediction models for mortality
of preterm infants, one of the aims of which was to identify important predictor variables.
As described in section 3.3.1, I selected infant risk factors to adjust for in the thesis based
on the ﬁndings of the review. The authors searched the MedLine database for studies
which provided mortality predictions for infants less than 32 weeks gestation and/or less
than 1500g birth weight, or subpopulations of this group provided they did not have a
speciﬁc disease or condition. Full methods for the study and the resulting papers can be
found in the published paper. I updated the search using the same search strategy as
there may have been further developments since publication of the study. The resulting
studies, including a brief description and the variables included are shown in tables B.1
and B.2. All variables included in prediction models of the studies in tables B.1 and B.2
were either already considered by Medlock et al., or only appeared in one or two studies
so were not considered further.
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Appendix D
OpenBUGS model code
This appendix contains the OpenBUGSOpenBUGS Project Management Group (2014)
code to specify the six single membership Bayesian hierarchical models and the multiple
membership model described in chapter 5. Note that in OpenBUGS distributions are
speciﬁed in terms of the precision, which is the inverse of the variance. In addition all
regression coeﬃcients were speciﬁed in the code in a single vector beta for convenience,
rahter than using than using separate Greek letters for the intercept, infant, and NNU
characteristics as described in chapter 5. Calculation of the weights for the multiple
membership models was performed outside of OpenBUGS and separate data ﬁles created
for each weighting with the same names, so the same code could be used to run the
analysis for all weights.
###########################################################
################ Model 1 ##################
###########################################################
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2]*ga1[i] + beta[3]*ga2[i] +
beta[4]*bwt1[i] + beta[5]*bwt2[i] +
beta[6]*ga1bwt1[i] + beta[7]*ga1bwt2[i] +
beta[8]*bwt1ga2[i] +
beta[9]*male[i] + beta[10]*steroids[i] +
u[unit[i]]
}
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for (i in 1:10) {
beta[i] ∼ dnorm(0,0.00001)
}
for (j in 1:J) {
u[j] ∼ dnorm(beta[1], tau.u)
du[j]<-u[j]-beta[1]
}
tau.u<-1/(sigma2.u)
sigma2.u<-pow(sigma.u,2)
sigma.u ∼ dunif(0,5)
}
###########################################################
################ Model 2 ##################
###########################################################
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2]*ga1[i] + beta[3]*ga2[i] +
beta[4]*bwt1[i] + beta[5]*bwt2[i] +
beta[6]*ga1bwt1[i] + beta[7]*ga1bwt2[i] +
beta[8]*bwt1ga2[i] +
beta[9]*male[i] + beta[10]*steroids[i] +
u[unit[i]]
}
for (i in 1:12) {
beta[i] ∼ dnorm(0,0.00001)
}
for (j in 1:J) {
u[j] ∼ dnorm(mu[j], tau.u)
mu[j]<-beta[1] + beta[11]*level1[j] + beta[12]*level3[j]
du[j]<-u[j]-mu[j]
}
tau.u<-1/(sigma2.u)
sigma2.u<-pow(sigma.u,2)
sigma.u ∼ dunif(0,5)
}
###########################################################
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################ Model 3 ##################
###########################################################
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2]*ga1[i] + beta[3]*ga2[i] +
beta[4]*bwt1[i] + beta[5]*bwt2[i] +
beta[6]*ga1bwt1[i] + beta[7]*ga1bwt2[i] +
beta[8]*bwt1ga2[i] +
beta[9]*male[i] + beta[10]*steroids[i] +
u[unit[i]]
}
for (i in 1:12) {
beta[i] ∼ dnorm(0,0.00001)
}
for (j in 1:J) {
u[j] ∼ dnorm(mu[j], tau.u[level[j]])
mu[j]<-beta[1] + beta[11]*level1[j] + beta[12]*level3[j]
du[j]<-u[j]-mu[j]
}
for (m in 1:3) {
tau.u[m] <- 1/(sigma2.u[m])
sigma2.u[m] <- pow(sigma.u[m], 2)
sigma.u[m] ∼ dunif(0, 5)
}
}
###########################################################
################ Model 4 ##################
###########################################################
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2]*ga1[i] + beta[3]*ga2[i] +
beta[4]*bwt1[i] + beta[5]*bwt2[i] +
beta[6]*ga1bwt1[i] + beta[7]*ga1bwt2[i] +
beta[8]*bwt1ga2[i] +
beta[9]*male[i] + beta[10]*steroids[i] +
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u[unit[i]]
}
for (i in 1:10) {
beta[i] ∼ dnorm(0,0.00001)
}
for (j in 1:J) {
u[j] ∼ dnorm(mu[j], tau.u)
mu[j] <- v[network[j]]
du[j]<-u[j]-mu[j]
}
for (k in 1:K) {
v[k] ∼ dnorm(beta[1], tau.v)
dv[k] <- v[k] - beta[1]
}
tau.u<-1/(sigma2.u)
sigma2.u<-pow(sigma.u,2)
sigma.u ∼ dunif(0,5)
tau.v <- 1/(sigma2.v)
sigma2.v <- pow(sigma.v, 2)
sigma.v ∼ dunif(0, 5)
}
###########################################################
################ Model 5 ##################
###########################################################
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2]*ga1[i] + beta[3]*ga2[i] +
beta[4]*bwt1[i] + beta[5]*bwt2[i] +
beta[6]*ga1bwt1[i] + beta[7]*ga1bwt2[i] +
beta[8]*bwt1ga2[i] +
beta[9]*male[i] + beta[10]*steroids[i] +
u[unit[i]]
}
for (i in 1:12) {
beta[i] ∼ dnorm(0,0.00001)
}
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for (j in 1:J) {
u[j] ∼ dnorm(mu[j], tau.u)
mu[j] <- v[network[j]] + beta[11]*level1[j] + beta[12]*level3[j]
du[j]<-u[j]-mu[j]
}
for (k in 1:K) {
v[k] ∼ dnorm(beta[1], tau.v)
dv[k] <- v[k] - beta[1]
}
tau.u<-1/(sigma2.u)
sigma2.u<-pow(sigma.u,2)
sigma.u ∼ dunif(0,5)
tau.v <- 1/(sigma2.v)
sigma2.v <- pow(sigma.v, 2)
sigma.v ∼ dunif(0, 5)
}
###########################################################
################ Model 6 ##################
###########################################################
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2]*ga1[i] + beta[3]*ga2[i] +
beta[4]*bwt1[i] + beta[5]*bwt2[i] +
beta[6]*ga1bwt1[i] + beta[7]*ga1bwt2[i] +
beta[8]*bwt1ga2[i] +
beta[9]*male[i] + beta[10]*steroids[i] +
u[unit[i]]
}
for (i in 1:12) {
beta[i] ∼ dnorm(0,0.00001)
}
for (j in 1:J) {
u[j] ∼ dnorm(mu[j], tau.u[level[j]])
mu[j] <- v[network[j]] + beta[11]*level1[j] + beta[12]*level3[j]
du[j]<-u[j]-mu[j]
}
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for (k in 1:K) {
v[k] ∼ dnorm(beta[1], tau.v)
dv[k] <- v[k] - beta[1]
}
for (m in 1:3) {
tau.u[m] <- 1/(sigma2.u[m])
sigma2.u[m] <- pow(sigma.u[m], 2)
sigma.u[m] ∼ dunif(0, 5)
}
tau.v <- 1/(sigma2.v)
sigma2.v <- pow(sigma.v, 2)
sigma.v ∼ dunif(0, 5)
}
#######################################################################
############# Multiple membership (MM) model ################
#######################################################################
# wt[i,j] is the multiple membership weight assigned to unit[i,j]
# the jth neonatal unit that the ith infant is in
# if an infant is cared for by t different neonatal units
# then wt[i,j]=0 for all j>t
# and unit[i,j]=170 for all j>t
# where u[170] is assigned a value of 0
# and does not contribute to the estimation of sigma.u
# as J=169
model{
for (i in 1:N) {
died[i] ∼ dbern(p[i])
logit(p[i]) <- beta[2] * ga1[i] + beta[3] * ga2[i] +
beta[4] * bwt1[i] + beta[5] * bwt2[i] + beta[6] *
ga1bwt1[i] + beta[7] * ga1bwt2[i] + beta[8] * bwt1ga2[i] +
beta[9] * male[i] + beta[10] * steroids[i] +
wt[i,1] * u[unit[i,1]] + wt[i,2] * u[unit[i,2]] +
wt[i,3] * u[unit[i,3]] + wt[i,4] * u[unit[i,4]] +
wt[i,5] * u[unit[i,5]] + wt[i,6] * u[unit[i,6]] +
wt[i,7] * u[unit[i,7]] + wt[i,8] * u[unit[i,8]] +
wt[i,9] * u[unit[i,9]] + wt[i,10] * u[unit[i,10]] +
wt[i,11] * u[unit[i,11]] + wt[i,12] * u[unit[i,12]]
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}u[170] <- 0
for (i in 1:12) {
beta[i] ∼ dnorm(0, 0.00001)
}
for (j in 1:J) {
u[j] ∼ dnorm(mu[j], tau.u[j])
mu[j] <- v[network[j]] + beta[11] * level1[j] + beta[12] * level3[j]
du[j] <- u[j] - mu[j]
tau.u[j] ∼ dgamma(2, sigma2.u)
}
for (k in 1:K) {
v[k] ∼ dnorm(beta[1], tau.v)
dv[k] <- v[k] - beta[1]
}
sigma2.u <- pow(sigma.u, 2)
sigma.u ∼ dunif(0, 5)
tau.v <- 1/(sigma2.v)
sigma2.v <- pow(sigma.v, 2)
sigma.v ∼ dunif(0, 5)
}
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Appendix E
Additional results for chapter 6
E.1 Convergence statistics
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Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Intercept 0.0081 0.0082 0.0101 0.0091 0.0087 0.0103
GA(1) 0.0083 0.0084 0.0096 0.0091 0.0083 0.0097
GA(2) 0.0077 0.0078 0.0088 0.0082 0.0078 0.0090
BWT 0.0020 0.0020 0.0021 0.0019 0.0018 0.0020
BWT2 0.0009 0.0009 0.0009 0.0009 0.0008 0.0009
GA(1)× BWT 0.0072 0.0074 0.0082 0.0076 0.0071 0.0082
GA(1)× BWT2 0.0012 0.0012 0.0013 0.0012 0.0011 0.0013
BWT × GA(2) 0.0040 0.0041 0.0044 0.0040 0.0038 0.0043
Male 0.0004 0.0004 0.0004 0.0004 0.0004 0.0004
Steroids 0.0011 0.0011 0.0011 0.0010 0.0009 0.0010
SCBU 0.0040 0.0042 0.0045 0.0025
NICU 0.0010 0.0010 0.0012 0.0009
σu 0.0016 0.0017 0.0022 0.0030
σuSCBU 0.0132 0.0056
σuLNU 0.0055 0.0024
σuNICU 0.0012 0.0013
σv 0.0014 0.0014 0.0015
u2 0.0007 0.0007 0.0013 0.0005 0.0005 0.0010
u92 0.0006 0.0006 0.0007 0.0005 0.0006 0.0006
u20 0.0004 0.0005 0.0005 0.0004 0.0005 0.0008
u73 0.0005 0.0004 0.0004 0.0005 0.0004 0.0007
u33 0.0007 0.0007 0.0013 0.0005 0.0004 0.0010
u136 0.0008 0.0010 0.0009 0.0010 0.0013 0.0012
u113 0.0007 0.0007 0.0008 0.0006 0.0005 0.0004
u137 0.0006 0.0006 0.0006 0.0005 0.0004 0.0004
u16 0.0005 0.0005 0.0005 0.0004 0.0004 0.0003
u48 0.0011 0.0009 0.0008 0.0014 0.0012 0.0012
v11 0.0007 0.0009 0.0013
v1 0.0023 0.0030 0.0032
v19 0.0021 0.0023 0.0027
v3 0.0006 0.0010 0.0014
v7 0.0020 0.0022 0.0025
Table E.1: Monte Carlo standard errors (log scale), t-4 NNU eﬀects U(0,5) prior
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Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Intercept 865 878 515 677 706 566
GA(1) 1291 1285 906 1031 1160 931
GA(2) 1167 1128 818 962 1015 835
BWT 4507 4761 4232 4842 5710 4561
BWT2 3976 4059 3768 4114 4972 4024
GA(1)× BWT 1659 1601 1196 1416 1558 1250
GA(1)× BWT2 3376 3316 2824 3353 3733 3050
BWT × GA(2) 2672 2630 2146 2584 2855 2308
Male 37706 39115 39303 44401 52727 44373
Steroids 10154 10116 9894 11335 13635 10860
SCBU 3942 4063 3181 13366
NICU 13451 14042 8642 15726
σu 2392 2172 1597 1062
σuSCBU 878 4175
σuLNU 696 2381
σuNICU 6835 6085
σv 4311 4336 3756
u2 312781 296587 218904 395850 387862 400907
u92 290541 257562 140939 358097 204439 115175
u20 283826 204975 228915 275823 161207 98014
u73 193038 284874 279508 147112 214424 99200
u33 297684 286962 197225 389244 397215 394943
u136 98818 70792 101813 59569 29812 43980
u113 230422 246170 137244 280005 286649 273890
u137 247345 273651 178654 265479 322956 252073
u16 291009 282524 272352 391209 399583 403285
u48 54920 66718 92157 28051 27645 38030
v11 39095 27255 12779
v1 9044 7026 5757
v19 8008 7406 5397
v3 45632 24568 11461
v7 7808 6906 5802
Table E.2: Estimated sample size, t-4 NNU eﬀects U(0,5) prior
288
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Intercept 0.0078 0.0077 0.0105 0.0094 0.0096 0.0118
GA(1) 0.0078 0.0081 0.0104 0.0097 0.0095 0.0109
GA(2) 0.0073 0.0074 0.0096 0.0088 0.0088 0.0102
BWT 0.0021 0.0021 0.0024 0.0022 0.0021 0.0022
BWT2 0.0009 0.0010 0.0011 0.0010 0.0010 0.0010
GA(1)× BWT 0.0069 0.0070 0.0091 0.0081 0.0082 0.0091
GA(1)× BWT2 0.0012 0.0012 0.0015 0.0013 0.0013 0.0014
BWT × GA(2) 0.0040 0.0040 0.0050 0.0045 0.0044 0.0047
Male 0.0005 0.0005 0.0005 0.0004 0.0004 0.0004
Steroids 0.0012 0.0011 0.0013 0.0012 0.0011 0.0011
SCBU 0.0038 0.0037 0.0042 0.0028
NICU 0.0009 0.0009 0.0011 0.0010
σu 0.0006 0.0007 0.0013 0.0023
σuSCBU 0.0073 0.0066
σuLNU 0.0035 0.0028
σuNICU 0.0005 0.0016
σv 0.0014 0.0015 0.0018
u2 0.0008 0.0008 0.0013 0.0005 0.0005 0.0012
u92 0.0007 0.0007 0.0008 0.0005 0.0006 0.0007
u20 0.0006 0.0006 0.0006 0.0005 0.0006 0.0009
u73 0.0005 0.0005 0.0005 0.0006 0.0005 0.0008
u33 0.0008 0.0008 0.0014 0.0006 0.0005 0.0012
u136 0.0007 0.0008 0.0007 0.0010 0.0014 0.0014
u113 0.0008 0.0008 0.0007 0.0005 0.0005 0.0005
u137 0.0007 0.0007 0.0006 0.0006 0.0005 0.0005
u16 0.0007 0.0007 0.0005 0.0005 0.0004 0.0004
u48 0.0008 0.0007 0.0007 0.0013 0.0014 0.0014
v11 0.0006 0.0008 0.0015
v1 0.0025 0.0031 0.0038
v19 0.0020 0.0025 0.0031
v3 0.0006 0.0011 0.0015
v7 0.0020 0.0023 0.0029
Table E.3: Monte Carlo standard errors (log scale), Normal NNU eﬀects U(0,5) prior
289
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Intercept 878 937 503 664 637 429
GA(1) 1358 1274 787 943 948 728
GA(2) 1228 1173 707 879 855 639
BWT 4290 4186 3122 3689 4059 3724
BWT2 3918 3712 2693 3342 3577 3290
GA(1)× BWT 1688 1640 1006 1280 1236 992
GA(1)× BWT2 3171 3112 2198 2741 2772 2487
BWT × GA(2) 2625 2569 1690 2094 2159 1873
Male 30246 30528 26295 34599 36194 34763
Steroids 8519 9114 6896 8727 9554 8889
SCBU 4634 5692 3662 10408
NICU 15448 16122 10203 11625
σu 9878 8515 3595 1692
σuSCBU 2209 3035
σuLNU 1445 1849
σuNICU 29217 4521
σv 4237 4122 2846
u2 199554 200000 200444 300000 301398 297911
u92 200000 193033 104718 296965 169643 88661
u20 191586 195101 197967 240791 135528 73262
u73 179632 197951 198701 122319 182185 75061
u33 200924 200000 184253 295539 298882 298990
u136 142010 112736 157502 61953 26201 33248
u113 196879 197542 159454 292066 281036 216328
u137 191764 198989 147763 257337 261345 187555
u16 200000 200000 204813 309626 309894 300695
u48 99161 104933 152402 33126 23128 28133
v11 49605 28511 9476
v1 8185 6188 4154
v19 8607 6453 4159
v3 47745 21032 9676
v7 7716 6363 4228
Table E.4: Estimated sample size, Normal NNU eﬀects U(0,5) prior
290
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Intercept 0.0083 0.0081 0.0107 0.0086 0.0098 0.0124
GA(1) 0.0089 0.0085 0.0107 0.0088 0.0098 0.0115
GA(2) 0.0082 0.0079 0.0099 0.0080 0.0091 0.0107
BWT 0.0022 0.0022 0.0024 0.0020 0.0021 0.0023
BWT2 0.0010 0.0010 0.0011 0.0009 0.0010 0.0011
GA(1)× BWT 0.0076 0.0075 0.0092 0.0075 0.0083 0.0097
GA(1)× BWT2 0.0013 0.0013 0.0015 0.0012 0.0013 0.0015
BWT × GA(2) 0.0044 0.0043 0.0050 0.0041 0.0045 0.0050
Male 0.0005 0.0005 0.0005 0.0004 0.0004 0.0004
Steroids 0.0012 0.0012 0.0013 0.0010 0.0011 0.0012
SCBU 0.0039 0.0040 0.0044 0.0033
NICU 0.0010 0.0009 0.0011 0.0010
σu 0.0006 0.0007 0.0014 0.0021
σuSCBU 0.0079 0.0064
σuLNU 0.0032 0.0030
σuNICU 0.0005 0.0015
σv 0.0015 0.0014 0.0019
u2 0.0008 0.0008 0.0014 0.0005 0.0005 0.0012
u92 0.0007 0.0007 0.0008 0.0005 0.0006 0.0007
u20 0.0006 0.0006 0.0006 0.0005 0.0006 0.0009
u73 0.0005 0.0005 0.0005 0.0006 0.0005 0.0008
u33 0.0008 0.0008 0.0013 0.0006 0.0005 0.0012
u136 0.0007 0.0008 0.0007 0.0010 0.0014 0.0014
u113 0.0008 0.0008 0.0007 0.0005 0.0005 0.0004
u137 0.0007 0.0007 0.0006 0.0006 0.0005 0.0004
u16 0.0007 0.0007 0.0005 0.0005 0.0004 0.0003
u48 0.0008 0.0008 0.0007 0.0014 0.0014 0.0014
v11 0.0007 0.0009 0.0017
v1 0.0026 0.0032 0.0040
v19 0.0021 0.0023 0.0034
v3 0.0006 0.0011 0.0017
v7 0.0022 0.0022 0.0032
Table E.5: Monte Carlo standard errors (log scale), Normal NNU eﬀects U(0,100) prior
291
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Intercept 822 885 504 719 637 401
GA(1) 1115 1216 765 1075 923 678
GA(2) 1033 1079 693 989 811 603
BWT 3680 3759 3158 4547 4144 3451
BWT2 3342 3389 2694 3937 3482 3118
GA(1)× BWT 1458 1472 998 1425 1219 925
GA(1)× BWT2 2751 2843 2077 3233 2706 2316
BWT × GA(2) 2234 2271 1674 2503 2140 1731
Male 25907 27542 26670 39137 34753 32919
Steroids 7574 7830 6929 10526 9310 8746
SCBU 4469 4746 3511 7628
NICU 14869 14968 10025 13034
σu 9540 8483 3502 1849
σuSCBU 1949 3258
σuLNU 1578 1603
σuNICU 27644 4528
σv 3804 4424 2495
u2 200000 200000 187926 300000 302722 289837
u92 197768 197885 110166 269540 182215 93709
u20 193948 189542 193367 229149 138555 74440
u73 175922 195614 198939 116461 186212 71457
u33 199246 200000 192154 297456 296303 294024
u136 146421 115517 158498 54303 27863 30956
u113 196856 200000 137589 296778 267938 241452
u137 197265 190255 154809 254033 281820 214390
u16 200000 196258 199290 305941 301670 304090
u48 96096 105241 146491 30497 24942 28964
v11 42256 26321 7612
v1 7172 6266 3683
v19 7673 7147 3439
v3 47587 22076 8023
v7 6627 7052 3561
Table E.6: Estimated sample size, Normal NNU eﬀects U(0,100) prior
292
E.2 Sensitivity analysis with alternative assumptions for
NNU eﬀects
E.2.1 Normal distribution for NNU eﬀects
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DIC Deviance Eﬀective parameters
Model 1 4728.00 4676.00 52.37
Model 2 4727.00 4675.00 51.97
Model 3 4728.00 4677.00 51.76
Model 4 4729.00 4678.00 50.66
Model 5 4726.00 4679.00 47.68
Model 6 4726.00 4675.00 51.62
Table E.8: Model performance, Normal NNU eﬀects U(0,5) prior
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Figure E.1: Posterior distribution provider SD terms, Normal NNU eﬀects, U(0,5) prior
for σu. Models 1-6 shown in ﬁgures (a) to (f)
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Figure E.2: Correlation of NNU eﬀects across models, Normal distribution for NNU
eﬀects with U(0,5) prior for σu
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E.2.2 Caterpillar plots for Normal NNU eﬀects
298
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
●●
●●
●●
●●
●●
●●
●●
●
●
●
●
●
●●
●●
●●
●●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
● ●
32
19
1
64
45
141
159
125
17
135
106
40
87
18
117
128
22
95
77
129
2
33
93
65
153
47
134
96
100
42
23
119
142
50
154
110
62
152
4
−2 −1 0 1 2
Log OR
N
N
U
●
●
●
●
●
●
Model 1
Model 2
Model 3
Model 4
Model 5
Model 6
Figure E.3: Caterpillar plot for SCBU, showing smallest and largest eﬀects across mod-
els, Normal NNU eﬀects
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Figure E.4: Caterpillar plot for LNU, showing smallest and largest eﬀects across models,
Normal NNU eﬀects
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Figure E.5: Caterpillar plot for NICU, showing smallest and largest eﬀects across models,
Normal NNU eﬀects
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Figure E.6: Caterpillar plot for networks, showing smallest and largest eﬀects across
models, Normal NNU eﬀects
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E.2.3 U(0,100) prior for the standard deviation of NNU eﬀects
DIC Deviance Eﬀective parameters
Model 1 4728.00 4676.00 52.38
Model 2 4727.00 4675.00 52.17
Model 3 4728.00 4677.00 51.71
Model 4 4729.00 4678.00 50.54
Model 5 4726.00 4678.00 47.88
Model 6 4726.00 4675.00 51.24
Table E.9: Model performance, Normal NNU eﬀects U(0,100) prior
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Figure E.7: Posterior distribution provider SD terms, Normal NNU eﬀects, U(0,100)
prior for σu. Models 1-6 shown in ﬁgures (a) to (f)
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Figure E.8: Correlation of NNU eﬀects across models, Normal distribution for NNU
eﬀects with U(0,100) prior for σu
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Appendix F
Additional results for chapter 7
F.1 Convergence statistics
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Equal LOS Beta2 Beta3 WLOS First
Intercept 0.0064 0.0063 0.0080 0.0076 0.0064 0.0091
GA(1) 0.0067 0.0066 0.0082 0.0080 0.0067 0.0093
GA(2) 0.0063 0.0061 0.0078 0.0076 0.0062 0.0089
BWT 0.0013 0.0013 0.0015 0.0014 0.0013 0.0014
BWT2 9e-04 9e-04 0.0011 0.0010 9e-04 0.0011
GA(1)× BWT 0.0061 0.0060 0.0074 0.0072 0.0061 0.0080
GA(1)× BWT2 0.0010 0.0010 0.0012 0.0011 0.0010 0.0012
BWT × GA(2) 0.0034 0.0034 0.0041 0.0038 0.0034 0.0040
Male 2e-04 3e-04 3e-04 2e-04 2e-04 3e-04
Steroids 6e-04 6e-04 7e-04 6e-04 6e-04 6e-04
SCBU 0.0036 0.0040 0.0051 0.0055 0.0051 0.0029
NICU 0.0011 0.0010 0.0011 0.0013 0.0011 0.0011
σu 0.0026 0.0022 0.0025 0.0034 0.0020 0.0029
σv 7e-04 7e-04 6e-04 7e-04 6e-04 7e-04
u2 7e-04 7e-04 4e-04 4e-04 5e-04 5e-04
u92 6e-04 8e-04 6e-04 5e-04 6e-04 3e-04
u20 0.0010 9e-04 7e-04 8e-04 9e-04 4e-04
u73 4e-04 5e-04 3e-04 3e-04 4e-04 2e-04
u33 4e-04 6e-04 5e-04 6e-04 6e-04 3e-04
u136 4e-04 5e-04 4e-04 4e-04 4e-04 4e-04
u113 5e-04 5e-04 3e-04 3e-04 4e-04 3e-04
u137 0.0015 0.0015 0.0012 0.0012 0.0013 0.0011
u16 6e-04 7e-04 6e-04 5e-04 6e-04 3e-04
u48 6e-04 6e-04 7e-04 9e-04 5e-04 4e-04
v11 7e-04 7e-04 8e-04 0.0010 7e-04 0.0012
v1 9e-04 8e-04 0.0010 0.0013 8e-04 0.0013
v19 0.0012 0.0011 0.0013 0.0015 0.0012 0.0016
v3 9e-04 8e-04 9e-04 0.0011 8e-04 0.0012
v7 0.0010 9e-04 9e-04 9e-04 8e-04 0.0011
Table F.1: Monte Carlo standard errors (log scale) for multiple membership models
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Equal LOS Beta2 Beta3 WLOS First
Intercept 955 1066 679 619 944 412
GA(1) 1380 1531 1031 985 1422 692
GA(2) 1218 1374 887 825 1271 587
BWT 7676 7341 5921 6512 7396 6235
BWT2 3762 3864 2836 3079 3788 2648
GA(1)× BWT 1822 1978 1337 1315 1854 1037
GA(1)× BWT2 3829 3851 2802 3075 3734 2755
BWT × GA(2) 3021 3097 2227 2333 2963 2126
Male 64569 62972 58166 63755 68063 57866
Steroids 18654 16929 13618 15438 17765 15723
SCBU 3458 3804 2147 1652 2516 2160
NICU 8703 11945 8279 5574 9652 5139
σu 1137 1580 981 639 1526 577
σv 9524 12129 13605 9607 14159 6309
u2 181593 236928 307950 317821 271984 94099
u92 229044 170276 168431 183368 208445 341133
u20 69312 104431 100132 64542 96170 122916
u73 322773 295824 329010 335330 317608 346927
u33 270971 206875 177845 108229 181442 194784
u136 224215 251526 266534 194300 250006 85895
u113 202599 298810 341805 350129 320472 277596
u137 26853 33833 31374 22738 36045 18172
u16 177999 167622 133561 130977 175351 195291
u48 132384 182358 77586 42446 205097 96233
v11 38524 44563 28093 17673 38146 9410
v1 34177 49453 29150 16206 40590 12276
v19 18868 24588 17180 11004 21531 7457
v3 27069 36982 23911 13847 31185 9394
v7 21465 29860 27849 21211 33426 12137
Table F.2: Estimated sample size for multiple membership models
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F.2 NNU eﬀects ordered by proportion transferred
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Figure F.1: Caterpillar plots for SCBU eﬀects, ordered by proportion transferred
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Figure F.2: Caterpillar plots for LNU eﬀects, ordered by proportion transferred
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Figure F.3: Caterpillar plots for NICU eﬀects, ordered by proportion transferred
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Figure F.4: Caterpillar plots for SCBU eﬀects, ordered by proportion transferred in
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Figure F.5: Caterpillar plots for LNU eﬀects, ordered by proportion transferred in
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Figure F.6: Caterpillar plots for NICU eﬀects, ordered by proportion transferred in
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Figure F.7: Caterpillar plots for SCBU eﬀects, ordered by proportion transferred out
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Figure F.8: Caterpillar plots for LNU eﬀects, ordered by proportion transferred out
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Figure F.9: Caterpillar plots for NICU eﬀects, ordered by proportion transferred out
319
●●●
● ●
●●
●●
●
●●
●●
●●
●●
●●
● ●
●●
●●
●●
●●
●●
●●
●●
● ●
●●
●
●
●●
● ●
●●
●●
●●
●●
●●
●
●●
●●
●●
●●
● ●
●
● ●
●●
●●
●●
●●
●●
●●
●●
1
2
4
8
18
19
20
23
24
33
34
36
42
44
47
49
52
64
67
89
94
97
99
100
104
114
121
123
125
130
133
134
135
140
141
147
154
159
160
161
166
66
79
148
110
−2 −1 0 1
Log OR
N
N
U
MM weighting
●
●
●
●
●
●
Equal
LOS
Beta2
Beta3
WLOS
First
Figure F.10: Caterpillar plots for SCBU eﬀects, ordered by proportion transferred in
within 24 hours of birth
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Figure F.11: Caterpillar plots for LNU eﬀects, ordered by proportion transferred in
within 24 hours of birth
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Figure F.12: Caterpillar plots for NICU eﬀects, ordered by proportion transferred in
within 24 hours of birth
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Figure F.13: Caterpillar plots for SCBU eﬀects, ordered by proportion transferred out
within 24 hours of birth
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Figure F.14: Caterpillar plots for NICU eﬀects, ordered by proportion transferred out
within 24 hours of birth
324
Appendix G
List of outputs relating to the
thesis
Articles related to this work:
S. Santhakumaran, Y. Statnikov, D. Gray, C. Battersby, D. Ashby, and N. Modi on
behalf of the Medicines for Neonates Investigator Group. Survival of very preterm
infants admitted to neonatal care in England 2008 to 2014: time trends and re-
gional variation Submitted
S. Santhakumaran. How to adjust for case-mix when comparing outcomes across health-
care providers. Arch. Dis. Child. Educ. Pract. Ed., 99:70-71, 2014
C. Gale, S. Santhakumaran, S. Nagarajan, Y. Statnikov, and N. Modi. Impact of man-
aged clinical networks on NHS specialist neonatal services in England: population
based study BMJ 344:e2105, 2012
Other co-authored publications cited in this thesis:
S. I. Watson, W. Arulampalam, S. Petrou, N. Marlow, A. S. Morgan, E. S. Draper, S.
Santhakumaran, and N. Modi. The eﬀects of designation and volume of neonatal
care on mortality and morbidity outcomes of very preterm infants in England:
retrospective population-based cohort study. BMJ Open 4(7):e004856, 2014
C. Battersby, S. Santhakumaran, and M. Upton. The impact of a regional care bundle
on maternal breast milk use in preterm infants: outcomes of the East of England
quality improvement programme. Arch. Dis. Child. Fetal Neonatal Ed., 2014.
doi: 10.1136/archdischild-2013-305475.
T. Cole, Y. Statnikov, S. Santhakumaran, and H. Pan. Birth weight and longitudinal
growth in infants born below 32 weeks’ gestation: a UK population study. Arch.
325
Dis. Child. Fetal Neonatal Ed., 2013. doi: 10.1136/archdischild-2012-303536.
C. Gale, A. Hay, C. Philipp, R. Khan, S. Santhakumaran, and N. Ratnavel. In-
utero transfer is too diﬃcult: results from a prospective study. Early human
development, 88(3):147–50, 2012
Conference abstracts related to this work:
Joint Perinatal Mortality Education Event, Staﬀordshire Shropshire & Black Country
Newborn and Maternity Network, October 2015. Oral presentation: Neonatal
Data Analysis Unit 2013 & 2014 Neonatal Mortality Reports
Royal College of Paediatrics and Child Health Annual Conference, June 2013. Oral
presentation: Survival of preterm infants admitted to neonatal care in England:
a population-based study using NHS electronic clinical records. Awarded a travel
grant from Chelsea and Westminster Joint Research Committee
International Society of Clinical Biostatistics, August 2012. Oral presentation: Evalu-
ating mortality rates for neonatal units using multiple membership models
National Neonatal Audit Program Collaborators Meeting, January 2011. Poster and
oral presentation: Report on Neonatal Mortality in 2009. Awarded prize for best
presentation and a travel grant from Chelsea and Westminster Joint Research
Committee
326
